1	J	NN	O	j	nn	3	SENT_1	[p1l52t83r67b108],
2	Thromb	NN	O	thromb	nn	3	SENT_1	[p1l80t82r203b108],
3	Thrombolysis	NN	O	thrombolysis	dep	8	SENT_1	[p1l217t82r424b116],
4	(	CD	NUMBER	(	num	5	SENT_1	[p1l439t81r533b116],
5	2006	CD	DATE	2006	dep	3	SENT_1	[p1l439t81r533b116],
6	)	CD	NUMBER	)	dep	8	SENT_1	[p1l439t81r533b116],
7	22:191	CD	NUMBER	22:191	num	8	SENT_1	[p1l547t82r713b108],
8	—	NN	O	—	dep	13	SENT_1	[p1l547t82r713b108],
9	197	CD	NUMBER	197	num	10	SENT_1	[p1l547t82r713b108],
10	DOI	NNP	O	DOI	dep	8	SENT_1	[p1l52t130r124b156],
11	10.1007	CD	NUMBER	10.1007	num	10	SENT_1	[p1l138t130r538b156],
12	/	:	O	/	punct	13	SENT_1	[p1l138t130r538b156],
13	S11239-006-9030-7	NN	O	s11239-006-9030-7	_	0	SENT_1	[p1l138t130r538b156],

1	Genotypes	NNS	O	genotype	dep	6	SENT_2	[p1l55t270r363b334],
2	of	IN	O	of	_	0	SENT_2	[p1l389t270r449b319],
3	the	DT	O	the	det	4	SENT_2	[p1l468t271r557b319],
4	cytochrome	NN	O	cytochrome	prep_of	1	SENT_2	[p1l583t271r918b334],
5	p450	NN	O	p450	dep	6	SENT_2	[p1l943t270r1077b333],
6	isoform	NN	O	isoform	dep	16	SENT_2	[p1l1101t270r1336b330],
7	,	,	O	,	_	0	SENT_2	[p1l1101t270r1336b330],
8	CYPZC9	NN	O	cypzc9	dep	16	SENT_2	[p1l1363t270r1633b330],
9	,	,	O	,	_	0	SENT_2	[p1l1363t270r1633b330],
10	and	CC	O	and	_	0	SENT_2	[p1l1658t271r1762b319],
11	the	DT	O	the	det	13	SENT_2	[p1l1785t271r1874b319],
12	vitamin	NN	O	vitamin	nn	13	SENT_2	[p1l53t344r269b393],
13	K	NN	O	k	conj_and	6	SENT_2	[p1l294t345r343b392],
14	epoxide	NN	O	epoxide	nn	16	SENT_2	[p1l368t344r592b408],
15	reductase	NN	O	reductase	nn	16	SENT_2	[p1l617t345r889b393],
16	complex	NN	O	complex	_	0	SENT_2	[p1l916t345r1157b408],
17	subunit	NN	O	subunit	nsubj	20	SENT_2	[p1l1181t344r1391b393],
18	1	CD	NUMBER	1	num	17	SENT_2	[p1l1417t344r1447b392],
19	conjointly	RB	O	conjointly	advmod	20	SENT_2	[p1l1472t344r1760b408],
20	determine	VB	O	determine	rcmod	16	SENT_2	[p1l54t419r344b468],
21	stable	JJ	O	stable	amod	23	SENT_2	[p1l370t420r536b468],
22	Warfarin	NNP	MISC	Warfarin	nn	23	SENT_2	[p1l561t419r802b468],
23	dose	NN	O	dose	dobj	20	SENT_2	[p1l826t420r971b468],
24	:	:	O	:	_	0	SENT_2	[p1l826t420r971b468],
25	a	DT	O	a	det	27	SENT_2	[p1l997t434r1028b468],
26	prospective	JJ	O	prospective	amod	27	SENT_2	[p1l1051t419r1380b482],
27	study	NN	O	study	dep	23	SENT_2	[p1l1406t420r1557b483],

1	John	NNP	PERSON	John	_	0	SENT_3	[p1l52t558r141b589],
2	F.	NNP	PERSON	F.	nn	3	SENT_3	[p1l156t559r190b588],
3	Carlquist	NNP	PERSON	Carlquist	dep	1	SENT_3	[p1l207t558r371b598],
4	-	:	O	-	_	0	SENT_3	[p1l386t570r393b577],
5	Benjamin	NNP	ORGANIZATION	Benjamin	nn	7	SENT_3	[p1l409t558r585b598],
6	D.	NNP	ORGANIZATION	D.	nn	7	SENT_3	[p1l600t559r643b589],
7	Home	NNP	ORGANIZATION	Home	dep	1	SENT_3	[p1l659t558r774b589],
8	-	:	O	-	_	0	SENT_3	[p1l791t570r798b577],
9	Joseph	NNP	PERSON	Joseph	nn	11	SENT_3	[p1l813t559r939b598],
10	B.	NNP	PERSON	B.	nn	11	SENT_3	[p1l954t559r992b589],
11	Muhlestein	NNP	PERSON	Muhlestein	dep	7	SENT_3	[p1l1008t558r1210b589],
12	Donald	NNP	PERSON	Donald	nn	14	SENT_3	[p1l1225t570r1232b577, p1l53t610r188b640],
13	L.	NNP	PERSON	L.	nn	14	SENT_3	[p1l203t610r239b640],
14	Lappé	NNP	PERSON	Lappé	dep	11	SENT_3	[p1l255t608r367b649],
15	-	:	O	-	_	0	SENT_3	[p1l384t621r391b628],
16	Bryant	NNP	PERSON	Bryant	nn	18	SENT_3	[p1l407t610r530b649],
17	M.	NNP	PERSON	M.	nn	18	SENT_3	[p1l545t610r593b640],
18	Whiting	NNP	PERSON	Whiting	dep	7	SENT_3	[p1l608t609r753b649],
19	-	:	O	-	_	0	SENT_3	[p1l768t621r776b628],
20	Matthew	NNP	PERSON	Matthew	nn	22	SENT_3	[p1l791t610r951b640],
21	J.	NNP	PERSON	J.	nn	22	SENT_3	[p1l965t610r995b640],
22	Kolek	NNP	PERSON	Kolek	dep	1	SENT_3	[p1l1012t610r1121b640],
23	Jessica	NNP	PERSON	Jessica	nn	25	SENT_3	[p1l1136t621r1144b628, p1l52t661r176b692],
24	L.	NNP	PERSON	L.	nn	25	SENT_3	[p1l192t661r228b692],
25	Clarke	NNP	PERSON	Clarke	dep	22	SENT_3	[p1l244t661r363b692],
26	-	:	O	-	_	0	SENT_3	[p1l380t673r387b680],
27	Brent	NNP	PERSON	Brent	nn	29	SENT_3	[p1l403t661r505b692],
28	C.	NNP	PERSON	C.	nn	29	SENT_3	[p1l521t661r558b692],
29	James	NNP	PERSON	James	dep	22	SENT_3	[p1l573t661r685b692],
30	-	:	O	-	_	0	SENT_3	[p1l701t673r708b680],
31	Jeffrey	NNP	PERSON	Jeffrey	nn	33	SENT_3	[p1l723t661r849b701],
32	L.	NNP	PERSON	L.	nn	33	SENT_3	[p1l865t662r900b692],
33	Anderson	NNP	PERSON	Anderson	dep	29	SENT_3	[p1l916t661r1095b692],

1	Published	VBN	O	publish	_	0	SENT_4	[p1l8t863r332b919],
2	online	NN	O	online	dobj	1	SENT_4	[p1l361t863r580b919],
3	:	:	O	:	_	0	SENT_4	[p1l361t863r580b919],
4	November	NNP	DATE	November	dep	2	SENT_4	[p1l611t863r961b919],
5	17	CD	DATE	17	num	4	SENT_4	[p1l992t864r1080b930],
6	,	,	DATE	,	_	0	SENT_4	[p1l992t864r1080b930],
7	2006	CD	DATE	2006	num	10	SENT_4	[p1l1109t863r1259b919],
8	©	CD	NUMBER	©	num	10	SENT_4	[p1l11t944r74b1006],
9	Springer	NNP	O	Springer	nn	10	SENT_4	[p1l106t950r386b1023],
10	Science	NNP	O	Science	appos	4	SENT_4	[p1l415t950r993b1006],
11	+	CC	O	+	_	0	SENT_4	[p1l415t950r993b1006],
12	Business	NNP	O	Business	conj_+	10	SENT_4	[p1l415t950r993b1006],
13	Media	NNP	O	Media	nn	15	SENT_4	[p1l1023t950r1249b1017],
14	,	,	O	,	_	0	SENT_4	[p1l1023t950r1249b1017],
15	LLC	NNP	O	LLC	dep	10	SENT_4	[p1l1280t950r1434b1006],
16	2006	CD	DATE	2006	num	15	SENT_4	[p1l1462t950r1611b1006],

1	Abstract	JJ	O	abstract	amod	3	SENT_5	[p1l9t1185r344b1250],
2	Background	NN	O	background	nn	3	SENT_5	[p1l8t1296r484b1381],
3	Warfarin	NNP	O	Warfarin	nsubj	4	SENT_5	[p1l576t1296r928b1362],
4	has	VBZ	O	have	_	0	SENT_5	[p1l952t1297r1077b1362],
5	a	DT	O	a	det	8	SENT_5	[p1l1105t1317r1145b1362],
6	narrow	JJ	O	narrow	amod	8	SENT_5	[p1l1169t1317r1446b1362],
7	therapeutic	JJ	O	therapeutic	amod	8	SENT_5	[p1l1469t1296r1911b1381],
8	range	NN	O	range	dobj	4	SENT_5	[p1l1935t1317r2150b1381],
9	and	CC	O	and	_	0	SENT_5	[p1l11t1407r149b1472],
10	wide	JJ	O	wide	amod	12	SENT_5	[p1l209t1407r390b1472],
11	inter	NN	O	inter	nn	12	SENT_5	[p1l452t1407r1052b1472],
12	—	NN	O	—	dobj	4	SENT_5	[p1l452t1407r1052b1472],
13	individual	JJ	O	individual	amod	15	SENT_5	[p1l452t1407r1052b1472],
14	dosing	NN	O	dosing	nn	15	SENT_5	[p1l1115t1407r1364b1492],
15	requirements	NNS	O	requirement	dep	8	SENT_5	[p1l1425t1407r1939b1492],
16	that	WDT	O	that	nsubjpass	19	SENT_5	[p1l2000t1407r2151b1472],
17	may	MD	O	may	aux	19	SENT_5	[p1l8t1539r170b1604],
18	be	VB	O	be	auxpass	19	SENT_5	[p1l197t1519r287b1584],
19	related	VBN	O	relate	rcmod	8	SENT_5	[p1l315t1519r587b1584],
20	to	TO	O	to	_	0	SENT_5	[p1l614t1528r689b1584],
21	functional	JJ	O	functional	amod	22	SENT_5	[p1l717t1519r1107b1584],
22	variants	NNS	O	variant	prep_to	19	SENT_5	[p1l1134t1519r1440b1584],
23	of	IN	O	of	_	0	SENT_5	[p1l1470t1519r1549b1584],
24	genes	NNS	O	gene	prep_of	22	SENT_5	[p1l1572t1539r1786b1604],
25	affecting	VBG	O	affect	xcomp	19	SENT_5	[p1l1816t1519r2151b1604],
26	Warfarin	NNP	MISC	Warfarin	nn	27	SENT_5	[p1l8t1630r335b1696],
27	metabolism	NN	O	metabolism	nsubj	29	SENT_5	[p1l372t1630r824b1696],
28	(	CD	NUMBER	(	num	27	SENT_5	[p1l866t1627r1029b1716],
29	i.e.	FW	O	i.e.	xcomp	25	SENT_5	[p1l866t1627r1029b1716],
30	,	,	O	,	_	0	SENT_5	[p1l866t1627r1029b1716],
31	CYP2C9	NN	O	cyp2c9	nn	32	SENT_5	[p1l1074t1627r1440b1716],
32	)	NN	O	)	xcomp	25	SENT_5	[p1l1074t1627r1440b1716],
33	and	CC	O	and	_	0	SENT_5	[p1l1484t1630r1624b1696],
34	activity	NN	O	activity	xcomp	25	SENT_5	[p1l1664t1630r1945b1716],
35	(	CD	NUMBER	(	num	34	SENT_5	[p1l1987t1627r2149b1716],
36	i.e.	FW	O	i.e.	dep	34	SENT_5	[p1l1987t1627r2149b1716],
37	,	,	O	,	_	0	SENT_5	[p1l1987t1627r2149b1716],
38	vitamin	NN	O	vitamin	nn	45	SENT_5	[p1l8t1741r301b1806],
39	K	NN	O	k	nn	45	SENT_5	[p1l371t1743r438b1806],
40	epoxide	NN	O	epoxide	nn	45	SENT_5	[p1l510t1741r813b1826],
41	reductase	NN	O	reductase	nn	45	SENT_5	[p1l885t1741r1254b1806],
42	complex	NN	O	complex	nn	45	SENT_5	[p1l1327t1741r1654b1826],
43	subunit	NN	O	subunit	nn	45	SENT_5	[p1l1725t1741r2009b1806],
44	1VKORC1	NN	O	1vkorc1	nn	45	SENT_5	[p1l2083t1742r2149b1806, p1l8t1849r454b1938],
45	)	NN	O	)	appos	36	SENT_5	[p1l2083t1742r2149b1806, p1l8t1849r454b1938],
46	.	.	O	.	_	0	SENT_5	[p1l2083t1742r2149b1806, p1l8t1849r454b1938],

1	We	PRP	O	we	nsubj	2	SENT_6	[p1l511t1854r641b1918],
2	hypothesized	VBD	O	hypothesize	_	0	SENT_6	[p1l697t1852r1207b1938],
3	that	IN	O	that	complm	9	SENT_6	[p1l1261t1852r1411b1918],
4	variants	NNS	O	variant	nsubj	9	SENT_6	[p1l1465t1852r1770b1918],
5	in	IN	O	in	_	0	SENT_6	[p1l1825t1852r1897b1917],
6	these	DT	O	these	det	8	SENT_6	[p1l1951t1852r2150b1918],
7	two	CD	NUMBER	two	num	8	SENT_6	[p1l9t1974r148b2030],
8	genes	NNS	O	gene	prep_in	4	SENT_6	[p1l183t1986r397b2051],
9	explain	VBP	O	explain	ccomp	2	SENT_6	[p1l433t1965r712b2051],
10	a	DT	O	a	det	12	SENT_6	[p1l748t1986r787b2030],
11	substantial	JJ	O	substantial	amod	12	SENT_6	[p1l821t1965r1235b2030],
12	proportion	NN	O	proportion	dobj	9	SENT_6	[p1l1267t1965r1688b2051],
13	of	IN	O	of	_	0	SENT_6	[p1l1722t1965r1801b2030],
14	variability	NN	O	variability	prep_of	12	SENT_6	[p1l1829t1965r2149b2030, p1l8t2076r106b2163],
15	in	IN	O	in	_	0	SENT_6	[p1l135t2077r207b2141],
16	stable	JJ	O	stable	amod	18	SENT_6	[p1l237t2077r460b2142],
17	Warfarin	NNP	MISC	Warfarin	nn	18	SENT_6	[p1l490t2077r817b2142],
18	dose	NN	O	dose	prep_in	14	SENT_6	[p1l848t2077r1021b2142],
19	and	CC	O	and	_	0	SENT_6	[p1l1054t2077r1193b2142],
20	could	MD	O	could	aux	22	SENT_6	[p1l1223t2077r1433b2142],
21	be	VB	O	be	auxpass	22	SENT_6	[p1l1463t2077r1553b2142],
22	used	VBN	O	use	ccomp	2	SENT_6	[p1l1584t2077r1759b2142],
23	as	IN	O	as	_	0	SENT_6	[p1l1791t2098r1864b2142],
24	a	DT	O	a	det	25	SENT_6	[p1l1897t2098r1937b2142],
25	basis	NN	O	basis	prep_as	22	SENT_6	[p1l1966t2077r2150b2142],
26	for	IN	O	for	_	0	SENT_6	[p1l8t2189r120b2254],
27	improved	VBN	O	improve	amod	29	SENT_6	[p1l153t2188r523b2275],
28	dosing	NN	O	dosing	nn	29	SENT_6	[p1l558t2189r807b2275],
29	algorithms	NNS	O	algorithm	prep_for	25	SENT_6	[p1l843t2189r1269b2275],
30	.	.	O	.	_	0	SENT_6	[p1l843t2189r1269b2275],

1	Methods	NNS	O	method	nsubjpass	21	SENT_7	[p1l8t2300r339b2365],
2	Consecutive	JJ	O	consecutive	amod	1	SENT_7	[p1l436t2300r907b2366],
3	consenting	VBG	O	consent	partmod	1	SENT_7	[p1l1106t2300r1520b2385],
4	outpatients	NNS	O	outpatient	dobj	3	SENT_7	[p1l1718t2300r2150b2385],
5	(	CD	NUMBER	(	num	6	SENT_7	[p1l12t2409r88b2498],
6	n	NN	O	n	npadvmod	7	SENT_7	[p1l12t2409r88b2498],
7	=	JJ	O	=	amod	4	SENT_7	[p1l125t2442r172b2465],
8	213	CD	NUMBER	213	number	9	SENT_7	[p1l207t2409r370b2498],
9	)	CD	NUMBER	)	dep	15	SENT_7	[p1l207t2409r370b2498],
10	With	IN	O	with	_	0	SENT_7	[p1l420t2412r588b2478],
11	stable	JJ	O	stable	amod	12	SENT_7	[p1l637t2412r861b2478],
12	INR	NN	O	inr	prep_with	9	SENT_7	[p1l911t2414r1082b2477],
13	(	CD	NUMBER	(	dep	15	SENT_7	[p1l1134t2409r1327b2498],
14	2-3	CD	NUMBER	2-3	num	15	SENT_7	[p1l1134t2409r1327b2498],
15	)	NN	O	)	dep	4	SENT_7	[p1l1134t2409r1327b2498],
16	for	IN	O	for	_	0	SENT_7	[p1l1378t2413r1490b2478],
17	>	JJR	O	>	prep_for	15	SENT_7	[p1l1540t2412r1628b2477],
18	1	CD	DURATION	1	num	19	SENT_7	[p1l1540t2412r1628b2477],
19	month	NN	NUMBER	month	tmod	17	SENT_7	[p1l1666t2412r1917b2478],
20	were	VBD	O	be	auxpass	21	SENT_7	[p1l1964t2433r2150b2478],
21	enrolled	VBN	O	enrol	_	0	SENT_7	[p1l10t2524r348b2589],
22	.	.	O	.	_	0	SENT_7	[p1l10t2524r348b2589],

1	Buccal	JJ	MISC	buccal	amod	2	SENT_8	[p1l394t2524r656b2589],
2	DNA	NN	MISC	dna	nsubjpass	4	SENT_8	[p1l698t2525r915b2588],
3	was	VBD	O	be	auxpass	4	SENT_8	[p1l956t2544r1096b2589],
4	extracted	VBN	O	extract	_	0	SENT_8	[p1l1141t2524r1501b2589],
5	using	VBG	O	use	xcomp	4	SENT_8	[p1l1543t2524r1743b2609],
6	a	DT	O	a	det	10	SENT_8	[p1l1788t2544r1828b2589],
7	Qiagen	NNP	ORGANIZATION	Qiagen	nn	10	SENT_8	[p1l1873t2524r2152b2609],
8	mini	NN	O	minus	nn	10	SENT_8	[p1l8t2634r500b2699],
9	—	NN	O	—	nn	10	SENT_8	[p1l8t2634r500b2699],
10	column	NN	O	column	dobj	5	SENT_8	[p1l8t2634r500b2699],
11	and	CC	O	and	_	0	SENT_8	[p1l528t2634r667b2699],
12	CYP2C9	NN	O	cyp2c9	nn	13	SENT_8	[p1l698t2635r1119b2700],
13	*	NN	O	*	conj_and	10	SENT_8	[p1l698t2635r1119b2700],
14	2	CD	NUMBER	2	dep	10	SENT_8	[p1l698t2635r1119b2700],
15	and	CC	O	and	_	0	SENT_8	[p1l1149t2634r1288b2699],
16	VKORCI	NNP	O	VKORCI	conj_and	10	SENT_8	[p1l1318t2635r1688b2700],
17	genotyping	VBG	O	genotype	amod	16	SENT_8	[p1l1721t2634r2151b2719],
18	performed	VBN	O	perform	partmod	16	SENT_8	[p1l8t2745r418b2831],
19	by	IN	O	by	_	0	SENT_8	[p1l450t2745r543b2831],
20	the	DT	O	the	det	25	SENT_8	[p1l574t2745r694b2811],
21	Taqman	NNP	O	Taqman	nn	25	SENT_8	[p1l727t2747r1048b2831],
22	3	CD	NUMBER	3	num	25	SENT_8	[p1l1081t2743r1145b2811],
23	’	NN	O	’	nn	25	SENT_8	[p1l1081t2743r1145b2811],
24	nuclease	NN	O	nuclease	nn	25	SENT_8	[p1l1176t2745r1506b2811],
25	assay	NN	O	assay	agent	18	SENT_8	[p1l1542t2766r1759b2831],
26	.	.	O	.	_	0	SENT_8	[p1l1542t2766r1759b2831],

1	SequencJ	NN	O	sequencj	_	0	SENT_9	[p1l1798t2746r2149b2831, p1l7t3027r55b3082],
2	.	.	O	.	_	0	SENT_9	[p1l1798t2746r2149b2831, p1l7t3027r55b3082],

1	F.	NNP	PERSON	F.	nn	2	SENT_10	[p1l86t3027r147b3081],
2	Carlquist	NNP	PERSON	Carlquist	nsubj	4	SENT_10	[p1l181t3025r480b3098],
3	(	CD	NUMBER	(	num	2	SENT_10	[p1l512t3022r648b3098],
4	E	NN	O	e	_	0	SENT_10	[p1l512t3022r648b3098],
5	)	SYM	O	)	dep	13	SENT_10	[p1l512t3022r648b3098],
6	-	:	O	-	_	0	SENT_10	[p1l684t3057r693b3065],
7	J.	NNP	PERSON	J.	nn	13	SENT_10	[p1l725t3027r773b3082],
8	B.	NNP	PERSON	B.	nn	13	SENT_10	[p1l804t3027r872b3081],
9	Muhlestein	NNP	PERSON	Muhlestein	nn	13	SENT_10	[p1l904t3025r1274b3081],
10	J.	NNP	PERSON	J.	nn	13	SENT_10	[p1l1307t3057r1316b3065, p1l7t3116r55b3170],
11	L.	NNP	PERSON	L.	nn	13	SENT_10	[p1l87t3116r151b3169],
12	Anderson	NNP	PERSON	Anderson	nn	13	SENT_10	[p1l182t3114r509b3169],
13	Department	NNP	ORGANIZATION	Department	dep	4	SENT_10	[p1l8t3204r412b3274],
14	of	IN	ORGANIZATION	of	_	0	SENT_10	[p1l434t3203r501b3257],
15	Medicine	NNP	ORGANIZATION	Medicine	nn	17	SENT_10	[p1l518t3202r843b3269],
16	,	,	O	,	_	0	SENT_10	[p1l518t3202r843b3269],
17	Division	NNP	O	Division	prep_of	13	SENT_10	[p1l865t3202r1143b3257],
18	of	IN	O	of	_	0	SENT_10	[p1l1164t3203r1232b3257],
19	Cardiology	NNP	O	Cardiology	nn	21	SENT_10	[p1l1251t3202r1631b3274],
20	,	,	O	,	_	0	SENT_10	[p1l1251t3202r1631b3274],
21	University	NNP	ORGANIZATION	University	prep_of	17	SENT_10	[p1l1654t3202r1999b3274],
22	of	IN	ORGANIZATION	of	_	0	SENT_10	[p1l9t3290r76b3345],
23	Utah	NNP	ORGANIZATION	Utah	nn	24	SENT_10	[p1l101t3290r268b3346],
24	School	NNP	ORGANIZATION	School	prep_of	17	SENT_10	[p1l297t3290r517b3346],
25	of	IN	ORGANIZATION	of	_	0	SENT_10	[p1l547t3290r614b3345],
26	Medicine	NNP	ORGANIZATION	Medicine	prep_of	24	SENT_10	[p1l639t3290r963b3357],
27	,	,	O	,	_	0	SENT_10	[p1l639t3290r963b3357],
28	Cardiovascular	NNP	ORGANIZATION	Cardiovascular	nn	29	SENT_10	[p1l996t3290r1490b3346],
29	Department	NNP	ORGANIZATION	Department	appos	26	SENT_10	[p1l1518t3292r1939b3362],
30	,	,	O	,	_	0	SENT_10	[p1l1518t3292r1939b3362],
31	LDS	NNP	ORGANIZATION	LDS	nn	32	SENT_10	[p1l9t3378r160b3434],
32	Hospital	NNP	ORGANIZATION	Hospital	appos	26	SENT_10	[p1l190t3378r489b3450],
33	,	,	O	,	_	0	SENT_10	[p1l190t3378r489b3450],
34	Salt	NNP	LOCATION	Salt	nn	36	SENT_10	[p1l520t3378r643b3434],
35	Lake	NNP	LOCATION	Lake	nn	36	SENT_10	[p1l672t3378r837b3433],
36	City	NNP	LOCATION	City	appos	26	SENT_10	[p1l869t3378r1021b3450],
37	,	,	O	,	_	0	SENT_10	[p1l869t3378r1021b3450],
38	Utah	NNP	LOCATION	Utah	appos	26	SENT_10	[p1l1051t3378r1235b3445],
39	,	,	O	,	_	0	SENT_10	[p1l1051t3378r1235b3445],
40	USA	NNP	LOCATION	USA	appos	26	SENT_10	[p1l1265t3378r1432b3434],
41	e-mail	VB	O	e-mail	dep	24	SENT_10	[p1l9t3466r229b3521],
42	:	:	O	:	_	0	SENT_10	[p1l9t3466r229b3521],
43	john.carlquist@ihc.com	NNP	O	john.carlquist@ihc.com	dep	17	SENT_10	[p1l257t3466r1027b3538],

1	B.	NNP	O	B.	nn	3	SENT_11	[p1l8t3646r76b3700],
2	D.	NNP	O	D.	nn	3	SENT_11	[p1l108t3646r184b3700],
3	Home	NNP	O	Home	_	0	SENT_11	[p1l216t3646r427b3700],

1	Department	NNP	ORGANIZATION	Department	_	0	SENT_12	[p2l8t25r412b96],
2	of	IN	ORGANIZATION	of	_	0	SENT_12	[p2l442t24r508b79],
3	Medical	NNP	ORGANIZATION	Medical	nn	4	SENT_12	[p2l533t24r798b79],
4	Informatics	NNP	ORGANIZATION	Informatics	prep_of	1	SENT_12	[p2l827t24r1222b91],
5	,	,	O	,	_	0	SENT_12	[p2l827t24r1222b91],
6	Division	NNP	O	Division	appos	4	SENT_12	[p2l1252t24r1529b79],
7	of	IN	O	of	_	0	SENT_12	[p2l1558t24r1625b79],
8	Genetic	NNP	ORGANIZATION	Genetic	nn	9	SENT_12	[p2l1652t24r1911b79],
9	Epidemiology	NNP	ORGANIZATION	Epidemiology	prep_of	6	SENT_12	[p2l8t111r489b183],
10	,	,	O	,	_	0	SENT_12	[p2l8t111r489b183],
11	University	NNP	ORGANIZATION	University	dep	1	SENT_12	[p2l519t111r864b183],
12	of	IN	ORGANIZATION	of	_	0	SENT_12	[p2l893t111r960b166],
13	Utah	NNP	ORGANIZATION	Utah	nn	14	SENT_12	[p2l985t111r1152b167],
14	School	NNP	ORGANIZATION	School	prep_of	11	SENT_12	[p2l1181t111r1400b167],
15	of	IN	ORGANIZATION	of	_	0	SENT_12	[p2l1431t111r1498b166],
16	Medicine	NNP	ORGANIZATION	Medicine	prep_of	14	SENT_12	[p2l1522t111r1847b178],
17	,	,	O	,	_	0	SENT_12	[p2l1522t111r1847b178],
18	Cardiovascular	NNP	ORGANIZATION	Cardiovascular	nn	19	SENT_12	[p2l10t199r505b255],
19	Department	NNP	ORGANIZATION	Department	appos	16	SENT_12	[p2l533t201r954b271],
20	,	,	O	,	_	0	SENT_12	[p2l533t201r954b271],
21	LDS	NNP	ORGANIZATION	LDS	nn	22	SENT_12	[p2l984t199r1136b255],
22	Hospital	NNP	ORGANIZATION	Hospital	appos	16	SENT_12	[p2l1166t199r1464b271],
23	,	,	O	,	_	0	SENT_12	[p2l1166t199r1464b271],
24	Salt	NNP	LOCATION	Salt	nn	26	SENT_12	[p2l1496t199r1619b255],
25	Lake	NNP	LOCATION	Lake	nn	26	SENT_12	[p2l1648t199r1812b254],
26	City	NNP	LOCATION	City	appos	16	SENT_12	[p2l1845t199r1997b271],
27	,	,	O	,	_	0	SENT_12	[p2l1845t199r1997b271],
28	Utah	NNP	LOCATION	Utah	appos	16	SENT_12	[p2l8t288r192b355],
29	,	,	O	,	_	0	SENT_12	[p2l8t288r192b355],
30	USA	NNP	LOCATION	USA	appos	16	SENT_12	[p2l222t289r389b344],

1	D.	NNP	PERSON	D.	_	0	SENT_13	[p2l8t468r85b522],
2	L.	NNP	PERSON	L.	nn	3	SENT_13	[p2l117t468r180b522],
3	Lappé	NNP	PERSON	Lappé	dep	1	SENT_13	[p2l212t465r419b540],
4	-	:	O	-	_	0	SENT_13	[p2l454t498r462b506],
5	B.	NNP	PERSON	B.	nn	7	SENT_13	[p2l495t468r563b522],
6	M.	NNP	PERSON	M.	nn	7	SENT_13	[p2l594t468r680b522],
7	Whiting	NNP	PERSON	Whiting	dep	1	SENT_13	[p2l711t466r976b540],
8	-	:	O	-	_	0	SENT_13	[p2l1009t498r1017b506],
9	M.	NNP	PERSON	M.	nn	16	SENT_13	[p2l1050t468r1135b522],
10	J.	NNP	PERSON	J.	nn	16	SENT_13	[p2l1166t468r1214b523],
11	Kolek	NNP	PERSON	Kolek	nn	16	SENT_13	[p2l1246t467r1446b523],
12	J.	NNP	PERSON	J.	nn	16	SENT_13	[p2l1480t498r1488b506, p2l7t557r55b611],
13	L.	NNP	PERSON	L.	nn	16	SENT_13	[p2l87t557r151b611],
14	Clarke	NNP	PERSON	Clarke	nn	16	SENT_13	[p2l185t556r402b611],
15	Cardiovascular	NNP	ORGANIZATION	Cardiovascular	nn	16	SENT_13	[p2l10t644r505b699],
16	Department	NNP	ORGANIZATION	Department	dep	7	SENT_13	[p2l533t645r954b716],
17	,	,	O	,	_	0	SENT_13	[p2l533t645r954b716],
18	LDS	NNP	ORGANIZATION	LDS	nn	19	SENT_13	[p2l984t644r1136b699],
19	Hospital	NNP	ORGANIZATION	Hospital	appos	16	SENT_13	[p2l1166t644r1464b716],
20	,	,	O	,	_	0	SENT_13	[p2l1166t644r1464b716],
21	Salt	NNP	LOCATION	Salt	nn	23	SENT_13	[p2l1496t644r1619b699],
22	Lake	NNP	LOCATION	Lake	nn	23	SENT_13	[p2l1648t644r1812b699],
23	City	NNP	LOCATION	City	appos	16	SENT_13	[p2l1845t644r1997b716],
24	,	,	O	,	_	0	SENT_13	[p2l1845t644r1997b716],
25	Utah	NNP	LOCATION	Utah	appos	16	SENT_13	[p2l8t733r192b800],
26	,	,	O	,	_	0	SENT_13	[p2l8t733r192b800],
27	USA	NNP	LOCATION	USA	appos	16	SENT_13	[p2l222t733r390b788],

1	B.	NNP	PERSON	B.	nn	4	SENT_14	[p2l8t913r76b966],
2	C.	NNP	PERSON	C.	nn	4	SENT_14	[p2l110t912r176b967],
3	James	NNP	PERSON	James	nn	4	SENT_14	[p2l206t913r407b967],
4	Department	NNP	PERSON	Department	nsubjpass	55	SENT_14	[p2l8t1002r412b1074],
5	of	IN	O	of	_	0	SENT_14	[p2l438t1001r505b1057],
6	Family	NNP	O	Family	nsubj	41	SENT_14	[p2l526t1000r754b1074],
7	and	CC	O	and	_	0	SENT_14	[p2l781t1000r899b1057],
8	Preventive	NNP	O	Preventive	nn	9	SENT_14	[p2l923t1000r1276b1057],
9	Medicine	NNP	O	Medicine	conj_and	6	SENT_14	[p2l1303t1000r1626b1068],
10	,	,	O	,	_	0	SENT_14	[p2l1303t1000r1626b1068],
11	University	NNP	ORGANIZATION	University	conj_and	6	SENT_14	[p2l1654t1000r1999b1074],
12	of	IN	ORGANIZATION	of	_	0	SENT_14	[p2l9t1090r76b1145],
13	Utah	NNP	ORGANIZATION	Utah	nn	14	SENT_14	[p2l101t1090r268b1145],
14	School	NNP	ORGANIZATION	School	prep_of	11	SENT_14	[p2l297t1089r517b1145],
15	of	IN	ORGANIZATION	of	_	0	SENT_14	[p2l547t1090r614b1145],
16	Medicine	NNP	ORGANIZATION	Medicine	prep_of	14	SENT_14	[p2l639t1089r963b1156],
17	,	,	O	,	_	0	SENT_14	[p2l639t1089r963b1156],
18	Institute	NNP	ORGANIZATION	Institute	conj_and	6	SENT_14	[p2l994t1089r1268b1145],
19	for	IN	ORGANIZATION	for	_	0	SENT_14	[p2l1298t1090r1393b1145],
20	Heathcare	NNP	ORGANIZATION	Heathcare	nn	22	SENT_14	[p2l1421t1090r1764b1145],
21	Delivery	NN	ORGANIZATION	delivery	nn	22	SENT_14	[p2l8t1177r295b1249],
22	Research	NN	ORGANIZATION	research	prep_for	18	SENT_14	[p2l323t1177r646b1244],
23	,	,	O	,	_	0	SENT_14	[p2l323t1177r646b1244],
24	Intermountain	NNP	ORGANIZATION	Intermountain	nn	25	SENT_14	[p2l677t1177r1156b1233],
25	Healthcare	NNP	ORGANIZATION	Healthcare	conj_and	6	SENT_14	[p2l1184t1177r1567b1244],
26	,	,	O	,	_	0	SENT_14	[p2l1184t1177r1567b1244],
27	Salt	NNP	LOCATION	Salt	nn	29	SENT_14	[p2l1599t1177r1721b1233],
28	Lake	NNP	LOCATION	Lake	nn	29	SENT_14	[p2l1750t1177r1915b1233],
29	City	NNP	LOCATION	City	conj_and	6	SENT_14	[p2l10t1265r163b1337],
30	,	,	O	,	_	0	SENT_14	[p2l10t1265r163b1337],
31	Utah	NNP	LOCATION	Utah	conj_and	6	SENT_14	[p2l193t1265r377b1332],
32	,	,	O	,	_	0	SENT_14	[p2l193t1265r377b1332],
33	USA	NNP	LOCATION	USA	nn	34	SENT_14	[p2l407t1266r574b1321],
34	ing	NN	O	ing	conj_and	6	SENT_14	[p2l8t1367r125b1452],
35	for	IN	O	for	_	0	SENT_14	[p2l151t1368r262b1433],
36	C	NN	O	c	nn	37	SENT_14	[p2l293t1368r352b1433],
37	YP2C9	NN	O	yp2c9	prep_for	34	SENT_14	[p2l358t1368r714b1433],
38	*	CD	NUMBER	*	number	39	SENT_14	[p2l358t1368r714b1433],
39	3	CD	NUMBER	3	num	37	SENT_14	[p2l358t1368r714b1433],
40	,	,	O	,	_	0	SENT_14	[p2l722t1422r735b1446],
41	genotyping	VBG	O	genotype	prepc_of	4	SENT_14	[p2l764t1367r1193b1452],
42	was	VBD	O	be	auxpass	43	SENT_14	[p2l1219t1388r1359b1433],
43	done	VBN	O	do	ccomp	41	SENT_14	[p2l1387t1367r1575b1433],
44	using	VBG	O	use	xcomp	43	SENT_14	[p2l1602t1367r1803b1452],
45	Big	JJ	O	big	amod	51	SENT_14	[p2l1830t1367r1961b1452],
46	Dye	NN	O	dye	nn	51	SENT_14	[p2l1987t1369r2147b1452],
47	V3	NN	O	v3	nn	51	SENT_14	[p2l8t1479r157b1544],
48	.1	CD	NUMBER	.1	num	51	SENT_14	[p2l8t1479r157b1544],
49	terminator	NN	O	terminator	nn	51	SENT_14	[p2l230t1478r646b1544],
50	chemistry	NN	O	chemistry	nn	51	SENT_14	[p2l714t1478r1089b1563],
51	Dose	NN	O	dose	dobj	44	SENT_14	[p2l1156t1480r1355b1544],
52	by	IN	O	by	_	0	SENT_14	[p2l1425t1478r1517b1563],
53	genotype	NN	O	genotype	prep_by	44	SENT_14	[p2l1585t1487r1938b1563],
54	was	VBD	O	be	auxpass	55	SENT_14	[p2l2006t1499r2147b1544],
55	assessed	VBN	O	assess	_	0	SENT_14	[p2l11t1590r328b1655],
56	by	IN	O	by	_	0	SENT_14	[p2l361t1590r453b1675],
57	linear	JJ	O	linear	amod	58	SENT_14	[p2l485t1590r707b1655],
58	regression	NN	O	regression	agent	55	SENT_14	[p2l740t1590r1153b1675],
59	.	.	O	.	_	0	SENT_14	[p2l740t1590r1153b1675],

1	Results	NNS	O	result	nsubj	5	SENT_15	[p2l8t1701r279b1766],
2	Weekly	NNP	SET	Weekly	nn	4	SENT_15	[p2l372t1701r669b1786],
3	warfarin	NN	O	warfarin	nn	4	SENT_15	[p2l719t1701r1045b1766],
4	dose	NN	O	dose	dep	1	SENT_15	[p2l1097t1701r1270b1766],
5	averaged	VBD	O	average	_	0	SENT_15	[p2l1324t1701r1672b1786],
6	30.8	CD	NUMBER	30.8	dobj	5	SENT_15	[p2l1723t1702r1876b1766],
7	i	FW	O	i	tmod	5	SENT_15	[p2l1912t1719r1959b1765],
8	13.9	CD	NUMBER	13.9	num	9	SENT_15	[p2l1998t1701r2147b1766],
9	mg/week	NN	O	mg/week	dep	7	SENT_15	[p2l8t1812r374b1897],
10	;	:	O	;	_	0	SENT_15	[p2l8t1812r374b1897],
11	average	JJ	O	average	amod	12	SENT_15	[p2l413t1832r710b1897],
12	INR	NN	O	inr	nsubj	14	SENT_15	[p2l747t1814r918b1876],
13	was	VBD	O	be	cop	14	SENT_15	[p2l951t1832r1092b1877],
14	2.42	CD	NUMBER	2.42	parataxis	5	SENT_15	[p2l1127t1813r1280b1877],
15	:	:	O	:	_	0	SENT_15	[p2l1316t1830r1363b1876],
16	0.72	CD	NUMBER	0.72	dep	14	SENT_15	[p2l1399t1813r1570b1877],
17	.	.	O	.	_	0	SENT_15	[p2l1399t1813r1570b1877],

1	CYP2C9	NN	O	cyp2c9	nn	2	SENT_16	[p2l1614t1812r2147b1877],
2	*	NN	O	*	_	0	SENT_16	[p2l1614t1812r2147b1877],
3	2	CD	NUMBER	2	dep	2	SENT_16	[p2l1614t1812r2147b1877],
4	/	:	O	/	punct	2	SENT_16	[p2l1614t1812r2147b1877],
5	*	CD	NUMBER	*	number	6	SENT_16	[p2l1614t1812r2147b1877],
6	3	CD	NUMBER	3	num	8	SENT_16	[p2l1614t1812r2147b1877],
7	genotype	NN	O	genotype	nn	8	SENT_16	[p2l9t1930r361b2006],
8	distribution	NN	O	distribution	nsubj	9	SENT_16	[p2l484t1921r932b1986],
9	was	VBD	O	be	dep	2	SENT_16	[p2l1050t1942r1210b1986],
10	:	:	O	:	_	0	SENT_16	[p2l1050t1942r1210b1986],
11	CC/AA	NN	O	cc/aa	nsubj	43	SENT_16	[p2l1336t1922r1634b1987],
12	(	CD	NUMBER	(	num	19	SENT_16	[p2l1757t1919r2147b2006],
13	Wild	NNP	O	Wild	nn	19	SENT_16	[p2l1757t1919r2147b2006],
14	—	CD	NUMBER	—	num	19	SENT_16	[p2l1757t1919r2147b2006],
15	type	NN	O	type	nn	19	SENT_16	[p2l1757t1919r2147b2006],
16	[	CD	NUMBER	[	num	19	SENT_16	[p2l14t2030r245b2119],
17	WT	NNP	O	WT	nn	19	SENT_16	[p2l14t2030r245b2119],
18	]	CD	NUMBER	]	num	19	SENT_16	[p2l14t2030r245b2119],
19	)	NN	O	)	nsubj	20	SENT_16	[p2l14t2030r245b2119],
20	=	JJ	O	=	rcmod	11	SENT_16	[p2l285t2064r331b2087],
21	71.4	CD	PERCENT	71.4	num	22	SENT_16	[p2l366t2034r631b2113],
22	%	NN	PERCENT	%	dobj	20	SENT_16	[p2l366t2034r631b2113],
23	,	,	O	,	_	0	SENT_16	[p2l366t2034r631b2113],
24	CT/AA	NN	O	ct/aa	dobj	20	SENT_16	[p2l739t2034r1032b2100],
25	=	JJ	O	=	amod	24	SENT_16	[p2l1068t2064r1114b2087],
26	18.3	CD	PERCENT	18.3	num	27	SENT_16	[p2l1154t2034r1413b2113],
27	%	NN	PERCENT	%	tmod	25	SENT_16	[p2l1154t2034r1413b2113],
28	,	,	O	,	_	0	SENT_16	[p2l1154t2034r1413b2113],
29	CC/AC	NN	O	cc/ac	appos	27	SENT_16	[p2l1521t2034r1810b2100],
30	=	JJ	O	=	dep	32	SENT_16	[p2l1845t2064r1891b2087],
31	9.4	CD	PERCENT	9.4	number	32	SENT_16	[p2l1928t2034r2146b2113],
32	%	NN	PERCENT	%	amod	24	SENT_16	[p2l1928t2034r2146b2113],
33	,	,	O	,	_	0	SENT_16	[p2l1928t2034r2146b2113],
34	and	CC	O	and	_	0	SENT_16	[p2l11t2146r149b2211],
35	CT/AC	NN	O	ct/ac	conj_and	22	SENT_16	[p2l224t2146r508b2211],
36	=	JJ	O	=	dep	38	SENT_16	[p2l543t2176r588b2198],
37	1	CD	PERCENT	1	number	38	SENT_16	[p2l628t2146r776b2224],
38	%	NN	PERCENT	%	amod	35	SENT_16	[p2l628t2146r776b2224],
39	;	:	O	;	_	0	SENT_16	[p2l628t2146r776b2224],
40	VKORCZ	NNP	O	VKORCZ	nn	41	SENT_16	[p2l855t2146r1224b2211],
41	genotypes	NNS	O	genotype	nsubj	43	SENT_16	[p2l1304t2154r1691b2231],
42	were	VBD	O	be	cop	43	SENT_16	[p2l1764t2166r1948b2211],
43	CC	NN	O	cc	ccomp	9	SENT_16	[p2l2025t2146r2149b2211],
44	(	CD	NUMBER	(	num	46	SENT_16	[p2l12t2254r220b2343],
45	WT	NNP	O	WT	nn	46	SENT_16	[p2l12t2254r220b2343],
46	)	NN	O	)	npadvmod	52	SENT_16	[p2l12t2254r220b2343],
47	=	JJ	O	=	amod	46	SENT_16	[p2l260t2287r306b2310],
48	36.6	CD	PERCENT	36.6	num	49	SENT_16	[p2l342t2257r605b2336],
49	%	NN	PERCENT	%	tmod	47	SENT_16	[p2l342t2257r605b2336],
50	,	,	O	,	_	0	SENT_16	[p2l342t2257r605b2336],
51	CT	NN	O	ct	appos	49	SENT_16	[p2l660t2257r779b2323],
52	=	JJ	O	=	amod	43	SENT_16	[p2l815t2287r860b2310],
53	50.7	CD	PERCENT	50.7	num	54	SENT_16	[p2l897t2256r1160b2336],
54	%	NN	PERCENT	%	dep	52	SENT_16	[p2l897t2256r1160b2336],
55	,	,	O	,	_	0	SENT_16	[p2l897t2256r1160b2336],
56	and	CC	O	and	_	0	SENT_16	[p2l1214t2257r1353b2322],
57	TT	NN	O	tt	npadvmod	58	SENT_16	[p2l1402t2259r1519b2322],
58	=	JJ	O	=	conj_and	52	SENT_16	[p2l1554t2287r1600b2310],
59	12.7	CD	PERCENT	12.7	num	60	SENT_16	[p2l1640t2257r1899b2323],
60	%	NN	PERCENT	%	dep	52	SENT_16	[p2l1640t2257r1899b2323],
61	.	.	O	.	_	0	SENT_16	[p2l1640t2257r1899b2323],

1	Warfarin	NN	O	warfarin	dep	103	SENT_17	[p2l1951t2259r2146b2322, p2l8t2368r190b2434],
2	doses	NNS	O	dose	dep	103	SENT_17	[p2l276t2369r484b2434],
3	(	VBP	O	(	dep	103	SENT_17	[p2l575t2366r982b2455],
4	mg/Week	JJ	O	mg/week	dep	103	SENT_17	[p2l575t2366r982b2455],
5	)	NN	O	)	dep	103	SENT_17	[p2l575t2366r982b2455],
6	varied	VBN	O	vary	dep	103	SENT_17	[p2l1071t2368r1312b2434],
7	by	IN	O	by	dep	103	SENT_17	[p2l1397t2368r1489b2454],
8	genotype	NN	O	genotype	dep	103	SENT_17	[p2l1575t2378r1947b2454],
9	:	:	O	:	_	0	SENT_17	[p2l1575t2378r1947b2454],
10	for	IN	O	for	dep	103	SENT_17	[p2l2037t2369r2149b2434],
11	CYP2C9	NN	O	cyp2c9	dep	103	SENT_17	[p2l13t2481r369b2560],
12	,	,	O	,	_	0	SENT_17	[p2l13t2481r369b2560],
13	33.3	CD	NUMBER	33.3	dep	103	SENT_17	[p2l419t2481r569b2546],
14	mg/Week	NN	O	mg/week	dep	103	SENT_17	[p2l619t2480r965b2566],
15	for	IN	O	for	dep	103	SENT_17	[p2l1013t2481r1125b2546],
16	WT	JJ	O	wt	dep	103	SENT_17	[p2l1170t2482r1318b2546],
17	(	NN	O	(	dep	103	SENT_17	[p2l1369t2477r1756b2566],
18	CC/AA	NN	O	cc/aa	dep	103	SENT_17	[p2l1369t2477r1756b2566],
19	)	NN	O	)	dep	103	SENT_17	[p2l1369t2477r1756b2566],
20	,	,	O	,	_	0	SENT_17	[p2l1369t2477r1756b2566],
21	27.2	CD	NUMBER	27.2	dep	103	SENT_17	[p2l1805t2481r1959b2546],
22	mg	NN	O	mg	dep	103	SENT_17	[p2l2006t2481r2149b2566],
23	/	:	O	/	dep	103	SENT_17	[p2l2006t2481r2149b2566],
24	Week	NN	DURATION	week	dep	103	SENT_17	[p2l8t2593r209b2659],
25	for	IN	O	for	dep	103	SENT_17	[p2l262t2594r373b2659],
26	CT/AA	NNP	O	CT/AA	dep	103	SENT_17	[p2l428t2593r721b2659],
27	(	CD	NUMBER	(	dep	103	SENT_17	[p2l778t2590r868b2679],
28	P	NN	O	p	dep	103	SENT_17	[p2l778t2590r868b2679],
29	=	JJ	O	=	dep	103	SENT_17	[p2l901t2623r947b2646],
30	0.04	CD	NUMBER	0.04	dep	103	SENT_17	[p2l983t2594r1136b2659],
31	vs.	CC	O	vs.	dep	103	SENT_17	[p2l1188t2614r1283b2659],
32	WT	NNP	O	WT	dep	103	SENT_17	[p2l1340t2590r1541b2679],
33	)	NNP	O	)	dep	103	SENT_17	[p2l1340t2590r1541b2679],
34	,	,	O	,	_	0	SENT_17	[p2l1340t2590r1541b2679],
35	23.0	CD	NUMBER	23.0	dep	103	SENT_17	[p2l1596t2594r1749b2659],
36	mg/Week	NN	O	mg/week	dep	103	SENT_17	[p2l1802t2593r2148b2679],
37	for	IN	O	for	dep	103	SENT_17	[p2l8t2705r120b2771],
38	CC/AC	NN	O	cc/ac	dep	103	SENT_17	[p2l162t2705r450b2771],
39	(	CD	NUMBER	(	dep	103	SENT_17	[p2l494t2702r584b2791],
40	P	NN	O	p	dep	103	SENT_17	[p2l494t2702r584b2791],
41	=	JJ	O	=	dep	103	SENT_17	[p2l617t2735r663b2758],
42	0.003	CD	NUMBER	0.003	dep	103	SENT_17	[p2l699t2702r952b2791],
43	)	NN	O	)	dep	103	SENT_17	[p2l699t2702r952b2791],
44	,	,	O	,	_	0	SENT_17	[p2l699t2702r952b2791],
45	and	CC	O	and	dep	103	SENT_17	[p2l997t2705r1136b2771],
46	6.0	CD	NUMBER	6.0	dep	103	SENT_17	[p2l1177t2705r1285b2771],
47	mg/Week	NN	O	mg/week	dep	103	SENT_17	[p2l1325t2705r1671b2791],
48	for	IN	O	for	dep	103	SENT_17	[p2l1711t2705r1823b2771],
49	CT/AC	NN	O	ct/ac	dep	103	SENT_17	[p2l1865t2705r2149b2771],
50	(	CD	NUMBER	(	dep	103	SENT_17	[p2l12t2813r102b2902],
51	P	NN	O	p	dep	103	SENT_17	[p2l12t2813r102b2902],
52	<	JJR	O	<	dep	103	SENT_17	[p2l135t2835r181b2882],
53	0.001	CD	NUMBER	0.001	dep	103	SENT_17	[p2l217t2813r470b2902],
54	)	NN	O	)	dep	103	SENT_17	[p2l217t2813r470b2902],
55	,	,	O	,	_	0	SENT_17	[p2l217t2813r470b2902],
56	representing	VBG	O	represent	dep	103	SENT_17	[p2l518t2816r1002b2902],
57	dose	NN	O	dose	dep	103	SENT_17	[p2l1048t2816r1220b2882],
58	reductions	NNS	O	reduction	dep	103	SENT_17	[p2l1266t2816r1670b2882],
59	of	IN	O	of	dep	103	SENT_17	[p2l1718t2817r1797b2882],
60	18-31	CD	PERCENT	18-31	dep	103	SENT_17	[p2l1841t2817r2140b2882],
61	%	NN	PERCENT	%	dep	103	SENT_17	[p2l1841t2817r2140b2882],
62	for	IN	O	for	dep	103	SENT_17	[p2l8t2929r120b2993],
63	single	JJ	O	single	dep	103	SENT_17	[p2l173t2928r391b3013],
64	and	CC	O	and	dep	103	SENT_17	[p2l448t2928r586b2993],
65	82	CD	PERCENT	82	dep	103	SENT_17	[p2l640t2929r807b2993],
66	%	NN	PERCENT	%	dep	103	SENT_17	[p2l640t2929r807b2993],
67	for	IN	O	for	dep	103	SENT_17	[p2l868t2929r979b2993],
68	double	JJ	O	double	dep	103	SENT_17	[p2l1033t2928r1294b2993],
69	variant	JJ	O	variant	dep	103	SENT_17	[p2l1347t2928r1620b2993],
70	carriers	NNS	O	carrier	dep	103	SENT_17	[p2l1673t2928r1983b3007],
71	;	:	O	;	_	0	SENT_17	[p2l1673t2928r1983b3007],
72	for	IN	O	for	dep	103	SENT_17	[p2l2037t2929r2149b2993],
73	VKORCI	NNP	O	VKORCI	dep	103	SENT_17	[p2l13t3040r408b3106],
74	:	:	O	:	_	0	SENT_17	[p2l13t3040r408b3106],
75	38.4	CD	NUMBER	38.4	dep	103	SENT_17	[p2l449t3040r602b3105],
76	mg/Week	NN	O	mg/week	dep	103	SENT_17	[p2l640t3039r986b3125],
77	for	IN	O	for	dep	103	SENT_17	[p2l1023t3040r1135b3105],
78	WT	NNP	O	WT	dep	103	SENT_17	[p2l1171t3041r1319b3105],
79	(	CD	NUMBER	(	dep	103	SENT_17	[p2l1360t3036r1571b3125],
80	CC	NN	O	cc	dep	103	SENT_17	[p2l1360t3036r1571b3125],
81	)	NN	O	)	dep	103	SENT_17	[p2l1360t3036r1571b3125],
82	,	,	O	,	_	0	SENT_17	[p2l1360t3036r1571b3125],
83	28.6	CD	NUMBER	28.6	dep	103	SENT_17	[p2l1611t3039r1764b3105],
84	mg/week	NN	O	mg/week	dep	103	SENT_17	[p2l1802t3039r2148b3125],
85	for	IN	O	for	dep	103	SENT_17	[p2l8t3152r120b3217],
86	CT	NN	O	ct	dep	103	SENT_17	[p2l175t3152r294b3218],
87	(	CD	NUMBER	(	dep	103	SENT_17	[p2l351t3149r440b3238],
88	P	NN	O	p	dep	103	SENT_17	[p2l351t3149r440b3238],
89	<	JJR	O	<	dep	103	SENT_17	[p2l473t3170r520b3217],
90	0.001	CD	NUMBER	0.001	dep	103	SENT_17	[p2l556t3152r749b3217],
91	vs.	CC	O	vs.	dep	103	SENT_17	[p2l807t3173r903b3217],
92	WT	NNP	O	WT	dep	103	SENT_17	[p2l959t3149r1161b3238],
93	)	NNP	O	)	dep	103	SENT_17	[p2l959t3149r1161b3238],
94	,	,	O	,	_	0	SENT_17	[p2l959t3149r1161b3238],
95	20.95	CD	NUMBER	20.95	dep	103	SENT_17	[p2l1216t3151r1412b3218],
96	mg/Week	NN	O	mg/week	dep	103	SENT_17	[p2l1468t3152r1814b3238],
97	for	IN	O	for	dep	103	SENT_17	[p2l1868t3152r1979b3217],
98	TT	NN	O	tt	dep	103	SENT_17	[p2l2031t3154r2149b3217],
99	(	CD	NUMBER	(	dep	103	SENT_17	[p2l12t3261r102b3350],
100	P	NN	O	p	dep	103	SENT_17	[p2l12t3261r102b3350],
101	<	JJR	O	<	dep	103	SENT_17	[p2l135t3282r181b3329],
102	0.001	CD	NUMBER	0.001	dep	103	SENT_17	[p2l217t3261r468b3350],
103	)	NN	O	)	_	0	SENT_17	[p2l217t3261r468b3350],
104	.	.	O	.	_	0	SENT_17	[p2l217t3261r468b3350],

1	In	IN	O	in	_	0	SENT_18	[p2l530t3266r610b3329],
2	multiple	JJ	O	multiple	amod	4	SENT_18	[p2l666t3264r986b3350],
3	linear	JJ	O	linear	amod	4	SENT_18	[p2l1043t3264r1265b3329],
4	regression	NN	O	regression	prep_in	10	SENT_18	[p2l1320t3264r1735b3350],
5	,	,	O	,	_	0	SENT_18	[p2l1320t3264r1735b3350],
6	genotype	NN	O	genotype	nsubj	10	SENT_18	[p2l1794t3273r2146b3350],
7	was	VBD	O	be	cop	10	SENT_18	[p2l8t3396r148b3441],
8	the	DT	O	the	det	10	SENT_18	[p2l245t3375r365b3441],
9	dominant	JJ	O	dominant	amod	10	SENT_18	[p2l464t3375r832b3441],
10	predictor	NN	O	predictor	_	0	SENT_18	[p2l928t3375r1284b3460],
11	of	IN	O	of	_	0	SENT_18	[p2l1381t3376r1460b3441],
12	warfarin	NN	O	warfarin	nn	15	SENT_18	[p2l1551t3375r1877b3441],
13	dose	NN	O	dose	nn	15	SENT_18	[p2l1975t3375r2147b3441],
14	(	NN	O	(	nn	15	SENT_18	[p2l12t3483r102b3572],
15	P	NN	O	p	prep_of	10	SENT_18	[p2l12t3483r102b3572],
16	=	JJ	O	=	amod	15	SENT_18	[p2l135t3517r181b3540],
17	2.4	CD	NUMBER	2.4	tmod	16	SENT_18	[p2l217t3487r326b3552],
18	x	CC	O	x	_	0	SENT_18	[p2l359t3504r406b3550],
19	10-15	CD	NUMBER	10-15	num	20	SENT_18	[p2l443t3468r681b3572],
20	)	NN	O	)	conj_x	10	SENT_18	[p2l443t3468r681b3572],
21	;	:	O	;	_	0	SENT_18	[p2l443t3468r681b3572],
22	Weak	JJ	O	weak	amod	23	SENT_18	[p2l734t3486r935b3552],
23	predictors	NNS	O	predictor	nsubj	25	SENT_18	[p2l986t3486r1375b3572],
24	were	VBD	O	be	cop	25	SENT_18	[p2l1427t3507r1612b3552],
25	age	NN	O	age	dep	20	SENT_18	[p2l1667t3507r1816b3572],
26	,	,	O	,	_	0	SENT_18	[p2l1667t3507r1816b3572],
27	weight	NN	O	weight	dep	20	SENT_18	[p2l1869t3486r2146b3572],
28	,	,	O	,	_	0	SENT_18	[p2l1869t3486r2146b3572],
29	and	CC	O	and	_	0	SENT_18	[p2l11t3598r149b3663],
30	sex	NN	O	sex	dep	20	SENT_18	[p2l188t3619r326b3663],
31	.	.	O	.	_	0	SENT_18	[p2l188t3619r326b3663],

1	Genotype-based	JJ	MISC	genotype-based	amod	2	SENT_19	[p2l372t3598r1007b3683],
2	modeling	NN	O	modeling	nsubj	3	SENT_19	[p2l1045t3598r1406b3683],
3	explained	VBD	O	explain	_	0	SENT_19	[p2l1445t3598r1820b3683],
4	33	CD	PERCENT	33	num	5	SENT_19	[p2l1858t3599r2026b3663],
5	%	NN	PERCENT	%	dobj	3	SENT_19	[p2l1858t3599r2026b3663],
6	of	IN	O	of	_	0	SENT_19	[p2l2073t3599r2152b3663],
7	dose-variance	NN	O	dose-variance	prep_of	5	SENT_19	[p2l10t3710r564b3788],
8	,	,	O	,	_	0	SENT_19	[p2l10t3710r564b3788],
9	compared	VBN	O	compare	_	0	SENT_19	[p2l616t3710r1000b3795],
10	with	IN	O	with	prepc_compared_with	3	SENT_19	[p2l1048t3710r1216b3775],
11	12	CD	PERCENT	12	num	12	SENT_19	[p2l1268t3710r1433b3775],
12	%	NN	PERCENT	%	pobj	3	SENT_19	[p2l1268t3710r1433b3775],
13	for	IN	O	for	_	0	SENT_19	[p2l1490t3710r1601b3775],
14	clinical	JJ	O	clinical	amod	15	SENT_19	[p2l1651t3710r1922b3775],
15	variables	NNS	O	variable	prep_for	12	SENT_19	[p2l1971t3710r2146b3775, p3l11t19r203b85],

1	alone	RB	O	alone	_	0	SENT_20	[p3l250t19r476b85],
2	.	.	O	.	_	0	SENT_20	[p3l250t19r476b85],

1	Conclusion	NN	O	conclusion	nsubj	23	SENT_21	[p3l13t131r441b197],
2	In	IN	O	in	_	0	SENT_21	[p3l537t133r617b196],
3	this	DT	O	this	det	6	SENT_21	[p3l668t131r803b196],
4	large	JJ	O	large	amod	6	SENT_21	[p3l856t131r1045b216],
5	prospective	JJ	O	prospective	amod	6	SENT_21	[p3l1097t131r1541b216],
6	study	NN	O	study	prep_in	23	SENT_21	[p3l1595t131r1799b216],
7	of	IN	O	of	_	0	SENT_21	[p3l1852t132r1930b196],
8	warfarin	NN	O	warfarin	prep_of	6	SENT_21	[p3l1977t152r2146b196, p3l8t242r190b307],
9	genetic	JJ	O	genetic	amod	12	SENT_21	[p3l239t242r515b327],
10	dose	NN	O	dose	nn	12	SENT_21	[p3l564t242r1301b321],
11	—	NN	O	—	nn	12	SENT_21	[p3l564t242r1301b321],
12	determinants	NNS	O	determinant	nsubj	23	SENT_21	[p3l564t242r1301b321],
13	,	,	O	,	_	0	SENT_21	[p3l564t242r1301b321],
14	carriage	NN	O	carriage	appos	12	SENT_21	[p3l1353t242r1662b327],
15	of	IN	O	of	_	0	SENT_21	[p3l1714t243r1792b307],
16	a	DT	O	a	det	21	SENT_21	[p3l1839t263r1879b307],
17	single	JJ	O	single	amod	21	SENT_21	[p3l1928t242r2146b327],
18	or	CC	O	or	_	0	SENT_21	[p3l10t373r90b418],
19	double	JJ	O	double	conj_or	17	SENT_21	[p3l149t353r411b418],
20	CYP2C9	NN	O	cyp2c9	nn	21	SENT_21	[p3l477t353r813b418],
21	variant	NN	O	variant	prep_of	14	SENT_21	[p3l869t353r1161b431],
22	,	,	O	,	_	0	SENT_21	[p3l869t353r1161b431],
23	reduced	VBD	O	reduce	_	0	SENT_21	[p3l1221t353r1531b418],
24	Warfarin	NNP	O	Warfarin	nn	25	SENT_21	[p3l1588t352r1915b418],
25	dose	NN	O	dose	iobj	23	SENT_21	[p3l1975t353r2147b418],
26	18-72	CD	PERCENT	18-72	num	27	SENT_21	[p3l12t465r340b543],
27	%	NN	PERCENT	%	dobj	23	SENT_21	[p3l12t465r340b543],
28	,	,	O	,	_	0	SENT_21	[p3l12t465r340b543],
29	and	CC	O	and	_	0	SENT_21	[p3l389t465r528b530],
30	of	IN	O	of	conj_and	23	SENT_21	[p3l574t465r653b530],
31	a	DT	O	a	det	33	SENT_21	[p3l696t485r736b530],
32	VKORCI	NN	O	vkorcus	nn	33	SENT_21	[p3l786t465r1155b530],
33	variant	NN	O	variant	pobj	30	SENT_21	[p3l1206t464r1477b530],
34	by	IN	O	by	_	0	SENT_21	[p3l1522t465r1614b550],
35	65	CD	PERCENT	65	num	36	SENT_21	[p3l1660t464r1853b530],
36	%	NN	PERCENT	%	prep_by	30	SENT_21	[p3l1660t464r1853b530],
37	.	.	O	.	_	0	SENT_21	[p3l1660t464r1853b530],

1	Genotype-based	JJ	MISC	genotype-based	amod	2	SENT_22	[p3l1905t465r2146b530, p3l9t576r428b661],
2	modeling	NN	O	modeling	nsubj	3	SENT_22	[p3l494t575r855b661],
3	explained	VBD	O	explain	_	0	SENT_22	[p3l923t576r1297b661],
4	almost	RB	O	almost	quantmod	6	SENT_22	[p3l1366t576r1619b641],
5	one	CD	NUMBER	one	number	6	SENT_22	[p3l1686t576r2010b641],
6	—	CD	NUMBER	—	num	7	SENT_22	[p3l1686t576r2010b641],
7	half	NN	O	half	dobj	3	SENT_22	[p3l1686t576r2010b641],
8	of	IN	O	of	_	0	SENT_22	[p3l2073t576r2152b641],
9	dose	NN	O	dose	nn	11	SENT_22	[p3l10t686r562b751],
10	—	NN	O	—	nn	11	SENT_22	[p3l10t686r562b751],
11	variance	NN	O	variance	prep_of	7	SENT_22	[p3l10t686r562b751],
12	.	.	O	.	_	0	SENT_22	[p3l10t686r562b751],

1	A	DT	O	a	det	4	SENT_23	[p3l604t687r676b750],
2	quantitative	JJ	O	quantitative	amod	4	SENT_23	[p3l716t686r1178b771],
3	dosing	NN	O	dosing	nn	4	SENT_23	[p3l1220t686r1468b771],
4	algorithm	NN	O	algorithm	nsubj	18	SENT_23	[p3l1510t686r1884b771],
5	incorporating	VBG	O	incorporate	partmod	4	SENT_23	[p3l1923t686r2146b751, p3l8t797r334b882],
6	genotypes	NNS	O	genotype	dobj	5	SENT_23	[p3l406t806r793b882],
7	for	IN	O	for	_	0	SENT_23	[p3l867t798r978b862],
8	2C9	NN	O	2c9	prep_for	6	SENT_23	[p3l1046t798r1202b863],
9	and	CC	O	and	_	0	SENT_23	[p3l1275t797r1413b862],
10	VKORCI	NN	O	vkorcus	conj_and	8	SENT_23	[p3l1490t798r1859b863],
11	could	MD	O	could	aux	13	SENT_23	[p3l1938t797r2148b862],
12	substantially	RB	O	substantially	advmod	13	SENT_23	[p3l9t909r494b994],
13	improve	VB	O	improve	_	0	SENT_23	[p3l553t909r872b994],
14	initial	JJ	O	initial	amod	16	SENT_23	[p3l932t909r1155b974],
15	Warfarin	NNP	O	Warfarin	nn	16	SENT_23	[p3l1213t909r1539b974],
16	dose-selection	NN	O	dose-selection	dobj	13	SENT_23	[p3l1600t909r2149b974],
17	and	CC	O	and	_	0	SENT_23	[p3l11t1019r149b1085],
18	reduce	VB	O	reduce	conj_and	13	SENT_23	[p3l192t1019r451b1085],
19	related	JJ	O	related	amod	20	SENT_23	[p3l495t1019r766b1085],
20	complications	NNS	O	complication	dobj	18	SENT_23	[p3l810t1019r1363b1104],
21	.	.	O	.	_	0	SENT_23	[p3l810t1019r1363b1104],

1	Keywords	NNPS	O	Keywords	_	0	SENT_24	[p3l9t1245r397b1329],
2	Anticoagulation	NN	O	anticoagulation	dep	1	SENT_24	[p3l491t1243r1122b1328],
3	-	:	O	-	_	0	SENT_24	[p3l1161t1280r1171b1289],
4	Pharmacogenetics	NNP	ORGANIZATION	Pharmacogenetics	nn	6	SENT_24	[p3l1209t1243r1913b1328],
5	Vitamin	NN	ORGANIZATION	vitamin	nn	6	SENT_24	[p3l1953t1280r1963b1289, p3l8t1352r326b1418],
6	K	NN	ORGANIZATION	k	dep	1	SENT_24	[p3l359t1355r425b1417],
7	-	:	O	-	_	0	SENT_24	[p3l465t1390r474b1399],
8	Warfarin	NN	O	warfarin	dep	6	SENT_24	[p3l512t1353r864b1418],

1	@	IN	O	@	_	0	SENT_25	[p3l1803t1580r1876b1669],
2	Springer	NNP	PERSON	Springer	pobj	1	SENT_25	[p3l1903t1602r2148b1672],

1	192	CD	NUMBER	192	num	4	SENT_26	[p3l54t1748r104b1774],
2	J	NN	O	j	nn	4	SENT_26	[p3l1445t1749r1460b1774],
3	Thromb	NN	O	thromb	nn	4	SENT_26	[p3l1472t1748r1596b1774],
4	Thrombolysis	NN	O	thrombolysis	_	0	SENT_26	[p3l1609t1748r1817b1782],
5	(	CD	NUMBER	(	num	6	SENT_26	[p3l1832t1747r1926b1782],
6	2006	CD	DATE	2006	dep	4	SENT_26	[p3l1832t1747r1926b1782],
7	)	CD	NUMBER	)	number	8	SENT_26	[p3l1832t1747r1926b1782],
8	22:191	CD	NUMBER	22:191	num	9	SENT_26	[p3l1940t1748r2106b1774],
9	—	NN	O	—	dep	6	SENT_26	[p3l1940t1748r2106b1774],
10	197	CD	NUMBER	197	dep	4	SENT_26	[p3l1940t1748r2106b1774],

1	Introduction	NN	O	introduction	_	0	SENT_27	[p3l8t1915r499b1980],

1	Warfarin	NNP	O	Warfarin	nsubj	22	SENT_28	[p3l8t2139r360b2204],
2	is	VBZ	O	be	cop	22	SENT_28	[p3l430t2139r485b2204],
3	an	DT	O	a	det	22	SENT_28	[p3l560t2160r650b2204],
4	anticoagulant	JJ	O	anticoagulant	amod	22	SENT_28	[p3l722t2139r1246b2224],
5	commonly	RB	O	commonly	advmod	6	SENT_28	[p3l1318t2139r1724b2224],
6	used	VBN	O	use	amod	22	SENT_28	[p3l1794t2139r1969b2204],
7	for	IN	O	for	_	0	SENT_28	[p3l2040t2140r2152b2204],
8	prevention	NN	O	prevention	prep_for	6	SENT_28	[p3l8t2251r429b2337],
9	of	IN	O	of	_	0	SENT_28	[p3l465t2251r544b2316],
10	thromboembolic	JJ	O	thromboembolic	amod	11	SENT_28	[p3l576t2251r1221b2316],
11	events	NNS	O	event	prep_of	8	SENT_28	[p3l1257t2260r1500b2316],
12	in	IN	O	in	_	0	SENT_28	[p3l1537t2250r1609b2315],
13	patients	NNS	O	patient	prep_in	6	SENT_28	[p3l1643t2250r1949b2337],
14	with	IN	O	with	_	0	SENT_28	[p3l1984t2251r2151b2316],
15	prosthetic	JJ	O	prosthetic	amod	17	SENT_28	[p3l8t2363r394b2449],
16	heart	NN	O	heart	nn	17	SENT_28	[p3l430t2363r630b2428],
17	valves	NNS	O	valve	prep_with	13	SENT_28	[p3l665t2363r923b2442],
18	,	,	O	,	_	0	SENT_28	[p3l665t2363r923b2442],
19	venous	JJ	O	venous	amod	22	SENT_28	[p3l959t2384r1229b2428],
20	or	CC	O	or	_	0	SENT_28	[p3l1268t2384r1348b2428],
21	arterial	JJ	O	arterial	conj_or	19	SENT_28	[p3l1384t2362r1664b2428],
22	thrombosis	NN	O	thrombosis	_	0	SENT_28	[p3l1700t2363r2149b2442],
23	,	,	O	,	_	0	SENT_28	[p3l1700t2363r2149b2442],
24	or	CC	O	or	_	0	SENT_28	[p3l10t2496r90b2540],
25	other	JJ	O	other	amod	26	SENT_28	[p3l126t2475r331b2540],
26	conditions	NNS	O	condition	nsubj	27	SENT_28	[p3l366t2474r764b2540],
27	predisposing	VBG	O	predispose	conj_or	22	SENT_28	[p3l801t2474r1290b2561],
28	to	TO	O	to	_	0	SENT_28	[p3l1325t2484r1400b2540],
29	thromboembolism	NN	O	thromboembolism	prep_to	27	SENT_28	[p3l1437t2475r2151b2540],
30	such	JJ	O	such	_	0	SENT_28	[p3l10t2586r179b2651],
31	as	IN	O	as	_	0	SENT_28	[p3l206t2607r280b2651],
32	atrial	JJ	O	atrial	amod	33	SENT_28	[p3l307t2586r506b2651],
33	ﬁbrillation	NN	O	ﬁbrillation	prep_such_as	29	SENT_28	[p3l531t2586r956b2651],
34	.	.	O	.	_	0	SENT_28	[p3l531t2586r956b2651],

1	Warfarin	NNP	O	Warfarin	nsubjpass	4	SENT_29	[p3l984t2586r1336b2651],
2	is	VBZ	O	be	auxpass	4	SENT_29	[p3l1360t2586r1416b2651],
3	widely	RB	O	widely	advmod	4	SENT_29	[p3l1441t2586r1693b2671],
4	used	VBN	O	use	_	0	SENT_29	[p3l1717t2586r1913b2665],
5	,	,	O	,	_	0	SENT_29	[p3l1717t2586r1913b2665],
6	being	VBG	O	be	auxpass	8	SENT_29	[p3l1940t2586r2151b2671],
7	currently	RB	DATE	currently	advmod	8	SENT_29	[p3l9t2697r360b2782],
8	prescribed	VBN	O	prescribe	xcomp	4	SENT_29	[p3l386t2697r792b2782],
9	to	TO	O	to	aux	10	SENT_29	[p3l820t2706r895b2762],
10	over	IN	O	over	xcomp	8	SENT_29	[p3l925t2718r1096b2762],
11	1	CD	NUMBER	1	number	12	SENT_29	[p3l1126t2697r1159b2761],
12	million	CD	NUMBER	million	num	13	SENT_29	[p3l1197t2697r1470b2762],
13	patients	NNS	O	patient	pobj	10	SENT_29	[p3l1497t2697r1803b2782],
14	per	IN	O	per	_	0	SENT_29	[p3l1830t2718r1958b2782],
15	year	NN	DURATION	year	prep_per	13	SENT_29	[p3l1984t2718r2152b2782],
16	in	IN	O	in	_	0	SENT_29	[p3l9t2809r81b2873],
17	the	DT	O	the	det	19	SENT_29	[p3l139t2809r258b2874],
18	United	NNP	LOCATION	United	nn	19	SENT_29	[p3l317t2809r589b2874],
19	States	NNPS	LOCATION	States	prep_in	15	SENT_29	[p3l648t2809r876b2874],
20	alone	RB	O	alone	advmod	10	SENT_29	[p3l938t2809r1165b2874],
21	.	.	O	.	_	0	SENT_29	[p3l938t2809r1165b2874],

1	Many	JJ	O	many	amod	2	SENT_30	[p3l1227t2811r1449b2894],
2	patients	NNS	O	patient	nsubj	3	SENT_30	[p3l1506t2809r1812b2894],
3	require	VBP	O	require	_	0	SENT_30	[p3l1870t2809r2150b2894],
4	prolonged	JJ	O	prolonged	amod	7	SENT_30	[p3l8t2919r403b3004],
5	or	CC	O	or	_	0	SENT_30	[p3l441t2940r521b2985],
6	lifetime	NN	O	lifetime	amod	7	SENT_30	[p3l557t2919r853b2985],
7	therapy	NN	O	therapy	dobj	3	SENT_30	[p3l891t2919r1205b3004],
8	.	.	O	.	_	0	SENT_30	[p3l891t2919r1205b3004],

1	Management	NN	O	management	nsubjpass	6	SENT_31	[p3l1245t2921r1756b3004],
2	of	IN	O	of	_	0	SENT_31	[p3l1795t2920r1873b2985],
3	warfarin	NN	O	warfarin	nn	4	SENT_31	[p3l1904t2920r2149b2985, p3l9t3030r115b3095],
4	therapy	NN	O	therapy	prep_of	1	SENT_31	[p3l160t3030r456b3115],
5	is	VBZ	O	be	auxpass	6	SENT_31	[p3l501t3030r557b3095],
6	complicated	VBN	O	complicate	_	0	SENT_31	[p3l605t3030r1076b3115],
7	by	IN	O	by	_	0	SENT_31	[p3l1121t3030r1213b3115],
8	its	PRP$	O	its	poss	11	SENT_31	[p3l1258t3030r1343b3095],
9	narrow	JJ	O	narrow	amod	11	SENT_31	[p3l1389t3051r1666b3095],
10	therapeutic	JJ	O	therapeutic	amod	11	SENT_31	[p3l1711t3030r2152b3115],
11	index	NN	O	index	agent	6	SENT_31	[p3l9t3141r220b3206],
12	and	CC	O	and	_	0	SENT_31	[p3l247t3141r386b3206],
13	by	IN	O	by	_	0	SENT_31	[p3l411t3141r503b3226],
14	Wide	NN	O	wide	nn	19	SENT_31	[p3l527t3141r707b3206],
15	inter	NN	O	inter	nn	19	SENT_31	[p3l734t3141r1335b3206],
16	—	CD	NUMBER	—	num	19	SENT_31	[p3l734t3141r1335b3206],
17	individual	JJ	O	individual	amod	19	SENT_31	[p3l734t3141r1335b3206],
18	dosing	NN	O	dosing	nn	19	SENT_31	[p3l1362t3141r1611b3226],
19	requirements	NNS	O	requirement	nsubj	20	SENT_31	[p3l1637t3141r2150b3226],
20	leading	VBG	O	lead	agent	6	SENT_31	[p3l9t3252r290b3339],
21	to	TO	O	to	_	0	SENT_31	[p3l327t3262r401b3318],
22	erratic	JJ	O	erratic	amod	25	SENT_31	[p3l440t3253r691b3318],
23	initial	JJ	O	initial	amod	25	SENT_31	[p3l727t3252r949b3318],
24	dose	NN	O	dose	nn	25	SENT_31	[p3l987t3253r1159b3318],
25	responses	NNS	O	response	prep_to	20	SENT_31	[p3l1198t3274r1571b3339],
26	and	CC	O	and	_	0	SENT_31	[p3l1610t3253r1750b3318],
27	increased	VBD	O	increase	amod	29	SENT_31	[p3l1785t3252r2151b3318],
28	bleeding	JJ	O	bleeding	amod	29	SENT_31	[p3l8t3364r340b3451],
29	risk	NN	O	risk	conj_and	25	SENT_31	[p3l374t3365r533b3430],
30	.	.	O	.	_	0	SENT_31	[p3l374t3365r533b3430],

1	One	CD	NUMBER	one	num	2	SENT_32	[p3l574t3365r736b3431],
2	study	NN	O	study	dep	3	SENT_32	[p3l773t3365r977b3451],
3	reported	VBD	O	report	_	0	SENT_32	[p3l1011t3365r1346b3451],
4	approximately	RB	O	approximately	quantmod	5	SENT_32	[p3l1383t3364r1941b3451],
5	50	CD	PERCENT	50	num	6	SENT_32	[p3l1975t3364r2143b3430],
6	%	NN	PERCENT	%	dobj	3	SENT_32	[p3l1975t3364r2143b3430],
7	inter	NN	O	inter	dep	9	SENT_32	[p3l9t3477r609b3543],
8	—	CD	NUMBER	—	num	7	SENT_32	[p3l9t3477r609b3543],
9	individual	JJ	O	individual	prep	3	SENT_32	[p3l9t3477r609b3543],
10	variability	NN	O	variability	dep	9	SENT_32	[p3l642t3477r1035b3563],
11	in	IN	O	in	_	0	SENT_32	[p3l1068t3477r1140b3542],
12	Warfarin	JJ	O	warfarin	amod	15	SENT_32	[p3l1172t3477r1499b3542],
13	clearance	NN	O	clearance	nn	15	SENT_32	[p3l1533t3477r1897b3543],
14	o	NN	O	o	nn	15	SENT_32	[p3l1939t3474r2052b3563],
15	xӪ	NN	O	xӫ	prep_in	3	SENT_32	[p3l1939t3474r2052b3563],
16	*	CD	NUMBER	*	nsubj	3	SENT_32	[p3l1939t3474r2052b3563],

1	Much	JJ	O	much	nsubjpass	11	SENT_33	[p3l111t3588r332b3653],
2	of	IN	O	of	_	0	SENT_33	[p3l391t3589r470b3653],
3	the	DT	O	the	det	4	SENT_33	[p3l523t3588r643b3653],
4	variation	NN	O	variation	prep_of	1	SENT_33	[p3l701t3588r1049b3653],
5	in	IN	O	in	_	0	SENT_33	[p3l1105t3588r1177b3652],
6	individual	JJ	O	individual	amod	7	SENT_33	[p3l1234t3588r1620b3653],
7	response	NN	O	response	prep_in	4	SENT_33	[p3l1678t3608r2016b3673],
8	to	TO	O	to	_	0	SENT_33	[p3l2075t3597r2150b3653],
9	drugs	NNS	O	drug	prep_to	7	SENT_33	[p3l10t3699r217b3784],
10	is	VBZ	O	be	auxpass	11	SENT_33	[p3l245t3699r300b3764],
11	believed	VBN	O	believe	_	0	SENT_33	[p3l328t3699r655b3764],
12	to	TO	O	to	aux	14	SENT_33	[p3l681t3708r756b3764],
13	be	VB	O	be	cop	14	SENT_33	[p3l783t3699r873b3764],
14	attributable	JJ	O	attributable	dobj	11	SENT_33	[p3l903t3699r1355b3764],
15	to	TO	O	to	_	0	SENT_33	[p3l1384t3708r1458b3764],
16	pharmacogenetic	JJ	O	pharmacogenetic	amod	17	SENT_33	[p3l1484t3699r2151b3784],
17	considerations	NNS	O	consideration	prep_to	14	SENT_33	[p4l9t20r588b99],
18	,	,	O	,	_	0	SENT_33	[p4l9t20r588b99],
19	i.e.	FW	O	i.e.	dep	14	SENT_33	[p4l642t20r774b99],
20	,	,	O	,	_	0	SENT_33	[p4l642t20r774b99],
21	variability	NN	O	variability	dep	14	SENT_33	[p4l826t20r1219b105],
22	in	IN	O	in	_	0	SENT_33	[p4l1269t20r1342b84],
23	the	DT	O	the	det	24	SENT_33	[p4l1392t20r1512b85],
24	genes	NNS	O	gene	prep_in	21	SENT_33	[p4l1565t40r1801b105],
25	,	,	O	,	_	0	SENT_33	[p4l1565t40r1801b105],
26	such	JJ	O	such	_	0	SENT_33	[p4l1854t20r2024b85],
27	as	IN	O	as	_	0	SENT_33	[p4l2077t40r2150b85],
28	those	DT	O	those	prep_such_as	24	SENT_33	[p4l9t130r212b195],
29	for	IN	O	for	_	0	SENT_33	[p4l270t131r381b195],
30	the	DT	O	the	det	33	SENT_33	[p4l436t130r556b195],
31	hepatic	JJ	O	hepatic	amod	33	SENT_33	[p4l613t130r895b215],
32	p450	NN	O	p450	nn	33	SENT_33	[p4l950t130r1131b215],
33	enzymes	NNS	O	enzyme	prep_for	28	SENT_33	[p4l1189t151r1539b215],
34	,	,	O	,	_	0	SENT_33	[p4l1189t151r1539b215],
35	that	IN	O	that	dep	39	SENT_33	[p4l1597t130r1748b195],
36	code	NN	O	code	dep	39	SENT_33	[p4l1805t130r1983b195],
37	for	IN	O	for	_	0	SENT_33	[p4l2040t131r2152b195],
38	molecules	NNS	O	molecule	prep_for	36	SENT_33	[p4l8t241r394b306],
39	necessary	JJ	O	necessary	dep	28	SENT_33	[p4l424t262r795b326],
40	for	IN	O	for	_	0	SENT_33	[p4l823t242r935b306],
41	their	PRP$	O	they	poss	42	SENT_33	[p4l964t241r1145b306],
42	activation	NN	O	activation	prep_for	39	SENT_33	[p4l1176t241r1556b306],
43	or	CC	O	or	_	0	SENT_33	[p4l1586t262r1666b306],
44	inactivation	NN	O	inactivation	nn	45	SENT_33	[p4l1695t241r2152b306],
45	[	NN	O	[	prep_for	39	SENT_33	[p4l14t350r129b438],
46	2	CD	NUMBER	2	num	47	SENT_33	[p4l14t350r129b438],
47	]	NN	O	]	dep	24	SENT_33	[p4l14t350r129b438],
48	.	.	O	.	_	0	SENT_33	[p4l14t350r129b438],

1	The	DT	O	the	det	4	SENT_34	[p4l173t352r324b418],
2	cytochrome	NN	O	cytochrome	nn	4	SENT_34	[p4l367t352r821b438],
3	p450	NN	O	p450	nn	4	SENT_34	[p4l863t352r1045b438],
4	enzymes	NNS	O	enzyme	nsubj	6	SENT_34	[p4l1088t373r1417b438],
5	are	VBP	O	be	cop	6	SENT_34	[p4l1461t373r1579b418],
6	monooXygenases	NNS	O	monooxygenase	_	0	SENT_34	[p4l1621t373r2149b438, p4l11t486r163b530],
7	that	WDT	O	that	nsubjpass	15	SENT_34	[p4l201t465r352b530],
8	catalyze	VBP	O	catalyze	rcmod	6	SENT_34	[p4l390t465r699b551],
9	oxidative	JJ	O	oxidative	amod	10	SENT_34	[p4l740t464r1093b530],
10	modiﬁcation	NN	O	modiﬁcation	dobj	8	SENT_34	[p4l1131t464r1617b530],
11	of	IN	O	of	_	0	SENT_34	[p4l1655t465r1734b530],
12	substrates	NNS	O	substrate	prep_of	10	SENT_34	[p4l1768t465r2150b530],
13	and	CC	O	and	_	0	SENT_34	[p4l11t577r149b642],
14	are	VBP	O	be	auxpass	15	SENT_34	[p4l183t597r300b642],
15	involved	VBN	O	involve	rcmod	6	SENT_34	[p4l333t577r665b642],
16	in	IN	O	in	_	0	SENT_34	[p4l695t577r768b641],
17	the	DT	O	the	det	18	SENT_34	[p4l799t577r918b642],
18	metabolism	NN	O	metabolism	prep_in	15	SENT_34	[p4l950t577r1402b642],
19	of	IN	O	of	_	0	SENT_34	[p4l1435t577r1514b642],
20	more	JJR	O	more	mwe	21	SENT_34	[p4l1540t597r1740b642],
21	than	IN	O	than	quantmod	22	SENT_34	[p4l1773t577r1944b642],
22	80	CD	PERCENT	80	num	23	SENT_34	[p4l1976t578r2061b642],
23	%	NN	PERCENT	%	prep_of	18	SENT_34	[p4l2073t578r2143b642],

1	of	IN	O	of	_	0	SENT_35	[p4l10t689r89b754],
2	pharmaceuticals	NNS	O	pharmaceutical	nn	4	SENT_35	[p4l123t689r753b775],
3	D8	NN	O	d8	nn	4	SENT_35	[p4l799t686r913b775],
4	k	NN	O	k	prep_of	12	SENT_35	[p4l799t686r913b775],
5	+	CC	O	+	_	0	SENT_35	[p4l799t686r913b775],
6	Variability	NN	O	variability	conj_+	4	SENT_35	[p4l955t689r1373b775],
7	in	IN	O	in	_	0	SENT_35	[p4l1412t689r1484b754],
8	Warfarin	NNP	O	Warfarin	nn	9	SENT_35	[p4l1521t689r1848b754],
9	dosage	NN	O	dosage	prep_in	6	SENT_35	[p4l1888t689r2150b775],
10	has	VBZ	O	have	aux	12	SENT_35	[p4l9t800r133b865],
11	been	VBN	O	be	auxpass	12	SENT_35	[p4l174t800r361b865],
12	traced	VBN	O	trace	_	0	SENT_35	[p4l401t800r642b865],
13	to	TO	O	to	_	0	SENT_35	[p4l682t809r757b865],
14	coding	VBG	O	code	amod	15	SENT_35	[p4l799t800r1054b885],
15	alterations	NNS	O	alteration	prep_to	12	SENT_35	[p4l1097t800r1504b865],
16	in	IN	O	in	_	0	SENT_35	[p4l1546t800r1618b864],
17	the	DT	O	the	det	18	SENT_35	[p4l1658t800r1777b865],
18	gene	NN	O	gene	prep_in	15	SENT_35	[p4l1820t821r1998b885],
19	for	IN	O	for	_	0	SENT_35	[p4l2040t801r2152b865],
20	the	DT	O	the	det	23	SENT_35	[p4l9t912r128b978],
21	cytochrome	NN	O	cytochrome	nn	23	SENT_35	[p4l185t912r639b998],
22	p450	NN	O	p450	nn	23	SENT_35	[p4l695t911r877b998],
23	isoform	NN	O	isoform	prep_for	18	SENT_35	[p4l932t912r1249b992],
24	,	,	O	,	_	0	SENT_35	[p4l932t912r1249b992],
25	CYP2C9	NN	O	cyp2c9	nn	26	SENT_35	[p4l1311t913r1648b978],
26	[	NN	O	[	appos	23	SENT_35	[p4l1707t909r1794b998],
27	4	CD	NUMBER	4	nsubjpass	12	SENT_35	[p4l1707t909r1794b998],
28	,	,	O	,	_	0	SENT_35	[p4l1707t909r1794b998],
29	5	CD	NUMBER	5	num	30	SENT_35	[p4l1851t909r1941b998],
30	]	NN	O	]	appos	27	SENT_35	[p4l1851t909r1941b998],
31	.	.	O	.	_	0	SENT_35	[p4l1851t909r1941b998],

1	The	DT	O	the	det	5	SENT_36	[p4l1999t912r2150b978],
2	CYP2C9	NN	O	cyp2c9	nn	5	SENT_36	[p4l14t1025r434b1089],
3	*	NN	O	*	nn	5	SENT_36	[p4l14t1025r434b1089],
4	2	CD	NUMBER	2	num	5	SENT_36	[p4l14t1025r434b1089],
5	variant	NN	O	variant	nsubj	16	SENT_36	[p4l465t1024r758b1103],
6	,	,	O	,	_	0	SENT_36	[p4l465t1024r758b1103],
7	a	DT	O	a	det	8	SENT_36	[p4l792t1044r831b1089],
8	C	NN	O	c	appos	5	SENT_36	[p4l864t1024r924b1090],
9	to	TO	O	to	_	0	SENT_36	[p4l953t1033r1028b1089],
10	T	NN	O	t	nn	11	SENT_36	[p4l1058t1026r1116b1088],
11	substitution	NN	O	substitution	prep_to	8	SENT_36	[p4l1147t1024r1601b1089],
12	at	IN	O	at	_	0	SENT_36	[p4l1633t1033r1702b1089],
13	codon	NN	O	codon	prep_at	11	SENT_36	[p4l1732t1024r1968b1089],
14	144	CD	NUMBER	144	num	13	SENT_36	[p4l2001t1024r2149b1103],
15	,	,	O	,	_	0	SENT_36	[p4l2001t1024r2149b1103],
16	results	VBZ	O	result	_	0	SENT_36	[p4l9t1135r258b1200],
17	in	IN	O	in	_	0	SENT_36	[p4l294t1135r366b1200],
18	the	DT	O	the	det	19	SENT_36	[p4l401t1135r521b1200],
19	replacement	NN	O	replacement	prep_in	16	SENT_36	[p4l558t1135r1039b1220],
20	of	IN	O	of	_	0	SENT_36	[p4l1076t1136r1155b1200],
21	arginine	NN	O	arginine	prep_of	19	SENT_36	[p4l1188t1135r1500b1220],
22	by	IN	O	by	_	0	SENT_36	[p4l1537t1135r1629b1220],
23	cysteine	NN	O	cysteine	prep_by	16	SENT_36	[p4l1665t1135r1973b1220],
24	and	CC	O	and	_	0	SENT_36	[p4l2013t1135r2151b1200],
25	occurs	VBZ	O	occur	conj_and	16	SENT_36	[p4l10t1267r253b1312],
26	in	IN	O	in	_	0	SENT_36	[p4l324t1246r396b1311],
27	11-12	CD	PERCENT	11-12	num	28	SENT_36	[p4l469t1247r769b1312],
28	%	NN	PERCENT	%	prep_in	25	SENT_36	[p4l469t1247r769b1312],
29	of	IN	O	of	_	0	SENT_36	[p4l847t1247r926b1312],
30	the	DT	O	the	det	31	SENT_36	[p4l992t1246r1112b1312],
31	population	NN	O	population	prep_of	28	SENT_36	[p4l1182t1246r1604b1332],
32	[	CD	NUMBER	[	number	33	SENT_36	[p4l1679t1244r1765b1332],
33	6	CD	NUMBER	6	num	31	SENT_36	[p4l1679t1244r1765b1332],
34	,	,	O	,	_	0	SENT_36	[p4l1679t1244r1765b1332],
35	7	CD	NUMBER	7	num	36	SENT_36	[p4l1836t1244r1926b1332],
36	]	NN	O	]	appos	31	SENT_36	[p4l1836t1244r1926b1332],
37	.	.	O	.	_	0	SENT_36	[p4l1836t1244r1926b1332],

1	The	DT	O	the	det	5	SENT_37	[p4l1999t1246r2150b1312],
2	CYP2C9	NN	O	cyp2c9	nn	5	SENT_37	[p4l14t1358r435b1423],
3	*	NN	O	*	nn	5	SENT_37	[p4l14t1358r435b1423],
4	3	CD	NUMBER	3	num	5	SENT_37	[p4l14t1358r435b1423],
5	variant	NN	O	variant	nsubj	16	SENT_37	[p4l481t1357r773b1437],
6	,	,	O	,	_	0	SENT_37	[p4l481t1357r773b1437],
7	an	DT	O	a	det	8	SENT_37	[p4l821t1378r911b1423],
8	A	NN	O	a	appos	5	SENT_37	[p4l956t1359r1028b1422],
9	to	TO	O	to	_	0	SENT_37	[p4l1072t1367r1147b1423],
10	C	NN	O	c	nn	11	SENT_37	[p4l1197t1358r1256b1423],
11	substitution	NN	O	substitution	prep_to	8	SENT_37	[p4l1300t1358r1754b1423],
12	in	IN	O	in	_	0	SENT_37	[p4l1799t1357r1871b1422],
13	codon	NN	O	codon	prep_in	11	SENT_37	[p4l1916t1358r2152b1423],
14	359	CD	NUMBER	359	num	13	SENT_37	[p4l9t1469r160b1549],
15	,	,	O	,	_	0	SENT_37	[p4l9t1469r160b1549],
16	results	VBZ	O	result	_	0	SENT_37	[p4l203t1470r452b1535],
17	in	IN	O	in	_	0	SENT_37	[p4l493t1470r565b1534],
18	replacement	NN	O	replacement	prep_in	16	SENT_37	[p4l604t1470r1086b1556],
19	of	IN	O	of	_	0	SENT_37	[p4l1127t1470r1206b1535],
20	isoleucine	NN	O	isoleucine	prep_of	18	SENT_37	[p4l1242t1469r1627b1535],
21	with	IN	O	with	_	0	SENT_37	[p4l1667t1469r1835b1535],
22	leucine	NN	O	leucine	prep_with	16	SENT_37	[p4l1875t1469r2150b1535],
23	and	CC	O	and	_	0	SENT_37	[p4l11t1582r149b1647],
24	occurs	VBZ	O	occur	conj_and	16	SENT_37	[p4l202t1603r444b1647],
25	in	IN	O	in	_	0	SENT_37	[p4l497t1582r569b1647],
26	7	CD	PERCENT	7	number	27	SENT_37	[p4l619t1583r833b1648],
27	—	CD	PERCENT	—	prep_in	24	SENT_37	[p4l619t1583r833b1648],
28	9	CD	PERCENT	9	num	29	SENT_37	[p4l619t1583r833b1648],
29	%	NN	PERCENT	%	dep	27	SENT_37	[p4l619t1583r833b1648],
30	[	CD	NUMBER	[	number	31	SENT_37	[p4l898t1579r984b1668],
31	6	CD	NUMBER	6	num	29	SENT_37	[p4l898t1579r984b1668],
32	,	,	O	,	_	0	SENT_37	[p4l898t1579r984b1668],
33	7	CD	NUMBER	7	num	34	SENT_37	[p4l1036t1579r1127b1668],
34	]	NN	O	]	appos	29	SENT_37	[p4l1036t1579r1127b1668],
35	.	.	O	.	_	0	SENT_37	[p4l1036t1579r1127b1668],

1	These	DT	O	these	det	3	SENT_38	[p4l1181t1582r1411b1647],
2	coding	VBG	O	code	amod	3	SENT_38	[p4l1464t1582r1719b1668],
3	variations	NNS	O	variation	nsubj	4	SENT_38	[p4l1770t1582r2150b1647],
4	produce	VBP	O	produce	_	0	SENT_38	[p4l8t1693r322b1778],
5	reductions	NNS	O	reduction	dobj	4	SENT_38	[p4l352t1693r757b1758],
6	in	IN	O	in	_	0	SENT_38	[p4l786t1693r858b1757],
7	enzymatic	JJ	O	enzymatic	amod	8	SENT_38	[p4l888t1693r1279b1778],
8	activity	NN	O	activity	prep_in	5	SENT_38	[p4l1309t1693r1590b1778],
9	of	IN	O	of	_	0	SENT_38	[p4l1620t1694r1699b1758],
10	30	CD	PERCENT	30	num	11	SENT_38	[p4l1723t1694r1891b1758],
11	%	NN	PERCENT	%	prep_of	8	SENT_38	[p4l1723t1694r1891b1758],
12	for	IN	O	for	_	0	SENT_38	[p4l1928t1694r2039b1758],
13	*	NN	O	*	prep_for	11	SENT_38	[p4l2074t1694r2149b1757],
14	2	CD	NUMBER	2	num	13	SENT_38	[p4l2074t1694r2149b1757],
15	and	CC	O	and	_	0	SENT_38	[p4l11t1804r149b1870],
16	80	CD	PERCENT	80	num	17	SENT_38	[p4l177t1805r344b1870],
17	%	NN	PERCENT	%	conj_and	11	SENT_38	[p4l177t1805r344b1870],
18	for	IN	O	for	_	0	SENT_38	[p4l379t1805r490b1870],
19	*	CD	NUMBER	*	number	20	SENT_38	[p4l523t1805r599b1870],
20	3	CD	NUMBER	3	num	21	SENT_38	[p4l523t1805r599b1870],
21	homozygotes	NNS	O	homozygote	prep_for	17	SENT_38	[p4l626t1804r1135b1890],
22	[	CD	NUMBER	[	number	23	SENT_38	[p4l1169t1801r1255b1890],
23	8	CD	NUMBER	8	num	21	SENT_38	[p4l1169t1801r1255b1890],
24	,	,	O	,	_	0	SENT_38	[p4l1169t1801r1255b1890],
25	9	CD	NUMBER	9	num	26	SENT_38	[p4l1284t1801r1373b1890],
26	]	NN	O	]	appos	8	SENT_38	[p4l1284t1801r1373b1890],
27	.	.	O	.	_	0	SENT_38	[p4l1284t1801r1373b1890],

1	Individuals	NNS	O	individual	nsubjpass	9	SENT_39	[p4l1404t1804r1833b1870],
2	bearing	VBG	O	bear	partmod	1	SENT_39	[p4l1860t1804r2151b1890],
3	one	CD	NUMBER	one	dobj	2	SENT_39	[p4l10t1937r148b1982],
4	or	CC	O	or	_	0	SENT_39	[p4l185t1937r266b1982],
5	both	DT	O	both	det	7	SENT_39	[p4l298t1917r474b1982],
6	genetic	JJ	O	genetic	amod	7	SENT_39	[p4l510t1917r786b2002],
7	variants	NNS	O	variant	conj_or	3	SENT_39	[p4l819t1917r1124b1982],
8	are	VBP	O	be	auxpass	9	SENT_39	[p4l1162t1937r1279b1982],
9	reported	VBN	O	report	ccomp	19	SENT_39	[p4l1315t1917r1650b2002],
10	to	TO	O	to	aux	11	SENT_39	[p4l1685t1926r1760b1982],
11	require	VB	O	require	xcomp	9	SENT_39	[p4l1795t1917r2074b2002],
12	a	DT	O	a	det	15	SENT_39	[p4l2112t1937r2152b1982],
13	lower	JJR	O	lower	amod	15	SENT_39	[p4l9t2027r225b2093],
14	maintenance	NN	O	maintenance	nn	15	SENT_39	[p4l275t2027r770b2093],
15	dose	NN	O	dose	dobj	11	SENT_39	[p4l823t2027r996b2093],
16	of	IN	O	of	_	0	SENT_39	[p4l1050t2028r1129b2093],
17	warfarin	NN	O	warfarin	prep_of	15	SENT_39	[p4l1174t2027r1521b2106],
18	,	,	O	,	_	0	SENT_39	[p4l1174t2027r1521b2106],
19	require	VBP	O	require	_	0	SENT_39	[p4l1574t2027r1853b2112],
20	longer	JJR	O	longer	amod	21	SENT_39	[p4l1905t2027r2152b2112],
21	time	NN	O	time	dobj	19	SENT_39	[p4l9t2138r178b2203],
22	to	TO	O	to	aux	23	SENT_39	[p4l208t2147r283b2203],
23	achieve	VB	O	achieve	xcomp	19	SENT_39	[p4l313t2138r601b2203],
24	stable	JJ	O	stable	amod	25	SENT_39	[p4l631t2138r854b2203],
25	dosing	NN	O	dosing	dobj	23	SENT_39	[p4l884t2138r1154b2223],
26	,	,	O	,	_	0	SENT_39	[p4l884t2138r1154b2223],
27	have	VBP	O	have	conj_and	23	SENT_39	[p4l1183t2138r1362b2203],
28	a	DT	O	a	det	30	SENT_39	[p4l1393t2159r1433b2203],
29	higher	JJR	O	higher	amod	30	SENT_39	[p4l1459t2138r1705b2223],
30	proportion	NN	O	proportion	dobj	27	SENT_39	[p4l1731t2138r2152b2223],
31	of	IN	O	of	_	0	SENT_39	[p4l10t2250r89b2314],
32	prothrombin	NN	O	prothrombin	nn	35	SENT_39	[p4l118t2249r816b2334],
33	—	CD	NUMBER	—	num	35	SENT_39	[p4l118t2249r816b2334],
34	time	NN	O	time	nn	35	SENT_39	[p4l118t2249r816b2334],
35	measurements	NNS	O	measurement	prep_of	30	SENT_39	[p4l852t2258r1410b2314],
36	above	IN	O	above	_	0	SENT_39	[p4l1448t2249r1675b2314],
37	therapeutic	JJ	O	therapeutic	amod	38	SENT_39	[p4l1711t2249r2152b2334],
38	range	NN	O	range	prep_above	27	SENT_39	[p4l9t2382r244b2447],
39	,	,	O	,	_	0	SENT_39	[p4l9t2382r244b2447],
40	and	CC	O	and	_	0	SENT_39	[p4l288t2361r427b2426],
41	experience	VB	O	experience	xcomp	19	SENT_39	[p4l468t2360r885b2447],
42	more	JJR	O	more	amod	45	SENT_39	[p4l926t2382r1126b2426],
43	frequent	JJ	O	frequent	amod	45	SENT_39	[p4l1166t2361r1496b2447],
44	bleeding	NN	O	bleeding	nn	45	SENT_39	[p4l1535t2361r1866b2447],
45	events	NNS	O	event	dobj	41	SENT_39	[p4l1907t2370r2150b2426],
46	as	IN	O	as	prep	41	SENT_39	[p4l11t2494r84b2538],
47	compared	VBN	O	compare	_	0	SENT_39	[p4l114t2473r498b2559],
48	to	TO	O	to	prepc_compared_to	41	SENT_39	[p4l526t2482r601b2538],
49	individuals	NNS	O	individual	pobj	41	SENT_39	[p4l630t2473r1050b2538],
50	with	IN	O	with	_	0	SENT_39	[p4l1078t2473r1246b2538],
51	the	DT	O	the	det	55	SENT_39	[p4l1273t2473r1393b2538],
52	wild-type	JJ	O	wild-type	amod	55	SENT_39	[p4l1421t2473r1781b2559],
53	C	NN	O	c	nn	55	SENT_39	[p4l1816t2473r1876b2539],
54	YP2	NN	O	yp2	nn	55	SENT_39	[p4l1881t2473r2040b2537],
55	C9	NN	O	c9	prep_with	49	SENT_39	[p4l2050t2473r2153b2539],
56	gene	NN	O	gene	dep	55	SENT_39	[p4l9t2606r188b2671],
57	[	CD	NUMBER	[	num	56	SENT_39	[p4l229t2582r523b2671],
58	10	CD	NUMBER	10	num	61	SENT_39	[p4l229t2582r523b2671],
59	—	NN	O	—	nn	61	SENT_39	[p4l229t2582r523b2671],
60	12	CD	NUMBER	12	num	61	SENT_39	[p4l229t2582r523b2671],
61	]	NN	O	]	nsubj	19	SENT_39	[p4l229t2582r523b2671],
62	.	.	O	.	_	0	SENT_39	[p4l229t2582r523b2671],

1	Variability	NN	O	variability	nsubj	7	SENT_40	[p4l110t2696r529b2781],
2	in	IN	O	in	_	0	SENT_40	[p4l570t2696r643b2760],
3	drug	NN	O	drug	nn	4	SENT_40	[p4l686t2696r860b2781],
4	response	NN	O	response	prep_in	1	SENT_40	[p4l902t2717r1241b2781],
5	is	VBZ	O	be	cop	7	SENT_40	[p4l1284t2696r1340b2761],
6	also	RB	O	also	advmod	7	SENT_40	[p4l1385t2696r1533b2761],
7	attributable	JJ	O	attributable	_	0	SENT_40	[p4l1579t2696r2031b2761],
8	to	TO	O	to	_	0	SENT_40	[p4l2075t2705r2150b2761],
9	variants	NNS	O	variant	prep_to	7	SENT_40	[p4l8t2807r313b2873],
10	in	IN	O	in	_	0	SENT_40	[p4l353t2807r426b2872],
11	the	DT	O	the	det	12	SENT_40	[p4l464t2807r584b2873],
12	genes	NNS	O	gene	prep_in	9	SENT_40	[p4l624t2828r838b2893],
13	coding	VBG	O	code	xcomp	7	SENT_40	[p4l879t2807r1134b2893],
14	for	IN	O	for	mark	17	SENT_40	[p4l1174t2808r1285b2873],
15	drug	NN	O	drug	nn	16	SENT_40	[p4l1325t2807r1499b2893],
16	targets	NNS	O	target	nsubj	17	SENT_40	[p4l1537t2816r1797b2893],
17	[	VBP	O	[	advcl	13	SENT_40	[p4l1843t2804r1957b2893],
18	2	CD	NUMBER	2	number	19	SENT_40	[p4l1843t2804r1957b2893],
19	]	CD	NUMBER	]	dobj	17	SENT_40	[p4l1843t2804r1957b2893],
20	.	.	O	.	_	0	SENT_40	[p4l1843t2804r1957b2893],

1	The	DT	O	the	det	3	SENT_41	[p4l1999t2807r2150b2873],
2	molecular	JJ	O	molecular	amod	3	SENT_41	[p4l8t2920r396b2985],
3	target	NN	O	target	nsubj	9	SENT_41	[p4l453t2929r680b3005],
4	of	IN	O	of	_	0	SENT_41	[p4l739t2920r818b2985],
5	warfarin	NN	O	warfarin	prep_of	3	SENT_41	[p4l871t2920r1197b2985],
6	is	VBZ	O	be	cop	9	SENT_41	[p4l1256t2920r1311b2985],
7	Vitamin	NN	O	vitamin	nn	9	SENT_41	[p4l1370t2920r1663b2985],
8	K	NN	O	k	nn	9	SENT_41	[p4l1721t2922r1788b2984],
9	epoxide	NN	O	epoxide	_	0	SENT_41	[p4l1847t2920r2150b3005],
10	reductase	NN	O	reductase	nn	26	SENT_41	[p4l9t3030r399b3109],
11	,	,	O	,	_	0	SENT_41	[p4l9t3030r399b3109],
12	the	DT	O	the	det	14	SENT_41	[p4l431t3030r550b3096],
13	enzyme	NN	O	enzyme	nn	14	SENT_41	[p4l582t3051r876b3115],
14	complex	NN	O	complex	npadvmod	24	SENT_41	[p4l907t3030r1233b3115],
15	responsible	JJ	O	responsible	amod	14	SENT_41	[p4l1262t3030r1700b3115],
16	for	IN	O	for	_	0	SENT_41	[p4l1730t3031r1842b3096],
17	gamma	NN	O	gamma	nn	18	SENT_41	[p4l1870t3051r2151b3115],
18	carboxylation	NN	O	carboxylation	prep_for	15	SENT_41	[p4l9t3141r539b3226],
19	of	IN	O	of	_	0	SENT_41	[p4l589t3142r668b3206],
20	multiple	JJ	O	multiple	amod	23	SENT_41	[p4l711t3141r1032b3226],
21	vitamin	NN	O	vitamin	nn	23	SENT_41	[p4l1081t3141r1373b3206],
22	K	NN	O	k	nn	23	SENT_41	[p4l1422t3141r1931b3226],
23	—	NN	O	—	prep_of	18	SENT_41	[p4l1422t3141r1931b3226],
24	dependent	JJ	O	dependent	amod	26	SENT_41	[p4l1422t3141r1931b3226],
25	clotting	NN	O	clotting	nn	26	SENT_41	[p4l1981t3141r2149b3206, p4l9t3252r155b3338],
26	factors	NNS	O	factor	nsubj	27	SENT_41	[p4l212t3253r472b3318],
27	[	VBP	O	[	rcmod	9	SENT_41	[p4l537t3250r695b3338],
28	13	CD	NUMBER	13	num	29	SENT_41	[p4l537t3250r695b3338],
29	]	CD	NUMBER	]	dobj	27	SENT_41	[p4l537t3250r695b3338],
30	.	.	O	.	_	0	SENT_41	[p4l537t3250r695b3338],

1	The	DT	O	the	det	2	SENT_42	[p4l756t3252r906b3318],
2	gene	NN	O	gene	nsubjpass	16	SENT_42	[p4l966t3273r1145b3338],
3	for	IN	O	for	_	0	SENT_42	[p4l1204t3253r1315b3318],
4	vitamin	NN	O	vitamin	nn	9	SENT_42	[p4l1372t3252r1664b3318],
5	K	NN	O	k	nn	9	SENT_42	[p4l1722t3254r1789b3317],
6	epoxide	NN	O	epoxide	nn	9	SENT_42	[p4l1847t3252r2150b3338],
7	reductase	NN	O	reductase	nn	9	SENT_42	[p4l9t3365r378b3430],
8	complex	NN	O	complex	nn	9	SENT_42	[p4l418t3365r744b3451],
9	subunit	NN	O	subunit	prep_for	2	SENT_42	[p4l782t3365r1067b3431],
10	I	PRP	O	I	nsubj	11	SENT_42	[p4l1105t3367r1135b3430],
11	(	VBP	O	(	rcmod	9	SENT_42	[p4l1177t3362r1620b3451],
12	VKORCI	NN	O	vkorcus	nn	13	SENT_42	[p4l1177t3362r1620b3451],
13	)	NN	O	)	dobj	11	SENT_42	[p4l1177t3362r1620b3451],
14	was	VBD	O	be	auxpass	16	SENT_42	[p4l1660t3386r1801b3430],
15	recently	RB	DATE	recently	advmod	16	SENT_42	[p4l1840t3365r2151b3451],
16	identiﬁed	VBN	O	identiﬁed	_	0	SENT_42	[p4l9t3477r375b3543],
17	[	NN	O	[	nn	19	SENT_42	[p4l412t3474r571b3563],
18	14	CD	NUMBER	14	num	19	SENT_42	[p4l412t3474r571b3563],
19	]	NN	O	]	dobj	16	SENT_42	[p4l412t3474r571b3563],
20	.	.	O	.	_	0	SENT_42	[p4l412t3474r571b3563],

1	Shortly	RB	O	shortly	advmod	2	SENT_43	[p4l608t3477r888b3563],
2	after	IN	O	after	advcl	19	SENT_43	[p4l921t3477r1101b3542],
3	its	PRP$	O	its	poss	4	SENT_43	[p4l1132t3477r1217b3542],
4	discovery	NN	O	discovery	pobj	2	SENT_43	[p4l1252t3477r1616b3563],
5	by	IN	O	by	_	0	SENT_43	[p4l1648t3477r1740b3563],
6	positional	JJ	O	positional	amod	7	SENT_43	[p4l1770t3477r2151b3563],
7	cloning	NN	O	cloning	prep_by	4	SENT_43	[p4l9t3589r311b3675],
8	,	,	O	,	_	0	SENT_43	[p4l9t3589r311b3675],
9	an	DT	O	a	det	17	SENT_43	[p4l351t3610r440b3654],
10	intronic	JJ	O	intronic	amod	17	SENT_43	[p4l476t3589r777b3654],
11	polymorphism	NN	O	polymorphism	nn	17	SENT_43	[p4l813t3589r1394b3675],
12	,	,	O	,	_	0	SENT_43	[p4l813t3589r1394b3675],
13	C1173T	NN	O	c1173t	dep	17	SENT_43	[p4l1435t3589r1733b3655],
14	(	CD	NUMBER	(	num	17	SENT_43	[p4l1773t3586r2039b3675],
15	intron	NN	O	intron	nn	17	SENT_43	[p4l1773t3586r2039b3675],
16	1	CD	NUMBER	1	num	17	SENT_43	[p4l2078t3586r2148b3675],
17	)	NN	O	)	nsubjpass	19	SENT_43	[p4l2078t3586r2148b3675],
18	was	VBD	O	be	auxpass	19	SENT_43	[p4l8t3721r148b3766],
19	identiﬁed	VBN	O	identiﬁed	_	0	SENT_43	[p4l177t3700r561b3766],
20	.	.	O	.	_	0	SENT_43	[p4l177t3700r561b3766],

1	The	DT	O	the	det	7	SENT_44	[p4l591t3700r742b3766],
2	wild	JJ	O	wild	amod	7	SENT_44	[p4l769t3700r932b3766],
3	type	NN	O	type	nn	7	SENT_44	[p4l960t3709r1124b3786],
4	(	CD	NUMBER	(	num	7	SENT_44	[p4l1157t3697r1344b3786],
5	CC	NN	O	cc	nn	7	SENT_44	[p4l1157t3697r1344b3786],
6	)	NN	O	)	nn	7	SENT_44	[p4l1157t3697r1344b3786],
7	genotype	NN	O	genotype	nsubjpass	9	SENT_44	[p4l1376t3709r1729b3786],
8	was	VBD	O	be	auxpass	9	SENT_44	[p4l1757t3721r1898b3766],
9	found	VBN	O	find	_	0	SENT_44	[p4l1926t3700r2152b3766],
10	to	TO	O	to	aux	12	SENT_44	[p5l9t29r84b85],
11	be	VB	O	be	auxpass	12	SENT_44	[p5l126t20r216b85],
12	associated	VBN	O	associate	xcomp	9	SENT_44	[p5l262t20r655b85],
13	with	IN	O	with	_	0	SENT_44	[p5l696t20r863b85],
14	almost	RB	O	almost	advmod	19	SENT_44	[p5l907t20r1161b85],
15	twice	RB	O	twice	advmod	17	SENT_44	[p5l1202t20r1402b85],
16	the	DT	O	the	det	17	SENT_44	[p5l1446t20r1566b85],
17	warfarin	NN	O	warfarin	pobj	14	SENT_44	[p5l1608t20r1935b85],
18	dose	NN	O	dose	nn	19	SENT_44	[p5l1978t20r2150b85],
19	requirement	NN	O	requirement	prep_with	12	SENT_44	[p5l9t133r489b219],
20	as	IN	O	as	_	0	SENT_44	[p5l531t154r604b199],
21	the	DT	O	the	det	23	SENT_44	[p5l645t133r764b199],
22	TT	NN	O	tt	nn	23	SENT_44	[p5l805t135r923b198],
23	genotype	NN	O	genotype	prep_as	12	SENT_44	[p5l963t142r1316b219],
24	[	CD	NUMBER	[	number	25	SENT_44	[p5l1363t130r1522b219],
25	15	CD	NUMBER	15	num	26	SENT_44	[p5l1363t130r1522b219],
26	]	NN	O	]	dep	12	SENT_44	[p5l1363t130r1522b219],
27	.	.	O	.	_	0	SENT_44	[p5l1363t130r1522b219],

1	More	RBR	O	more	dep	2	SENT_45	[p5l1566t135r1776b199],
2	recently	RB	DATE	recently	_	0	SENT_45	[p5l1817t133r2149b219],
3	,	,	O	,	_	0	SENT_45	[p5l1817t133r2149b219],

1	@	IN	O	@	_	0	SENT_46	[p5l7t381r80b470],
2	Springer	NNP	PERSON	Springer	prep_@	6	SENT_46	[p5l107t403r352b473],
3	nine	CD	NUMBER	nine	num	2	SENT_46	[p5l6t499r171b564],
4	haplotypes	NNS	O	haplotype	nsubjpass	6	SENT_46	[p5l222t499r642b585],
5	were	VBD	O	be	auxpass	6	SENT_46	[p5l690t520r876b564],
6	constructed	VBN	O	construct	_	0	SENT_46	[p5l927t499r1377b564],
7	from	IN	O	from	_	0	SENT_46	[p5l1426t499r1612b564],
8	10	CD	NUMBER	10	num	9	SENT_46	[p5l1664t499r1747b564],
9	polymorphisms	NNS	O	polymorphism	prep_from	6	SENT_46	[p5l1796t499r2150b585, p5l6t611r272b697],
10	in	IN	O	in	_	0	SENT_46	[p5l332t610r404b675],
11	VKORC1	NN	O	vkorc1	prep_in	9	SENT_46	[p5l468t611r838b677],
12	that	WDT	O	that	nsubj	13	SENT_46	[p5l904t611r1056b676],
13	showed	VBD	O	show	rcmod	9	SENT_46	[p5l1116t611r1406b676],
14	associations	NNS	O	association	dobj	13	SENT_46	[p5l1467t611r1925b676],
15	with	IN	O	with	_	0	SENT_46	[p5l1985t610r2152b676],
16	daily	JJ	SET	daily	amod	18	SENT_46	[p5l8t722r194b808],
17	warfarin	NN	O	warfarin	nn	18	SENT_46	[p5l254t722r582b788],
18	dose	NN	O	dose	prep_with	13	SENT_46	[p5l644t722r837b788],
19	.	.	O	.	_	0	SENT_46	[p5l644t722r837b788],

1	In	IN	O	in	_	0	SENT_47	[p5l904t724r984b787],
2	that	DT	O	that	det	3	SENT_47	[p5l1046t722r1197b788],
3	study	NN	O	study	prep_in	7	SENT_47	[p5l1260t722r1485b808],
4	,	,	O	,	_	0	SENT_47	[p5l1260t722r1485b808],
5	the	DT	O	the	det	6	SENT_47	[p5l1548t722r1668b788],
6	haplotypes	NNS	O	haplotype	nsubj	7	SENT_47	[p5l1731t722r2151b808],
7	associated	VBN	O	associate	_	0	SENT_47	[p5l9t834r403b900],
8	with	IN	O	with	_	0	SENT_47	[p5l427t834r594b900],
9	the	DT	O	the	det	12	SENT_47	[p5l619t834r739b900],
10	highest	JJS	O	highest	amod	12	SENT_47	[p5l765t834r1042b920],
11	warfarin	NN	O	warfarin	nn	12	SENT_47	[p5l1065t834r1392b900],
12	dose	NN	O	dose	prep_with	7	SENT_47	[p5l1418t834r1591b900],
13	all	DT	O	all	nsubj	14	SENT_47	[p5l1620t834r1710b900],
14	carried	VBD	O	carry	rcmod	12	SENT_47	[p5l1736t834r2006b900],
15	the	DT	O	the	det	18	SENT_47	[p5l2031t834r2151b900],
16	1173	CD	DATE	1173	num	18	SENT_47	[p5l10t946r180b1012],
17	C	NN	O	c	nn	18	SENT_47	[p5l233t947r293b1013],
18	allele	NN	O	allele	dobj	14	SENT_47	[p5l341t946r546b1012],
19	[	CD	NUMBER	[	number	20	SENT_47	[p5l600t943r759b1032],
20	13	CD	NUMBER	13	num	21	SENT_47	[p5l600t943r759b1032],
21	]	NN	O	]	dep	14	SENT_47	[p5l600t943r759b1032],
22	.	.	O	.	_	0	SENT_47	[p5l600t943r759b1032],

1	D’Andrea	NNP	O	D’Andrea	nsubj	15	SENT_48	[p5l810t946r1206b1012],
2	et	FW	O	et	dep	1	SENT_48	[p5l1255t955r1326b1012],
3	al.	FW	O	al.	nn	4	SENT_48	[p5l1374t946r1458b1012],
4	[	FW	O	[	dep	1	SENT_48	[p5l1515t943r1650b1032],
5	15	CD	NUMBER	15	num	6	SENT_48	[p5l1515t943r1650b1032],
6	]	NN	O	]	dep	4	SENT_48	[p5l1515t943r1650b1032],
7	studied	VBD	O	study	_	0	SENT_48	[p5l1704t946r1984b1012],
8	the	DT	O	the	det	12	SENT_48	[p5l2031t946r2151b1012],
9	CYP2C9	NN	O	cyp2c9	nn	12	SENT_48	[p5l11t1059r349b1125],
10	and	CC	O	and	_	0	SENT_48	[p5l419t1058r558b1124],
11	VKORCI	NN	O	vkorcus	nn	12	SENT_48	[p5l631t1059r1001b1125],
12	variants	NNS	O	variant	dobj	7	SENT_48	[p5l1075t1058r1381b1124],
13	concurrently	RB	O	concurrently	advmod	7	SENT_48	[p5l1452t1058r1943b1144],
14	and	CC	O	and	_	0	SENT_48	[p5l2014t1059r2153b1124],
15	found	VBD	O	find	conj_and	7	SENT_48	[p5l7t1170r232b1236],
16	that	IN	O	that	complm	28	SENT_48	[p5l274t1170r426b1236],
17	as	RB	O	as	quantmod	18	SENT_48	[p5l471t1191r544b1236],
18	much	JJ	O	much	nsubj	28	SENT_48	[p5l587t1171r799b1236],
19	as	IN	O	as	_	0	SENT_48	[p5l843t1192r916b1236],
20	one-third	NN	ORDINAL	one-third	prep_as	18	SENT_48	[p5l961t1170r1321b1236],
21	of	IN	O	of	_	0	SENT_48	[p5l1365t1171r1444b1236],
22	the	DT	O	the	det	23	SENT_48	[p5l1482t1170r1602b1236],
23	variability	NN	O	variability	prep_of	20	SENT_48	[p5l1645t1170r2039b1256],
24	in	IN	O	in	_	0	SENT_48	[p5l2080t1170r2153b1236],
25	dose	NN	O	dose	prep_in	23	SENT_48	[p5l8t1282r181b1348],
26	could	MD	O	could	aux	28	SENT_48	[p5l243t1282r453b1348],
27	be	VB	O	be	cop	28	SENT_48	[p5l513t1282r603b1348],
28	attributable	JJ	O	attributable	ccomp	15	SENT_48	[p5l665t1282r1118b1348],
29	to	TO	O	to	_	0	SENT_48	[p5l1179t1291r1254b1348],
30	them	PRP	O	they	prep_to	28	SENT_48	[p5l1314t1282r1530b1348],
31	.	.	O	.	_	0	SENT_48	[p5l1314t1282r1530b1348],

1	However	RB	O	however	advmod	11	SENT_49	[p5l1593t1284r1969b1361],
2	,	,	O	,	_	0	SENT_49	[p5l1593t1284r1969b1361],
3	the	DT	O	the	det	5	SENT_49	[p5l2031t1282r2151b1348],
4	combinatorial	JJ	O	combinatorial	amod	5	SENT_49	[p5l7t1395r548b1460],
5	effect	NN	O	effect	nsubjpass	11	SENT_49	[p5l583t1395r799b1460],
6	of	IN	O	of	_	0	SENT_49	[p5l834t1395r913b1460],
7	these	DT	O	these	det	8	SENT_49	[p5l942t1395r1141b1460],
8	loci	NNS	O	locus	prep_of	5	SENT_49	[p5l1177t1395r1314b1460],
9	was	VBD	O	be	auxpass	11	SENT_49	[p5l1346t1416r1487b1460],
10	not	RB	O	not	neg	11	SENT_49	[p5l1521t1404r1648b1460],
11	estimated	VBN	O	estimate	_	0	SENT_49	[p5l1683t1395r2076b1460],
12	.	.	O	.	_	0	SENT_49	[p5l1683t1395r2076b1460],

1	The	DT	O	the	det	3	SENT_50	[p5l108t1507r259b1573],
2	present	JJ	DATE	present	amod	3	SENT_50	[p5l286t1516r573b1593],
3	study	NN	O	study	nsubjpass	5	SENT_50	[p5l601t1507r806b1593],
4	was	VBD	O	be	auxpass	5	SENT_50	[p5l832t1528r973b1573],
5	designed	VBN	O	design	_	0	SENT_50	[p5l1002t1507r1342b1593],
6	to	TO	O	to	aux	8	SENT_50	[p5l1370t1516r1445b1573],
7	prospectively	RB	O	prospectively	advmod	8	SENT_50	[p5l1472t1507r1990b1593],
8	test	VB	O	test	xcomp	5	SENT_50	[p5l2016t1516r2152b1573],
9	whether	IN	O	whether	complm	21	SENT_50	[p5l6t1618r323b1684],
10	the	DT	O	the	det	12	SENT_50	[p5l379t1618r499b1684],
11	combined	JJ	O	combined	amod	12	SENT_50	[p5l559t1618r940b1684],
12	assessment	NN	O	assessment	nsubj	21	SENT_50	[p5l999t1627r1422b1684],
13	of	IN	O	of	_	0	SENT_50	[p5l1481t1619r1560b1684],
14	CYP2C9	NN	O	cyp2c9	nn	18	SENT_50	[p5l1618t1619r1955b1684],
15	and	CC	O	and	_	0	SENT_50	[p5l2014t1618r2152b1684],
16	VKORCI	NN	O	vkorcus	conj_and	14	SENT_50	[p5l11t1731r381b1796],
17	gene	NN	O	gene	nn	18	SENT_50	[p5l392t1751r571b1816],
18	variants	NNS	O	variant	prep_of	12	SENT_50	[p5l625t1730r931b1796],
19	could	MD	O	could	aux	21	SENT_50	[p5l987t1730r1198b1796],
20	best	RB	O	best	advmod	21	SENT_50	[p5l1251t1730r1408b1796],
21	determine	VB	O	determine	ccomp	8	SENT_50	[p5l1463t1730r1856b1796],
22	differences	NNS	O	difference	dobj	21	SENT_50	[p5l1912t1730r2150b1796, p5l8t1863r216b1908],
23	in	IN	O	in	_	0	SENT_50	[p5l274t1842r346b1907],
24	the	DT	O	the	det	26	SENT_50	[p5l402t1842r522b1908],
25	warfarin	NN	O	warfarin	nn	26	SENT_50	[p5l578t1842r905b1908],
26	dose	NN	O	dose	prep_in	21	SENT_50	[p5l963t1842r1136b1908],
27	required	VBN	O	require	partmod	26	SENT_50	[p5l1193t1842r1524b1928],
28	to	TO	O	to	aux	29	SENT_50	[p5l1580t1851r1655b1908],
29	maintain	VB	O	maintain	xcomp	27	SENT_50	[p5l1712t1842r2055b1908],
30	a	DT	O	a	det	33	SENT_50	[p5l2113t1863r2153b1908],
31	therapeutic	JJ	O	therapeutic	amod	33	SENT_50	[p5l7t1955r448b2041],
32	prothrombin	NN	O	prothrombin	nn	33	SENT_50	[p5l496t1955r992b2041],
33	time	NN	O	time	nsubj	36	SENT_50	[p5l1040t1955r1211b2021],
34	(	JJ	O	(	amod	35	SENT_50	[p5l1265t1952r1797b2041],
35	international	JJ	O	international	amod	33	SENT_50	[p5l1265t1952r1797b2041],
36	normalized	VBD	O	normalize	ccomp	29	SENT_50	[p5l1846t1955r2150b2021, p5l6t2067r163b2132],
37	ratio	NN	O	ratio	nn	39	SENT_50	[p5l188t2067r368b2132],
38	{	CD	NUMBER	{	num	39	SENT_50	[p5l398t2064r623b2153],
39	INR	NN	O	inr	dobj	36	SENT_50	[p5l398t2064r623b2153],
40	}	CD	NUMBER	}	number	41	SENT_50	[p5l398t2064r623b2153],
41	2-3	CD	NUMBER	2-3	num	42	SENT_50	[p5l651t2064r814b2153],
42	)	NN	O	)	dep	36	SENT_50	[p5l651t2064r814b2153],
43	and	CC	O	and	_	0	SENT_50	[p5l845t2067r984b2132],
44	whether	IN	O	whether	complm	48	SENT_50	[p5l1008t2067r1324b2132],
45	results	NNS	O	result	nsubjpass	48	SENT_50	[p5l1349t2067r1598b2133],
46	could	MD	O	could	aux	48	SENT_50	[p5l1625t2067r1836b2132],
47	be	VB	O	be	auxpass	48	SENT_50	[p5l1860t2067r1951b2133],
48	used	VBN	O	use	conj_and	21	SENT_50	[p5l1976t2067r2152b2133],
49	to	TO	O	to	aux	50	SENT_50	[p5l6t2188r82b2244],
50	develop	VB	O	develop	xcomp	48	SENT_50	[p5l117t2178r421b2264],
51	an	DT	O	a	det	54	SENT_50	[p5l458t2200r548b2244],
52	empirical	JJ	O	empirical	amod	54	SENT_50	[p5l582t2178r943b2264],
53	dosing	NN	O	dosing	nn	54	SENT_50	[p5l978t2178r1227b2264],
54	algorithm	NN	O	algorithm	dobj	50	SENT_50	[p5l1263t2178r1656b2264],
55	.	.	O	.	_	0	SENT_50	[p5l1263t2178r1656b2264],

1	Methods	NNS	O	method	_	0	SENT_51	[p5l6t2427r346b2491],

1	Subjects	NNS	O	subject	_	0	SENT_52	[p5l8t2650r327b2736],

1	Consecutive	JJ	O	consecutive	amod	2	SENT_53	[p5l9t2874r481b2941],
2	outpatients	NNS	O	outpatient	nsubj	10	SENT_53	[p5l558t2874r991b2960],
3	routinely	RB	O	routinely	advmod	4	SENT_53	[p5l1066t2874r1418b2960],
4	attending	VBG	O	attend	partmod	2	SENT_53	[p5l1493t2874r1857b2960],
5	Intermountain	NNP	ORGANIZATION	Intermountain	nn	9	SENT_53	[p5l1932t2876r2150b2940, p5l6t2986r378b3052],
6	Health	NNP	ORGANIZATION	Health	nn	9	SENT_53	[p5l498t2986r765b3052],
7	Care	NNP	ORGANIZATION	Care	nn	9	SENT_53	[p5l889t2987r1070b3052],
8	anticoagulation	NN	O	anticoagulation	nn	9	SENT_53	[p5l1194t2986r1795b3072],
9	clinics	NNS	O	clinic	dobj	4	SENT_53	[p5l1916t2986r2151b3052],
10	(	VBP	O	(	_	0	SENT_53	[p5l10t3095r86b3184],
11	n	NN	O	n	dobj	10	SENT_53	[p5l10t3095r86b3184],
12	=	JJ	O	=	amod	14	SENT_53	[p5l123t3128r170b3152],
13	213	CD	NUMBER	213	num	14	SENT_53	[p5l205t3095r368b3184],
14	)	NN	O	)	nsubjpass	16	SENT_53	[p5l205t3095r368b3184],
15	were	VBD	O	be	auxpass	16	SENT_53	[p5l417t3119r603b3164],
16	enrolled	VBN	O	enrol	rcmod	11	SENT_53	[p5l653t3098r972b3164],
17	in	IN	O	in	_	0	SENT_53	[p5l1019t3098r1091b3163],
18	the	DT	O	the	det	19	SENT_53	[p5l1138t3098r1257b3164],
19	study	NN	O	study	prep_in	16	SENT_53	[p5l1307t3098r1512b3184],
20	after	IN	O	after	_	0	SENT_53	[p5l1560t3099r1740b3164],
21	obtaining	VBG	O	obtain	prepc_after	16	SENT_53	[p5l1788t3098r2152b3184],
22	written	VBN	O	write	amod	24	SENT_53	[p5l6t3210r282b3276],
23	informed	VBN	O	inform	amod	24	SENT_53	[p5l306t3210r662b3276],
24	consent	NN	O	consent	dobj	21	SENT_53	[p5l686t3220r1000b3276],
25	.	.	O	.	_	0	SENT_53	[p5l686t3220r1000b3276],

1	Qualifying	JJ	O	qualifying	amod	2	SENT_54	[p5l1030t3210r1438b3296],
2	conditions	NNS	O	condition	nsubj	19	SENT_54	[p5l1463t3210r1862b3276],
3	requiring	VBG	O	require	partmod	2	SENT_54	[p5l1886t3210r2150b3296, p5l6t3322r123b3408],
4	anticoagulation	NN	O	anticoagulation	dobj	3	SENT_54	[p5l152t3322r752b3408],
5	with	IN	O	with	_	0	SENT_54	[p5l778t3322r945b3388],
6	a	DT	O	a	det	8	SENT_54	[p5l974t3344r1014b3388],
7	target	NN	O	target	nn	8	SENT_54	[p5l1040t3332r1266b3408],
8	INR	NN	O	inr	prep_with	3	SENT_54	[p5l1294t3324r1465b3388],
9	of	IN	O	of	_	0	SENT_54	[p5l1493t3323r1573b3388],
10	2-3	CD	NUMBER	2-3	prep_of	8	SENT_54	[p5l1595t3324r1723b3388],
11	were	VBD	O	be	cop	19	SENT_54	[p5l1753t3344r1938b3388],
12	deep	JJ	O	deep	amod	19	SENT_54	[p5l1968t3322r2151b3408],
13	vein	NN	O	vein	nn	19	SENT_54	[p5l6t3434r169b3500],
14	thrombosis	NN	O	thrombosis	nn	19	SENT_54	[p5l256t3434r684b3500],
15	(	CD	NUMBER	(	num	19	SENT_54	[p5l777t3432r853b3521],
16	n	NN	O	n	nn	19	SENT_54	[p5l777t3432r853b3521],
17	=	JJ	O	=	amod	19	SENT_54	[p5l890t3465r937b3488],
18	107	CD	NUMBER	107	num	19	SENT_54	[p5l976t3432r1135b3521],
19	)	NN	O	)	_	0	SENT_54	[p5l976t3432r1135b3521],
20	and	CC	O	and	_	0	SENT_54	[p5l1229t3434r1368b3500],
21	atrial	JJ	O	atrial	amod	24	SENT_54	[p5l1458t3434r1657b3500],
22	ﬁbrillation	NN	O	ﬁbrillation	nn	24	SENT_54	[p5l1745t3434r2152b3500],
23	(	NN	O	(	nn	24	SENT_54	[p5l10t3544r86b3633],
24	n	NN	O	n	dep	27	SENT_54	[p5l10t3544r86b3633],
25	=	JJ	O	=	amod	27	SENT_54	[p5l123t3577r170b3600],
26	106	CD	NUMBER	106	num	27	SENT_54	[p5l209t3544r390b3633],
27	)	NN	O	)	conj_and	19	SENT_54	[p5l209t3544r390b3633],
28	.	.	O	.	_	0	SENT_54	[p5l209t3544r390b3633],

1	The	DT	O	the	det	5	SENT_55	[p5l457t3547r607b3613],
2	stable	JJ	O	stable	amod	5	SENT_55	[p5l673t3547r897b3613],
3	daily	JJ	SET	daily	amod	5	SENT_55	[p5l963t3547r1149b3633],
4	maintenance	NN	O	maintenance	nn	5	SENT_55	[p5l1212t3547r1707b3613],
5	dose	NN	O	dose	nsubjpass	7	SENT_55	[p5l1774t3547r1947b3613],
6	was	VBD	O	be	auxpass	7	SENT_55	[p5l2011t3568r2151b3613],
7	ascertained	VBN	O	ascertain	_	0	SENT_55	[p5l9t3659r448b3725],
8	for	IN	O	for	_	0	SENT_55	[p5l485t3659r597b3724],
9	each	DT	O	each	det	10	SENT_55	[p5l636t3659r811b3725],
10	subject	NN	O	subject	prep_for	7	SENT_55	[p5l850t3659r1121b3745],
11	following	VBG	O	follow	_	0	SENT_55	[p5l1158t3659r1520b3745],
12	a	DT	O	a	det	14	SENT_55	[p5l1560t3680r1599b3725],
13	stable	JJ	O	stable	amod	14	SENT_55	[p5l1638t3659r1862b3725],
14	period	NN	O	period	prep_following	10	SENT_55	[p5l1901t3659r2152b3745],
15	of	IN	O	of	_	0	SENT_55	[p6l8t20r87b85],
16	>	JJR	O	>	prep_of	14	SENT_55	[p6l132t20r221b85],
17	1	CD	DURATION	1	num	18	SENT_55	[p6l132t20r221b85],
18	month	NN	NUMBER	month	tmod	16	SENT_55	[p6l259t20r510b85],
19	during	IN	O	during	_	0	SENT_55	[p6l559t20r808b106],
20	which	WDT	O	which	rel	24	SENT_55	[p6l854t19r1082b85],
21	the	DT	O	the	det	22	SENT_55	[p6l1129t20r1249b85],
22	subjects	NNS	O	subject	nsubj	24	SENT_55	[p6l1299t20r1602b106],
23	international	JJ	O	international	amod	22	SENT_55	[p6l1650t19r2152b85],
24	normalized	VBD	O	normalize	rcmod	16	SENT_55	[p6l6t131r443b197],
25	ratio	NN	O	ratio	nn	28	SENT_55	[p6l474t131r654b197],
26	(	CD	NUMBER	(	num	28	SENT_55	[p6l689t128r923b217],
27	INR	NN	O	inr	nn	28	SENT_55	[p6l689t128r923b217],
28	)	NN	O	)	dobj	24	SENT_55	[p6l689t128r923b217],
29	remained	VBD	O	remain	cop	31	SENT_55	[p6l957t131r1324b197],
30	between	IN	O	between	quantmod	31	SENT_55	[p6l1354t131r1680b197],
31	2	CD	NUMBER	2	rcmod	28	SENT_55	[p6l1710t132r1752b196],
32	and	CC	NUMBER	and	_	0	SENT_55	[p6l1785t131r1924b197],
33	3	CD	NUMBER	3	rcmod	28	SENT_55	[p6l1955t132r2014b197],
34	.	.	O	.	_	0	SENT_55	[p6l1955t132r2014b197],

1	Allele	NN	O	allele	nn	2	SENT_56	[p6l6t356r242b421],
2	determination	NN	O	determination	_	0	SENT_56	[p6l279t356r830b421],

1	Buccal	JJ	MISC	buccal	amod	2	SENT_57	[p6l6t581r269b647],
2	swabs	NNS	O	swab	nsubjpass	4	SENT_57	[p6l296t581r519b647],
3	were	VBD	O	be	auxpass	4	SENT_57	[p6l545t602r731b647],
4	obtained	VBN	O	obtain	_	0	SENT_57	[p6l760t581r1099b647],
5	during	IN	O	during	_	0	SENT_57	[p6l1127t581r1375b667],
6	routine	JJ	O	routine	amod	8	SENT_57	[p6l1402t581r1682b647],
7	clinic	NN	O	clinic	nn	8	SENT_57	[p6l1710t581r1912b647],
8	Visits	NNS	O	visit	prep_during	4	SENT_57	[p6l1937t581r2148b647],
9	.	.	O	.	_	0	SENT_57	[p6l1937t581r2148b647],

1	Swabs	NNS	O	swab	nsubj	3	SENT_58	[p6l8t692r246b759],
2	were	VBD	O	be	cop	3	SENT_58	[p6l275t714r461b758],
3	air	NN	O	air	_	0	SENT_58	[p6l494t692r594b758],
4	dried	VBD	O	dry	rcmod	3	SENT_58	[p6l624t692r824b758],
5	for	IN	O	for	_	0	SENT_58	[p6l853t693r965b758],
6	2	CD	NUMBER	2	num	7	SENT_58	[p6l993t694r1034b757],
7	h	NN	O	h	prep_for	4	SENT_58	[p6l1068t692r1115b757],
8	and	CC	O	and	_	0	SENT_58	[p6l1146t692r1285b758],
9	DNA	NN	O	dna	prep_for	4	SENT_58	[p6l1314t694r1531b758],
10	extracted	VBN	O	extract	partmod	9	SENT_58	[p6l1562t692r1922b758],
11	using	VBG	O	use	xcomp	10	SENT_58	[p6l1951t692r2152b778],
12	the	DT	O	the	det	16	SENT_58	[p6l6t804r126b870],
13	QIAamp	NN	O	qiaamp	nn	16	SENT_58	[p6l169t805r517b890],
14	DNA	NN	O	dna	nn	16	SENT_58	[p6l556t805r774b869],
15	Mini	NNP	O	Mini	nn	16	SENT_58	[p6l813t804r994b869],
16	Kit	NN	O	kit	dobj	11	SENT_58	[p6l1034t804r1174b870],
17	.	.	O	.	_	0	SENT_58	[p6l1034t804r1174b870],

1	The	DT	O	the	det	4	SENT_59	[p6l1217t804r1454b870],
2	*	NN	O	*	nn	4	SENT_59	[p6l1217t804r1454b870],
3	2	CD	NUMBER	2	num	4	SENT_59	[p6l1217t804r1454b870],
4	allele	NN	O	allele	nsubjpass	6	SENT_59	[p6l1497t804r1701b870],
5	was	VBD	O	be	auxpass	6	SENT_59	[p6l1740t825r1881b870],
6	determined	VBN	O	determine	_	0	SENT_59	[p6l1922t804r2150b870, p6l6t916r248b982],
7	using	VBG	O	use	xcomp	6	SENT_59	[p6l284t916r485b1002],
8	the	DT	O	the	det	11	SENT_59	[p6l522t916r642b982],
9	3	CD	NUMBER	3	num	11	SENT_59	[p6l680t914r744b982],
10	’	NN	O	’	nn	11	SENT_59	[p6l680t914r744b982],
11	nuclease	NN	O	nuclease	nsubj	13	SENT_59	[p6l780t916r1111b982],
12	(	CD	NUMBER	(	num	13	SENT_59	[p6l1153t913r1535b1002],
13	Taqman	NNP	O	Taqman	xcomp	7	SENT_59	[p6l1153t913r1535b1002],
14	)	CD	NUMBER	)	num	13	SENT_59	[p6l1153t913r1535b1002],
15	allelic	JJ	O	allelic	amod	20	SENT_59	[p6l1578t916r1804b982],
16	discrimination	NN	O	discrimination	nn	20	SENT_59	[p6l1842t916r2150b982, p6l6t1029r278b1094],
17	assay	NN	O	assay	nn	20	SENT_59	[p6l339t1050r538b1115],
18	(	CD	NUMBER	(	num	20	SENT_59	[p6l600t1026r855b1115],
19	ABI	NN	O	abus	nn	20	SENT_59	[p6l600t1026r855b1115],
20	)	NN	O	)	dep	13	SENT_59	[p6l600t1026r855b1115],
21	.	.	O	.	_	0	SENT_59	[p6l600t1026r855b1115],

1	The	DT	O	the	det	3	SENT_60	[p6l917t1029r1067b1094],
2	upstream	JJ	O	upstream	amod	3	SENT_60	[p6l1127t1038r1488b1115],
3	primer	NN	O	primer	_	0	SENT_60	[p6l1545t1029r1809b1115],
4	was	VBD	O	be	partmod	3	SENT_60	[p6l1865t1050r2025b1094],
5	:	:	O	:	_	0	SENT_60	[p6l1865t1050r2025b1094],
6	5	CD	NUMBER	5	number	7	SENT_60	[p6l2089t1027r2152b1095],
7	’	CD	NUMBER	’	num	8	SENT_60	[p6l2089t1027r2152b1095],
8	GACGCTGCGGAATTTTGG	NN	O	gacgctgcggaattttgg	dep	3	SENT_60	[p6l9t1140r1248b1205],
9	3	CD	NUMBER	3	num	10	SENT_60	[p6l1312t1138r1395b1205],
10	’	NN	O	’	dep	8	SENT_60	[p6l1312t1138r1395b1205],
11	.	.	O	.	_	0	SENT_60	[p6l1312t1138r1395b1205],

1	The	DT	O	the	det	3	SENT_61	[p6l1462t1140r1612b1205],
2	downstream	JJ	O	downstream	amod	3	SENT_61	[p6l1678t1140r2152b1205],
3	primer	NN	O	primer	_	0	SENT_61	[p6l6t1251r268b1337],
4	was	VBD	O	be	partmod	3	SENT_61	[p6l315t1272r476b1317],
5	:	:	O	:	_	0	SENT_61	[p6l315t1272r476b1317],
6	5	CD	NUMBER	5	number	7	SENT_61	[p6l529t1249r592b1317],
7	’	CD	NUMBER	’	num	8	SENT_61	[p6l529t1249r592b1317],
8	AAGGCAGCGGGCTTCCT	NN	O	aaggcagcgggcttcct	dep	3	SENT_61	[p6l641t1252r1818b1317],
9	3	CD	NUMBER	3	num	10	SENT_61	[p6l1866t1249r1948b1317],
10	’	NN	O	’	dep	8	SENT_61	[p6l1866t1249r1948b1317],
11	.	.	O	.	_	0	SENT_61	[p6l1866t1249r1948b1317],

1	The	DT	O	the	det	2	SENT_62	[p6l2000t1251r2151b1317],
2	probe	NN	O	probe	_	0	SENT_62	[p6l6t1363r230b1449],
3	was	VBD	O	be	partmod	2	SENT_62	[p6l277t1384r437b1429],
4	:	:	O	:	_	0	SENT_62	[p6l277t1384r437b1429],
5	5	CD	NUMBER	5	number	6	SENT_62	[p6l488t1361r551b1429],
6	’	CD	NUMBER	’	num	10	SENT_62	[p6l488t1361r551b1429],
7	6FAM	NN	O	6fam	nn	10	SENT_62	[p6l598t1363r854b1429],
8	GTAGGAC	NN	O	gtaggac	nn	10	SENT_62	[p6l903t1360r2152b1449],
9	[	CD	NUMBER	[	num	10	SENT_62	[p6l903t1360r2152b1449],
10	C/T	NN	O	c/t	dep	2	SENT_62	[p6l903t1360r2152b1449],
11	]	CD	NUMBER	]	num	12	SENT_62	[p6l903t1360r2152b1449],
12	GTGTTCAA	NN	O	gtgttcaa	dep	10	SENT_62	[p6l903t1360r2152b1449],
13	3	CD	NUMBER	3	num	14	SENT_62	[p6l7t1472r89b1539],
14	’	NN	O	’	dep	10	SENT_62	[p6l7t1472r89b1539],
15	.	.	O	.	_	0	SENT_62	[p6l7t1472r89b1539],

1	Allele	NN	O	allele	nn	2	SENT_63	[p6l152t1474r388b1539],
2	determination	NN	O	determination	nsubj	9	SENT_63	[p6l451t1474r1001b1539],
3	for	IN	O	for	_	0	SENT_63	[p6l1060t1475r1171b1539],
4	the	DT	O	the	det	7	SENT_63	[p6l1230t1474r1349b1539],
5	VKORCZ	NNP	O	VKORCZ	nn	7	SENT_63	[p6l1415t1475r1785b1540],
6	C1173T	NN	O	c1173t	nn	7	SENT_63	[p6l1854t1474r2153b1540],
7	polymorphism	NN	O	polymorphism	prep_for	2	SENT_63	[p6l6t1586r568b1672],
8	also	RB	O	also	advmod	9	SENT_63	[p6l628t1586r776b1652],
9	used	VBD	O	use	_	0	SENT_63	[p6l835t1586r1011b1652],
10	the	DT	O	the	det	13	SENT_63	[p6l1070t1586r1189b1652],
11	3	CD	NUMBER	3	num	13	SENT_63	[p6l1249t1585r1313b1652],
12	’	NN	O	’	nn	13	SENT_63	[p6l1249t1585r1313b1652],
13	nuclease	NN	O	nuclease	nsubj	19	SENT_63	[p6l1372t1587r1701b1652],
14	(	CD	NUMBER	(	num	19	SENT_63	[p6l1766t1584r2148b1673],
15	Taqman	NNP	O	Taqman	nn	19	SENT_63	[p6l1766t1584r2148b1673],
16	)	CD	NUMBER	)	num	19	SENT_63	[p6l1766t1584r2148b1673],
17	allelic	JJ	O	allelic	amod	19	SENT_63	[p6l9t1698r235b1764],
18	discrimination	NN	O	discrimination	nn	19	SENT_63	[p6l269t1698r825b1764],
19	assay	NN	O	assay	xcomp	9	SENT_63	[p6l861t1719r1078b1784],
20	.	.	O	.	_	0	SENT_63	[p6l861t1719r1078b1784],

1	The	DT	O	the	det	3	SENT_64	[p6l1115t1698r1265b1764],
2	upstream	JJ	O	upstream	amod	3	SENT_64	[p6l1300t1708r1661b1784],
3	primer	NN	O	primer	_	0	SENT_64	[p6l1693t1698r1956b1784],
4	was	VBD	O	be	partmod	3	SENT_64	[p6l1988t1720r2148b1764],
5	:	:	O	:	_	0	SENT_64	[p6l1988t1720r2148b1764],
6	5	CD	NUMBER	5	number	7	SENT_64	[p6l7t1807r70b1875],
7	’	CD	NUMBER	’	num	8	SENT_64	[p6l7t1807r70b1875],
8	CCCGGTGCCAGGAGATC	NN	O	cccggtgccaggagatc	dep	3	SENT_64	[p6l128t1810r1307b1875],
9	3	CD	NUMBER	3	num	10	SENT_64	[p6l1361t1807r1446b1888],
10	’	NN	O	’	dep	8	SENT_64	[p6l1361t1807r1446b1888],
11	;	:	O	;	_	0	SENT_64	[p6l1361t1807r1446b1888],
12	the	DT	O	the	det	14	SENT_64	[p6l1501t1809r1621b1875],
13	downstream	JJ	O	downstream	amod	14	SENT_64	[p6l1679t1809r2152b1875],
14	primer	NN	O	primer	dep	3	SENT_64	[p6l6t1922r268b2008],
15	was	VBD	O	be	partmod	14	SENT_64	[p6l313t1943r473b1988],
16	:	:	O	:	_	0	SENT_64	[p6l313t1943r473b1988],
17	5	CD	NUMBER	5	number	18	SENT_64	[p6l525t1920r588b1988],
18	’	CD	NUMBER	’	num	19	SENT_64	[p6l525t1920r588b1988],
19	CACCTGGGCTATCCTCTGTTC	NN	O	cacctgggctatcctctgttc	dep	14	SENT_64	[p6l637t1922r2020b1988],
20	3	CD	NUMBER	3	num	21	SENT_64	[p6l2066t1920r2149b1988],
21	’	NN	O	’	dep	19	SENT_64	[p6l2066t1920r2149b1988],
22	.	.	O	.	_	0	SENT_64	[p6l2066t1920r2149b1988],

1	Reporter	NN	O	reporter	nn	2	SENT_65	[p6l8t2036r363b2120],
2	probe	NN	O	probe	nsubj	4	SENT_65	[p6l387t2034r612b2120],
3	1	CD	NUMBER	1	dep	2	SENT_65	[p6l643t2034r676b2098],
4	was	VBD	O	be	_	0	SENT_65	[p6l706t2055r866b2099],
5	:	:	O	:	_	0	SENT_65	[p6l706t2055r866b2099],
6	VICCCTAGTCCAAGGGTCGAT	NN	O	viccctagtccaagggtcgat	nsubj	13	SENT_65	[p6l895t2034r2150b2100, p6l9t2146r234b2225],
7	;	:	O	;	_	0	SENT_65	[p6l895t2034r2150b2100, p6l9t2146r234b2225],
8	reporter	NN	O	reporter	nn	9	SENT_65	[p6l421t2155r742b2232],
9	probe	NN	O	probe	dep	6	SENT_65	[p6l925t2146r1149b2232],
10	2	CD	NUMBER	2	nsubj	11	SENT_65	[p6l1335t2147r1377b2210],
11	was	VBD	O	be	rcmod	9	SENT_65	[p6l1561t2166r1721b2211],
12	:	:	O	:	_	0	SENT_65	[p6l1561t2166r1721b2211],
13	FAMCTAGTCCAAGAGTCGAT	NN	O	famctagtccaagagtcgat	parataxis	4	SENT_65	[p6l1908t2147r2150b2210, p6l9t2258r1196b2323],
14	.	.	O	.	_	0	SENT_65	[p6l1908t2147r2150b2210, p6l9t2258r1196b2323],

1	Both	DT	O	both	det	2	SENT_66	[p6l1258t2257r1449b2323],
2	assays	NNS	O	assay	nsubjpass	4	SENT_66	[p6l1507t2278r1740b2343],
3	was	VBD	O	be	auxpass	4	SENT_66	[p6l1797t2278r1938b2323],
4	performed	VBN	O	perform	_	0	SENT_66	[p6l1996t2278r2150b2343, p6l7t2369r288b2435],
5	on	IN	O	on	_	0	SENT_66	[p6l328t2390r423b2435],
6	an	DT	O	a	det	11	SENT_66	[p6l463t2390r553b2435],
7	ABI	NNP	O	ABI	nn	11	SENT_66	[p6l592t2370r762b2434],
8	7000	CD	NUMBER	7000	num	11	SENT_66	[p6l801t2370r978b2435],
9	Sequence	NN	O	sequence	nn	11	SENT_66	[p6l1020t2370r1387b2455],
10	Detection	NN	O	detection	nn	11	SENT_66	[p6l1427t2369r1815b2435],
11	System	NN	O	system	prep_on	4	SENT_66	[p6l1855t2370r2148b2455],
12	.	.	O	.	_	0	SENT_66	[p6l1855t2370r2148b2455],

1	Genotyping	VBG	O	genotype	_	0	SENT_67	[p6l9t2481r468b2567],
2	for	IN	O	for	_	0	SENT_67	[p6l510t2482r621b2547],
3	the	DT	O	the	det	6	SENT_67	[p6l662t2481r782b2547],
4	*	NN	O	*	nn	6	SENT_67	[p6l831t2482r908b2547],
5	3	CD	NUMBER	3	num	6	SENT_67	[p6l831t2482r908b2547],
6	polymorphism	NN	O	polymorphism	prep_for	1	SENT_67	[p6l950t2481r1512b2567],
7	employed	VBN	O	employ	partmod	6	SENT_67	[p6l1555t2481r1935b2567],
8	ﬂuoJ	NN	O	ﬂuoj	nn	10	SENT_67	[p6l1976t2482r2150b2547, p6l52t2644r67b2669],
9	Thromb	NN	O	thromb	nn	10	SENT_67	[p6l80t2643r203b2669],
10	Thrombolysis	NN	O	thrombolysis	dep	7	SENT_67	[p6l217t2643r424b2677],
11	(	CD	NUMBER	(	num	12	SENT_67	[p6l439t2642r533b2677],
12	2006	CD	DATE	2006	dep	10	SENT_67	[p6l439t2642r533b2677],
13	)	CD	NUMBER	)	number	14	SENT_67	[p6l439t2642r533b2677],
14	22:191	CD	NUMBER	22:191	num	15	SENT_67	[p6l547t2643r713b2669],
15	—	NN	O	—	dep	10	SENT_67	[p6l547t2643r713b2669],
16	197	CD	NUMBER	197	num	17	SENT_67	[p6l547t2643r713b2669],
17	193	CD	NUMBER	193	dep	15	SENT_67	[p6l2056t2644r2105b2669],

1	rescence	NN	O	rescence	nn	3	SENT_68	[p6l7t2830r336b2875],
2	cycle	NN	O	cycle	nn	3	SENT_68	[p6l369t2810r559b2895],
3	sequencing	NN	O	sequencing	_	0	SENT_68	[p6l593t2810r1023b2895],
4	with	IN	O	with	_	0	SENT_68	[p6l1053t2810r1220b2875],
5	Big	JJ	MISC	big	amod	10	SENT_68	[p6l1251t2810r1382b2895],
6	Dye	NN	MISC	dye	nn	10	SENT_68	[p6l1413t2812r1573b2895],
7	V	NN	O	v	nn	10	SENT_68	[p6l1605t2831r1648b2875],
8	3.1	CD	NUMBER	3.1	num	10	SENT_68	[p6l1678t2810r1782b2875],
9	terminator	NN	O	terminator	nn	10	SENT_68	[p6l1818t2810r2147b2875, p6l7t2930r118b2987],
10	chemistry	NN	O	chemistry	prep_with	3	SENT_68	[p6l229t2921r624b3007],
11	;	:	O	;	_	0	SENT_68	[p6l229t2921r624b3007],
12	the	DT	O	the	det	14	SENT_68	[p6l737t2921r857b2987],
13	upstream	JJ	O	upstream	amod	14	SENT_68	[p6l968t2930r1329b3007],
14	primer	NN	O	primer	dep	10	SENT_68	[p6l1439t2921r1701b3007],
15	was	VBD	O	be	partmod	14	SENT_68	[p6l1810t2942r1970b2987],
16	:	:	O	:	_	0	SENT_68	[p6l1810t2942r1970b2987],
17	5	CD	NUMBER	5	number	18	SENT_68	[p6l2086t2919r2149b2987],
18	’	CD	NUMBER	’	num	19	SENT_68	[p6l2086t2919r2149b2987],
19	GCCACATGCCCTACACAGATG	NN	O	gccacatgccctacacagatg	conj_and	14	SENT_68	[p6l9t3032r1449b3097],
20	3	CD	NUMBER	3	num	21	SENT_68	[p6l1478t3029r1562b3110],
21	’	NN	O	’	dep	19	SENT_68	[p6l1478t3029r1562b3110],
22	,	,	O	,	_	0	SENT_68	[p6l1478t3029r1562b3110],
23	and	CC	O	and	_	0	SENT_68	[p6l1594t3031r1733b3097],
24	the	DT	O	the	det	26	SENT_68	[p6l1760t3031r1880b3096],
25	downstream	JJ	O	downstream	amod	26	SENT_68	[p6l1911t3031r2147b3097, p6l8t3153r267b3209],
26	primer	NN	O	primer	conj_and	14	SENT_68	[p6l317t3143r579b3229],
27	was	VBD	O	be	partmod	26	SENT_68	[p6l629t3165r789b3209],
28	:	:	O	:	_	0	SENT_68	[p6l629t3165r789b3209],
29	5	CD	NUMBER	5	number	30	SENT_68	[p6l844t3141r908b3209],
30	’	CD	NUMBER	’	dep	3	SENT_68	[p6l844t3141r908b3209],
31	TTTCTGAATTTAATGTCA	NN	O	tttctgaatttaatgtca	nn	33	SENT_68	[p6l958t3144r2149b3210],
32	CAGGTCACT3	NN	O	caggtcact3	nn	33	SENT_68	[p6l9t3252r703b3320],
33	’	NN	O	’	dep	30	SENT_68	[p6l9t3252r703b3320],
34	.	.	O	.	_	0	SENT_68	[p6l9t3252r703b3320],

1	Statistical	JJ	O	statistical	amod	2	SENT_69	[p6l8t3477r383b3543],
2	methods	NNS	O	method	_	0	SENT_69	[p6l417t3477r746b3543],

1	Statistical	JJ	MISC	statistical	amod	2	SENT_70	[p6l8t3702r383b3768],
2	analysis	NN	O	analysis	nsubj	3	SENT_70	[p6l424t3702r722b3787],
3	used	VBD	O	use	_	0	SENT_70	[p6l762t3702r937b3768],
4	one	CD	NUMBER	one	npadvmod	5	SENT_70	[p6l977t3723r1115b3768],
5	Variable	JJ	O	variable	acomp	3	SENT_70	[p6l1154t3702r1465b3768],
6	for	IN	O	for	_	0	SENT_70	[p6l1505t3703r1617b3768],
7	groupings	NNS	O	grouping	prep_for	3	SENT_70	[p6l1655t3702r2033b3787],
8	of	IN	O	of	prep	7	SENT_70	[p6l2074t3703r2153b3768],
9	the	DT	O	the	det	10	SENT_70	[p7l7t20r126b85],
10	*	NN	O	*	dep	8	SENT_70	[p7l175t21r370b86],
11	2	CD	NUMBER	2	dep	10	SENT_70	[p7l175t21r370b86],
12	/	:	O	/	punct	10	SENT_70	[p7l175t21r370b86],
13	*	CD	NUMBER	*	number	14	SENT_70	[p7l175t21r370b86],
14	3	CD	NUMBER	3	dep	10	SENT_70	[p7l175t21r370b86],
15	2C9	NN	O	2c9	nn	16	SENT_70	[p7l412t21r569b86],
16	genotypes	NNS	O	genotype	dep	14	SENT_70	[p7l612t29r1000b105],
17	and	CC	O	and	_	0	SENT_70	[p7l1047t20r1185b85],
18	a	DT	O	a	det	20	SENT_70	[p7l1231t41r1271b85],
19	separate	JJ	O	separate	amod	20	SENT_70	[p7l1315t29r1638b105],
20	variable	NN	O	variable	dep	10	SENT_70	[p7l1683t20r1993b85],
21	for	IN	O	for	_	0	SENT_70	[p7l2038t21r2150b85],
22	VKORCI	NN	O	vkorcus	nn	23	SENT_70	[p7l11t133r381b197],
23	genotypes	NNS	O	genotype	prep_for	20	SENT_70	[p7l426t140r834b217],
24	.	.	O	.	_	0	SENT_70	[p7l426t140r834b217],

1	Simple	JJ	O	simple	amod	2	SENT_71	[p7l878t132r1141b217],
2	analysis	NN	O	analysis	_	0	SENT_71	[p7l1183t132r1481b217],
3	of	IN	O	of	_	0	SENT_71	[p7l1521t132r1600b197],
4	average	JJ	O	average	amod	5	SENT_71	[p7l1637t152r1934b217],
5	dose	NN	O	dose	prep_of	2	SENT_71	[p7l1975t132r2148b197],
6	by	IN	O	by	_	0	SENT_71	[p7l6t243r98b329],
7	genotype	NN	O	genotype	nn	9	SENT_71	[p7l148t252r500b329],
8	used	JJ	O	used	amod	9	SENT_71	[p7l552t243r727b308],
9	analysis	NN	O	analysis	prep_by	5	SENT_71	[p7l779t243r1076b328],
10	of	IN	O	of	_	0	SENT_71	[p7l1128t243r1207b308],
11	variance	NN	O	variance	prep_of	9	SENT_71	[p7l1252t243r1578b308],
12	with	IN	O	with	_	0	SENT_71	[p7l1627t243r1794b308],
13	Tukey	NN	PERSON	tukey	poss	15	SENT_71	[p7l1843t243r2148b328],
14	’s	POS	O	’s	_	0	SENT_71	[p7l1843t243r2148b328],
15	HSD	NN	O	hsd	prep_with	2	SENT_71	[p7l7t355r199b420],
16	for	IN	O	for	_	0	SENT_71	[p7l238t355r350b419],
17	multiple	JJ	O	multiple	amod	18	SENT_71	[p7l385t354r705b439],
18	comparisons	NNS	O	comparison	prep_for	2	SENT_71	[p7l743t354r1246b439],
19	.	.	O	.	_	0	SENT_71	[p7l743t354r1246b439],

1	Multivariable	JJ	O	multivariable	amod	2	SENT_72	[p7l1285t354r1810b419],
2	analysis	NN	O	analysis	nsubj	3	SENT_72	[p7l1850t354r2148b439],
3	used	VBD	O	use	_	0	SENT_72	[p7l7t465r182b530],
4	linear	JJ	O	linear	amod	5	SENT_72	[p7l225t465r447b530],
5	regression	NN	O	regression	dobj	3	SENT_72	[p7l490t465r885b550],
6	to	TO	O	to	aux	7	SENT_72	[p7l928t474r1003b530],
7	predict	VB	O	predict	xcomp	3	SENT_72	[p7l1046t465r1318b550],
8	warfarin	NN	O	warfarin	nn	9	SENT_72	[p7l1360t465r1687b530],
9	dose	NN	O	dose	dobj	7	SENT_72	[p7l1731t465r1904b530],
10	using	VBG	O	use	conj_and	10	SENT_72	[p7l1948t465r2149b550],
11	CYP2C9	NN	O	cyp2c9	nn	14	SENT_72	[p7l11t577r346b642],
12	and	CC	O	and	_	0	SENT_72	[p7l380t576r518b641],
13	VKORCI	NN	O	vkorcus	conj_and	11	SENT_72	[p7l553t577r923b642],
14	genotypes	NNS	O	genotype	dobj	10	SENT_72	[p7l960t585r1348b661],
15	while	IN	O	while	_	0	SENT_72	[p7l1379t576r1584b641],
16	also	RB	O	also	advmod	17	SENT_72	[p7l1619t576r1767b641],
17	adjusting	VBG	O	adjust	prepc_while	10	SENT_72	[p7l1801t576r2149b661],
18	for	IN	O	for	_	0	SENT_72	[p7l7t688r118b753],
19	demographics	NNS	O	demographic	prep_for	17	SENT_72	[p7l183t687r720b772],
20	and	CC	O	and	_	0	SENT_72	[p7l788t687r927b753],
21	for	IN	O	for	_	0	SENT_72	[p7l991t688r1103b753],
22	the	DT	O	the	det	23	SENT_72	[p7l1167t687r1287b753],
23	use	NN	O	use	prep_for	10	SENT_72	[p7l1352t708r1476b753],
24	of	IN	O	of	_	0	SENT_72	[p7l1544t688r1623b753],
25	medications	NNS	O	medication	prep_of	23	SENT_72	[p7l1683t687r2148b753],
26	potentially	RB	O	potentially	advmod	27	SENT_72	[p7l6t798r424b883],
27	affecting	VBG	O	affect	partmod	25	SENT_72	[p7l454t798r787b883],
28	warfarin	NN	O	warfarin	nn	29	SENT_72	[p7l816t798r1142b864],
29	metabolism	NN	O	metabolism	dobj	27	SENT_72	[p7l1170t798r1640b864],
30	.	.	O	.	_	0	SENT_72	[p7l1170t798r1640b864],

1	Medications	NNS	O	medication	nsubjpass	28	SENT_73	[p7l1673t798r2148b864],
2	known	VBN	O	know	partmod	1	SENT_73	[p7l7t909r266b975],
3	to	TO	O	to	aux	4	SENT_73	[p7l325t918r400b975],
4	prolong	VB	O	prolong	xcomp	2	SENT_73	[p7l458t910r759b994],
5	INR	NNP	O	INR	dobj	4	SENT_73	[p7l818t911r1010b988],
6	,	,	O	,	_	0	SENT_73	[p7l818t911r1010b988],
7	including	VBG	O	include	_	0	SENT_73	[p7l1070t909r1426b994],
8	amiodarone	NN	O	amiodarone	prep_including	1	SENT_73	[p7l1487t909r1948b975],
9	and	CC	O	and	_	0	SENT_73	[p7l2011t909r2149b975],
10	cyclooxygenase	NN	O	cyclooxygenase	prep_including	1	SENT_73	[p7l7t1021r605b1106],
11	2	CD	NUMBER	2	num	12	SENT_73	[p7l645t1022r686b1085],
12	inhibitors	NNS	O	inhibitor	dep	8	SENT_73	[p7l724t1021r1115b1100],
13	,	,	O	,	_	0	SENT_73	[p7l724t1021r1115b1100],
14	and	CC	O	and	_	0	SENT_73	[p7l1158t1021r1297b1086],
15	other	JJ	O	other	amod	17	SENT_73	[p7l1335t1021r1540b1086],
16	clinical	JJ	O	clinical	amod	17	SENT_73	[p7l1578t1021r1850b1086],
17	factors	NNS	O	factor	prep_including	1	SENT_73	[p7l1888t1021r2148b1086],
18	such	JJ	O	such	_	0	SENT_73	[p7l8t1132r177b1197],
19	as	IN	O	as	_	0	SENT_73	[p7l243t1152r316b1197],
20	age	NN	O	age	prep_such_as	17	SENT_73	[p7l382t1152r532b1217],
21	,	,	O	,	_	0	SENT_73	[p7l382t1152r532b1217],
22	sex	NN	O	sex	prep_such_as	17	SENT_73	[p7l598t1152r738b1210],
23	,	,	O	,	_	0	SENT_73	[p7l598t1152r738b1210],
24	and	CC	O	and	_	0	SENT_73	[p7l806t1132r945b1197],
25	weight	NN	O	weight	conj_and	20	SENT_73	[p7l1007t1132r1284b1217],
26	,	,	O	,	_	0	SENT_73	[p7l1007t1132r1284b1217],
27	were	VBD	O	be	auxpass	28	SENT_73	[p7l1349t1152r1534b1197],
28	evaluated	VBN	O	evaluate	_	0	SENT_73	[p7l1600t1132r1975b1197],
29	for	IN	O	for	_	0	SENT_73	[p7l2038t1132r2150b1197],
30	potential	JJ	O	potential	amod	31	SENT_73	[p7l6t1242r352b1329],
31	confounding	NN	O	confounding	prep_for	28	SENT_73	[p7l396t1242r880b1329],
32	of	IN	O	of	_	0	SENT_73	[p7l925t1243r1003b1308],
33	the	DT	O	the	det	34	SENT_73	[p7l1042t1243r1162b1308],
34	association	NN	O	association	prep_of	31	SENT_73	[p7l1209t1243r1633b1308],
35	of	IN	O	of	_	0	SENT_73	[p7l1676t1243r1755b1308],
36	genotype	NN	O	genotype	prep_of	34	SENT_73	[p7l1795t1252r2148b1329],
37	with	IN	O	with	_	0	SENT_73	[p7l6t1354r173b1419],
38	warfarin	NN	O	warfarin	nn	39	SENT_73	[p7l199t1354r525b1419],
39	dose	NN	O	dose	prep_with	28	SENT_73	[p7l554t1354r746b1419],
40	.	.	O	.	_	0	SENT_73	[p7l554t1354r746b1419],

1	Because	IN	O	because	mark	8	SENT_74	[p7l778t1356r1097b1419],
2	the	DT	O	the	det	3	SENT_74	[p7l1126t1354r1246b1419],
3	range	NN	O	range	nsubj	8	SENT_74	[p7l1274t1375r1488b1439],
4	of	IN	O	of	_	0	SENT_74	[p7l1519t1355r1598b1419],
5	warfarin	NN	O	warfarin	nn	6	SENT_74	[p7l1620t1354r1947b1419],
6	dose	NN	O	dose	prep_of	3	SENT_74	[p7l1975t1354r2148b1419],
7	was	VBD	O	be	cop	8	SENT_74	[p7l6t1486r146b1530],
8	skewed	JJ	O	skewed	advcl	13	SENT_74	[p7l173t1465r477b1544],
9	,	,	O	,	_	0	SENT_74	[p7l173t1465r477b1544],
10	logarithmic	JJ	O	logarithmic	amod	11	SENT_74	[p7l504t1465r946b1550],
11	transformation	NN	O	transformation	nsubjpass	13	SENT_74	[p7l971t1465r1550b1530],
12	was	VBD	O	be	auxpass	13	SENT_74	[p7l1573t1486r1714b1530],
13	performed	VBN	O	perform	_	0	SENT_74	[p7l1739t1465r2149b1550],
14	prior	RB	O	prior	_	0	SENT_74	[p7l6t1576r197b1661],
15	to	TO	O	to	_	0	SENT_74	[p7l246t1585r321b1641],
16	analysis	NN	O	analysis	prep_prior_to	13	SENT_74	[p7l374t1576r671b1661],
17	to	TO	O	to	aux	18	SENT_74	[p7l722t1585r796b1641],
18	normalize	VB	O	normalize	xcomp	13	SENT_74	[p7l846t1576r1231b1641],
19	the	DT	O	the	det	21	SENT_74	[p7l1282t1576r1401b1641],
20	dose	NN	O	dose	nn	21	SENT_74	[p7l1453t1576r1626b1641],
21	distribution	NN	O	distribution	dobj	18	SENT_74	[p7l1678t1576r2145b1641],
22	.	.	O	.	_	0	SENT_74	[p7l1678t1576r2145b1641],

1	Comparisons	NNS	O	comparison	nsubj	9	SENT_75	[p7l9t1687r514b1772],
2	between	IN	O	between	_	0	SENT_75	[p7l577t1688r903b1753],
3	genotypes	NNS	O	genotype	prep_between	1	SENT_75	[p7l966t1696r1354b1772],
4	for	IN	O	for	_	0	SENT_75	[p7l1417t1688r1529b1753],
5	differences	NNS	O	difference	prep_for	3	SENT_75	[p7l1591t1687r2015b1753],
6	in	IN	O	in	_	0	SENT_75	[p7l2077t1687r2150b1752],
7	weekly	JJ	SET	weekly	amod	8	SENT_75	[p7l6t1798r278b1883],
8	doses	NNS	O	dose	prep_in	5	SENT_75	[p7l312t1798r520b1864],
9	used	VBN	O	use	_	0	SENT_75	[p7l555t1798r730b1864],
10	log	NN	O	log	nn	11	SENT_75	[p7l764t1798r1388b1883],
11	—	NN	O	—	dobj	9	SENT_75	[p7l764t1798r1388b1883],
12	transformed	VBN	O	transform	partmod	11	SENT_75	[p7l764t1798r1388b1883],
13	t	NN	O	t	nn	15	SENT_75	[p7l1423t1807r1666b1864],
14	—	NN	O	—	nn	15	SENT_75	[p7l1423t1807r1666b1864],
15	tests	NNS	O	test	dobj	12	SENT_75	[p7l1423t1807r1666b1864],
16	.	.	O	.	_	0	SENT_75	[p7l1423t1807r1666b1864],

1	Results	NNS	O	result	_	0	SENT_76	[p7l7t2045r292b2109],

1	Demographics	NNS	O	demographic	_	0	SENT_77	[p7l7t2267r571b2353],
2	and	CC	O	and	_	0	SENT_77	[p7l607t2267r746b2332],
3	genotypes	NNS	O	genotype	conj_and	1	SENT_77	[p7l780t2276r1168b2353],

1	The	DT	O	the	det	4	SENT_78	[p7l6t2492r156b2557],
2	key	JJ	O	key	amod	4	SENT_78	[p7l205t2492r342b2578],
3	demographic	JJ	O	demographic	amod	4	SENT_78	[p7l390t2491r894b2578],
4	variables	NNS	O	variable	nsubj	10	SENT_78	[p7l940t2492r1286b2557],
5	of	IN	O	of	_	0	SENT_78	[p7l1335t2492r1414b2557],
6	the	DT	O	the	det	8	SENT_78	[p7l1457t2492r1577b2557],
7	study	NN	O	study	nn	8	SENT_78	[p7l1626t2492r1831b2577],
8	sample	NN	O	sample	prep_of	4	SENT_78	[p7l1879t2492r2148b2578],
9	were	VBD	O	be	cop	10	SENT_78	[p7l6t2624r191b2669],
10	age	NN	O	age	_	0	SENT_78	[p7l234t2624r362b2689],
11	(	FW	O	(	nsubj	12	SENT_78	[p7l406t2600r649b2689],
12	mean	VB	O	mean	rcmod	10	SENT_78	[p7l406t2600r649b2689],
13	71	CD	NUMBER	71	dobj	12	SENT_78	[p7l687t2604r769b2669],
14	:	:	O	:	_	0	SENT_78	[p7l810t2622r856b2668],
15	12	CD	DURATION	12	num	16	SENT_78	[p7l895t2604r978b2668],
16	years	NNS	NUMBER	year	conj_and	10	SENT_78	[p7l1011t2624r1233b2689],
17	,	,	O	,	_	0	SENT_78	[p7l1011t2624r1233b2689],
18	range	NN	O	range	nn	20	SENT_78	[p7l1275t2624r1489b2689],
19	28-100	CD	NUMBER	28-100	num	20	SENT_78	[p7l1530t2600r1852b2689],
20	)	NN	O	)	appos	16	SENT_78	[p7l1530t2600r1852b2689],
21	;	:	O	;	_	0	SENT_78	[p7l1530t2600r1852b2689],
22	weight	NN	O	weight	conj_and	10	SENT_78	[p7l1892t2603r2149b2689],
23	(	CD	NUMBER	(	num	24	SENT_78	[p7l11t2713r273b2802],
24	mean	NN	O	mean	dep	22	SENT_78	[p7l11t2713r273b2802],
25	,	,	O	,	_	0	SENT_78	[p7l11t2713r273b2802],
26	84	CD	NUMBER	84	conj_and	10	SENT_78	[p7l313t2717r398b2782],
27	i	FW	O	i	dep	26	SENT_78	[p7l434t2735r480b2781],
28	23	CD	NUMBER	23	num	30	SENT_78	[p7l516t2717r600b2782],
29	kg	NN	O	kg	nn	30	SENT_78	[p7l636t2713r783b2802],
30	)	NN	O	)	dep	26	SENT_78	[p7l636t2713r783b2802],
31	;	:	O	;	_	0	SENT_78	[p7l636t2713r783b2802],
32	and	CC	O	and	_	0	SENT_78	[p7l825t2716r963b2782],
33	sex	NN	O	sex	nn	34	SENT_78	[p7l1002t2737r1123b2782],
34	(	NN	O	(	conj_and	10	SENT_78	[p7l1163t2713r1362b2802],
35	51	CD	PERCENT	51	number	36	SENT_78	[p7l1163t2713r1362b2802],
36	%	NN	PERCENT	%	amod	38	SENT_78	[p7l1163t2713r1362b2802],
37	female	JJ	O	female	amod	38	SENT_78	[p7l1408t2713r1723b2802],
38	)	NN	O	)	dep	34	SENT_78	[p7l1408t2713r1723b2802],
39	.	.	O	.	_	0	SENT_78	[p7l1408t2713r1723b2802],

1	The	DT	O	the	det	5	SENT_79	[p7l1763t2716r1914b2782],
2	average	JJ	O	average	amod	5	SENT_79	[p7l1955t2737r2147b2782, p7l9t2848r136b2913],
3	warfarin	NN	O	warfarin	nn	5	SENT_79	[p7l196t2828r522b2893],
4	weekly	JJ	SET	weekly	amod	5	SENT_79	[p7l580t2828r852b2913],
5	dose	NN	O	dose	nsubj	7	SENT_79	[p7l912t2828r1084b2893],
6	was	VBD	O	be	cop	7	SENT_79	[p7l1144t2848r1284b2893],
7	30.8	CD	NUMBER	30.8	_	0	SENT_79	[p7l1344t2829r1497b2893],
8	i	FW	O	i	nsubj	24	SENT_79	[p7l1533t2846r1580b2892],
9	13.9	CD	NUMBER	13.9	num	11	SENT_79	[p7l1619t2828r1768b2893],
10	mg/week	JJ	O	mg/week	amod	11	SENT_79	[p7l1803t2828r2149b2913],
11	(	NN	O	(	dep	8	SENT_79	[p7l10t2935r341b3024],
12	average	JJ	O	average	amod	14	SENT_79	[p7l10t2935r341b3024],
13	daily	JJ	SET	daily	amod	14	SENT_79	[p7l405t2938r590b3024],
14	dose	NN	O	dose	dep	8	SENT_79	[p7l652t2938r825b3004],
15	4.4	CD	NUMBER	4.4	dep	14	SENT_79	[p7l885t2939r994b3004],
16	:	:	O	:	_	0	SENT_79	[p7l1031t2957r1077b3003],
17	2.0	CD	NUMBER	2.0	num	19	SENT_79	[p7l1112t2939r1222b3004],
18	mg	NN	O	mg	nn	19	SENT_79	[p7l1255t2936r1427b3024],
19	)	NN	O	)	dep	14	SENT_79	[p7l1255t2936r1427b3024],
20	,	,	O	,	_	0	SENT_79	[p7l1255t2936r1427b3024],
21	and	CC	O	and	_	0	SENT_79	[p7l1492t2938r1630b3004],
22	stable	JJ	O	stable	amod	23	SENT_79	[p7l1692t2938r1915b3004],
23	INR	NN	O	inr	conj_and	19	SENT_79	[p7l1978t2940r2149b3004],
24	averaged	VBD	O	average	rcmod	7	SENT_79	[p7l9t3050r357b3135],
25	2.42	CD	NUMBER	2.42	number	26	SENT_79	[p7l410t3051r564b3115],
26	1	CD	NUMBER	1	num	27	SENT_79	[p7l601t3068r647b3115],
27	0.72	CD	NUMBER	0.72	dobj	24	SENT_79	[p7l683t3051r855b3115],
28	.	.	O	.	_	0	SENT_79	[p7l683t3051r855b3115],

1	CYP2C9	NN	O	cyp2c9	nn	5	SENT_80	[p7l917t3051r1253b3116],
2	*	NN	O	*	nn	5	SENT_80	[p7l1312t3051r1388b3115],
3	2	CD	NUMBER	2	num	5	SENT_80	[p7l1312t3051r1388b3115],
4	allele	NN	O	allele	nn	5	SENT_80	[p7l1445t3050r1648b3115],
5	frequencies	NNS	O	frequency	nsubj	26	SENT_80	[p7l1703t3050r2148b3135],
6	were	VBD	O	be	cop	26	SENT_80	[p7l6t3183r211b3227],
7	:	:	O	:	_	0	SENT_80	[p7l6t3183r211b3227],
8	C	NN	O	c	nn	26	SENT_80	[p7l286t3162r365b3241],
9	,	,	O	,	_	0	SENT_80	[p7l286t3162r365b3241],
10	90.6	CD	PERCENT	90.6	num	11	SENT_80	[p7l437t3161r671b3228],
11	%	NN	PERCENT	%	conj_and	8	SENT_80	[p7l437t3161r671b3228],
12	(	CD	NUMBER	(	num	13	SENT_80	[p7l752t3158r828b3247],
13	n	NN	O	n	dep	11	SENT_80	[p7l752t3158r828b3247],
14	=	JJ	O	=	amod	16	SENT_80	[p7l865t3192r911b3215],
15	386	CD	NUMBER	386	tmod	14	SENT_80	[p7l948t3158r1109b3247],
16	)	NN	O	)	dep	13	SENT_80	[p7l948t3158r1109b3247],
17	and	CC	O	and	_	0	SENT_80	[p7l1184t3161r1323b3227],
18	T	NN	O	t	nn	26	SENT_80	[p7l1391t3163r1468b3241],
19	,	,	O	,	_	0	SENT_80	[p7l1391t3163r1468b3241],
20	9.4	CD	PERCENT	9.4	num	21	SENT_80	[p7l1541t3162r1730b3228],
21	%	NN	PERCENT	%	appos	8	SENT_80	[p7l1541t3162r1730b3228],
22	(	CD	NUMBER	(	num	23	SENT_80	[p7l1811t3158r1886b3247],
23	n	NN	O	n	dep	21	SENT_80	[p7l1811t3158r1886b3247],
24	=	JJ	O	=	amod	26	SENT_80	[p7l1923t3192r1969b3215],
25	40	CD	NUMBER	40	tmod	24	SENT_80	[p7l2005t3158r2145b3247],
26	)	NN	O	)	_	0	SENT_80	[p7l2005t3158r2145b3247],
27	.	.	O	.	_	0	SENT_80	[p7l2005t3158r2145b3247],

1	CYP2C9	NN	O	cyp2c9	nn	5	SENT_81	[p7l11t3274r348b3340],
2	*	NN	O	*	nn	5	SENT_81	[p7l389t3274r465b3338],
3	2	CD	NUMBER	2	num	5	SENT_81	[p7l389t3274r465b3338],
4	genotype	NN	O	genotype	nn	5	SENT_81	[p7l503t3283r856b3360],
5	frequencies	NNS	O	frequency	nsubj	8	SENT_81	[p7l894t3274r1338b3360],
6	were	VBD	O	be	cop	8	SENT_81	[p7l1374t3295r1560b3339],
7	81.5	CD	PERCENT	81.5	num	8	SENT_81	[p7l1598t3273r1832b3339],
8	%	NN	PERCENT	%	_	0	SENT_81	[p7l1598t3273r1832b3339],
9	for	IN	O	for	_	0	SENT_81	[p7l1877t3274r1988b3339],
10	CC	NN	O	cc	prep_for	8	SENT_81	[p7l2026t3274r2150b3340],
11	and	CC	O	and	_	0	SENT_81	[p7l9t3386r147b3451],
12	18.5	CD	PERCENT	18.5	num	13	SENT_81	[p7l193t3385r426b3451],
13	%	NN	PERCENT	%	conj_and	8	SENT_81	[p7l193t3385r426b3451],
14	for	IN	O	for	_	0	SENT_81	[p7l477t3386r588b3451],
15	CT	NN	O	ct	prep_for	13	SENT_81	[p7l633t3386r772b3465],
16	;	:	O	;	_	0	SENT_81	[p7l633t3386r772b3465],
17	no	DT	O	no	det	19	SENT_81	[p7l817t3407r912b3451],
18	TT	NN	O	tt	nn	19	SENT_81	[p7l955t3388r1073b3450],
19	genotypes	NNS	O	genotype	nsubjpass	21	SENT_81	[p7l1116t3395r1504b3472],
20	were	VBD	O	be	auxpass	21	SENT_81	[p7l1547t3407r1732b3451],
21	observed	VBN	O	observe	parataxis	8	SENT_81	[p7l1779t3386r2145b3451],
22	.	.	O	.	_	0	SENT_81	[p7l1779t3386r2145b3451],

1	The	DT	O	the	det	6	SENT_82	[p7l6t3497r156b3562],
2	CYP2C9	NN	O	cyp2c9	nn	6	SENT_82	[p7l227t3498r649b3563],
3	*	NN	O	*	nn	6	SENT_82	[p7l227t3498r649b3563],
4	3	CD	NUMBER	3	num	6	SENT_82	[p7l227t3498r649b3563],
5	allele	NN	O	allele	nn	6	SENT_82	[p7l716t3497r920b3562],
6	frequencies	NNS	O	frequency	nsubj	11	SENT_82	[p7l986t3497r1431b3582],
7	were	VBD	O	be	cop	11	SENT_82	[p7l1495t3518r1681b3562],
8	A	DT	O	a	det	11	SENT_82	[p7l1746t3498r1838b3576],
9	,	,	O	,	_	0	SENT_82	[p7l1746t3498r1838b3576],
10	94.8	CD	PERCENT	94.8	num	11	SENT_82	[p7l1906t3498r2141b3563],
11	%	NN	PERCENT	%	_	0	SENT_82	[p7l1906t3498r2141b3563],
12	(	CD	NUMBER	(	num	13	SENT_82	[p7l11t3605r86b3694],
13	n	NN	O	n	dep	11	SENT_82	[p7l11t3605r86b3694],
14	=	JJ	O	=	amod	13	SENT_82	[p7l123t3638r169b3662],
15	404	CD	NUMBER	404	tmod	14	SENT_82	[p7l205t3605r367b3694],
16	)	NN	O	)	dep	13	SENT_82	[p7l205t3605r367b3694],
17	and	CC	O	and	_	0	SENT_82	[p7l412t3608r550b3674],
18	C	NN	O	c	conj_and	16	SENT_82	[p7l591t3609r670b3688],
19	,	,	O	,	_	0	SENT_82	[p7l591t3609r670b3688],
20	5.2	CD	PERCENT	5.2	num	21	SENT_82	[p7l710t3608r901b3674],
21	%	NN	PERCENT	%	attr	11	SENT_82	[p7l710t3608r901b3674],
22	(	CD	NUMBER	(	num	23	SENT_82	[p7l951t3605r1026b3694],
23	n	NN	O	n	dep	21	SENT_82	[p7l951t3605r1026b3694],
24	=	JJ	O	=	amod	26	SENT_82	[p7l1064t3638r1110b3662],
25	22	CD	NUMBER	22	tmod	24	SENT_82	[p7l1146t3605r1286b3694],
26	)	NN	O	)	dep	23	SENT_82	[p7l1146t3605r1286b3694],
27	.	.	O	.	_	0	SENT_82	[p7l1146t3605r1286b3694],

1	CYP2C9	NN	O	cyp2c9	_	0	SENT_83	[p7l1333t3609r1754b3674],
2	*	CD	NUMBER	*	number	3	SENT_83	[p7l1333t3609r1754b3674],
3	3	CD	NUMBER	3	num	5	SENT_83	[p7l1333t3609r1754b3674],
4	genotype	NN	O	genotype	nn	5	SENT_83	[p7l1795t3617r2148b3694],
5	frequencies	NNS	O	frequency	nsubj	8	SENT_83	[p7l7t3721r451b3806],
6	were	VBD	O	be	cop	8	SENT_83	[p7l476t3741r661b3786],
7	89.9	CD	PERCENT	89.9	num	8	SENT_83	[p7l688t3722r923b3786],
8	%	NN	PERCENT	%	rcmod	1	SENT_83	[p7l688t3722r923b3786],
9	for	IN	O	for	_	0	SENT_83	[p7l956t3721r1067b3786],
10	AA	NN	O	aa	prep_for	8	SENT_83	[p7l1091t3722r1259b3799],
11	,	,	O	,	_	0	SENT_83	[p7l1091t3722r1259b3799],
12	for	IN	O	for	_	0	SENT_83	[p7l1285t3721r1396b3786],
13	and	CC	O	and	cc	14	SENT_83	[p7l1423t3721r1562b3786],
14	10.1	CD	PERCENT	10.1	num	15	SENT_83	[p7l1590t3721r1735b3786],
15	%	NN	PERCENT	%	prep_for	8	SENT_83	[p7l1752t3722r1822b3786],
16	for	IN	O	for	_	0	SENT_83	[p7l1855t3721r1966b3786],
17	AC	NN	O	ac	prep_for	15	SENT_83	[p7l1991t3721r2147b3800],
18	;	:	O	;	_	0	SENT_83	[p7l1991t3721r2147b3800],

1	no	DT	O	no	det	3	SENT_84	[p8l7t40r101b85],
2	CC	NN	O	cc	nn	3	SENT_84	[p8l156t20r280b85],
3	genotypes	NNS	O	genotype	nsubjpass	5	SENT_84	[p8l332t28r720b104],
4	were	VBD	O	be	auxpass	5	SENT_84	[p8l772t40r957b85],
5	observed	VBN	O	observe	_	0	SENT_84	[p8l1011t19r1378b85],
6	.	.	O	.	_	0	SENT_84	[p8l1011t19r1378b85],

1	The	DT	O	the	det	2	SENT_85	[p8l1433t19r1583b85],
2	genotypes	NNS	O	genotype	nsubj	6	SENT_85	[p8l1637t28r2025b104],
3	at	IN	O	at	_	0	SENT_85	[p8l2079t28r2149b85],
4	both	DT	O	both	det	5	SENT_85	[p8l6t130r182b195],
5	loci	NNS	O	locus	prep_at	2	SENT_85	[p8l216t130r352b195],
6	were	VBD	O	be	_	0	SENT_85	[p8l385t151r570b195],
7	in	IN	O	in	_	0	SENT_85	[p8l605t130r677b195],
8	Hardy	NNP	LOCATION	Hardy	prep_in	6	SENT_85	[p8l710t130r1385b215],
9	.	.	O	.	_	0	SENT_85	[p8l710t130r1385b215],

1	—	NN	O	—	_	0	SENT_86	[p8l710t130r1385b215],
2	.	.	O	.	_	0	SENT_86	[p8l710t130r1385b215],

1	Weinberg	NNP	PERSON	Weinberg	_	0	SENT_87	[p8l710t130r1385b215],
2	equilibrium	NN	O	equilibrium	dep	1	SENT_87	[p8l1420t130r1888b215],
3	.	.	O	.	_	0	SENT_87	[p8l1420t130r1888b215],

1	Combining	VBG	O	combine	partmod	14	SENT_88	[p8l112t241r539b326],
2	the	DT	O	the	det	3	SENT_88	[p8l570t241r689b306],
3	*	NN	O	*	dobj	1	SENT_88	[p8l725t242r808b306],
4	2	CD	NUMBER	2	dep	3	SENT_88	[p8l725t242r808b306],
5	and	CC	O	and	_	0	SENT_88	[p8l840t241r979b306],
6	*	CD	NUMBER	*	number	7	SENT_88	[p8l1013t242r1093b306],
7	3	CD	NUMBER	3	num	9	SENT_88	[p8l1013t242r1093b306],
8	CYPZC9	NN	O	cypzc9	nn	9	SENT_88	[p8l1131t242r1468b307],
9	loci	NNS	O	locus	dobj	1	SENT_88	[p8l1497t241r1654b320],
10	,	,	O	,	_	0	SENT_88	[p8l1497t241r1654b320],
11	9	CD	NUMBER	9	num	12	SENT_88	[p8l1689t242r1728b307],
12	genotypes	NNS	O	genotype	nsubj	14	SENT_88	[p8l1760t250r2148b326],
13	were	VBD	O	be	cop	14	SENT_88	[p8l6t374r190b418],
14	possible	JJ	O	possible	_	0	SENT_88	[p8l217t353r546b439],
15	.	.	O	.	_	0	SENT_88	[p8l217t353r546b439],

1	Of	IN	O	of	_	0	SENT_89	[p8l579t353r682b419],
2	these	DT	O	these	prep_of	9	SENT_89	[p8l703t353r924b432],
3	,	,	O	,	_	0	SENT_89	[p8l703t353r924b432],
4	only	RB	O	only	quantmod	5	SENT_89	[p8l954t353r1119b438],
5	4	CD	NUMBER	4	num	7	SENT_89	[p8l1144t354r1185b417],
6	two-loci	JJ	O	two-loci	amod	7	SENT_89	[p8l1211t353r1522b418],
7	genotypes	NNS	O	genotype	nsubjpass	9	SENT_89	[p8l1548t362r1937b439],
8	were	VBD	O	be	auxpass	9	SENT_89	[p8l1963t374r2148b418],
9	observed	VBN	O	observe	_	0	SENT_89	[p8l8t465r374b530],
10	.	.	O	.	_	0	SENT_89	[p8l8t465r374b530],

1	Their	PRP$	O	they	poss	3	SENT_90	[p8l420t465r632b530],
2	genotype	NN	O	genotype	nn	3	SENT_90	[p8l674t474r1027b551],
3	distributions	NNS	O	distribution	nsubj	6	SENT_90	[p8l1072t464r1554b530],
4	were	VBD	O	be	cop	6	SENT_90	[p8l1597t486r1802b530],
5	:	:	O	:	_	0	SENT_90	[p8l1597t486r1802b530],
6	CC/AA	NN	O	cc/aa	_	0	SENT_90	[p8l1851t465r2149b531],
7	(	CD	NUMBER	(	num	6	SENT_90	[p8l11t574r401b663],
8	wild	JJ	O	wild	amod	14	SENT_90	[p8l11t574r401b663],
9	—	NN	O	—	nn	14	SENT_90	[p8l11t574r401b663],
10	type	NN	O	type	nn	14	SENT_90	[p8l11t574r401b663],
11	[	CD	NUMBER	[	num	14	SENT_90	[p8l504t574r736b663],
12	WT	NNP	O	WT	nn	14	SENT_90	[p8l504t574r736b663],
13	]	CD	NUMBER	]	num	14	SENT_90	[p8l504t574r736b663],
14	)	NN	O	)	dep	6	SENT_90	[p8l504t574r736b663],
15	=	JJ	O	=	advmod	14	SENT_90	[p8l776t607r822b630],
16	71.4	CD	PERCENT	71.4	num	17	SENT_90	[p8l857t577r1122b656],
17	%	NN	PERCENT	%	dep	15	SENT_90	[p8l857t577r1122b656],
18	,	,	O	,	_	0	SENT_90	[p8l857t577r1122b656],
19	CT/AA	NN	O	ct/aa	appos	6	SENT_90	[p8l1223t577r1517b643],
20	=	JJ	O	=	amod	19	SENT_90	[p8l1553t607r1599b630],
21	18.3	CD	PERCENT	18.3	num	22	SENT_90	[p8l1639t577r1899b656],
22	%	NN	PERCENT	%	dep	20	SENT_90	[p8l1639t577r1899b656],
23	,	,	O	,	_	0	SENT_90	[p8l1639t577r1899b656],
24	CC	NN	O	cc	conj_and	6	SENT_90	[p8l2000t577r2150b643],
25	/	:	O	/	punct	27	SENT_90	[p8l2000t577r2150b643],
26	AC	NN	O	ac	dep	27	SENT_90	[p8l7t689r144b754],
27	=	JJ	O	=	dep	24	SENT_90	[p8l178t718r225b741],
28	9.4	CD	PERCENT	9.4	number	29	SENT_90	[p8l262t689r480b767],
29	%	NN	PERCENT	%	amod	24	SENT_90	[p8l262t689r480b767],
30	,	,	O	,	_	0	SENT_90	[p8l262t689r480b767],
31	and	CC	O	and	_	0	SENT_90	[p8l523t688r662b753],
32	CT/AC	NN	O	ct/ac	conj_and	6	SENT_90	[p8l703t689r987b754],
33	=	JJ	O	=	amod	32	SENT_90	[p8l1022t718r1068b741],
34	1.0	CD	PERCENT	1.0	num	35	SENT_90	[p8l1107t689r1321b753],
35	%	NN	PERCENT	%	dep	33	SENT_90	[p8l1107t689r1321b753],
36	.	.	O	.	_	0	SENT_90	[p8l1107t689r1321b753],

1	Based	VBN	O	base	_	0	SENT_91	[p8l1365t688r1600b753],
2	on	IN	O	on	prepc_based_on	17	SENT_91	[p8l1640t709r1735b753],
3	the	DT	O	the	det	5	SENT_91	[p8l1774t688r1893b753],
4	genotype	NN	O	genotype	nn	5	SENT_91	[p8l1934t709r2147b773, p8l7t808r171b884],
5	frequencies	NNS	O	frequency	pobj	17	SENT_91	[p8l208t799r653b884],
6	observed	VBN	O	observe	partmod	5	SENT_91	[p8l691t799r1039b864],
7	at	IN	O	at	_	0	SENT_91	[p8l1077t808r1146b864],
8	the	DT	O	the	det	10	SENT_91	[p8l1183t799r1302b864],
9	two	CD	NUMBER	two	num	10	SENT_91	[p8l1339t808r1478b864],
10	loci	NNS	O	locus	prep_at	6	SENT_91	[p8l1516t799r1673b878],
11	,	,	O	,	_	0	SENT_91	[p8l1516t799r1673b878],
12	all	DT	O	all	det	15	SENT_91	[p8l1713t799r1803b864],
13	possible	JJ	O	possible	amod	15	SENT_91	[p8l1838t799r2147b884],
14	two-locus	NN	O	two-locus	nn	15	SENT_91	[p8l7t911r376b976],
15	genotypes	NNS	O	genotype	nsubjpass	17	SENT_91	[p8l411t920r799b996],
16	were	VBD	O	be	auxpass	17	SENT_91	[p8l833t931r1018b976],
17	observed	VBN	O	observe	_	0	SENT_91	[p8l1054t911r1421b976],
18	.	.	O	.	_	0	SENT_91	[p8l1054t911r1421b976],

1	For	IN	O	for	_	0	SENT_92	[p8l109t1024r247b1087],
2	the	DT	O	the	det	4	SENT_92	[p8l275t1022r394b1087],
3	VKORCI	NN	O	vkorcus	nn	4	SENT_92	[p8l427t1022r797b1087],
4	alleles	NNS	O	allele	prep_for	17	SENT_92	[p8l833t1022r1093b1100],
5	,	,	O	,	_	0	SENT_92	[p8l833t1022r1093b1100],
6	the	DT	O	the	det	9	SENT_92	[p8l1123t1022r1242b1087],
7	C	NN	O	c	nn	9	SENT_92	[p8l1274t1022r1334b1087],
8	allele	NN	O	allele	nn	9	SENT_92	[p8l1362t1022r1566b1087],
9	frequency	NN	O	frequency	nsubj	17	SENT_92	[p8l1595t1022r1980b1107],
10	was	VBD	O	be	cop	17	SENT_92	[p8l2007t1042r2147b1087],
11	62.2	CD	PERCENT	62.2	num	12	SENT_92	[p8l9t1133r244b1199],
12	%	NN	PERCENT	%	nn	17	SENT_92	[p8l9t1133r244b1199],
13	(	CD	NUMBER	(	num	14	SENT_92	[p8l283t1130r358b1219],
14	n	NN	O	n	dep	12	SENT_92	[p8l283t1130r358b1219],
15	=	JJ	O	=	amod	17	SENT_92	[p8l396t1163r441b1186],
16	265	CD	NUMBER	265	tmod	15	SENT_92	[p8l477t1130r664b1219],
17	)	NN	O	)	_	0	SENT_92	[p8l477t1130r664b1219],
18	,	,	O	,	_	0	SENT_92	[p8l477t1130r664b1219],
19	and	CC	O	and	_	0	SENT_92	[p8l695t1133r833b1199],
20	the	DT	O	the	det	23	SENT_92	[p8l860t1133r979b1199],
21	T	NN	O	t	nn	23	SENT_92	[p8l1008t1135r1065b1198],
22	allele	NN	O	allele	nn	23	SENT_92	[p8l1093t1133r1297b1199],
23	frequency	NN	O	frequency	nsubj	31	SENT_92	[p8l1325t1133r1711b1219],
24	was	VBD	O	be	cop	31	SENT_92	[p8l1736t1154r1877b1199],
25	37.8	CD	PERCENT	37.8	num	26	SENT_92	[p8l1905t1134r2140b1199],
26	%	NN	PERCENT	%	nn	31	SENT_92	[p8l1905t1134r2140b1199],
27	(	CD	NUMBER	(	num	28	SENT_92	[p8l12t1241r88b1330],
28	n	NN	O	n	dep	26	SENT_92	[p8l12t1241r88b1330],
29	=	JJ	O	=	amod	31	SENT_92	[p8l125t1274r171b1298],
30	161	CD	NUMBER	161	tmod	29	SENT_92	[p8l210t1241r391b1330],
31	)	NN	O	)	conj_and	17	SENT_92	[p8l210t1241r391b1330],
32	.	.	O	.	_	0	SENT_92	[p8l210t1241r391b1330],

1	VKORCI	NNP	O	VKORCI	nn	3	SENT_93	[p8l448t1245r817b1310],
2	genotype	NN	O	genotype	nn	3	SENT_93	[p8l872t1253r1224b1330],
3	frequencies	NNS	O	frequency	nsubj	4	SENT_93	[p8l1274t1244r1718b1330],
4	were	VBD	O	be	_	0	SENT_93	[p8l1765t1265r1971b1310],
5	:	:	O	:	_	0	SENT_93	[p8l1765t1265r1971b1310],
6	CC	NN	O	cc	dep	31	SENT_93	[p8l2025t1245r2149b1311],
7	36.6	CD	PERCENT	36.6	num	8	SENT_93	[p8l9t1356r244b1422],
8	%	NN	PERCENT	%	dep	6	SENT_93	[p8l9t1356r244b1422],
9	(	CD	NUMBER	(	num	10	SENT_93	[p8l330t1353r405b1442],
10	n	NN	O	n	dep	6	SENT_93	[p8l330t1353r405b1442],
11	=	JJ	O	=	amod	13	SENT_93	[p8l442t1386r489b1409],
12	78	CD	NUMBER	78	tmod	11	SENT_93	[p8l524t1353r666b1442],
13	)	NN	O	)	dep	10	SENT_93	[p8l524t1353r666b1442],
14	;	:	O	;	_	0	SENT_93	[p8l524t1353r666b1442],
15	CT	NNP	O	CT	dep	10	SENT_93	[p8l745t1357r863b1423],
16	50.7	CD	PERCENT	50.7	num	17	SENT_93	[p8l937t1356r1172b1422],
17	%	NN	PERCENT	%	dep	15	SENT_93	[p8l937t1356r1172b1422],
18	(	CD	NUMBER	(	num	19	SENT_93	[p8l1258t1353r1333b1442],
19	n	NN	O	n	dep	15	SENT_93	[p8l1258t1353r1333b1442],
20	=	JJ	O	=	amod	22	SENT_93	[p8l1370t1386r1416b1410],
21	108	CD	NUMBER	108	tmod	20	SENT_93	[p8l1455t1353r1638b1442],
22	)	NN	O	)	dep	19	SENT_93	[p8l1455t1353r1638b1442],
23	;	:	O	;	_	0	SENT_93	[p8l1455t1353r1638b1442],
24	TT	NN	O	tt	dep	10	SENT_93	[p8l1714t1358r1831b1421],
25	12.7	CD	PERCENT	12.7	num	26	SENT_93	[p8l1908t1357r2140b1422],
26	%	NN	PERCENT	%	dep	24	SENT_93	[p8l1908t1357r2140b1422],
27	(	CD	NUMBER	(	num	28	SENT_93	[p8l12t1465r88b1554],
28	n	NN	O	n	dep	24	SENT_93	[p8l12t1465r88b1554],
29	=	JJ	O	=	amod	31	SENT_93	[p8l125t1498r171b1522],
30	27	CD	NUMBER	27	num	31	SENT_93	[p8l207t1465r346b1554],
31	)	NN	O	)	parataxis	4	SENT_93	[p8l207t1465r346b1554],
32	.	.	O	.	_	0	SENT_93	[p8l207t1465r346b1554],

1	These	DT	O	these	det	2	SENT_94	[p8l389t1468r620b1534],
2	genotypes	NNS	O	genotype	nsubj	4	SENT_94	[p8l661t1477r1049b1554],
3	also	RB	O	also	advmod	4	SENT_94	[p8l1092t1468r1240b1534],
4	were	VBD	O	be	_	0	SENT_94	[p8l1280t1489r1465b1534],
5	in	IN	O	in	_	0	SENT_94	[p8l1507t1468r1579b1533],
6	Hardy	NNP	O	Hardy	prep_in	4	SENT_94	[p8l1618t1468r2146b1554, p8l8t1580r179b1665],
7	.	.	O	.	_	0	SENT_94	[p8l1618t1468r2146b1554, p8l8t1580r179b1665],

1	—	NN	O	—	_	0	SENT_95	[p8l1618t1468r2146b1554, p8l8t1580r179b1665],
2	.	.	O	.	_	0	SENT_95	[p8l1618t1468r2146b1554, p8l8t1580r179b1665],

1	Weinberg	NNP	PERSON	Weinberg	_	0	SENT_96	[p8l1618t1468r2146b1554, p8l8t1580r179b1665],
2	equilibrium	NN	O	equilibrium	dep	1	SENT_96	[p8l214t1580r681b1665],
3	.	.	O	.	_	0	SENT_96	[p8l214t1580r681b1665],

1	Warfarin	NNP	O	Warfarin	_	0	SENT_97	[p8l8t1804r359b1869],
2	dose	NN	O	dose	dep	1	SENT_97	[p8l394t1804r566b1869],
3	by	IN	O	by	_	0	SENT_97	[p8l601t1804r692b1889],
4	genotype	NN	O	genotype	prep_by	2	SENT_97	[p8l726t1813r1079b1889],

1	C	NN	O	c	_	0	SENT_98	[p8l13t2029r73b2094],
2	YP2	NN	O	yp2	nn	3	SENT_98	[p8l78t2029r237b2093],
3	C9	NN	O	c9	dep	1	SENT_98	[p8l248t2029r350b2094],

1	The	DT	O	the	det	3	SENT_99	[p8l8t2252r158b2317],
2	stable	JJ	O	stable	amod	3	SENT_99	[p8l188t2252r412b2317],
3	maintenance	NN	O	maintenance	nsubjpass	23	SENT_99	[p8l440t2252r934b2317],
4	Warfarin	NNP	O	Warfarin	nn	7	SENT_99	[p8l963t2252r1289b2317],
5	dose	NN	O	dose	nn	7	SENT_99	[p8l1318t2252r1490b2317],
6	(	NN	O	(	nn	7	SENT_99	[p8l1524t2249r1726b2338],
7	INR	NN	O	inr	npadvmod	3	SENT_99	[p8l1524t2249r1726b2338],
8	between	IN	O	between	_	0	SENT_99	[p8l1754t2252r2079b2318],
9	2	CD	NUMBER	2	prep_between	7	SENT_99	[p8l2106t2253r2148b2317],
10	and	CC	O	and	_	0	SENT_99	[p8l11t2362r149b2428],
11	3	CD	DATE	3	prep_between	7	SENT_99	[p8l183t2364r221b2428],
12	for	IN	O	for	_	0	SENT_99	[p8l257t2363r368b2428],
13	a	DT	O	a	det	14	SENT_99	[p8l403t2383r443b2428],
14	period	NN	O	period	prep_for	3	SENT_99	[p8l475t2362r726b2447],
15	>	JJR	O	>	amod	14	SENT_99	[p8l761t2363r850b2427],
16	1	CD	DURATION	1	num	17	SENT_99	[p8l761t2363r850b2427],
17	month	NN	NUMBER	month	tmod	15	SENT_99	[p8l888t2360r1169b2447],
18	)	RB	O	)	advmod	3	SENT_99	[p8l888t2360r1169b2447],
19	by	IN	O	by	_	0	SENT_99	[p8l1206t2362r1298b2447],
20	CYP2C9	NN	O	cyp2c9	nn	21	SENT_99	[p8l1335t2363r1672b2428],
21	genotype	NN	O	genotype	prep_by	3	SENT_99	[p8l1705t2372r2056b2447],
22	is	VBZ	O	be	auxpass	23	SENT_99	[p8l2091t2362r2147b2428],
23	given	VBN	O	give	_	0	SENT_99	[p8l9t2474r215b2559],
24	in	IN	O	in	_	0	SENT_99	[p8l275t2474r347b2538],
25	Fig	NN	O	fig	prep_in	23	SENT_99	[p8l406t2474r548b2559],
26	.	.	O	.	_	0	SENT_99	[p8l406t2474r548b2559],

1	1	LS	NUMBER	1	_	0	SENT_100	[p8l589t2474r646b2539],
2	.	.	O	.	_	0	SENT_100	[p8l589t2474r646b2539],

1	For	IN	O	for	_	0	SENT_101	[p8l709t2476r846b2539],
2	both	CC	O	both	preconj	4	SENT_101	[p8l906t2474r1083b2539],
3	the	DT	O	the	det	4	SENT_101	[p8l1143t2474r1262b2539],
4	*	NN	O	*	prep_for	12	SENT_101	[p8l1329t2475r1410b2538],
5	2	CD	NUMBER	2	num	4	SENT_101	[p8l1329t2475r1410b2538],
6	and	CC	O	and	_	0	SENT_101	[p8l1474t2474r1612b2539],
7	*	CD	NUMBER	*	number	8	SENT_101	[p8l1677t2475r1756b2539],
8	3	CD	NUMBER	3	num	9	SENT_101	[p8l1677t2475r1756b2539],
9	variants	NNS	O	variant	conj_and	4	SENT_101	[p8l1820t2474r2146b2553],
10	,	,	O	,	_	0	SENT_101	[p8l1820t2474r2146b2553],
11	heterozygotes	NNS	O	heterozygote	nsubj	12	SENT_101	[p8l8t2586r546b2671],
12	had	VBD	O	have	_	0	SENT_101	[p8l597t2586r738b2651],
13	a	DT	O	a	det	17	SENT_101	[p8l789t2606r829b2651],
14	signiﬁcantly	RB	O	signiﬁcantly	advmod	15	SENT_101	[p8l879t2586r1339b2671],
15	lower	JJR	O	lower	amod	17	SENT_101	[p8l1387t2586r1604b2651],
16	maintenance	NN	O	maintenance	nn	17	SENT_101	[p8l1652t2586r2146b2651],
17	dose	NN	O	dose	dobj	12	SENT_101	[p8l10t2697r182b2762],
18	than	IN	O	than	_	0	SENT_101	[p8l221t2697r391b2762],
19	WT	JJ	O	wt	amod	20	SENT_101	[p8l427t2699r575b2762],
20	homozygotes	NNS	O	homozygote	prep_than	12	SENT_101	[p8l611t2697r1138b2782],
21	:	:	O	:	_	0	SENT_101	[p8l611t2697r1138b2782],
22	for	IN	O	for	_	0	SENT_101	[p8l1179t2697r1290b2762],
23	*	NN	O	*	prep_for	48	SENT_101	[p8l1331t2698r1433b2776],
24	2	CD	NUMBER	2	num	23	SENT_101	[p8l1331t2698r1433b2776],
25	,	,	O	,	_	0	SENT_101	[p8l1331t2698r1433b2776],
26	the	DT	O	the	det	29	SENT_101	[p8l1472t2697r1592b2762],
27	mean	JJ	O	mean	amod	29	SENT_101	[p8l1629t2717r1841b2762],
28	weekly	JJ	SET	weekly	amod	29	SENT_101	[p8l1877t2697r2148b2782],
29	dose	NN	O	dose	nsubj	48	SENT_101	[p8l10t2807r182b2872],
30	for	IN	O	for	_	0	SENT_101	[p8l232t2808r343b2872],
31	the	DT	O	the	det	33	SENT_101	[p8l391t2807r510b2872],
32	CC	NN	O	cc	nn	33	SENT_101	[p8l563t2808r687b2873],
33	genotype	NN	O	genotype	prep_for	29	SENT_101	[p8l735t2816r1088b2892],
34	was	VBD	O	be	cop	48	SENT_101	[p8l1138t2828r1277b2872],
35	31.8	CD	NUMBER	31.8	num	36	SENT_101	[p8l1328t2808r1479b2872],
36	mg/week	JJ	O	mg/week	nn	48	SENT_101	[p8l1514t2807r1860b2892],
37	versus	CC	O	versus	prep	36	SENT_101	[p8l1908t2828r2147b2872],
38	26.6	CD	NUMBER	26.6	num	39	SENT_101	[p8l8t2918r161b2984],
39	mg/week	NN	O	mg/week	dep	37	SENT_101	[p8l196t2919r541b3004],
40	for	IN	O	for	_	0	SENT_101	[p8l566t2919r678b2984],
41	the	DT	O	the	det	45	SENT_101	[p8l703t2919r823b2984],
42	CT	NNP	O	CT	nn	45	SENT_101	[p8l852t2919r971b2985],
43	genotype	NN	O	genotype	nn	45	SENT_101	[p8l996t2928r1349b3004],
44	(	CD	NUMBER	(	num	45	SENT_101	[p8l1380t2916r1470b3004],
45	P	NN	O	p	prep_for	39	SENT_101	[p8l1380t2916r1470b3004],
46	=	JJ	O	=	amod	48	SENT_101	[p8l1503t2949r1549b2972],
47	0.004	CD	NUMBER	0.004	tmod	46	SENT_101	[p8l1585t2916r1836b3005],
48	)	NN	O	)	parataxis	12	SENT_101	[p8l1585t2916r1836b3005],
49	.	.	O	.	_	0	SENT_101	[p8l1585t2916r1836b3005],

1	For	IN	O	for	_	0	SENT_102	[p8l1865t2920r2002b2984],
2	the	DT	O	the	det	5	SENT_102	[p8l2027t2919r2147b2984],
3	*	NN	O	*	nn	5	SENT_102	[p8l12t3031r92b3095],
4	3	CD	NUMBER	3	num	5	SENT_102	[p8l12t3031r92b3095],
5	variant	NN	O	variant	prep_for	15	SENT_102	[p8l122t3030r413b3109],
6	,	,	O	,	_	0	SENT_102	[p8l122t3030r413b3109],
7	the	DT	O	the	det	10	SENT_102	[p8l443t3030r562b3095],
8	mean	JJ	O	mean	amod	10	SENT_102	[p8l592t3051r803b3095],
9	weekly	JJ	SET	weekly	amod	10	SENT_102	[p8l830t3030r1102b3115],
10	dose	NN	O	dose	nsubj	15	SENT_102	[p8l1130t3030r1302b3095],
11	for	IN	O	for	_	0	SENT_102	[p8l1332t3031r1444b3095],
12	the	DT	O	the	det	14	SENT_102	[p8l1470t3030r1590b3095],
13	AA	NNP	O	AA	nn	14	SENT_102	[p8l1619t3031r1766b3095],
14	genotype	NN	O	genotype	prep_for	10	SENT_102	[p8l1794t3039r2146b3115],
15	was	VBD	O	be	_	0	SENT_102	[p8l8t3162r148b3207],
16	31.9	CD	NUMBER	31.9	advmod	15	SENT_102	[p8l204t3142r356b3207],
17	mg/week	JJ	O	mg/week	dep	27	SENT_102	[p8l390t3142r736b3227],
18	versus	CC	O	versus	prep	17	SENT_102	[p8l790t3162r1029b3207],
19	21.4	CD	NUMBER	21.4	num	20	SENT_102	[p8l1085t3142r1238b3207],
20	mg/week	NN	O	mg/week	dep	18	SENT_102	[p8l1272t3142r1617b3227],
21	for	IN	O	for	_	0	SENT_102	[p8l1672t3142r1783b3207],
22	the	DT	O	the	det	24	SENT_102	[p8l1837t3142r1956b3207],
23	AC	NN	O	ac	nn	24	SENT_102	[p8l2012t3142r2149b3207],
24	genotype	NN	O	genotype	prep_for	20	SENT_102	[p8l9t3262r361b3339],
25	(	CD	NUMBER	(	num	26	SENT_102	[p8l438t3250r528b3339],
26	P	NN	O	p	dep	27	SENT_102	[p8l438t3250r528b3339],
27	<	JJR	O	<	dep	15	SENT_102	[p8l561t3271r607b3318],
28	0.001	CD	NUMBER	0.001	num	29	SENT_102	[p8l643t3250r895b3339],
29	)	NN	O	)	dep	27	SENT_102	[p8l643t3250r895b3339],
30	.	.	O	.	_	0	SENT_102	[p8l643t3250r895b3339],

1	Warfarin	NNP	O	Warfarin	nn	2	SENT_103	[p8l969t3253r1321b3319],
2	dose	NN	O	dose	nsubj	4	SENT_103	[p8l1392t3253r1565b3319],
3	also	RB	O	also	advmod	4	SENT_103	[p8l1639t3253r1786b3319],
4	showed	VBD	O	show	_	0	SENT_103	[p8l1860t3253r2148b3319],
5	signiﬁcant	JJ	O	signiﬁcant	amod	6	SENT_103	[p8l10t3365r398b3449],
6	variation	NN	O	variation	dobj	4	SENT_103	[p8l436t3364r782b3430],
7	by	IN	O	by	_	0	SENT_103	[p8l819t3365r911b3449],
8	combinatorial	JJ	O	combinatorial	amod	10	SENT_103	[p8l949t3365r1488b3430],
9	two-locus	NN	O	two-locus	nn	10	SENT_103	[p8l1525t3365r1895b3430],
10	genotype	NN	O	genotype	prep_by	4	SENT_103	[p8l1934t3385r2146b3450, p8l9t3484r193b3560],
11	:	:	O	:	_	0	SENT_103	[p8l1934t3385r2146b3450, p8l9t3484r193b3560],
12	the	DT	O	the	det	14	SENT_103	[p8l236t3475r355b3540],
13	mean	NN	O	mean	nn	14	SENT_103	[p8l395t3496r606b3540],
14	dose	NN	O	dose	nsubj	23	SENT_103	[p8l646t3475r818b3540],
15	for	IN	O	for	_	0	SENT_103	[p8l859t3476r970b3540],
16	wild	JJ	O	wild	amod	19	SENT_103	[p8l1007t3475r1367b3560],
17	—	NN	O	—	nn	19	SENT_103	[p8l1007t3475r1367b3560],
18	type	NN	O	type	nn	19	SENT_103	[p8l1007t3475r1367b3560],
19	alleles	NNS	O	allele	prep_for	14	SENT_103	[p8l1409t3475r1648b3540],
20	at	IN	O	at	_	0	SENT_103	[p8l1690t3484r1759b3540],
21	both	DT	O	both	det	22	SENT_103	[p8l1797t3475r1973b3540],
22	loci	NNS	O	locus	prep_at	19	SENT_103	[p8l2011t3475r2148b3540],
23	(	VBP	O	(	parataxis	4	SENT_103	[p8l12t3583r375b3672],
24	CC/AA	NN	O	cc/aa	nn	25	SENT_103	[p8l12t3583r375b3672],
25	)	NN	O	)	nsubj	28	SENT_103	[p8l12t3583r375b3672],
26	was	VBD	O	be	cop	28	SENT_103	[p8l421t3607r561b3652],
27	32.2	CD	NUMBER	32.2	num	28	SENT_103	[p8l606t3587r759b3652],
28	mg/week	NN	O	mg/week	ccomp	23	SENT_103	[p8l792t3586r1138b3672],
29	compared	VBN	O	compare	_	0	SENT_103	[p8l1183t3586r1567b3672],
30	with	IN	O	with	prepc_compared_with	28	SENT_103	[p8l1609t3586r1776b3652],
31	27.2	CD	NUMBER	27.2	num	32	SENT_103	[p8l1819t3587r1973b3652],
32	mg	NN	O	mg	pobj	28	SENT_103	[p8l2006t3587r2149b3672],
33	/	:	O	/	punct	34	SENT_103	[p8l2006t3587r2149b3672],
34	week	NN	DURATION	week	dep	32	SENT_103	[p8l8t3698r209b3764],
35	for	IN	O	for	_	0	SENT_103	[p8l241t3699r353b3764],
36	CT/AA	NNP	O	CT/AA	nn	38	SENT_103	[p8l387t3699r680b3765],
37	(	CD	NUMBER	(	num	38	SENT_103	[p8l716t3695r806b3784],
38	P	NN	O	p	prep_for	34	SENT_103	[p8l716t3695r806b3784],
39	=	JJ	O	=	amod	34	SENT_103	[p8l839t3728r885b3752],
40	0.04	CD	NUMBER	0.04	tmod	39	SENT_103	[p8l921t3699r1074b3764],
41	vs.	CC	O	vs.	prep	32	SENT_103	[p8l1106t3719r1201b3764],
42	WT	NNP	O	WT	nn	43	SENT_103	[p8l1236t3695r1438b3784],
43	)	NNP	O	)	dep	41	SENT_103	[p8l1236t3695r1438b3784],
44	,	,	O	,	_	0	SENT_103	[p8l1236t3695r1438b3784],
45	3.28	CD	NUMBER	3.28	num	46	SENT_103	[p8l1473t3699r1625b3764],
46	mg/week	NN	O	mg/week	appos	43	SENT_103	[p8l1659t3698r2005b3784],
47	for	IN	O	for	prep	46	SENT_103	[p8l2037t3699r2149b3764],

1	CC/AC	NN	O	cc/ac	_	0	SENT_104	[p9l11t22r300b88],
2	(	CD	NUMBER	(	num	3	SENT_104	[p9l375t19r464b107],
3	P	NN	O	p	dep	1	SENT_104	[p9l375t19r464b107],
4	=	JJ	O	=	amod	1	SENT_104	[p9l497t52r544b75],
5	0.003	CD	NUMBER	0.003	num	6	SENT_104	[p9l580t19r833b107],
6	)	NN	O	)	dep	4	SENT_104	[p9l580t19r833b107],
7	,	,	O	,	_	0	SENT_104	[p9l580t19r833b107],
8	and	CC	O	and	cc	9	SENT_104	[p9l909t22r1048b87],
9	6.0	CD	NUMBER	6.0	num	10	SENT_104	[p9l1121t21r1228b87],
10	mg/Week	NN	O	mg/week	appos	1	SENT_104	[p9l1262t21r1608b107],
11	for	IN	O	for	_	0	SENT_104	[p9l1680t22r1791b87],
12	CT/AC	NN	O	ct/ac	prep_for	10	SENT_104	[p9l1865t22r2149b88],
13	(	CD	NUMBER	(	num	14	SENT_104	[p9l12t131r102b220],
14	P	NN	O	p	npadvmod	15	SENT_104	[p9l12t131r102b220],
15	<	JJR	O	<	amod	10	SENT_104	[p9l135t151r181b199],
16	0.001	CD	NUMBER	0.001	num	17	SENT_104	[p9l217t131r471b220],
17	)	NN	O	)	dep	10	SENT_104	[p9l217t131r471b220],
18	,	,	O	,	_	0	SENT_104	[p9l217t131r471b220],
19	representing	VBG	O	represent	partmod	1	SENT_104	[p9l518t133r1002b219],
20	dose	NN	O	dose	nn	21	SENT_104	[p9l1048t133r1220b199],
21	reductions	NNS	O	reduction	dobj	19	SENT_104	[p9l1266t133r1670b199],
22	of	IN	O	of	_	0	SENT_104	[p9l1718t134r1797b199],
23	18-31	CD	PERCENT	18-31	num	24	SENT_104	[p9l1841t134r2140b199],
24	%	NN	PERCENT	%	prep_of	21	SENT_104	[p9l1841t134r2140b199],
25	for	IN	O	for	_	0	SENT_104	[p9l8t246r120b310],
26	single	JJ	O	single	prep_for	24	SENT_104	[p9l148t245r367b330],
27	and	CC	O	and	_	0	SENT_104	[p9l399t245r537b310],
28	82	CD	PERCENT	82	num	29	SENT_104	[p9l566t246r733b310],
29	%	NN	PERCENT	%	prep_for	24	SENT_104	[p9l566t246r733b310],
30	for	IN	O	for	_	0	SENT_104	[p9l769t246r881b310],
31	double	JJ	O	double	amod	33	SENT_104	[p9l910t245r1171b310],
32	Variant	JJ	O	variant	amod	33	SENT_104	[p9l1200t245r1472b310],
33	carriers	NNS	O	carrier	prep_for	1	SENT_104	[p9l1501t245r1809b310],
34	.	.	O	.	_	0	SENT_104	[p9l1501t245r1809b310],

1	In	IN	O	in	_	0	SENT_105	[p9l1842t247r1922b310],
2	total	NN	O	total	prep_in	8	SENT_105	[p9l1950t245r2146b324],
3	,	,	O	,	_	0	SENT_105	[p9l1950t245r2146b324],
4	29	CD	PERCENT	29	num	5	SENT_105	[p9l8t358r177b422],
5	%	NN	PERCENT	%	nsubj	8	SENT_105	[p9l8t358r177b422],
6	of	IN	O	of	_	0	SENT_105	[p9l220t357r298b422],
7	subjects	NNS	O	subject	prep_of	5	SENT_105	[p9l329t357r632b442],
8	carried	VBD	O	carry	_	0	SENT_105	[p9l667t357r936b422],
9	at	IN	O	at	quantmod	11	SENT_105	[p9l972t366r1042b422],
10	least	JJS	O	least	mwe	9	SENT_105	[p9l1075t357r1252b422],
11	one	CD	NUMBER	one	num	13	SENT_105	[p9l1286t377r1423b422],
12	Variant	JJ	O	variant	amod	13	SENT_105	[p9l1458t357r1730b422],
13	allele	NN	O	allele	dobj	8	SENT_105	[p9l1765t357r1989b422],
14	.	.	O	.	_	0	SENT_105	[p9l1765t357r1989b422],

1	VKORCI	NN	O	vkorcus	_	0	SENT_106	[p9l13t584r382b649],

1	Weekly	NNP	SET	Weekly	nn	3	SENT_107	[p9l8t807r305b892],
2	Warfarin	NNP	O	Warfarin	nn	3	SENT_107	[p9l364t807r690b872],
3	doses	NNS	O	dose	nsubjpass	8	SENT_107	[p9l751t807r959b872],
4	by	IN	O	by	_	0	SENT_107	[p9l1020t807r1112b892],
5	VKORCI	NNP	O	VKORCI	nn	6	SENT_107	[p9l1176t808r1545b872],
6	genotype	NN	O	genotype	prep_by	3	SENT_107	[p9l1612t815r1965b892],
7	are	VBP	O	be	auxpass	8	SENT_107	[p9l2029t827r2146b872],
8	presented	VBN	O	present	_	0	SENT_107	[p9l8t917r388b1002],
9	in	IN	O	in	_	0	SENT_107	[p9l439t917r510b982],
10	Fig	NN	O	fig	prep_in	8	SENT_107	[p9l560t917r702b1002],
11	.	.	O	.	_	0	SENT_107	[p9l560t917r702b1002],

1	2	LS	NUMBER	2	_	0	SENT_108	[p9l738t919r799b982],
2	.	.	O	.	_	0	SENT_108	[p9l738t919r799b982],

1	The	DT	O	the	det	4	SENT_109	[p9l853t917r1003b983],
2	mean	JJ	O	mean	amod	4	SENT_109	[p9l1056t938r1266b983],
3	weekly	JJ	SET	weekly	amod	4	SENT_109	[p9l1316t918r1589b1002],
4	dose	NN	O	dose	_	0	SENT_109	[p9l1641t917r1813b983],
5	for	IN	O	for	_	0	SENT_109	[p9l1865t918r1977b983],
6	the	DT	O	the	prep_for	4	SENT_109	[p9l2027t917r2147b983],

1	\	NN	O	\	_	0	SENT_110	[p9l231t1173r259b1213],
2	l	NN	O	l	dep	1	SENT_110	[p9l231t1173r259b1213],
3	O	NN	O	o	dep	1	SENT_110	[p9l263t1172r291b1214],

1	/	:	PERCENT	/	punct	2	SENT_111	[p9l112t1245r179b1266],
2	%	NN	PERCENT	%	_	0	SENT_111	[p9l112t1245r179b1266],
3	a	DT	O	a	det	4	SENT_111	[p9l113t1267r165b1344],
4	q	NN	O	q	dep	2	SENT_111	[p9l125t1347r165b1383],
5	;	:	O	;	_	0	SENT_111	[p9l125t1347r165b1383],
6	60	CD	PERCENT	60	num	7	SENT_111	[p9l231t1331r291b1373],
7	%	NN	PERCENT	%	dep	4	SENT_111	[p9l112t1385r180b1499],
8	.	.	O	.	_	0	SENT_111	[p9l112t1385r180b1499],

1	g	NN	O	g	_	0	SENT_112	[p9l112t1506r179b1586],
2	50	CD	NUMBER	50	num	1	SENT_112	[p9l231t1490r291b1532],
3	3	CD	NUMBER	3	number	4	SENT_112	[p9l125t1609r165b1684],
4	40	CD	NUMBER	40	num	5	SENT_112	[p9l230t1649r291b1691],
5	o	NN	O	o	dep	1	SENT_112	[p9l126t1688r165b1727],
6	-	:	O	-	_	0	SENT_112	[p9l113t1733r165b1770],
7	a	DT	O	a	dep	1	SENT_112	[p9l113t1733r165b1770],
8	.	.	O	.	_	0	SENT_112	[p9l113t1796r164b1849],

1	E	NN	O	e	_	0	SENT_113	[p9l113t1796r164b1849],
2	30	CD	NUMBER	30	num	1	SENT_113	[p9l231t1808r291b1850],
3	&	CC	O	&	_	0	SENT_113	[p9l125t1855r164b1877],
4	(	CD	NUMBER	(	conj_and	1	SENT_113	[p9l125t1883r165b1919],
5	U	NN	O	u	dep	4	SENT_113	[p9l125t1883r165b1919],
6	"	''	O	"	punct	5	SENT_113	[p9l113t1921r164b1967],
7	5	CD	NUMBER	5	num	8	SENT_113	[p9l113t1921r164b1967],
8	cs	NNS	O	c	dep	1	SENT_113	[p9l125t1973r165b2009],
9	20	CD	NUMBER	20	number	10	SENT_113	[p9l230t1967r291b2009],
10	3	CD	NUMBER	3	num	11	SENT_113	[p9l113t2012r164b2076],
11	10	CD	NUMBER	10	dep	8	SENT_113	[p9l235t2126r291b2168],

1	i	LS	O	i	dep	3	SENT_114	[p9l1703t2199r1856b2235],
2	o	NN	O	o	nn	3	SENT_114	[p9l263t2285r291b2327],
3	p	NN	O	p	_	0	SENT_114	[p9l925t2272r1097b2325],
4	=	JJ	O	=	amod	6	SENT_114	[p9l925t2272r1097b2325],
5	0.04	CD	NUMBER	0.04	tmod	4	SENT_114	[p9l925t2272r1097b2325],
6	p	NN	O	p	dep	3	SENT_114	[p9l1298t2272r1502b2325],
7	=	JJ	O	=	quantmod	8	SENT_114	[p9l1298t2272r1502b2325],
8	0.003	CD	NUMBER	0.003	num	9	SENT_114	[p9l1298t2272r1502b2325],
9	p	NN	O	p	npadvmod	10	SENT_114	[p9l1684t2272r1879b2325],
10	<	JJR	O	<	amod	6	SENT_114	[p9l1684t2272r1879b2325],
11	0.001	CD	NUMBER	0.001	dep	3	SENT_114	[p9l1684t2272r1879b2325],

1	CC/AA	NN	O	cc/aa	nn	4	SENT_115	[p9l549t2429r721b2472],
2	CT/AA	NN	O	ct/aa	nn	4	SENT_115	[p9l937t2429r1102b2472],
3	CC/AC	NN	O	cc/ac	nn	4	SENT_115	[p9l1318t2429r1492b2472],
4	CT/AC	NN	O	ct/ac	_	0	SENT_115	[p9l1706t2429r1873b2472],

1	CYP2C9	NN	O	cyp2c9	_	0	SENT_116	[p9l755t2518r1024b2572],
2	genotype	NN	O	genotype	nn	3	SENT_116	[p9l1048t2522r1357b2584],
3	group	NN	O	group	dep	1	SENT_116	[p9l1381t2531r1576b2584],

1	Fig	NN	O	fig	_	0	SENT_117	[p9l8t2692r130b2765],
2	.	.	O	.	_	0	SENT_117	[p9l8t2692r130b2765],

1	1	CD	NUMBER	1	num	2	SENT_118	[p9l161t2692r195b2747],
2	Box	NNP	O	Box	nsubj	13	SENT_118	[p9l243t2694r376b2747],
3	and	CC	O	and	_	0	SENT_118	[p9l438t2692r556b2747],
4	whisker	NN	O	whisker	nn	5	SENT_118	[p9l616t2692r871b2747],
5	plots	NNS	O	plot	conj_and	2	SENT_118	[p9l931t2692r1088b2764],
6	showing	VBG	O	show	partmod	2	SENT_118	[p9l1151t2692r1417b2764],
7	the	DT	O	the	det	8	SENT_118	[p9l1478t2692r1580b2747],
8	distribution	NN	O	distribution	dobj	6	SENT_118	[p9l1643t2692r2023b2747],
9	of	IN	O	of	_	0	SENT_118	[p9l2085t2692r2152b2747],
10	Warfarin	NNP	MISC	Warfarin	nn	12	SENT_118	[p9l7t2780r285b2836],
11	weekly	JJ	SET	weekly	amod	12	SENT_118	[p9l318t2781r549b2853],
12	doses	NNS	O	dose	prep_of	8	SENT_118	[p9l585t2781r761b2836],
13	based	VBN	O	base	_	0	SENT_118	[p9l796t2780r983b2836],
14	on	IN	O	on	_	0	SENT_118	[p9l1019t2798r1099b2836],
15	*	NN	O	*	prep_on	13	SENT_118	[p9l1137t2781r1302b2836],
16	2	CD	NUMBER	2	num	15	SENT_118	[p9l1137t2781r1302b2836],
17	/	:	O	/	punct	18	SENT_118	[p9l1137t2781r1302b2836],
18	*	CD	NUMBER	*	dep	13	SENT_118	[p9l1137t2781r1302b2836],
19	3	CD	NUMBER	3	num	21	SENT_118	[p9l1137t2781r1302b2836],
20	genotype	NN	O	genotype	nn	21	SENT_118	[p9l1340t2788r1639b2853],
21	groups	NNS	O	group	dep	18	SENT_118	[p9l1675t2798r1910b2853],
22	.	.	O	.	_	0	SENT_118	[p9l1675t2798r1910b2853],

1	Boxes	NNPS	O	Boxes	nsubj	2	SENT_119	[p9l1949t2782r2148b2836],
2	represent	VBP	O	represent	_	0	SENT_119	[p9l8t2876r317b2941],
3	25th	JJ	ORDINAL	25th	amod	6	SENT_119	[p9l350t2868r673b2924],
4	—	NN	O	—	nn	6	SENT_119	[p9l350t2868r673b2924],
5	75th	JJ	ORDINAL	75th	amod	6	SENT_119	[p9l350t2868r673b2924],
6	percentiles	NNS	O	percentile	dobj	2	SENT_119	[p9l705t2869r1061b2941],
7	of	IN	O	of	_	0	SENT_119	[p9l1096t2869r1163b2924],
8	Warfarin	NNP	MISC	Warfarin	nn	9	SENT_119	[p9l1191t2869r1468b2924],
9	doses	NNS	O	dose	prep_of	6	SENT_119	[p9l1501t2869r1695b2935],
10	,	,	O	,	_	0	SENT_119	[p9l1501t2869r1695b2935],
11	whiskers	NNS	O	whisker	nsubj	14	SENT_119	[p9l1729t2869r2012b2924],
12	are	VBP	O	be	cop	14	SENT_119	[p9l2048t2886r2147b2924],
13	5th	JJ	ORDINAL	5th	amod	14	SENT_119	[p9l9t2956r293b3012],
14	—	NN	O	—	ccomp	2	SENT_119	[p9l9t2956r293b3012],
15	95th	JJ	ORDINAL	95th	amod	16	SENT_119	[p9l9t2956r293b3012],
16	percentiles	NNS	O	percentile	attr	14	SENT_119	[p9l332t2956r706b3028],
17	,	,	O	,	_	0	SENT_119	[p9l332t2956r706b3028],
18	and	CC	O	and	_	0	SENT_119	[p9l749t2956r867b3011],
19	solid	JJ	O	solid	amod	20	SENT_119	[p9l907t2956r1059b3011],
20	lines	NNS	O	line	nsubj	23	SENT_119	[p9l1099t2956r1247b3011],
21	are	VBP	O	be	cop	23	SENT_119	[p9l1289t2973r1389b3011],
22	median	JJ	O	median	amod	23	SENT_119	[p9l1429t2956r1672b3011],
23	dose	NN	O	dose	conj_and	2	SENT_119	[p9l1712t2956r1858b3011],
24	in	IN	O	in	_	0	SENT_119	[p9l1899t2956r1960b3011],
25	each	DT	O	each	det	26	SENT_119	[p9l2000t2956r2149b3011],
26	group	NN	O	group	prep_in	23	SENT_119	[p9l9t3044r198b3099],

1	@	IN	O	@	_	0	SENT_120	[p9l1803t3261r1876b3350],
2	Springer	NNP	PERSON	Springer	pobj	1	SENT_120	[p9l1903t3283r2148b3353],

1	194	CD	NUMBER	194	num	4	SENT_121	[p9l54t3429r104b3455],
2	J	NN	O	j	nn	4	SENT_121	[p9l1445t3430r1460b3455],
3	Thromb	NN	O	thromb	nn	4	SENT_121	[p9l1472t3429r1596b3455],
4	Thrombolysis	NN	O	thrombolysis	_	0	SENT_121	[p9l1609t3429r1817b3463],
5	(	CD	NUMBER	(	num	6	SENT_121	[p9l1832t3428r1926b3463],
6	2006	CD	DATE	2006	dep	4	SENT_121	[p9l1832t3428r1926b3463],
7	)	CD	NUMBER	)	number	8	SENT_121	[p9l1832t3428r1926b3463],
8	22:191	CD	NUMBER	22:191	num	9	SENT_121	[p9l1940t3429r2106b3455],
9	—	NN	O	—	dep	6	SENT_121	[p9l1940t3429r2106b3455],
10	197	CD	NUMBER	197	dep	4	SENT_121	[p9l1940t3429r2106b3455],

1	70	CD	NUMBER	70	_	0	SENT_122	[p10l147t103r208b143],
2	60	CD	NUMBER	60	number	3	SENT_122	[p10l147t258r208b298],
3	50	CD	NUMBER	50	num	5	SENT_122	[p10l147t412r208b452],
4	40	CD	NUMBER	40	number	5	SENT_122	[p10l147t567r208b607],
5	30	CD	NUMBER	30	dep	1	SENT_122	[p10l147t722r208b761],
6	20	CD	NUMBER	20	num	9	SENT_122	[p10l147t876r208b916],
7	Warfarin	NNP	O	Warfarin	nn	9	SENT_122	[p10l31t733r81b983],
8	dose	NN	O	dose	nn	9	SENT_122	[p10l32t566r81b710],
9	(	NN	O	(	dep	5	SENT_122	[p10l30t242r95b545],
10	mg/week	JJ	O	mg/week	amod	11	SENT_122	[p10l30t242r95b545],
11	)	NN	O	)	dep	1	SENT_122	[p10l30t242r95b545],

1	CC	NN	O	cc	_	0	SENT_123	[p10l558t1325r637b1366],
2	CT	NN	O	ct	nn	3	SENT_123	[p10l1059t1325r1133b1367],
3	TT	NN	O	tt	dep	1	SENT_123	[p10l1557t1326r1627b1366],

1	VKORC1	NN	O	vkorc1	nn	2	SENT_124	[p10l746t1412r1028b1463],
2	genotype	NN	O	genotype	_	0	SENT_124	[p10l1062t1416r1373b1474],

1	Fig	NN	O	fig	_	0	SENT_125	[p10l17t1617r139b1690],
2	.	.	O	.	_	0	SENT_125	[p10l17t1617r139b1690],

1	2	CD	NUMBER	2	num	2	SENT_126	[p10l167t1618r203b1672],
2	Box	NNP	O	Box	nsubj	23	SENT_126	[p10l251t1619r383b1672],
3	and	CC	O	and	_	0	SENT_126	[p10l445t1617r563b1672],
4	whisker	NN	O	whisker	nn	5	SENT_126	[p10l623t1617r877b1672],
5	plots	NNS	O	plot	conj_and	2	SENT_126	[p10l937t1617r1094b1689],
6	showing	VBG	O	show	partmod	2	SENT_126	[p10l1156t1617r1421b1689],
7	the	DT	O	the	det	8	SENT_126	[p10l1482t1617r1583b1672],
8	distribution	NN	O	distribution	dobj	6	SENT_126	[p10l1647t1617r2026b1672],
9	of	IN	O	of	_	0	SENT_126	[p10l2087t1618r2154b1672],
10	Warfarin	NNP	O	Warfarin	nn	12	SENT_126	[p10l16t1705r292b1760],
11	Weekly	NNP	SET	Weekly	nn	12	SENT_126	[p10l319t1705r550b1777],
12	doses	NNS	O	dose	prep_of	8	SENT_126	[p10l579t1705r754b1760],
13	based	VBN	O	base	_	0	SENT_126	[p10l783t1705r969b1760],
14	on	IN	O	on	prepc_based_on	6	SENT_126	[p10l999t1722r1079b1760],
15	VKORC1	NN	O	vkorc1	nn	16	SENT_126	[p10l1106t1705r1434b1760],
16	genotypes	NNS	O	genotype	pobj	6	SENT_126	[p10l1467t1712r1795b1777],
17	wild-type	JJ	O	wild-type	amod	20	SENT_126	[p10l17t1941r374b2026],
18	(	NN	O	(	nn	20	SENT_126	[p10l412t1939r598b2027],
19	CC	NN	O	cc	nn	20	SENT_126	[p10l412t1939r598b2027],
20	)	NN	O	)	dep	16	SENT_126	[p10l412t1939r598b2027],
21	was	VBD	O	be	cop	23	SENT_126	[p10l632t1962r772b2007],
22	38.4	CD	NUMBER	38.4	num	23	SENT_126	[p10l805t1942r957b2007],
23	mg/week	NN	O	mg/week	_	0	SENT_126	[p10l991t1942r1356b2026],
24	,	,	O	,	_	0	SENT_126	[p10l991t1942r1356b2026],
25	which	WDT	O	which	nsubj	26	SENT_126	[p10l1388t1941r1614b2007],
26	decreased	VBD	O	decrease	rcmod	23	SENT_126	[p10l1646t1942r2028b2007],
27	by	IN	O	by	_	0	SENT_126	[p10l2059t1941r2151b2026],
28	25	CD	PERCENT	25	num	29	SENT_126	[p10l17t2052r185b2118],
29	%	NN	PERCENT	%	prep_by	26	SENT_126	[p10l17t2052r185b2118],
30	for	IN	O	for	_	0	SENT_126	[p10l266t2053r377b2118],
31	the	DT	O	the	det	34	SENT_126	[p10l449t2052r568b2118],
32	CT	NN	O	ct	nn	34	SENT_126	[p10l646t2053r764b2118],
33	heterozygote	NN	O	heterozygote	nn	34	SENT_126	[p10l837t2052r1339b2137],
34	(	NN	O	(	prep_for	29	SENT_126	[p10l1417t2050r1522b2137],
35	to	TO	O	to	_	0	SENT_126	[p10l1417t2050r1522b2137],
36	28.6	CD	NUMBER	28.6	num	37	SENT_126	[p10l1596t2052r1749b2118],
37	mg/week	NN	O	mg/week	prep_to	26	SENT_126	[p10l1783t2053r2148b2137],
38	,	,	O	,	_	0	SENT_126	[p10l1783t2053r2148b2137],
39	P	NN	O	p	dep	40	SENT_126	[p10l17t2165r76b2227],
40	<	JJR	O	<	appos	37	SENT_126	[p10l109t2181r155b2227],
41	0.001	CD	NUMBER	0.001	num	44	SENT_126	[p10l191t2163r383b2228],
42	VS.	NNP	O	VS.	nn	44	SENT_126	[p10l433t2184r528b2228],
43	WT	NNP	O	WT	nn	44	SENT_126	[p10l577t2160r755b2248],
44	)	NN	O	)	dep	40	SENT_126	[p10l577t2160r755b2248],
45	and	CC	O	and	_	0	SENT_126	[p10l806t2163r944b2228],
46	by	IN	O	by	_	0	SENT_126	[p10l989t2163r1081b2248],
47	45	CD	PERCENT	45	num	48	SENT_126	[p10l1126t2163r1293b2228],
48	%	NN	PERCENT	%	prep_by	26	SENT_126	[p10l1126t2163r1293b2228],
49	for	IN	O	for	_	0	SENT_126	[p10l1347t2163r1458b2228],
50	the	DT	O	the	det	53	SENT_126	[p10l1503t2163r1621b2228],
51	minor	JJ	O	minor	amod	53	SENT_126	[p10l1668t2163r1899b2228],
52	allele	NN	O	allele	nn	53	SENT_126	[p10l1946t2163r2148b2228],
53	homozygote	NN	O	homozygote	prep_for	48	SENT_126	[p10l17t2274r510b2359],
54	,	,	O	,	_	0	SENT_126	[p10l17t2274r510b2359],
55	TT	NN	O	tt	appos	53	SENT_126	[p10l543t2276r660b2338],
56	(	CD	NUMBER	(	number	58	SENT_126	[p10l695t2271r800b2359],
57	to	TO	O	to	dep	58	SENT_126	[p10l695t2271r800b2359],
58	20.9	CD	NUMBER	20.9	num	59	SENT_126	[p10l831t2275r984b2339],
59	mg/week	NN	O	mg/week	dep	55	SENT_126	[p10l1018t2274r1383b2359],
60	,	,	O	,	_	0	SENT_126	[p10l1018t2274r1383b2359],
61	P	NN	O	p	appos	53	SENT_126	[p10l1415t2276r1475b2338],
62	<	JJR	O	<	dep	61	SENT_126	[p10l1508t2292r1553b2339],
63	0.001	CD	NUMBER	0.001	num	66	SENT_126	[p10l1590t2274r1782b2339],
64	VS.	NNP	O	VS.	nn	66	SENT_126	[p10l1818t2294r1913b2339],
65	WT	NNP	O	WT	nn	66	SENT_126	[p10l1947t2271r2146b2359],
66	)	NNP	O	)	dep	26	SENT_126	[p10l1947t2271r2146b2359],
67	.	.	O	.	_	0	SENT_126	[p10l1947t2271r2146b2359],

1	Combined	VBN	O	combine	_	0	SENT_127	[p10l22t2500r417b2566],
2	2-gene	JJ	O	2-gene	amod	3	SENT_127	[p10l445t2501r694b2584],
3	effects	NNS	O	effect	dep	1	SENT_127	[p10l728t2500r964b2584],
4	on	IN	O	on	_	0	SENT_127	[p10l998t2522r1091b2565],
5	Warfarin	NNP	O	Warfarin	nn	6	SENT_127	[p10l1128t2500r1449b2584],
6	dose	NN	O	dose	prep_on	3	SENT_127	[p10l1484t2500r1653b2565],

1	Variants	NNS	O	variant	nsubjpass	12	SENT_128	[p10l16t2722r346b2788],
2	in	IN	O	in	_	0	SENT_128	[p10l374t2722r446b2787],
3	the	DT	O	the	det	5	SENT_128	[p10l473t2722r592b2788],
4	3	CD	NUMBER	3	num	5	SENT_128	[p10l621t2724r659b2788],
5	SNPs	NNS	O	snp	prep_in	1	SENT_128	[p10l691t2723r894b2788],
6	at	IN	O	at	_	0	SENT_128	[p10l925t2732r994b2788],
7	the	DT	O	the	det	10	SENT_128	[p10l1021t2723r1140b2788],
8	2	CD	NUMBER	2	num	10	SENT_128	[p10l1170t2724r1211b2787],
9	gene	NN	O	gene	nn	10	SENT_128	[p10l1239t2743r1417b2807],
10	loci	NNS	O	locus	prep_at	5	SENT_128	[p10l1446t2722r1582b2788],
11	were	VBD	O	be	auxpass	12	SENT_128	[p10l1609t2743r1794b2788],
12	found	VBN	O	find	_	0	SENT_128	[p10l1822t2722r2047b2788],
13	to	TO	O	to	aux	14	SENT_128	[p10l2074t2731r2149b2788],
14	have	VB	O	have	xcomp	12	SENT_128	[p10l17t2833r196b2899],
15	independent	JJ	O	independent	amod	18	SENT_128	[p10l249t2833r753b2918],
16	,	,	O	,	_	0	SENT_128	[p10l249t2833r753b2918],
17	incremental	JJ	O	incremental	amod	18	SENT_128	[p10l807t2833r1266b2899],
18	effects	NNS	O	effect	dobj	14	SENT_128	[p10l1319t2834r1566b2899],
19	on	IN	O	on	_	0	SENT_128	[p10l1622t2854r1716b2899],
20	the	DT	O	the	det	24	SENT_128	[p10l1768t2833r1886b2899],
21	mean	NN	O	mean	npadvmod	22	SENT_128	[p10l1940t2854r2150b2899],
22	stable	JJ	O	stable	amod	24	SENT_128	[p10l18t2944r241b3009],
23	Warfarin	NNP	O	Warfarin	nn	24	SENT_128	[p10l266t2944r591b3009],
24	dose	NN	O	dose	prep_on	18	SENT_128	[p10l617t2944r789b3009],
25	as	IN	O	as	mark	26	SENT_128	[p10l817t2965r889b3009],
26	shown	VBN	O	show	advcl	14	SENT_128	[p10l916t2944r1159b3009],
27	in	IN	O	in	_	0	SENT_128	[p10l1183t2944r1255b3009],
28	Table	NNP	O	Table	prep_in	26	SENT_128	[p10l1278t2944r1497b3009],
29	1	CD	NUMBER	1	num	28	SENT_128	[p10l1536t2945r1592b3009],
30	.	.	O	.	_	0	SENT_128	[p10l1536t2945r1592b3009],

1	No	DT	O	no	det	3	SENT_129	[p10l1620t2946r1735b3009],
2	signiﬁcant	NN	O	signiﬁcant	nn	3	SENT_129	[p10l1762t2944r2150b3029],
3	differences	NNS	O	difference	nsubjpass	9	SENT_129	[p10l19t3056r440b3121],
4	in	IN	O	in	_	0	SENT_129	[p10l491t3056r563b3120],
5	mean	JJ	O	mean	amod	7	SENT_129	[p10l613t3077r823b3121],
6	stable	JJ	O	stable	amod	7	SENT_129	[p10l875t3056r1097b3121],
7	INR	NN	O	inr	prep_in	3	SENT_129	[p10l1150t3058r1320b3120],
8	were	VBD	O	be	auxpass	9	SENT_129	[p10l1369t3076r1554b3121],
9	seen	VBN	O	see	_	0	SENT_129	[p10l1607t3076r1776b3121],
10	between	IN	O	between	_	0	SENT_129	[p10l1825t3056r2151b3121],
11	CYPZC9	NN	O	cypzc9	nn	14	SENT_129	[p10l22t3168r357b3233],
12	or	CC	O	or	_	0	SENT_129	[p10l391t3188r471b3233],
13	VKORC1	NN	O	vkorc1	nn	14	SENT_129	[p10l507t3168r876b3233],
14	genotypes	NNS	O	genotype	prep_between	9	SENT_129	[p10l916t3176r1322b3253],
15	.	.	O	.	_	0	SENT_129	[p10l916t3176r1322b3253],

1	Dose	NN	O	dose	nn	2	SENT_130	[p10l17t3394r212b3458],
2	prediction	NN	O	prediction	_	0	SENT_130	[p10l237t3392r629b3476],
3	using	VBG	O	use	dep	2	SENT_130	[p10l666t3395r865b3477],
4	multiple	JJ	O	multiple	amod	7	SENT_130	[p10l896t3392r1207b3476],
5	linear	JJ	O	linear	amod	7	SENT_130	[p10l1242t3392r1460b3458],
6	regression	NN	O	regression	nn	7	SENT_130	[p10l1491t3395r1872b3477],
7	modeling	NN	O	modeling	dobj	3	SENT_130	[p10l17t3503r374b3588],

1	In	IN	O	in	_	0	SENT_131	[p10l18t3728r98b3791],
2	a	DT	O	a	det	6	SENT_131	[p10l145t3747r185b3791],
3	multiple	JJ	O	multiple	amod	6	SENT_131	[p10l229t3726r548b3811],
4	linear	JJ	O	linear	amod	6	SENT_131	[p10l595t3726r816b3791],
5	regression	NN	O	regression	nn	6	SENT_131	[p10l861t3726r1254b3811],
6	model	NN	O	model	prep_in	11	SENT_131	[p10l1298t3726r1559b3805],
7	,	,	O	,	_	0	SENT_131	[p10l1298t3726r1559b3805],
8	Warfarin	NNP	O	Warfarin	nn	9	SENT_131	[p10l1606t3726r1930b3791],
9	dose	NN	O	dose	nsubjpass	11	SENT_131	[p10l1977t3726r2149b3791],
10	was	VBD	O	be	auxpass	11	SENT_131	[p11l17t41r156b86],
11	predicted	VBN	O	predict	_	0	SENT_131	[p11l195t21r559b106],
12	by	IN	O	by	_	0	SENT_131	[p11l597t21r689b106],
13	CYP2C9	NN	O	cyp2c9	nn	14	SENT_131	[p11l732t22r1067b86],
14	genotype	NN	O	genotype	agent	11	SENT_131	[p11l1104t30r1478b106],
15	,	,	O	,	_	0	SENT_131	[p11l1104t30r1478b106],
16	VKORC1	NN	O	vkorc1	nn	17	SENT_131	[p11l1523t22r1891b86],
17	genotype	NN	O	genotype	agent	11	SENT_131	[p11l1936t41r2148b106, p11l17t141r203b217],
18	,	,	O	,	_	0	SENT_131	[p11l1936t41r2148b106, p11l17t141r203b217],
19	age	NN	O	age	agent	11	SENT_131	[p11l250t152r399b217],
20	,	,	O	,	_	0	SENT_131	[p11l250t152r399b217],
21	and	CC	O	and	_	0	SENT_131	[p11l447t132r585b197],
22	weight	NN	O	weight	conj_and	14	SENT_131	[p11l628t132r903b217],
23	,	,	O	,	_	0	SENT_131	[p11l628t132r903b217],
24	and	CC	O	and	_	0	SENT_131	[p11l951t132r1089b197],
25	sex	NN	O	sex	conj_and	14	SENT_131	[p11l1134t152r1254b197],
26	(	JJ	O	(	amod	28	SENT_131	[p11l1300t129r1589b217],
27	trend	NN	O	trend	nn	28	SENT_131	[p11l1300t129r1589b217],
28	)	NN	O	)	dep	25	SENT_131	[p11l1300t129r1589b217],
29	.	.	O	.	_	0	SENT_131	[p11l1300t129r1589b217],

1	The	DT	O	the	det	4	SENT_132	[p11l1636t132r1785b197],
2	multiple	JJ	O	multiple	amod	4	SENT_132	[p11l1830t132r2148b217],
3	linear	JJ	O	linear	amod	4	SENT_132	[p11l17t243r238b308],
4	regression	NN	O	regression	nsubj	5	SENT_132	[p11l277t243r671b328],
5	identiﬁed	VBD	O	identiﬁed	_	0	SENT_132	[p11l709t243r1073b308],
6	genotype	NN	O	genotype	dobj	5	SENT_132	[p11l1114t251r1465b328],
7	as	IN	O	as	_	0	SENT_132	[p11l1508t263r1581b308],
8	the	DT	O	the	det	9	SENT_132	[p11l1622t243r1741b308],
9	dominant	JJ	O	dominant	prep_as	5	SENT_132	[p11l1782t243r2150b308],

1	Table	NNP	O	Table	_	0	SENT_133	[p11l7t490r193b544],
2	1	CD	NUMBER	1	num	1	SENT_133	[p11l224t488r259b543],
3	Combined	JJ	O	combined	amod	4	SENT_133	[p11l309t488r649b544],
4	effect	NN	O	effect	dep	1	SENT_133	[p11l679t489r860b543],
5	of	IN	O	of	_	0	SENT_133	[p11l890t489r957b543],
6	all	DT	O	all	det	8	SENT_133	[p11l984t488r1060b543],
7	three	CD	NUMBER	three	num	8	SENT_133	[p11l1088t488r1257b543],
8	SNPS	NNS	O	snp	prep_of	4	SENT_133	[p11l1287t489r1460b544],
9	in	IN	O	in	_	0	SENT_133	[p11l1489t488r1550b543],
10	the	DT	O	the	det	12	SENT_133	[p11l1578t488r1679b543],
11	two	CD	NUMBER	two	num	12	SENT_133	[p11l1709t495r1827b543],
12	genes	NNS	O	gene	prep_in	8	SENT_133	[p11l1857t506r2038b560],
13	on	IN	O	on	_	0	SENT_133	[p11l2069t506r2149b543],
14	warfarin	NN	O	warfarin	nn	15	SENT_133	[p11l7t576r283b632],
15	dose	NN	O	dose	prep_on	12	SENT_133	[p11l312t576r458b632],
16	(	CD	NUMBER	(	num	15	SENT_133	[p11l490t574r616b649],
17	SD	NN	O	sd	nn	21	SENT_133	[p11l490t574r616b649],
18	=	JJ	O	=	amod	21	SENT_133	[p11l649t602r688b621],
19	standard	JJ	O	standard	amod	21	SENT_133	[p11l719t576r1001b632],
20	deviation	NN	O	deviation	nn	21	SENT_133	[p11l1031t574r1361b649],
21	)	NN	O	)	dep	1	SENT_133	[p11l1031t574r1361b649],

1	VKORC1	NN	O	vkorc1	nn	3	SENT_134	[p11l7t751r334b807],
2	CYP	NN	O	cyp	nn	3	SENT_134	[p11l523t751r754b807],
3	*	NN	O	*	_	0	SENT_134	[p11l523t751r754b807],
4	2	CD	NUMBER	2	num	5	SENT_134	[p11l523t751r754b807],
5	CYP	NN	O	cyp	dep	3	SENT_134	[p11l968t751r1197b807],
6	*	CD	NUMBER	*	number	7	SENT_134	[p11l968t751r1197b807],
7	3	CD	NUMBER	3	num	8	SENT_134	[p11l968t751r1197b807],
8	Weekly	NNP	SET	Weekly	dep	5	SENT_134	[p11l1410t751r1662b823],
9	dose	NN	O	dose	nn	17	SENT_134	[p11l1691t751r1837b806],
10	SD	NN	O	sd	nn	17	SENT_134	[p11l1893t751r1991b807],
11	n	NN	O	n	nn	17	SENT_134	[p11l2075t770r2113b806],
12	genotype	NN	O	genotype	nn	17	SENT_134	[p11l8t848r307b912],
13	genotype	NN	O	genotype	nn	17	SENT_134	[p11l521t848r820b912],
14	genotype	NN	O	genotype	nn	17	SENT_134	[p11l966t848r1265b912],
15	(	CD	NUMBER	(	num	17	SENT_134	[p11l1414t838r1565b912],
16	mg	NN	O	mg	nn	17	SENT_134	[p11l1414t838r1565b912],
17	)	NN	O	)	dep	3	SENT_134	[p11l1414t838r1565b912],

1	CC	NN	ORGANIZATION	cc	nn	3	SENT_135	[p11l10t1011r115b1066],
2	CC	NN	ORGANIZATION	cc	nn	3	SENT_135	[p11l523t1011r628b1066],
3	AA	NN	ORGANIZATION	aa	dep	25	SENT_135	[p11l966t1011r1090b1065],
4	40.7	CD	NUMBER	40.7	number	5	SENT_135	[p11l1411t1011r1540b1066],
5	15.9	CD	NUMBER	15.9	dep	3	SENT_135	[p11l1894t1010r2021b1066],
6	61	CD	NUMBER	61	num	7	SENT_135	[p11l2076t1010r2144b1066],
7	AC	NN	ORGANIZATION	ac	dep	5	SENT_135	[p11l966t1099r1082b1154],
8	25.4	CD	NUMBER	25.4	number	9	SENT_135	[p11l1411t1098r1541b1154],
9	16.1	CD	NUMBER	16.1	dep	5	SENT_135	[p11l1894t1098r2017b1154],
10	6	CD	NUMBER	6	num	12	SENT_135	[p11l2114t1098r2148b1154],
11	CT	NN	ORGANIZATION	ct	nn	12	SENT_135	[p11l523t1187r623b1242],
12	AA	NN	ORGANIZATION	aa	dep	9	SENT_135	[p11l966t1188r1090b1241],
13	35.7	CD	NUMBER	35.7	number	14	SENT_135	[p11l1411t1186r1540b1242],
14	4.4	CD	NUMBER	4.4	dep	9	SENT_135	[p11l1929t1188r2022b1242],
15	12	CD	NUMBER	12	num	16	SENT_135	[p11l2078t1187r2149b1241],
16	AC	NN	ORGANIZATION	ac	dep	14	SENT_135	[p11l966t1275r1082b1330],
17	5	CD	NUMBER	5	number	18	SENT_135	[p11l1450t1274r1482b1330],
18	1	CD	NUMBER	1	num	20	SENT_135	[p11l2116t1275r2144b1329],
19	CT	NN	ORGANIZATION	ct	nn	20	SENT_135	[p11l10t1363r110b1418],
20	CC	NN	ORGANIZATION	cc	dep	14	SENT_135	[p11l523t1363r628b1418],
21	AA	NN	ORGANIZATION	aa	dep	25	SENT_135	[p11l966t1363r1090b1417],
22	30.5	CD	NUMBER	30.5	num	21	SENT_135	[p11l1411t1362r1539b1418],
23	11	CD	NUMBER	11	num	25	SENT_135	[p11l1894t1363r1960b1417],
24	79	CD	NUMBER	79	num	25	SENT_135	[p11l2075t1363r2148b1418],
25	AC	NN	ORGANIZATION	ac	dep	30	SENT_135	[p11l966t1451r1082b1506],
26	22.1	CD	NUMBER	22.1	number	27	SENT_135	[p11l1411t1451r1537b1506],
27	5.9	CD	NUMBER	5.9	dep	25	SENT_135	[p11l1930t1450r2021b1506],
28	11	CD	NUMBER	11	num	29	SENT_135	[p11l2078t1451r2145b1505],
29	CT	NN	O	ct	dep	27	SENT_135	[p11l523t1540r623b1595],
30	AA	NN	O	aa	dep	33	SENT_135	[p11l966t1541r1090b1594],
31	24.8	CD	NUMBER	24.8	num	30	SENT_135	[p11l1411t1541r1540b1595],
32	10.3	CD	NUMBER	10.3	num	33	SENT_135	[p11l1894t1540r2019b1595],
33	20	CD	NUMBER	20	_	0	SENT_135	[p11l2075t1541r2149b1595],

1	AC	NN	O	ac	nn	2	SENT_136	[p11l966t1627r1082b1683],
2	o	NN	O	o	_	0	SENT_136	[p11l1450t1628r1484b1682],

1	TT	NN	ORGANIZATION	tt	nn	3	SENT_137	[p11l7t1718r106b1771],
2	CC	NN	ORGANIZATION	cc	nn	3	SENT_137	[p11l523t1717r628b1772],
3	AA	NN	ORGANIZATION	aa	dep	11	SENT_137	[p11l966t1718r1090b1771],
4	22.7	CD	NUMBER	22.7	number	5	SENT_137	[p11l1411t1718r1540b1772],
5	11.8	CD	NUMBER	11.8	dep	3	SENT_137	[p11l1894t1717r2021b1772],
6	20	CD	NUMBER	20	dep	5	SENT_137	[p11l2075t1718r2149b1772],
7	AC	NN	ORGANIZATION	ac	dep	11	SENT_137	[p11l966t1806r1082b1861],
8	17	CD	NUMBER	17	num	7	SENT_137	[p11l1414t1806r1483b1861],
9	0.7	CD	NUMBER	0.7	num	11	SENT_137	[p11l1930t1807r2021b1861],
10	2	CD	NUMBER	2	num	11	SENT_137	[p11l2113t1807r2148b1860],
11	CT	NN	O	ct	dep	18	SENT_137	[p11l523t1893r623b1949],
12	AA	NN	O	aa	dep	11	SENT_137	[p11l966t1894r1090b1948],
13	16.2	CD	NUMBER	16.2	num	12	SENT_137	[p11l1414t1893r1541b1948],
14	8.1	CD	NUMBER	8.1	number	15	SENT_137	[p11l1930t1893r2018b1948],
15	3	CD	NUMBER	3	num	16	SENT_137	[p11l2114t1894r2146b1948],
16	AC	NN	ORGANIZATION	ac	dep	12	SENT_137	[p11l966t1983r1082b2038],
17	7	CD	NUMBER	7	num	18	SENT_137	[p11l1449t1984r1483b2038],
18	1	CD	NUMBER	1	_	0	SENT_137	[p11l2116t1983r2144b2037],

1	@Springer	NN	O	@springer	nn	2	SENT_138	[p11l16t2286r359b2378],
2	predictor	NN	O	predictor	nsubj	12	SENT_138	[p11l10t2385r366b2470],
3	of	IN	O	of	_	0	SENT_138	[p11l427t2385r505b2450],
4	warfarin	NN	O	warfarin	nn	5	SENT_138	[p11l560t2385r887b2450],
5	dose	NN	O	dose	prep_of	2	SENT_138	[p11l947t2385r1141b2464],
6	,	,	O	,	_	0	SENT_138	[p11l947t2385r1141b2464],
7	with	IN	O	with	_	0	SENT_138	[p11l1203t2385r1369b2450],
8	an	DT	O	a	det	11	SENT_138	[p11l1432t2405r1521b2450],
9	overall	JJ	O	overall	amod	11	SENT_138	[p11l1582t2385r1846b2450],
10	model	NN	O	model	nn	11	SENT_138	[p11l1906t2385r2147b2450],
11	P	NN	O	p	prep_with	5	SENT_138	[p11l10t2498r70b2561],
12	=	JJ	O	=	_	0	SENT_138	[p11l103t2527r149b2549],
13	2.4	CD	NUMBER	2.4	num	14	SENT_138	[p11l184t2497r293b2562],
14	X	NN	O	x	iobj	12	SENT_138	[p11l326t2514r373b2560],
15	1045	CD	DATE	1045	dobj	12	SENT_138	[p11l409t2477r612b2562],
16	.	.	O	.	_	0	SENT_138	[p11l409t2477r612b2562],

1	Highly	RB	O	highly	advmod	2	SENT_139	[p11l675t2496r937b2582],
2	signiﬁcant	JJ	O	signiﬁcant	amod	3	SENT_139	[p11l997t2496r1386b2582],
3	predictors	NNS	O	predictor	nsubj	7	SENT_139	[p11l1445t2496r1834b2582],
4	in	IN	O	in	_	0	SENT_139	[p11l1895t2496r1967b2561],
5	the	DT	O	the	det	6	SENT_139	[p11l2027t2496r2146b2562],
6	model	NN	O	model	prep_in	3	SENT_139	[p11l10t2607r251b2672],
7	Were	VBD	O	be	dep	44	SENT_139	[p11l275t2628r480b2672],
8	:	:	O	:	_	0	SENT_139	[p11l275t2628r480b2672],
9	*	NN	O	*	nsubj	14	SENT_139	[p11l512t2608r594b2672],
10	2	CD	NUMBER	2	number	11	SENT_139	[p11l512t2608r594b2672],
11	C	NN	O	c	amod	9	SENT_139	[p11l624t2608r683b2673],
12	YP2	NN	O	yp2	nn	14	SENT_139	[p11l688t2608r847b2672],
13	C9	NN	O	c9	nn	14	SENT_139	[p11l858t2608r959b2673],
14	variant	NN	O	variant	parataxis	7	SENT_139	[p11l982t2607r1254b2672],
15	compared	VBN	O	compare	_	0	SENT_139	[p11l1278t2607r1662b2692],
16	to	TO	O	to	prepc_compared_to	14	SENT_139	[p11l1687t2616r1761b2672],
17	wild	JJ	O	wild	amod	19	SENT_139	[p11l1786t2607r2145b2692],
18	—	NN	O	—	nn	19	SENT_139	[p11l1786t2607r2145b2692],
19	type	NN	O	type	pobj	14	SENT_139	[p11l1786t2607r2145b2692],
20	(	CD	NUMBER	(	num	21	SENT_139	[p11l14t2714r104b2802],
21	P	NN	O	p	npadvmod	22	SENT_139	[p11l14t2714r104b2802],
22	=	JJ	O	=	amod	19	SENT_139	[p11l137t2747r183b2770],
23	0.001	CD	NUMBER	0.001	number	24	SENT_139	[p11l219t2714r472b2802],
24	)	CD	NUMBER	)	num	31	SENT_139	[p11l219t2714r472b2802],
25	,	,	O	,	_	0	SENT_139	[p11l219t2714r472b2802],
26	*	CD	NUMBER	*	number	27	SENT_139	[p11l513t2718r592b2782],
27	3	CD	NUMBER	3	num	28	SENT_139	[p11l513t2718r592b2782],
28	CYP2C9	NN	O	cyp2c9	npadvmod	29	SENT_139	[p11l634t2718r969b2783],
29	variant	JJ	O	variant	amod	31	SENT_139	[p11l1001t2717r1273b2782],
30	(	NN	O	(	nn	31	SENT_139	[p11l1310t2715r1400b2802],
31	P	NN	O	p	dep	19	SENT_139	[p11l1310t2715r1400b2802],
32	<	JJR	O	<	amod	31	SENT_139	[p11l1433t2735r1479b2782],
33	0.001	CD	NUMBER	0.001	num	34	SENT_139	[p11l1515t2715r1744b2802],
34	)	NN	O	)	dep	31	SENT_139	[p11l1515t2715r1744b2802],
35	and	CC	O	and	_	0	SENT_139	[p11l1784t2717r1922b2782],
36	combined	JJ	O	combined	amod	37	SENT_139	[p11l1957t2738r2145b2782, p11l10t2828r226b2893],
37	*	NN	O	*	pobj	14	SENT_139	[p11l276t2829r357b2893],
38	2	CD	NUMBER	2	number	41	SENT_139	[p11l276t2829r357b2893],
39	and	CC	O	and	_	0	SENT_139	[p11l405t2828r544b2893],
40	*	CD	NUMBER	*	conj_and	41	SENT_139	[p11l593t2829r672b2893],
41	3	CD	NUMBER	3	num	43	SENT_139	[p11l593t2829r672b2893],
42	CYP2C9	NN	O	cyp2c9	nn	43	SENT_139	[p11l724t2829r1061b2894],
43	variants	NNS	O	variant	dep	37	SENT_139	[p11l1106t2828r1410b2893],
44	(	VBP	O	(	_	0	SENT_139	[p11l1461t2825r1550b2913],
45	P	NN	O	p	dep	46	SENT_139	[p11l1461t2825r1550b2913],
46	<	JJR	O	<	dobj	44	SENT_139	[p11l1584t2846r1630b2893],
47	0.001	CD	NUMBER	0.001	num	48	SENT_139	[p11l1666t2825r1917b2913],
48	)	NN	O	)	nsubj	44	SENT_139	[p11l1666t2825r1917b2913],
49	.	.	O	.	_	0	SENT_139	[p11l1666t2825r1917b2913],

1	Also	RB	O	also	advmod	2	SENT_140	[p11l1967t2828r2146b2893],
2	signiﬁcant	JJ	O	signiﬁcant	dep	4	SENT_140	[p11l12t2941r400b3026],
3	were	VBD	O	be	cop	4	SENT_140	[p11l519t2961r704b3006],
4	heterozygous	JJ	O	heterozygous	_	0	SENT_140	[p11l825t2941r1338b3026],
5	(	NN	O	(	nn	6	SENT_140	[p11l1462t2938r1643b3026],
6	CT	NN	O	ct	dep	11	SENT_140	[p11l1462t2938r1643b3026],
7	)	CD	NUMBER	)	num	8	SENT_140	[p11l1462t2938r1643b3026],
8	VKORC1	NN	O	vkorc1	dep	6	SENT_140	[p11l1772t2941r2140b3006],
9	(	CD	NUMBER	(	num	10	SENT_140	[p11l14t3049r104b3137],
10	P	NN	O	p	dep	11	SENT_140	[p11l14t3049r104b3137],
11	<	JJR	O	<	dep	21	SENT_140	[p11l137t3069r183b3116],
12	0.001	CD	NUMBER	0.001	num	13	SENT_140	[p11l219t3049r448b3137],
13	)	NN	O	)	dep	11	SENT_140	[p11l219t3049r448b3137],
14	and	CC	O	and	_	0	SENT_140	[p11l494t3051r633b3117],
15	homozygous	JJ	O	homozygous	amod	17	SENT_140	[p11l673t3052r1155b3136],
16	(	NN	O	(	nn	17	SENT_140	[p11l1201t3049r1378b3137],
17	TT	NN	O	tt	dep	11	SENT_140	[p11l1201t3049r1378b3137],
18	)	CD	NUMBER	)	num	20	SENT_140	[p11l1201t3049r1378b3137],
19	VKORC1	NN	O	vkorc1	nn	20	SENT_140	[p11l1427t3052r1794b3117],
20	variants	NNS	O	variant	nsubj	21	SENT_140	[p11l1841t3051r2146b3117],
21	(	VBP	O	(	ccomp	4	SENT_140	[p11l14t3160r104b3248],
22	P	NN	O	p	dep	23	SENT_140	[p11l14t3160r104b3248],
23	<	JJR	O	<	dobj	21	SENT_140	[p11l137t3180r183b3227],
24	0.001	CD	NUMBER	0.001	num	25	SENT_140	[p11l219t3160r470b3248],
25	)	NN	O	)	nsubj	4	SENT_140	[p11l219t3160r470b3248],
26	.	.	O	.	_	0	SENT_140	[p11l219t3160r470b3248],

1	Adjustment	NNP	O	Adjustment	nsubj	9	SENT_141	[p11l543t3162r1002b3247],
2	for	IN	O	for	_	0	SENT_141	[p11l1070t3163r1182b3228],
3	age	NN	O	age	prep_for	1	SENT_141	[p11l1251t3183r1400b3247],
4	,	,	O	,	_	0	SENT_141	[p11l1251t3183r1400b3247],
5	weight	NN	O	weight	prep_for	1	SENT_141	[p11l1470t3162r1747b3247],
6	,	,	O	,	_	0	SENT_141	[p11l1470t3162r1747b3247],
7	and	CC	O	and	_	0	SENT_141	[p11l1820t3163r1958b3228],
8	sex	NN	O	sex	prep_for	1	SENT_141	[p11l2027t3183r2148b3228],
9	changed	VBD	O	change	_	0	SENT_141	[p11l11t3274r330b3359],
10	the	DT	O	the	det	11	SENT_141	[p11l370t3274r489b3339],
11	results	NNS	O	result	dobj	9	SENT_141	[p11l531t3274r780b3339],
12	for	IN	O	for	_	0	SENT_141	[p11l821t3274r932b3339],
13	genotype	NN	O	genotype	nn	14	SENT_141	[p11l972t3283r1325b3359],
14	groups	NNS	O	group	prep_for	9	SENT_141	[p11l1367t3294r1624b3359],
15	only	RB	O	only	prep	9	SENT_141	[p11l1667t3274r1832b3359],
16	slightly	RB	O	slightly	advmod	18	SENT_141	[p11l1872t3274r2147b3359],
17	(	CD	NUMBER	(	num	18	SENT_141	[p11l14t3382r104b3470],
18	P	NN	O	p	npadvmod	25	SENT_141	[p11l14t3382r104b3470],
19	=	JJ	O	=	amod	18	SENT_141	[p11l137t3415r183b3438],
20	0.004	CD	NUMBER	0.004	tmod	19	SENT_141	[p11l219t3386r417b3450],
21	for	IN	O	for	_	0	SENT_141	[p11l475t3385r586b3450],
22	CT/AA	NN	O	ct/aa	prep_for	19	SENT_141	[p11l646t3385r939b3451],
23	and	CC	O	and	_	0	SENT_141	[p11l999t3385r1137b3450],
24	P	NN	O	p	prep_for	19	SENT_141	[p11l1194t3387r1254b3449],
25	<	JJR	O	<	pobj	15	SENT_141	[p11l1287t3403r1333b3450],
26	0.001	CD	NUMBER	0.001	tmod	9	SENT_141	[p11l1369t3385r1561b3450],
27	for	IN	O	for	_	0	SENT_141	[p11l1624t3385r1736b3450],
28	all	DT	O	all	det	31	SENT_141	[p11l1795t3385r1884b3450],
29	other	JJ	O	other	amod	31	SENT_141	[p11l1944t3385r2148b3450],
30	CYP2C9	NN	O	cyp2c9	nn	31	SENT_141	[p11l13t3495r350b3560],
31	groups	NNS	O	group	prep_for	9	SENT_141	[p11l377t3515r634b3579],
32	and	CC	O	and	_	0	SENT_141	[p11l663t3494r801b3559],
33	for	IN	O	for	_	0	SENT_141	[p11l826t3495r938b3559],
34	the	DT	O	the	det	36	SENT_141	[p11l962t3494r1081b3559],
35	VKORC1	NN	O	vkorc1	nn	36	SENT_141	[p11l1108t3495r1495b3560],
36	genotypes	NNS	O	genotype	prep_for	9	SENT_141	[p11l1525t3491r1967b3579],
37	)	CD	NUMBER	)	dep	9	SENT_141	[p11l1525t3491r1967b3579],
38	.	.	O	.	_	0	SENT_141	[p11l1525t3491r1967b3579],

1	The	DT	O	the	det	6	SENT_142	[p11l1996t3494r2145b3559],
2	ﬁnal	JJ	O	ﬁnal	amod	6	SENT_142	[p11l10t3606r176b3671],
3	multiple	JJ	O	multiple	amod	6	SENT_142	[p11l240t3606r559b3691],
4	linear	JJ	O	linear	amod	6	SENT_142	[p11l625t3606r846b3671],
5	regression	NN	O	regression	nn	6	SENT_142	[p11l909t3606r1303b3691],
6	model	NN	O	model	nsubj	8	SENT_142	[p11l1367t3606r1607b3671],
7	in	IN	O	in	prep	6	SENT_142	[p11l1671t3606r1743b3671],
8	given	VBN	O	give	_	0	SENT_142	[p11l1807t3606r2012b3691],
9	in	IN	O	in	_	0	SENT_142	[p11l2075t3606r2147b3671],
10	Table	NNP	O	Table	prep_in	8	SENT_142	[p11l10t3717r230b3783],
11	2	CD	NUMBER	2	num	10	SENT_142	[p11l265t3718r325b3782],
12	.	.	O	.	_	0	SENT_142	[p11l265t3718r325b3782],

1	Impact	NN	O	impact	_	0	SENT_143	[p12l9t143r280b224],
2	of	IN	O	of	_	0	SENT_143	[p12l308t141r397b225],
3	genotype	NN	O	genotype	nn	6	SENT_143	[p12l413t153r755b225],
4	and	CC	O	and	_	0	SENT_143	[p12l787t141r929b206],
5	clinical	JJ	O	clinical	nn	6	SENT_143	[p12l960t141r1233b206],
6	variables	NNS	O	variable	prep_of	1	SENT_143	[p12l1264t141r1603b206],
7	on	IN	O	on	_	0	SENT_143	[p12l1636t163r1729b206],
8	individual	JJ	O	individual	amod	10	SENT_143	[p12l1763t141r2150b206],
9	dose	NN	O	dose	nn	10	SENT_143	[p12l11t252r180b317],
10	variance	NN	O	variance	prep_on	1	SENT_143	[p12l216t254r534b317],

1	Individually	RB	O	individually	advmod	7	SENT_144	[p12l11t475r496b561],
2	,	,	O	,	_	0	SENT_144	[p12l11t475r496b561],
3	the	DT	O	the	det	5	SENT_144	[p12l530t476r649b541],
4	VKORCI	NN	O	vkorcus	nn	5	SENT_144	[p12l687t476r1056b541],
5	gene	NN	O	gene	nsubj	7	SENT_144	[p12l1096t496r1274b561],
6	variant	JJ	O	variant	amod	5	SENT_144	[p12l1306t476r1578b541],
7	accounted	VBD	O	account	_	0	SENT_144	[p12l1612t476r2005b541],
8	for	IN	O	for	_	0	SENT_144	[p12l2036t476r2148b541],
9	15.1	CD	PERCENT	15.1	num	10	SENT_144	[p12l14t586r246b652],
10	%	NN	PERCENT	%	prep_for	7	SENT_144	[p12l14t586r246b652],
11	of	IN	O	of	_	0	SENT_144	[p12l320t587r399b652],
12	the	DT	O	the	det	13	SENT_144	[p12l459t586r578b652],
13	variance	NN	O	variance	prep_of	10	SENT_144	[p12l644t586r968b652],
14	in	IN	O	in	_	0	SENT_144	[p12l1034t586r1106b651],
15	warfarin	NN	O	warfarin	nn	16	SENT_144	[p12l1169t586r1494b652],
16	dose	NN	O	dose	prep_in	7	SENT_144	[p12l1561t586r1755b665],
17	,	,	O	,	_	0	SENT_144	[p12l1561t586r1755b665],
18	and	CC	O	and	_	0	SENT_144	[p12l1823t586r1962b652],
19	the	DT	O	the	det	23	SENT_144	[p12l2026t586r2146b652],
20	CYPZC9	NN	O	cypzc9	nn	23	SENT_144	[p12l16t698r351b763],
21	gene	NN	O	gene	nn	23	SENT_144	[p12l420t718r598b782],
22	(	CD	NUMBER	(	num	23	SENT_144	[p12l673t694r789b782],
23	*	NN	O	*	nsubj	30	SENT_144	[p12l673t694r789b782],
24	2	CD	NUMBER	2	number	27	SENT_144	[p12l673t694r789b782],
25	and	CC	O	and	_	0	SENT_144	[p12l861t697r999b762],
26	*	CD	NUMBER	*	num	23	SENT_144	[p12l1072t698r1151b762],
27	3	CD	NUMBER	3	num	23	SENT_144	[p12l1072t698r1151b762],
28	jointly	RB	O	jointly	advmod	23	SENT_144	[p12l1218t694r1500b782],
29	)	CD	NUMBER	)	pobj	28	SENT_144	[p12l1218t694r1500b782],
30	accounted	VBD	O	account	conj_and	7	SENT_144	[p12l1575t697r1968b762],
31	for	IN	O	for	_	0	SENT_144	[p12l2036t698r2148b762],
32	18.3	CD	PERCENT	18.3	num	33	SENT_144	[p12l14t809r272b874],
33	%	NN	PERCENT	%	prep_for	30	SENT_144	[p12l14t809r272b874],
34	.	.	O	.	_	0	SENT_144	[p12l14t809r272b874],

1	Together	RB	O	together	advmod	6	SENT_145	[p12l312t809r688b894],
2	,	,	O	,	_	0	SENT_145	[p12l312t809r688b894],
3	the	DT	O	the	det	5	SENT_145	[p12l726t809r845b874],
4	2	CD	NUMBER	2	num	5	SENT_145	[p12l883t810r925b873],
5	genes	NNS	O	gene	nsubj	6	SENT_145	[p12l962t830r1175b894],
6	accounted	VBD	O	account	_	0	SENT_145	[p12l1215t809r1608b874],
7	for	IN	O	for	_	0	SENT_145	[p12l1644t810r1755b874],
8	33.2	CD	PERCENT	33.2	num	9	SENT_145	[p12l1792t810r2026b874],
9	%	NN	PERCENT	%	prep_for	6	SENT_145	[p12l1792t810r2026b874],
10	of	IN	O	of	_	0	SENT_145	[p12l2072t810r2151b874],
11	variance	NN	O	variance	prep_of	9	SENT_145	[p12l10t920r357b999],
12	,	,	O	,	_	0	SENT_145	[p12l10t920r357b999],
13	suggesting	VBG	O	suggest	xcomp	6	SENT_145	[p12l399t920r797b1005],
14	that	IN	O	that	complm	23	SENT_145	[p12l836t921r987b986],
15	the	DT	O	the	det	16	SENT_145	[p12l1027t920r1146b986],
16	effects	NNS	O	effect	nsubj	23	SENT_145	[p12l1188t921r1436b986],
17	of	IN	O	of	_	0	SENT_145	[p12l1478t921r1557b986],
18	the	DT	O	the	det	20	SENT_145	[p12l1592t920r1711b986],
19	two	CD	NUMBER	two	num	20	SENT_145	[p12l1752t929r1891b986],
20	genes	NNS	O	gene	prep_of	16	SENT_145	[p12l1933t941r2146b1005],
21	are	VBP	O	be	cop	23	SENT_145	[p12l13t1052r130b1097],
22	largely	RB	O	largely	advmod	23	SENT_145	[p12l197t1031r458b1116],
23	independent	JJ	O	independent	ccomp	13	SENT_145	[p12l522t1031r1006b1116],
24	of	IN	O	of	_	0	SENT_145	[p12l1073t1032r1151b1097],
25	one	CD	NUMBER	one	prep_of	23	SENT_145	[p12l1214t1052r1351b1097],
26	another	DT	O	another	dep	25	SENT_145	[p12l1420t1031r1735b1097],
27	.	.	O	.	_	0	SENT_145	[p12l1420t1031r1735b1097],

1	The	DT	O	the	det	5	SENT_146	[p12l1804t1031r1954b1097],
2	full	JJ	O	full	amod	5	SENT_146	[p12l2020t1031r2147b1097],
3	multiple	JJ	O	multiple	amod	5	SENT_146	[p12l10t1142r330b1227],
4	regression	NN	O	regression	nn	5	SENT_146	[p12l379t1142r773b1227],
5	model	NN	O	model	nsubj	17	SENT_146	[p12l820t1142r1081b1221],
6	,	,	O	,	_	0	SENT_146	[p12l820t1142r1081b1221],
7	including	VBG	O	include	_	0	SENT_146	[p12l1131t1142r1487b1227],
8	genotypes	NNS	O	genotype	prep_including	5	SENT_146	[p12l1535t1151r1944b1227],
9	,	,	O	,	_	0	SENT_146	[p12l1535t1151r1944b1227],
10	age	NN	O	age	appos	8	SENT_146	[p12l1996t1163r2145b1227],
11	,	,	O	,	_	0	SENT_146	[p12l1996t1163r2145b1227],
12	weight	NN	O	weight	conj_and	10	SENT_146	[p12l10t1254r286b1339],
13	,	,	O	,	_	0	SENT_146	[p12l10t1254r286b1339],
14	and	CC	O	and	_	0	SENT_146	[p12l337t1254r475b1319],
15	sex	NN	O	sex	appos	8	SENT_146	[p12l522t1274r662b1333],
16	,	,	O	,	_	0	SENT_146	[p12l522t1274r662b1333],
17	described	VBN	O	describe	_	0	SENT_146	[p12l712t1254r1079b1319],
18	44.6	CD	PERCENT	44.6	num	19	SENT_146	[p12l1125t1254r1361b1319],
19	%	NN	PERCENT	%	dobj	17	SENT_146	[p12l1125t1254r1361b1319],
20	of	IN	O	of	_	0	SENT_146	[p12l1417t1254r1495b1319],
21	the	DT	O	the	det	22	SENT_146	[p12l1537t1254r1656b1319],
22	variance	NN	O	variance	prep_of	19	SENT_146	[p12l1703t1254r2028b1319],
23	in	IN	O	in	_	0	SENT_146	[p12l2075t1254r2147b1318],
24	warfarin	NN	O	warfarin	nn	25	SENT_146	[p12l10t1365r336b1430],
25	dose	NN	O	dose	prep_in	22	SENT_146	[p12l370t1365r562b1430],
26	.	.	O	.	_	0	SENT_146	[p12l370t1365r562b1430],

1	Discussion	NN	O	discussion	_	0	SENT_147	[p12l10t1592r426b1657],

1	Pharmocogenetics	NNP	O	Pharmocogenetics	_	0	SENT_148	[p12l10t1815r739b1900],
2	,	,	O	,	_	0	SENT_148	[p12l10t1815r739b1900],
3	drug	NN	O	drug	nn	4	SENT_148	[p12l777t1815r950b1900],
4	safety	NN	O	safety	conj_and	1	SENT_148	[p12l984t1816r1229b1900],
5	,	,	O	,	_	0	SENT_148	[p12l984t1816r1229b1900],
6	and	CC	O	and	_	0	SENT_148	[p12l1267t1815r1405b1881],
7	impact	NN	O	impact	conj_and	1	SENT_148	[p12l1438t1815r1699b1900],
8	of	IN	O	of	_	0	SENT_148	[p12l1734t1816r1813b1881],
9	present	JJ	DATE	present	amod	10	SENT_148	[p12l10t1935r295b2011],
10	study	NN	O	study	prep_of	1	SENT_148	[p12l329t1926r533b2011],

1	The	DT	O	the	det	2	SENT_149	[p12l10t2150r160b2215],
2	hypothesis	NN	O	hypothesis	nsubj	15	SENT_149	[p12l187t2150r595b2235],
3	that	IN	O	that	complm	6	SENT_149	[p12l622t2150r773b2215],
4	genetic	JJ	O	genetic	amod	5	SENT_149	[p12l800t2150r1076b2235],
5	variations	NNS	O	variation	nsubj	6	SENT_149	[p12l1100t2150r1479b2215],
6	underlie	VBP	O	underlie	dep	2	SENT_149	[p12l1507t2150r1825b2215],
7	adverse	JJ	O	adverse	amod	10	SENT_149	[p12l1854t2150r2145b2215],
8	or	CC	O	or	_	0	SENT_149	[p12l12t2281r92b2326],
9	subtherapeutic	JJ	O	subtherapeutic	amod	10	SENT_149	[p12l117t2260r689b2346],
10	responses	NNS	O	response	dobj	6	SENT_149	[p12l713t2281r1086b2346],
11	to	TO	O	to	_	0	SENT_149	[p12l1111t2270r1186b2326],
12	drug	NN	O	drug	nn	13	SENT_149	[p12l1213t2261r1387b2346],
13	treatment	NN	O	treatment	prep_to	6	SENT_149	[p12l1411t2269r1791b2326],
14	is	VBZ	O	be	cop	15	SENT_149	[p12l1815t2260r1871b2326],
15	attractive	JJ	O	attractive	_	0	SENT_149	[p12l1898t2270r2145b2326, p12l11t2371r151b2437],
16	because	IN	O	because	mark	18	SENT_149	[p12l202t2372r506b2437],
17	it	PRP	O	it	nsubj	18	SENT_149	[p12l558t2371r610b2437],
18	holds	VBZ	O	hold	advcl	15	SENT_149	[p12l660t2372r864b2437],
19	promise	NN	O	promise	dobj	18	SENT_149	[p12l915t2371r1224b2457],
20	for	IN	O	for	_	0	SENT_149	[p12l1276t2372r1387b2437],
21	the	DT	O	the	det	22	SENT_149	[p12l1437t2372r1557b2437],
22	pre-treatment	NN	O	pre-treatment	prep_for	19	SENT_149	[p12l1608t2380r2147b2457],

1	Table	NNP	O	Table	_	0	SENT_150	[p12l8t2621r195b2675],
2	2	CD	NUMBER	2	num	6	SENT_150	[p12l223t2620r260b2674],
3	Multiple	JJ	O	multiple	amod	6	SENT_150	[p12l308t2619r588b2691],
4	linear	JJ	O	linear	amod	6	SENT_150	[p12l617t2619r805b2674],
5	regression	NN	O	regression	nn	6	SENT_150	[p12l833t2619r1167b2691],
6	model	NN	O	model	dep	1	SENT_150	[p12l1195t2619r1399b2674],
7	for	IN	O	for	_	0	SENT_150	[p12l1428t2620r1522b2674],
8	prediction	NN	O	prediction	prep_for	6	SENT_150	[p12l1549t2619r1885b2691],
9	of	IN	O	of	_	0	SENT_150	[p12l1914t2620r1981b2674],
10	warfarin	NN	O	warfarin	nn	11	SENT_150	[p12l2005t2637r2149b2674, p12l8t2708r162b2763],
11	dose	NN	O	dose	prep_of	8	SENT_150	[p12l191t2708r337b2763],

1	Standardized	JJ	O	standardized	_	0	SENT_151	[p12l10t2882r440b2937],

1	Variable	JJ	O	variable	amod	3	SENT_152	[p12l8t3083r292b3138],
2	Beta-coefﬁcient	JJ	O	beta-coefﬁcient	amod	3	SENT_152	[p12l636t3083r1156b3138],
3	t	NN	O	t	dep	10	SENT_152	[p12l1383t3083r1675b3138],
4	—	NN	O	—	nn	9	SENT_152	[p12l1383t3083r1675b3138],
5	statistic	NN	O	statistic	nn	9	SENT_152	[p12l1383t3083r1675b3138],
6	P-value	JJ	O	p-value	amod	9	SENT_152	[p12l1899t3083r2150b3138],
7	Age	NN	O	age	nn	9	SENT_152	[p12l8t3172r144b3243],
8	(	CD	NUMBER	(	num	9	SENT_152	[p12l177t3169r399b3243],
9	years	NNS	NUMBER	year	dep	3	SENT_152	[p12l177t3169r399b3243],
10	)	VBP	O	)	_	0	SENT_152	[p12l177t3169r399b3243],
11	-0.236	CD	NUMBER	-0.236	num	12	SENT_152	[p12l634t3171r841b3226],
12	-3.966	CD	NUMBER	-3.966	nsubj	15	SENT_152	[p12l1380t3171r1587b3227],
13	<	JJR	O	<	amod	12	SENT_152	[p12l1902t3171r2110b3226],
14	0.001	CD	NUMBER	0.001	num	15	SENT_152	[p12l1902t3171r2110b3226],
15	Sex	NN	O	sex	xcomp	10	SENT_152	[p12l10t3260r124b3315],
16	(	CD	NUMBER	(	num	18	SENT_152	[p12l156t3257r366b3331],
17	male	JJ	O	male	amod	18	SENT_152	[p12l156t3257r366b3331],
18	)	NN	O	)	dep	15	SENT_152	[p12l156t3257r366b3331],
19	0.098	CD	NUMBER	0.098	dep	15	SENT_152	[p12l636t3260r803b3315],
20	1.658	CD	NUMBER	1.658	number	21	SENT_152	[p12l1384t3259r1549b3315],
21	0.099	CD	NUMBER	0.099	num	25	SENT_152	[p12l1900t3260r2067b3315],
22	Weight	NNP	O	Weight	nn	25	SENT_152	[p12l8t3347r247b3419],
23	(	CD	NUMBER	(	num	25	SENT_152	[p12l278t3345r407b3419],
24	kg	NN	O	kg	nn	25	SENT_152	[p12l278t3345r407b3419],
25	)	NN	O	)	dep	19	SENT_152	[p12l278t3345r407b3419],
26	0.146	CD	NUMBER	0.146	number	27	SENT_152	[p12l636t3347r803b3402],
27	2.331	CD	NUMBER	2.331	num	25	SENT_152	[p12l1381t3347r1546b3402],
28	0.021	CD	NUMBER	0.021	num	29	SENT_152	[p12l1900t3348r2064b3402],
29	Cyp2C9	NN	O	cyp2c9	nsubj	10	SENT_152	[p12l11t3436r270b3507],

1	CC/AA	NN	O	cc/aa	nn	3	SENT_153	[p12l112t3525r365b3580],
2	o.o	NN	O	o.o	nn	3	SENT_153	[p12l636t3525r728b3580],
3	CT/AA	NN	O	ct/aa	dep	10	SENT_153	[p12l112t3613r361b3668],
4	-0.163	CD	NUMBER	-0.163	dep	3	SENT_153	[p12l634t3612r840b3668],
5	2.892	CD	NUMBER	2.892	number	6	SENT_153	[p12l1381t3613r1550b3668],
6	0.004	CD	NUMBER	0.004	dep	4	SENT_153	[p12l1900t3613r2068b3668],
7	CC/AC	NN	O	cc/ac	dep	10	SENT_153	[p12l112t3701r357b3756],
8	-0.218	CD	NUMBER	-0.218	num	7	SENT_153	[p12l634t3701r841b3755],
9	-3.922	CD	NUMBER	-3.922	num	10	SENT_153	[p12l1380t3701r1588b3756],
10	<	JJR	O	<	_	0	SENT_153	[p12l1902t3700r2110b3755],
11	0.001	CD	NUMBER	0.001	dep	10	SENT_153	[p12l1902t3700r2110b3755],

1	CT/AC	NN	O	ct/ac	_	0	SENT_154	[p13l112t24r352b79],
2	-0.341	CD	NUMBER	-0.341	num	1	SENT_154	[p13l634t24r838b79],
3	-6.202	CD	NUMBER	-6.202	num	4	SENT_154	[p13l1380t23r1588b79],
4	<	JJR	O	<	dep	1	SENT_154	[p13l1902t24r2110b79],
5	0.001	CD	NUMBER	0.001	dep	1	SENT_154	[p13l1902t24r2110b79],

1	VKORC1	NN	O	vkorc1	_	0	SENT_155	[p13l8t113r336b168],

1	CC	NN	O	cc	nn	3	SENT_156	[p13l112t202r217b257],
2	o.o	NN	O	o.o	nn	3	SENT_156	[p13l636t202r728b257],
3	CT	NN	O	ct	dep	9	SENT_156	[p13l112t290r213b345],
4	-0.319	CD	NUMBER	-0.319	dep	3	SENT_156	[p13l634t290r841b345],
5	-5.369	CD	NUMBER	-5.369	num	6	SENT_156	[p13l1380t289r1587b345],
6	<	JJR	O	<	dep	4	SENT_156	[p13l1902t290r2110b345],
7	0.001	CD	NUMBER	0.001	num	8	SENT_156	[p13l1902t290r2110b345],
8	TT	NN	O	tt	dep	9	SENT_156	[p13l109t379r209b432],
9	-0.398	CD	NUMBER	-0.398	dep	12	SENT_156	[p13l634t378r841b433],
10	-6.685	CD	NUMBER	-6.685	num	11	SENT_156	[p13l1380t377r1586b433],
11	<	JJR	O	<	dep	9	SENT_156	[p13l1902t378r2110b433],
12	0.001	CD	NUMBER	0.001	_	0	SENT_156	[p13l1902t378r2110b433],

1	J	NN	O	j	nn	3	SENT_157	[p13l52t593r67b618],
2	Thromb	NN	O	thromb	nn	3	SENT_157	[p13l80t592r203b618],
3	Thrombolysis	NN	O	thrombolysis	_	0	SENT_157	[p13l217t592r424b626],
4	(	CD	NUMBER	(	num	5	SENT_157	[p13l439t591r533b626],
5	2006	CD	DATE	2006	dep	3	SENT_157	[p13l439t591r533b626],
6	)	CD	NUMBER	)	number	7	SENT_157	[p13l439t591r533b626],
7	22:191	CD	NUMBER	22:191	num	8	SENT_157	[p13l547t592r713b618],
8	—	NN	O	—	dep	5	SENT_157	[p13l547t592r713b618],
9	197	CD	NUMBER	197	num	10	SENT_157	[p13l547t592r713b618],
10	195	CD	NUMBER	195	dep	3	SENT_157	[p13l2056t592r2105b618],

1	identiﬁcation	NN	O	identiﬁcation	_	0	SENT_158	[p13l9t759r519b824],
2	of	IN	O	of	_	0	SENT_158	[p13l551t759r630b824],
3	those	DT	O	those	det	4	SENT_158	[p13l656t759r859b824],
4	individuals	NNS	O	individual	prep_of	1	SENT_158	[p13l891t759r1311b824],
5	who	WP	O	who	nsubjpass	7	SENT_158	[p13l1342t759r1501b824],
6	are	VBP	O	be	auxpass	7	SENT_158	[p13l1535t779r1652b824],
7	predisposed	VBN	O	predispose	rcmod	4	SENT_158	[p13l1684t759r2148b844],
8	to	TO	O	to	_	0	SENT_158	[p13l9t879r84b935],
9	these	DT	O	these	det	11	SENT_158	[p13l121t870r320b935],
10	suboptimal	JJ	O	suboptimal	amod	11	SENT_158	[p13l360t870r788b955],
11	outcomes	NNS	O	outcome	prep_to	7	SENT_158	[p13l827t878r1214b935],
12	.	.	O	.	_	0	SENT_158	[p13l827t878r1214b935],

1	Warfarin	NNP	O	Warfarin	nsubj	8	SENT_159	[p13l1253t870r1606b935],
2	is	VBZ	O	be	cop	8	SENT_159	[p13l1641t870r1697b935],
3	a	DT	O	a	det	8	SENT_159	[p13l1737t890r1776b935],
4	common	JJ	O	common	amod	8	SENT_159	[p13l1814t890r2149b935],
5	but	CC	O	but	_	0	SENT_159	[p13l8t980r134b1045],
6	especially	RB	O	especially	advmod	7	SENT_159	[p13l165t980r541b1065],
7	difficult	JJ	O	difficult	conj_but	4	SENT_159	[p13l571t980r866b1045],
8	drug	NN	O	drug	_	0	SENT_159	[p13l897t980r1071b1065],
9	to	TO	O	to	aux	10	SENT_159	[p13l1101t989r1176b1045],
10	manage	VB	O	manage	infmod	8	SENT_159	[p13l1207t1001r1505b1065],
11	clinically	RB	O	clinically	advmod	10	SENT_159	[p13l1537t980r1898b1065],
12	.	.	O	.	_	0	SENT_159	[p13l1537t980r1898b1065],

1	It	PRP	O	it	nsubj	2	SENT_160	[p13l1933t982r1993b1045],
2	has	VBZ	O	have	_	0	SENT_160	[p13l2022t980r2147b1045],
3	a	DT	O	a	det	6	SENT_160	[p13l11t1112r50b1156],
4	narrow	JJ	O	narrow	amod	6	SENT_160	[p13l97t1112r372b1156],
5	therapeutic	JJ	O	therapeutic	amod	6	SENT_160	[p13l419t1091r859b1176],
6	range	NN	O	range	dobj	2	SENT_160	[p13l906t1112r1142b1176],
7	,	,	O	,	_	0	SENT_160	[p13l906t1112r1142b1176],
8	and	CC	O	and	_	0	SENT_160	[p13l1194t1091r1332b1156],
9	the	DT	O	the	det	13	SENT_160	[p13l1380t1091r1499b1156],
10	inter	NN	O	inter	nn	13	SENT_160	[p13l1548t1091r2148b1156],
11	—	NN	O	—	nn	13	SENT_160	[p13l1548t1091r2148b1156],
12	individual	JJ	O	individual	amod	13	SENT_160	[p13l1548t1091r2148b1156],
13	variability	NN	O	variability	nsubj	19	SENT_160	[p13l8t1202r400b1287],
14	in	IN	O	in	_	0	SENT_160	[p13l431t1202r503b1266],
15	response	NN	O	response	prep_in	13	SENT_160	[p13l535t1222r872b1287],
16	to	TO	O	to	_	0	SENT_160	[p13l906t1211r980b1267],
17	this	DT	O	this	det	18	SENT_160	[p13l1014t1202r1149b1267],
18	drug	NN	O	drug	prep_to	15	SENT_160	[p13l1183t1202r1356b1287],
19	requires	VBZ	O	require	conj_and	2	SENT_160	[p13l1388t1202r1702b1287],
20	patients	NNS	O	patient	nsubj	23	SENT_160	[p13l1734t1202r2039b1287],
21	to	TO	O	to	aux	23	SENT_160	[p13l2072t1211r2147b1267],
22	routinely	RB	O	routinely	advmod	23	SENT_160	[p13l9t1313r359b1398],
23	visit	VB	O	visit	xcomp	19	SENT_160	[p13l421t1313r579b1379],
24	coagulation	NN	O	coagulation	nn	25	SENT_160	[p13l643t1314r1092b1399],
25	clinics	NNS	O	clinic	dobj	23	SENT_160	[p13l1156t1313r1391b1379],
26	and	CC	O	and	_	0	SENT_160	[p13l1458t1314r1596b1379],
27	undergo	VBP	O	undergo	conj_and	19	SENT_160	[p13l1660t1314r1977b1399],
28	repeated	VBN	O	repeat	amod	30	SENT_160	[p13l2042t1334r2146b1379, p13l8t1424r269b1509],
29	INR	NN	O	inr	nn	30	SENT_160	[p13l309t1426r480b1489],
30	measurements	NNS	O	measurement	xcomp	27	SENT_160	[p13l519t1433r1097b1490],
31	.	.	O	.	_	0	SENT_160	[p13l519t1433r1097b1490],

1	Failure	NN	O	failure	nsubj	7	SENT_161	[p13l1139t1424r1415b1490],
2	to	TO	O	to	aux	4	SENT_161	[p13l1456t1434r1531b1490],
3	carefully	RB	O	carefully	advmod	4	SENT_161	[p13l1573t1424r1909b1509],
4	monitor	VB	O	monitor	infmod	1	SENT_161	[p13l1947t1445r2146b1490, p13l9t1535r145b1601],
5	administration	NN	O	administration	dobj	4	SENT_161	[p13l228t1535r790b1601],
6	can	MD	O	can	aux	7	SENT_161	[p13l873t1556r1003b1601],
7	lead	VB	O	lead	_	0	SENT_161	[p13l1085t1535r1246b1601],
8	to	TO	O	to	_	0	SENT_161	[p13l1328t1544r1403b1601],
9	either	CC	O	either	advmod	11	SENT_161	[p13l1486t1535r1711b1601],
10	excessive	JJ	O	excessive	amod	11	SENT_161	[p13l1794t1535r2146b1601],
11	anticoagulation	NN	O	anticoagulation	prep_to	7	SENT_161	[p13l11t1648r609b1733],
12	with	IN	O	with	_	0	SENT_161	[p13l644t1648r811b1713],
13	increased	VBN	O	increase	amod	14	SENT_161	[p13l846t1648r1212b1713],
14	risk	NN	O	risk	prep_with	7	SENT_161	[p13l1247t1648r1388b1713],
15	of	IN	O	of	_	0	SENT_161	[p13l1425t1648r1504b1713],
16	bleeding	VBG	O	bleed	amod	17	SENT_161	[p13l1536t1648r1867b1733],
17	events	NNS	O	event	prep_of	14	SENT_161	[p13l1904t1657r2147b1713],
18	or	CC	O	or	_	0	SENT_161	[p13l10t1779r90b1824],
19	sub	JJ	O	sub	amod	21	SENT_161	[p13l127t1759r254b1824],
20	therapeutic	JJ	O	therapeutic	amod	21	SENT_161	[p13l292t1759r732b1844],
21	anticoagulation	NN	O	anticoagulation	prep_of	14	SENT_161	[p13l770t1759r1368b1844],
22	with	IN	O	with	_	0	SENT_161	[p13l1403t1759r1570b1824],
23	increased	VBN	O	increase	amod	24	SENT_161	[p13l1606t1759r1972b1824],
24	risk	NN	O	risk	prep_with	21	SENT_161	[p13l2007t1759r2148b1824],
25	for	IN	O	for	_	0	SENT_161	[p13l9t1870r120b1935],
26	stroke	NN	O	stroke	nn	30	SENT_161	[p13l194t1869r431b1935],
27	or	CC	O	or	_	0	SENT_161	[p13l507t1890r587b1934],
28	other	JJ	O	other	conj_or	26	SENT_161	[p13l661t1869r866b1935],
29	thromboembolic	JJ	O	thromboembolic	amod	30	SENT_161	[p13l938t1869r1583b1935],
30	events	NNS	O	event	prep_for	24	SENT_161	[p13l1658t1878r1920b1935],
31	.	.	O	.	_	0	SENT_161	[p13l1658t1878r1920b1935],

1	The	DT	O	the	det	4	SENT_162	[p13l1996t1869r2147b1935],
2	average	JJ	O	average	amod	4	SENT_162	[p13l11t2002r307b2066],
3	annual	JJ	SET	annual	amod	4	SENT_162	[p13l347t1981r605b2046],
4	frequencies	NNS	O	frequency	nsubjpass	20	SENT_162	[p13l641t1981r1084b2066],
5	of	IN	O	of	_	0	SENT_162	[p13l1122t1982r1201b2046],
6	fatal	JJ	O	fatal	dep	11	SENT_162	[p13l1233t1981r1425b2060],
7	,	,	O	,	_	0	SENT_162	[p13l1233t1981r1425b2060],
8	major	JJ	O	major	conj_and	11	SENT_162	[p13l1462t1981r1708b2066],
9	,	,	O	,	_	0	SENT_162	[p13l1462t1981r1708b2066],
10	and	CC	O	and	_	0	SENT_162	[p13l1748t1981r1887b2046],
11	major	JJ	O	major	amod	14	SENT_162	[p13l1922t1981r2149b2066],
12	or	CC	O	or	_	0	SENT_162	[p13l10t2113r90b2157],
13	minor	JJ	O	minor	amod	14	SENT_162	[p13l163t2092r394b2157],
14	bleeding	NN	O	bleeding	prep_of	4	SENT_162	[p13l467t2092r797b2177],
15	during	IN	O	during	_	0	SENT_162	[p13l873t2092r1121b2177],
16	Warfarin	NNP	O	Warfarin	nn	17	SENT_162	[p13l1195t2092r1520b2157],
17	therapy	NN	O	therapy	prep_during	14	SENT_162	[p13l1594t2092r1889b2177],
18	were	VBD	O	be	auxpass	20	SENT_162	[p13l1962t2113r2147b2157],
19	recently	RB	DATE	recently	advmod	20	SENT_162	[p13l9t2204r320b2289],
20	reported	VBN	O	report	_	0	SENT_162	[p13l368t2204r702b2289],
21	as	IN	O	as	_	0	SENT_162	[p13l753t2224r826b2269],
22	0.6	CD	PERCENT	0.6	num	23	SENT_162	[p13l875t2203r1094b2282],
23	%	NN	PERCENT	%	prep_as	20	SENT_162	[p13l875t2203r1094b2282],
24	,	,	O	,	_	0	SENT_162	[p13l875t2203r1094b2282],
25	3.0	CD	PERCENT	3.0	num	26	SENT_162	[p13l1145t2205r1364b2282],
26	%	NN	PERCENT	%	conj_and	23	SENT_162	[p13l1145t2205r1364b2282],
27	,	,	O	,	_	0	SENT_162	[p13l1145t2205r1364b2282],
28	and	CC	O	and	_	0	SENT_162	[p13l1416t2204r1555b2269],
29	9.6	CD	PERCENT	9.6	num	30	SENT_162	[p13l1604t2203r1822b2282],
30	%	NN	PERCENT	%	prep_as	20	SENT_162	[p13l1604t2203r1822b2282],
31	,	,	O	,	_	0	SENT_162	[p13l1604t2203r1822b2282],
32	respectively	RB	O	respectively	advmod	35	SENT_162	[p13l1872t2224r2146b2289, p13l9t2315r221b2401],
33	[	CD	NUMBER	[	number	34	SENT_162	[p13l273t2312r434b2401],
34	16	CD	NUMBER	16	num	35	SENT_162	[p13l273t2312r434b2401],
35	]	NN	O	]	rcmod	30	SENT_162	[p13l273t2312r434b2401],
36	,	,	O	,	_	0	SENT_162	[p13l273t2312r434b2401],
37	and	CC	O	and	_	0	SENT_162	[p13l485t2315r623b2380],
38	the	DT	O	the	det	41	SENT_162	[p13l670t2315r789b2380],
39	aggregate	JJ	O	aggregate	amod	41	SENT_162	[p13l840t2324r1212b2401],
40	bleeding	NN	O	bleeding	nn	41	SENT_162	[p13l1260t2315r1590b2401],
41	risk	NN	O	risk	nsubjpass	47	SENT_162	[p13l1637t2315r1777b2380],
42	for	IN	O	for	_	0	SENT_162	[p13l1824t2315r1936b2380],
43	nine	CD	NUMBER	nine	num	45	SENT_162	[p13l1982t2315r2146b2380],
44	combined	JJ	O	combined	amod	45	SENT_162	[p13l9t2426r389b2492],
45	studies	NNS	O	study	prep_for	41	SENT_162	[p13l422t2426r684b2492],
46	was	VBD	O	be	auxpass	47	SENT_162	[p13l715t2447r856b2492],
47	estimated	VBN	O	estimate	conj_and	20	SENT_162	[p13l890t2426r1264b2492],
48	to	TO	O	to	aux	50	SENT_162	[p13l1295t2436r1370b2492],
49	be	VB	O	be	cop	50	SENT_162	[p13l1402t2426r1492b2492],
50	2.26	CD	NUMBER	2.26	xcomp	47	SENT_162	[p13l1525t2426r1678b2492],
51	for	IN	O	for	_	0	SENT_162	[p13l1710t2427r1822b2492],
52	individuals	NNS	O	individual	prep_for	50	SENT_162	[p13l1852t2426r2146b2492, p13l8t2538r158b2603],
53	bearing	VBG	O	bear	partmod	52	SENT_162	[p13l185t2538r476b2623],
54	either	CC	O	either	preconj	60	SENT_162	[p13l504t2538r729b2603],
55	the	DT	O	the	det	60	SENT_162	[p13l754t2538r873b2603],
56	cytochrome	NN	O	cytochrome	nn	60	SENT_162	[p13l902t2538r1354b2623],
57	p450	NN	O	p450	nn	60	SENT_162	[p13l1382t2538r1563b2623],
58	C	NN	O	c	nn	60	SENT_162	[p13l1594t2539r1653b2603],
59	YP2C9	NN	O	yp2c9	nn	60	SENT_162	[p13l1659t2539r1930b2603],
60	*	NN	O	*	dobj	53	SENT_162	[p13l1959t2539r2041b2602],
61	2	CD	NUMBER	2	dep	60	SENT_162	[p13l1959t2539r2041b2602],
62	or	CC	O	or	_	0	SENT_162	[p13l2069t2559r2149b2603],
63	*	CD	NUMBER	*	number	64	SENT_162	[p13l13t2651r92b2716],
64	3	CD	NUMBER	3	num	66	SENT_162	[p13l13t2651r92b2716],
65	Variant	JJ	O	variant	amod	66	SENT_162	[p13l128t2650r399b2716],
66	[	NN	O	[	dobj	53	SENT_162	[p13l438t2647r597b2736],
67	17	CD	NUMBER	17	num	68	SENT_162	[p13l438t2647r597b2736],
68	]	NN	O	]	dep	66	SENT_162	[p13l438t2647r597b2736],
69	.	.	O	.	_	0	SENT_162	[p13l438t2647r597b2736],

1	In	IN	O	in	_	0	SENT_163	[p13l112t2764r192b2826],
2	addition	NN	O	addition	_	0	SENT_163	[p13l237t2762r556b2827],
3	to	TO	O	to	_	0	SENT_163	[p13l600t2770r674b2827],
4	the	DT	O	the	det	5	SENT_163	[p13l720t2762r839b2827],
5	morbidity	NN	O	morbidity	prep_in_addition_to	14	SENT_163	[p13l884t2762r1265b2847],
6	and	CC	O	and	_	0	SENT_163	[p13l1310t2762r1449b2827],
7	mortality	NN	O	mortality	prep_in_addition_to	14	SENT_163	[p13l1493t2762r1849b2847],
8	associated	VBN	O	associate	csubj	14	SENT_163	[p13l1895t2762r2146b2827, p13l11t2872r175b2937],
9	with	IN	O	with	_	0	SENT_163	[p13l228t2872r395b2937],
10	these	DT	O	these	det	11	SENT_163	[p13l449t2872r648b2937],
11	events	NNS	O	event	prep_with	8	SENT_163	[p13l706t2881r948b2937],
12	is	VBZ	O	be	cop	14	SENT_163	[p13l1004t2872r1059b2937],
13	the	DT	O	the	det	14	SENT_163	[p13l1115t2872r1234b2937],
14	cost	NN	O	cost	_	0	SENT_163	[p13l1291t2881r1440b2937],
15	of	IN	O	of	_	0	SENT_163	[p13l1497t2873r1575b2937],
16	management	NN	O	management	prep_of	14	SENT_163	[p13l1625t2881r2144b2957],
17	.	.	O	.	_	0	SENT_163	[p13l1625t2881r2144b2957],

1	Previously	RB	DATE	previously	advmod	2	SENT_164	[p13l9t2983r414b3068],
2	published	VBN	O	publish	_	0	SENT_164	[p13l472t2983r847b3068],
3	cost	NN	O	cost	nn	4	SENT_164	[p13l906t2992r1056b3048],
4	estimates	NNS	O	estimate	dobj	2	SENT_164	[p13l1116t2983r1474b3048],
5	place	VBP	O	place	dep	2	SENT_164	[p13l1533t2983r1733b3068],
6	warfarin	NN	O	warfarin	dobj	5	SENT_164	[p13l1792t2983r2146b3048],
7	—	RB	O	—	advmod	5	SENT_164	[p13l1792t2983r2146b3048],
8	related	JJ	O	related	amod	10	SENT_164	[p13l9t3094r279b3160],
9	adverse	JJ	O	adverse	amod	10	SENT_164	[p13l329t3094r620b3160],
10	events	NNS	O	event	nsubj	2	SENT_164	[p13l670t3104r913b3160],
11	at	IN	O	at	_	0	SENT_164	[p13l964t3104r1033b3160],
12	approximately	RB	O	approximately	quantmod	13	SENT_164	[p13l1082t3094r1641b3180],
13	$	$	MONEY	$	prep_at	10	SENT_164	[p13l1690t3090r2148b3168],
14	7500/event	CD	MONEY	7500/event	number	13	SENT_164	[p13l1690t3090r2148b3168],
15	[	CD	MONEY	[	number	13	SENT_164	[p13l14t3204r173b3293],
16	18	CD	MONEY	18	num	17	SENT_164	[p13l14t3204r173b3293],
17	]	NN	O	]	dep	13	SENT_164	[p13l14t3204r173b3293],
18	.	.	O	.	_	0	SENT_164	[p13l14t3204r173b3293],

1	Moreover	RB	O	moreover	advmod	7	SENT_165	[p13l230t3209r636b3286],
2	,	,	O	,	_	0	SENT_165	[p13l230t3209r636b3286],
3	it	PRP	O	it	nsubjpass	7	SENT_165	[p13l691t3207r743b3272],
4	has	VBZ	O	have	aux	7	SENT_165	[p13l796t3207r921b3272],
5	been	VBN	O	be	auxpass	7	SENT_165	[p13l975t3207r1162b3272],
6	recently	RB	DATE	recently	advmod	7	SENT_165	[p13l1214t3207r1526b3293],
7	projected	VBN	O	project	_	0	SENT_165	[p13l1578t3207r1944b3293],
8	that	IN	O	that	complm	28	SENT_165	[p13l1997t3207r2148b3272],
9	elimination	NN	O	elimination	nsubj	28	SENT_165	[p13l10t3318r450b3384],
10	of	IN	O	of	_	0	SENT_165	[p13l484t3319r563b3384],
11	sub	NN	O	sub	num	17	SENT_165	[p13l594t3318r751b3384],
12	—	CD	NUMBER	—	num	11	SENT_165	[p13l594t3318r751b3384],
13	or	CC	O	or	_	0	SENT_165	[p13l789t3339r869b3384],
14	supra	NN	O	supra	num	17	SENT_165	[p13l902t3318r1585b3403],
15	—	CD	NUMBER	—	num	14	SENT_165	[p13l902t3318r1585b3403],
16	therapeutic	JJ	O	therapeutic	amod	17	SENT_165	[p13l902t3318r1585b3403],
17	dosing	NN	O	dosing	prep_of	9	SENT_165	[p13l1620t3318r1869b3403],
18	of	IN	O	of	_	0	SENT_165	[p13l1904t3319r1983b3384],
19	just	RB	O	just	quantmod	20	SENT_165	[p13l2007t3318r2148b3403],
20	50	CD	PERCENT	50	num	21	SENT_165	[p13l9t3429r177b3495],
21	%	NN	PERCENT	%	prep_of	17	SENT_165	[p13l9t3429r177b3495],
22	of	IN	O	of	_	0	SENT_165	[p13l256t3430r335b3495],
23	patients	NNS	O	patient	prep_of	21	SENT_165	[p13l400t3429r705b3514],
24	receiving	VBG	O	receive	partmod	23	SENT_165	[p13l777t3429r1127b3514],
25	routine	JJ	O	routine	amod	26	SENT_165	[p13l1198t3429r1476b3495],
26	anticoagulation	NN	O	anticoagulation	dobj	24	SENT_165	[p13l1550t3429r2148b3514],
27	would	MD	O	would	aux	28	SENT_165	[p13l8t3541r243b3606],
28	result	VB	O	result	ccomp	7	SENT_165	[p13l304t3541r519b3606],
29	in	IN	O	in	_	0	SENT_165	[p13l578t3541r650b3605],
30	a	DT	O	a	det	33	SENT_165	[p13l712t3561r751b3606],
31	projected	VBN	O	project	amod	33	SENT_165	[p13l810t3541r1176b3626],
32	annual	JJ	SET	annual	amod	33	SENT_165	[p13l1238t3541r1496b3606],
33	savings	NNS	O	savings	prep_in	28	SENT_165	[p13l1557t3541r1830b3626],
34	to	TO	O	to	_	0	SENT_165	[p13l1892t3550r1966b3606],
35	the	DT	O	the	det	38	SENT_165	[p13l2027t3541r2147b3606],
36	health	NN	O	health	nn	38	SENT_165	[p13l8t3652r249b3718],
37	care	NN	O	care	nn	38	SENT_165	[p13l308t3673r466b3718],
38	system	NN	O	system	prep_to	33	SENT_165	[p13l527t3661r786b3738],
39	of	IN	O	of	_	0	SENT_165	[p13l845t3653r924b3718],
40	$	$	MONEY	$	num	43	SENT_165	[p13l980t3647r1126b3726],
41	1.1	CD	MONEY	1.1	number	40	SENT_165	[p13l980t3647r1126b3726],
42	billion	CD	MONEY	billion	number	40	SENT_165	[p13l1188t3652r1436b3718],
43	[	NN	O	[	prep_of	38	SENT_165	[p13l1499t3649r1658b3738],
44	19	CD	NUMBER	19	num	45	SENT_165	[p13l1499t3649r1658b3738],
45	]	NN	O	]	dep	43	SENT_165	[p13l1499t3649r1658b3738],
46	.	.	O	.	_	0	SENT_165	[p13l1499t3649r1658b3738],

1	This	DT	O	this	det	2	SENT_166	[p13l1719t3652r1884b3718],
2	study	NN	O	study	nsubj	3	SENT_166	[p13l1944t3652r2148b3738],
3	suggests	VBZ	O	suggest	_	0	SENT_166	[p14l10t28r323b105],
4	an	DT	O	a	det	5	SENT_166	[p14l361t40r451b85],
5	approach	NN	O	approach	dobj	3	SENT_166	[p14l488t20r845b105],
6	to	TO	O	to	_	0	SENT_166	[p14l881t28r956b85],
7	achieving	VBG	O	achieve	prepc_to	5	SENT_166	[p14l995t20r1359b105],
8	this	DT	O	this	det	9	SENT_166	[p14l1395t20r1530b85],
9	goal	NN	O	goal	dobj	7	SENT_166	[p14l1567t20r1746b105],
10	.	.	O	.	_	0	SENT_166	[p14l1567t20r1746b105],

1	We	PRP	O	we	nsubj	2	SENT_167	[p14l1785t22r1916b85],
2	show	VBP	O	show	_	0	SENT_167	[p14l1954t20r2149b85],
3	here	RB	O	here	advmod	2	SENT_167	[p14l8t130r178b195],
4	that	IN	O	that	complm	15	SENT_167	[p14l207t130r358b195],
5	knowledge	NN	O	knowledge	nsubj	15	SENT_167	[p14l386t130r804b215],
6	of	IN	O	of	_	0	SENT_167	[p14l835t131r914b195],
7	genotype	NN	O	genotype	prep_of	5	SENT_167	[p14l939t139r1291b215],
8	for	IN	O	for	_	0	SENT_167	[p14l1321t131r1432b195],
9	3	CD	NUMBER	3	num	10	SENT_167	[p14l1460t131r1498b195],
10	SNPs	NNS	O	snp	prep_for	7	SENT_167	[p14l1531t131r1734b196],
11	in	IN	O	in	_	0	SENT_167	[p14l1764t130r1836b195],
12	2	CD	NUMBER	2	num	13	SENT_167	[p14l1863t131r1904b195],
13	genes	NNS	O	gene	prep_in	10	SENT_167	[p14l1934t151r2147b215],
14	can	MD	O	can	aux	15	SENT_167	[p14l9t262r140b306],
15	explain	VB	O	explain	ccomp	2	SENT_167	[p14l178t241r458b326],
16	almost	RB	O	almost	quantmod	18	SENT_167	[p14l496t241r749b306],
17	4	CD	NUMBER	4	number	18	SENT_167	[p14l785t242r827b306],
18	times	NNS	O	time	num	20	SENT_167	[p14l863t241r1068b306],
19	as	RB	O	as	advmod	20	SENT_167	[p14l1108t262r1181b306],
20	much	RB	O	much	dobj	15	SENT_167	[p14l1218t241r1429b306],
21	of	IN	O	of	_	0	SENT_167	[p14l1467t242r1545b306],
22	interindividual	JJ	O	interindividual	amod	23	SENT_167	[p14l1578t241r2148b306],
23	dose-variance	NN	O	dose-variance	prep_of	20	SENT_167	[p14l10t352r542b418],
24	than	IN	O	than	_	0	SENT_167	[p14l607t352r777b418],
25	clinical	JJ	O	clinical	amod	26	SENT_167	[p14l842t352r1113b418],
26	factors	NNS	O	factor	prep_than	23	SENT_167	[p14l1177t353r1436b418],
27	alone	RB	O	alone	advmod	26	SENT_167	[p14l1503t352r1710b418],
28	(	RB	O	(	advmod	23	SENT_167	[p14l1779t349r1978b438],
29	45	CD	PERCENT	45	num	30	SENT_167	[p14l1779t349r1978b438],
30	%	NN	PERCENT	%	dep	23	SENT_167	[p14l1779t349r1978b438],
31	vs.	CC	O	vs.	_	0	SENT_167	[p14l2049t373r2144b418],
32	12	CD	PERCENT	12	num	33	SENT_167	[p14l12t462r237b551],
33	%	NN	PERCENT	%	dobj	15	SENT_167	[p14l12t462r237b551],
34	)	CD	NUMBER	)	dep	33	SENT_167	[p14l12t462r237b551],
35	.	.	O	.	_	0	SENT_167	[p14l12t462r237b551],

1	Accounting	NN	O	accounting	nsubj	19	SENT_168	[p14l293t465r743b551],
2	for	IN	O	for	_	0	SENT_168	[p14l794t465r906b530],
3	one-half	NN	O	one-half	prep_for	1	SENT_168	[p14l957t465r1280b530],
4	of	IN	O	of	_	0	SENT_168	[p14l1329t465r1407b530],
5	dose	NN	O	dose	nn	6	SENT_168	[p14l1455t465r1628b530],
6	variance	NN	O	variance	prep_of	3	SENT_168	[p14l1679t465r2005b530],
7	by	IN	O	by	_	0	SENT_168	[p14l2057t465r2149b551],
8	initiation	NN	O	initiation	prep_by	6	SENT_168	[p14l8t576r360b642],
9	of	IN	O	of	_	0	SENT_168	[p14l410t577r488b642],
10	therapy	NN	O	therapy	prep_of	8	SENT_168	[p14l533t576r828b661],
11	using	VBG	O	use	partmod	10	SENT_168	[p14l876t576r1076b661],
12	a	DT	O	a	det	14	SENT_168	[p14l1128t597r1167b642],
13	genotype	NN	O	genotype	nn	14	SENT_168	[p14l1216t576r1850b661],
14	—	NN	O	—	dobj	11	SENT_168	[p14l1216t576r1850b661],
15	driven	VBN	O	drive	partmod	14	SENT_168	[p14l1216t576r1850b661],
16	dosing	NN	O	dosing	nn	17	SENT_168	[p14l1899t576r2148b661],
17	algorithm	NN	O	algorithm	dobj	15	SENT_168	[p14l11t687r384b772],
18	is	VBZ	O	be	cop	19	SENT_168	[p14l416t687r472b753],
19	likely	JJ	O	likely	_	0	SENT_168	[p14l506t687r718b772],
20	to	TO	O	to	_	0	SENT_168	[p14l750t696r825b753],
21	impact	NN	O	impact	prep_to	19	SENT_168	[p14l858t687r1120b772],
22	importantly	RB	O	importantly	advmod	21	SENT_168	[p14l1152t687r1607b772],
23	on	IN	O	on	_	0	SENT_168	[p14l1641t708r1736b753],
24	morbidity	NN	O	morbidity	prep_on	22	SENT_168	[p14l1767t687r2149b772],
25	and	CC	O	and	_	0	SENT_168	[p14l11t799r149b864],
26	mortality	NN	O	mortality	prep_on	22	SENT_168	[p14l182t799r539b884],
27	of	IN	O	of	_	0	SENT_168	[p14l573t799r652b864],
28	warfarin	NN	O	warfarin	nn	29	SENT_168	[p14l680t799r1006b864],
29	therapy	NN	O	therapy	prep_of	21	SENT_168	[p14l1040t799r1353b884],
30	.	.	O	.	_	0	SENT_168	[p14l1040t799r1353b884],

1	Factors	NNS	O	factor	_	0	SENT_169	[p14l7t1025r293b1088],
2	affecting	VBG	O	affect	partmod	1	SENT_169	[p14l330t1023r664b1108],
3	warfarin	NN	O	warfarin	nn	4	SENT_169	[p14l696t1023r1022b1088],
4	anticoagulation	NN	O	anticoagulation	dobj	2	SENT_169	[p14l1058t1023r1656b1108],

1	Historically	NNP	O	Historically	nsubjpass	7	SENT_170	[p14l8t1247r480b1332],
2	,	,	O	,	_	0	SENT_170	[p14l8t1247r480b1332],
3	several	JJ	O	several	amod	4	SENT_170	[p14l558t1247r828b1312],
4	factors	NNS	O	factor	appos	1	SENT_170	[p14l902t1247r1162b1312],
5	have	VBP	O	have	aux	7	SENT_170	[p14l1237t1247r1417b1312],
6	been	VBN	O	be	auxpass	7	SENT_170	[p14l1493t1247r1679b1312],
7	shown	VBN	O	show	_	0	SENT_170	[p14l1754t1247r1998b1312],
8	to	TO	O	to	aux	9	SENT_170	[p14l2072t1255r2147b1312],
9	contribute	VB	O	contribute	xcomp	7	SENT_170	[p14l9t1357r407b1422],
10	to	TO	O	to	_	0	SENT_170	[p14l454t1366r528b1422],
11	the	DT	O	the	det	12	SENT_170	[p14l575t1357r694b1422],
12	variability	NN	O	variability	prep_to	9	SENT_170	[p14l740t1357r1133b1442],
13	in	IN	O	in	_	0	SENT_170	[p14l1178t1357r1250b1421],
14	response	NN	O	response	prep_in	12	SENT_170	[p14l1294t1378r1632b1442],
15	to	TO	O	to	_	0	SENT_170	[p14l1679t1366r1754b1422],
16	warfarin	NN	O	warfarin	prep_to	9	SENT_170	[p14l1800t1357r2144b1422],
17	.	.	O	.	_	0	SENT_170	[p14l1800t1357r2144b1422],

1	Diet	NNP	O	Diet	nsubj	3	SENT_171	[p14l8t1468r180b1533],
2	can	MD	O	can	aux	3	SENT_171	[p14l223t1489r354b1533],
3	affect	VB	O	affect	_	0	SENT_171	[p14l398t1469r612b1533],
4	anticoagulation	JJ	O	anticoagulation	amod	5	SENT_171	[p14l657t1468r1255b1553],
5	status	NN	O	status	dobj	3	SENT_171	[p14l1298t1477r1516b1533],
6	as	RB	O	as	_	0	SENT_171	[p14l1561t1489r1634b1533],
7	well	RB	O	well	_	0	SENT_171	[p14l1677t1468r1834b1533],
8	as	IN	O	as	_	0	SENT_171	[p14l1878t1489r1951b1533],
9	age	NN	O	age	dobj	3	SENT_171	[p14l1996t1489r2146b1553],
10	,	,	O	,	_	0	SENT_171	[p14l1996t1489r2146b1553],
11	gender	NN	O	gender	conj_and	5	SENT_171	[p14l9t1579r275b1664],
12	and	CC	O	and	_	0	SENT_171	[p14l310t1579r448b1644],
13	weight	NN	O	weight	conj_and	9	SENT_171	[p14l481t1579r756b1664],
14	.	.	O	.	_	0	SENT_171	[p14l481t1579r756b1664],

1	In	IN	O	in	_	0	SENT_172	[p14l795t1581r875b1643],
2	the	DT	O	the	det	4	SENT_172	[p14l908t1579r1028b1644],
3	present	JJ	DATE	present	amod	4	SENT_172	[p14l1062t1588r1348b1664],
4	study	NN	O	study	prep_in	13	SENT_172	[p14l1383t1579r1607b1664],
5	,	,	O	,	_	0	SENT_172	[p14l1383t1579r1607b1664],
6	age	NN	O	age	nsubj	13	SENT_172	[p14l1645t1600r1795b1664],
7	,	,	O	,	_	0	SENT_172	[p14l1645t1600r1795b1664],
8	sex	NN	O	sex	nsubj	13	SENT_172	[p14l1831t1599r1972b1658],
9	,	,	O	,	_	0	SENT_172	[p14l1831t1599r1972b1658],
10	and	CC	O	and	_	0	SENT_172	[p14l2010t1579r2148b1644],
11	weight	NN	O	weight	conj_and	6	SENT_172	[p14l8t1690r264b1775],
12	together	RB	O	together	advmod	6	SENT_172	[p14l297t1690r623b1775],
13	explained	VBD	O	explain	_	0	SENT_172	[p14l656t1690r1030b1775],
14	only	RB	O	only	quantmod	15	SENT_172	[p14l1063t1690r1229b1775],
15	12	CD	PERCENT	12	num	16	SENT_172	[p14l1264t1691r1429b1756],
16	%	NN	PERCENT	%	nn	26	SENT_172	[p14l1264t1691r1429b1756],
17	of	IN	O	of	_	0	SENT_172	[p14l1471t1691r1549b1756],
18	interindividual	JJ	O	interindividual	amod	20	SENT_172	[p14l1578t1690r2148b1756],
19	dosing	NN	O	dosing	nn	20	SENT_172	[p14l10t1801r258b1886],
20	variability	NN	O	variability	prep_of	16	SENT_172	[p14l329t1801r722b1886],
21	on	IN	O	on	_	0	SENT_172	[p14l795t1822r890b1867],
22	the	DT	O	the	det	23	SENT_172	[p14l960t1801r1080b1867],
23	patients	NNS	O	patient	prep_on	20	SENT_172	[p14l1153t1801r1479b1886],
24	’	RB	O	’	advmod	25	SENT_172	[p14l1153t1801r1479b1886],
25	usual	JJ	O	usual	amod	26	SENT_172	[p14l1555t1801r1755b1867],
26	diet	NN	O	diet	dobj	13	SENT_172	[p14l1829t1801r1991b1867],
27	.	.	O	.	_	0	SENT_172	[p14l1829t1801r1991b1867],

1	In	IN	O	in	_	0	SENT_173	[p14l2069t1803r2149b1866],
2	contrast	NN	O	contrast	prep_in	11	SENT_173	[p14l9t1921r339b1991],
3	,	,	O	,	_	0	SENT_173	[p14l9t1921r339b1991],
4	the	DT	O	the	det	6	SENT_173	[p14l406t1912r526b1977],
5	variant	JJ	O	variant	amod	6	SENT_173	[p14l591t1912r863b1977],
6	allele	NN	O	allele	nsubj	11	SENT_173	[p14l930t1912r1133b1977],
7	in	IN	O	in	_	0	SENT_173	[p14l1199t1912r1271b1977],
8	the	DT	O	the	det	10	SENT_173	[p14l1336t1912r1456b1977],
9	VKORCI	NN	O	vkorcus	nn	10	SENT_173	[p14l1526t1913r1896b1978],
10	gene	NN	O	gene	prep_in	6	SENT_173	[p14l1968t1933r2147b1997],
11	accounted	VBD	O	account	_	0	SENT_173	[p14l11t2023r404b2088],
12	for	IN	O	for	_	0	SENT_173	[p14l470t2023r582b2088],
13	15.1	CD	PERCENT	15.1	num	14	SENT_173	[p14l651t2022r883b2088],
14	%	NN	PERCENT	%	prep_for	11	SENT_173	[p14l651t2022r883b2088],
15	of	IN	O	of	_	0	SENT_173	[p14l959t2023r1038b2088],
16	dose	NN	O	dose	nn	17	SENT_173	[p14l1101t2023r1274b2088],
17	variance	NN	O	variance	prep_of	14	SENT_173	[p14l1341t2023r1666b2088],
18	,	,	O	,	_	0	SENT_173	[p14l1738t2078r1751b2102],
19	and	CC	O	and	_	0	SENT_173	[p14l1822t2023r1961b2088],
20	the	DT	O	the	det	23	SENT_173	[p14l2027t2023r2147b2088],
21	CYPZC9	NN	O	cypzc9	nn	23	SENT_173	[p14l13t2135r350b2201],
22	gene	NN	O	gene	nn	23	SENT_173	[p14l390t2156r570b2221],
23	variants	NNS	O	variant	nsubj	24	SENT_173	[p14l611t2135r916b2201],
24	(	VBP	O	(	conj_and	11	SENT_173	[p14l963t2132r1079b2221],
25	*	NN	O	*	nsubj	32	SENT_173	[p14l963t2132r1079b2221],
26	2	CD	NUMBER	2	num	25	SENT_173	[p14l963t2132r1079b2221],
27	and	CC	O	and	_	0	SENT_173	[p14l1123t2135r1262b2200],
28	*	CD	NUMBER	*	number	29	SENT_173	[p14l1307t2132r1420b2221],
29	3	CD	NUMBER	3	num	30	SENT_173	[p14l1307t2132r1420b2221],
30	)	NN	O	)	conj_and	25	SENT_173	[p14l1307t2132r1420b2221],
31	jointly	RB	O	jointly	advmod	32	SENT_173	[p14l1460t2135r1712b2221],
32	accounted	VBD	O	account	ccomp	24	SENT_173	[p14l1755t2135r2148b2200],
33	for	IN	O	for	_	0	SENT_173	[p14l8t2247r120b2312],
34	18.3	CD	PERCENT	18.3	num	35	SENT_173	[p14l159t2247r417b2312],
35	%	NN	PERCENT	%	prep_for	32	SENT_173	[p14l159t2247r417b2312],
36	.	.	O	.	_	0	SENT_173	[p14l159t2247r417b2312],

1	These	DT	O	these	det	3	SENT_174	[p14l457t2247r686b2312],
2	genetic	JJ	O	genetic	amod	3	SENT_174	[p14l725t2247r1001b2332],
3	contributions	NNS	O	contribution	nsubj	5	SENT_174	[p14l1037t2247r1550b2312],
4	were	VBD	O	be	cop	5	SENT_174	[p14l1586t2267r1771b2312],
5	independent	JJ	O	independent	_	0	SENT_174	[p14l1808t2247r2146b2332, p14l10t2357r199b2436],
6	,	,	O	,	_	0	SENT_174	[p14l1808t2247r2146b2332, p14l10t2357r199b2436],
7	so	RB	O	so	advmod	5	SENT_174	[p14l278t2377r357b2422],
8	together	RB	O	together	advmod	11	SENT_174	[p14l433t2357r778b2442],
9	,	,	O	,	_	0	SENT_174	[p14l433t2357r778b2442],
10	they	PRP	O	they	nsubj	11	SENT_174	[p14l856t2357r1022b2442],
11	accounted	VBD	O	account	ccomp	5	SENT_174	[p14l1099t2357r1492b2422],
12	for	IN	O	for	_	0	SENT_174	[p14l1567t2358r1679b2422],
13	33.2	CD	PERCENT	33.2	num	14	SENT_174	[p14l1753t2358r1988b2422],
14	%	NN	PERCENT	%	prep_for	11	SENT_174	[p14l1753t2358r1988b2422],
15	of	IN	O	of	_	0	SENT_174	[p14l2073t2358r2152b2422],
16	variance	NN	O	variance	prep_of	14	SENT_174	[p14l8t2468r353b2533],
17	.	.	O	.	_	0	SENT_174	[p14l8t2468r353b2533],

1	Thus	RB	O	thus	advmod	8	SENT_175	[p14l398t2468r610b2547],
2	,	,	O	,	_	0	SENT_175	[p14l398t2468r610b2547],
3	their	PRP$	O	they	poss	4	SENT_175	[p14l653t2468r834b2533],
4	contribution	NN	O	contribution	nsubj	8	SENT_175	[p14l876t2468r1355b2533],
5	to	TO	O	to	_	0	SENT_175	[p14l1397t2477r1472b2533],
6	dosedetermination	NN	O	dosedetermination	prep_to	4	SENT_175	[p14l1516t2468r2146b2533, p14l9t2580r160b2645],
7	far	RB	O	far	advmod	8	SENT_175	[p14l201t2581r308b2645],
8	exceeds	VBZ	O	exceed	_	0	SENT_175	[p14l351t2580r649b2645],
9	those	DT	O	those	dobj	8	SENT_175	[p14l692t2580r895b2645],
10	of	IN	O	of	_	0	SENT_175	[p14l940t2581r1019b2645],
11	known	JJ	O	known	amod	13	SENT_175	[p14l1057t2580r1316b2645],
12	clinical	JJ	O	clinical	amod	13	SENT_175	[p14l1359t2580r1630b2645],
13	factors	NNS	O	factor	prep_of	9	SENT_175	[p14l1672t2581r1951b2645],
14	.	.	O	.	_	0	SENT_175	[p14l1672t2581r1951b2645],

1	The	DT	O	the	det	3	SENT_176	[p14l1996t2580r2146b2645],
2	independent	JJ	O	independent	amod	3	SENT_176	[p14l8t2692r493b2777],
3	effects	NNS	O	effect	nsubj	10	SENT_176	[p14l530t2693r778b2758],
4	of	IN	O	of	_	0	SENT_176	[p14l817t2693r895b2758],
5	these	DT	O	these	det	7	SENT_176	[p14l927t2693r1125b2758],
6	two	CD	NUMBER	two	num	7	SENT_176	[p14l1163t2701r1303b2758],
7	genes	NNS	O	gene	prep_of	3	SENT_176	[p14l1340t2713r1554b2777],
8	on	IN	O	on	_	0	SENT_176	[p14l1592t2713r1687b2758],
9	dose	NN	O	dose	prep_on	7	SENT_176	[p14l1723t2692r1895b2758],
10	arises	VBZ	O	arise	_	0	SENT_176	[p14l1935t2692r2147b2758],
11	from	IN	O	from	_	0	SENT_176	[p14l8t2804r194b2869],
12	their	PRP$	O	they	poss	14	SENT_176	[p14l244t2803r425b2869],
13	independent	JJ	O	independent	amod	14	SENT_176	[p14l474t2803r958b2888],
14	effects	NNS	O	effect	prep_from	10	SENT_176	[p14l1009t2804r1257b2869],
15	on	IN	O	on	_	0	SENT_176	[p14l1309t2824r1404b2869],
16	warfarin	NN	O	warfarin	nn	17	SENT_176	[p14l1452t2803r1778b2869],
17	metabolism	NN	O	metabolism	prep_on	10	SENT_176	[p14l1828t2803r2146b2869, p14l7t2914r164b2980],
18	and	CC	O	and	_	0	SENT_176	[p14l213t2915r352b2980],
19	on	IN	O	on	_	0	SENT_176	[p14l400t2936r495b2980],
20	the	DT	O	the	det	23	SENT_176	[p14l541t2915r661b2980],
21	warfarin	NN	O	warfarin	nn	23	SENT_176	[p14l708t2914r1034b2980],
22	molecular	JJ	O	molecular	amod	23	SENT_176	[p14l1081t2915r1468b2980],
23	target	NN	O	target	prep_on	10	SENT_176	[p14l1515t2924r1759b3001],
24	:	:	O	:	_	0	SENT_176	[p14l1515t2924r1759b3001],
25	CYPZC9	NN	O	cypzc9	nn	26	SENT_176	[p14l1815t2915r2152b2981],
26	loss	NN	O	loss	nsubj	30	SENT_176	[p14l7t3027r147b3092],
27	of	IN	O	of	_	0	SENT_176	[p14l190t3027r269b3092],
28	function	NN	O	function	nn	29	SENT_176	[p14l304t3027r625b3092],
29	variation	NN	O	variation	prep_of	26	SENT_176	[p14l664t3027r1011b3092],
30	decreases	VBZ	O	decrease	parataxis	10	SENT_176	[p14l1053t3027r1420b3092],
31	drug	NN	O	drug	nn	32	SENT_176	[p14l1463t3027r1636b3113],
32	metabolism	NN	O	metabolism	dobj	30	SENT_176	[p14l1676t3026r2148b3107],
33	,	,	O	,	_	0	SENT_176	[p14l1676t3026r2148b3107],
34	whereas	IN	O	whereas	mark	39	SENT_176	[p14l7t3138r322b3203],
35	VKORCI	NNP	O	VKORCI	nn	36	SENT_176	[p14l365t3139r735b3204],
36	loss	NN	O	loss	nsubj	39	SENT_176	[p14l779t3138r919b3203],
37	of	IN	O	of	_	0	SENT_176	[p14l960t3139r1038b3203],
38	function	NN	O	function	prep_of	36	SENT_176	[p14l1072t3138r1393b3203],
39	reduces	VBZ	O	reduce	advcl	30	SENT_176	[p14l1430t3138r1725b3203],
40	molecular	JJ	O	molecular	amod	41	SENT_176	[p14l1763t3138r2151b3203],
41	targets	NNS	O	target	dobj	39	SENT_176	[p14l8t3259r267b3335],
42	for	IN	O	for	_	0	SENT_176	[p14l317t3251r429b3315],
43	drug	NN	O	drug	nn	44	SENT_176	[p14l478t3250r652b3335],
44	action	NN	O	action	prep_for	41	SENT_176	[p14l703t3250r956b3315],
45	.	.	O	.	_	0	SENT_176	[p14l703t3250r956b3315],

1	The	DT	O	the	det	5	SENT_177	[p14l1008t3250r1158b3315],
2	full	JJ	O	full	amod	5	SENT_177	[p14l1209t3250r1336b3315],
3	multiple	JJ	O	multiple	amod	5	SENT_177	[p14l1384t3250r1705b3335],
4	regression	NN	O	regression	nn	5	SENT_177	[p14l1756t3250r2151b3335],
5	model	NN	O	model	nsubj	17	SENT_177	[p14l7t3361r269b3440],
6	,	,	O	,	_	0	SENT_177	[p14l7t3361r269b3440],
7	including	VBG	O	include	_	0	SENT_177	[p14l337t3361r693b3446],
8	genotypes	NNS	O	genotype	prep_including	5	SENT_177	[p14l760t3370r1169b3446],
9	,	,	O	,	_	0	SENT_177	[p14l760t3370r1169b3446],
10	age	NN	O	age	appos	8	SENT_177	[p14l1239t3382r1388b3446],
11	,	,	O	,	_	0	SENT_177	[p14l1239t3382r1388b3446],
12	weight	NN	O	weight	conj_and	10	SENT_177	[p14l1455t3361r1732b3446],
13	,	,	O	,	_	0	SENT_177	[p14l1455t3361r1732b3446],
14	and	CC	O	and	_	0	SENT_177	[p14l1802t3361r1941b3426],
15	sex	NN	O	sex	appos	8	SENT_177	[p14l2008t3381r2148b3440],
16	,	,	O	,	_	0	SENT_177	[p14l2008t3381r2148b3440],
17	accounted	VBD	O	account	_	0	SENT_177	[p14l9t3473r403b3538],
18	for	IN	O	for	_	0	SENT_177	[p14l444t3473r556b3538],
19	almost	RB	O	almost	quantmod	20	SENT_177	[p14l599t3472r853b3538],
20	one-half	JJ	O	one-half	num	21	SENT_177	[p14l896t3472r1219b3538],
21	(	NN	O	(	prep_for	17	SENT_177	[p14l1261t3470r1498b3558],
22	45	CD	PERCENT	45	number	23	SENT_177	[p14l1261t3470r1498b3558],
23	%	NN	PERCENT	%	amod	21	SENT_177	[p14l1261t3470r1498b3558],
24	)	CD	NUMBER	)	dobj	17	SENT_177	[p14l1261t3470r1498b3558],
25	of	IN	O	of	_	0	SENT_177	[p14l1545t3473r1624b3538],
26	the	DT	O	the	det	27	SENT_177	[p14l1661t3473r1781b3538],
27	variance	NN	O	variance	prep_of	24	SENT_177	[p14l1823t3472r2149b3538],
28	in	IN	O	in	_	0	SENT_177	[p14l7t3584r79b3649],
29	warfarin	NN	O	warfarin	nn	30	SENT_177	[p14l134t3584r460b3650],
30	dose	NN	O	dose	prep_in	27	SENT_177	[p14l517t3584r710b3650],
31	.	.	O	.	_	0	SENT_177	[p14l517t3584r710b3650],

1	The	DT	O	the	det	2	SENT_178	[p14l769t3584r919b3650],
2	explanation	NN	O	explanation	nsubj	8	SENT_178	[p14l978t3584r1433b3669],
3	for	IN	O	for	_	0	SENT_178	[p14l1488t3585r1600b3650],
4	unaccounted	JJ	O	unaccounted	amod	6	SENT_178	[p14l1655t3584r2150b3650],
5	dose	NN	O	dose	nn	6	SENT_178	[p14l9t3695r181b3761],
6	variance	NN	O	variance	prep_for	2	SENT_178	[p14l242t3695r568b3761],
7	is	VBZ	O	be	cop	8	SENT_178	[p14l630t3695r685b3761],
8	uncertain	JJ	O	uncertain	_	0	SENT_178	[p14l746t3695r1132b3774],
9	,	,	O	,	_	0	SENT_178	[p14l746t3695r1132b3774],
10	but	CC	O	but	_	0	SENT_178	[p14l1194t3695r1320b3761],
11	could	MD	O	could	aux	13	SENT_178	[p14l1382t3695r1592b3761],
12	well	RB	O	well	advmod	13	SENT_178	[p14l1651t3695r1808b3761],
13	involve	VB	O	involve	conj_but	8	SENT_178	[p14l1868t3695r2149b3761],
14	additional	JJ	O	additional	amod	15	SENT_178	[p15l9t25r398b91],
15	(	NN	O	(	dobj	13	SENT_178	[p15l458t22r835b111],
16	probably	RB	O	probably	advmod	13	SENT_178	[p15l458t22r835b111],
17	multiple	JJ	O	multiple	amod	20	SENT_178	[p15l890t22r1243b111],
18	)	JJ	O	)	amod	20	SENT_178	[p15l890t22r1243b111],
19	genetic	JJ	O	genetic	amod	20	SENT_178	[p15l1303t25r1579b111],
20	variant	NN	O	variant	nsubj	13	SENT_178	[p15l1634t25r1926b105],
21	,	,	O	,	_	0	SENT_178	[p15l1634t25r1926b105],
22	concomitant	JJ	O	concomitant	amod	24	SENT_178	[p15l1985t46r2148b91, p15l8t135r348b201],
23	clinical	JJ	O	clinical	amod	24	SENT_178	[p15l404t136r676b201],
24	disease	NN	O	disease	appos	20	SENT_178	[p15l732t136r1026b215],
25	,	,	O	,	_	0	SENT_178	[p15l732t136r1026b215],
26	environmental	JJ	O	environmental	appos	20	SENT_178	[p15l1084t136r1668b215],
27	,	,	O	,	_	0	SENT_178	[p15l1084t136r1668b215],
28	and	CC	O	and	_	0	SENT_178	[p15l1727t136r1865b201],
29	therapeutic	JJ	O	therapeutic	amod	30	SENT_178	[p15l1919t136r2148b201, p15l7t247r244b332],
30	factors	NNS	O	factor	appos	20	SENT_178	[p15l283t248r562b312],
31	.	.	O	.	_	0	SENT_178	[p15l283t248r562b312],

1	Population	NNP	O	Population	_	0	SENT_179	[p15l7t471r433b556],
2	prevalence	NN	O	prevalence	nn	6	SENT_179	[p15l466t471r886b556],
3	and	CC	O	and	_	0	SENT_179	[p15l923t471r1062b536],
4	potential	JJ	O	potential	nn	6	SENT_179	[p15l1095t471r1441b556],
5	dosing	NN	O	dosing	nn	6	SENT_179	[p15l1477t471r1725b556],
6	impact	NN	O	impact	dep	1	SENT_179	[p15l1759t471r2021b556],
7	of	IN	O	of	_	0	SENT_179	[p15l9t583r88b647],
8	genotype	NN	O	genotype	nn	9	SENT_179	[p15l117t591r471b667],
9	variants	NNS	O	variant	prep_of	6	SENT_179	[p15l505t582r811b647],

1	Approximately	RB	O	approximately	quantmod	2	SENT_180	[p15l7t805r598b890],
2	70	CD	PERCENT	70	num	3	SENT_180	[p15l654t806r823b871],
3	%	NN	PERCENT	%	nsubj	11	SENT_180	[p15l654t806r823b871],
4	of	IN	O	of	_	0	SENT_180	[p15l889t806r968b871],
5	the	DT	O	the	det	6	SENT_180	[p15l1020t805r1139b871],
6	patients	NNS	O	patient	prep_of	3	SENT_180	[p15l1197t805r1502b890],
7	in	IN	O	in	_	0	SENT_180	[p15l1559t805r1632b870],
8	the	DT	O	the	det	10	SENT_180	[p15l1688t805r1807b871],
9	present	JJ	DATE	present	amod	10	SENT_180	[p15l1864t814r2150b890],
10	study	NN	O	study	prep_in	6	SENT_180	[p15l9t916r213b1001],
11	had	VBD	O	have	_	0	SENT_180	[p15l265t916r406b981],
12	at	IN	O	at	quantmod	14	SENT_180	[p15l460t925r529b981],
13	least	JJS	O	least	mwe	12	SENT_180	[p15l581t916r758b981],
14	one	CD	NUMBER	one	num	16	SENT_180	[p15l811t937r949b981],
15	variant	JJ	O	variant	amod	16	SENT_180	[p15l1002t916r1274b981],
16	allele	NN	O	allele	dobj	11	SENT_180	[p15l1328t916r1531b981],
17	at	IN	O	at	_	0	SENT_180	[p15l1587t925r1657b981],
18	one	CD	NUMBER	one	prep_at	11	SENT_180	[p15l1710t937r1847b981],
19	of	IN	O	of	_	0	SENT_180	[p15l1902t917r1981b981],
20	the	DT	O	the	det	22	SENT_180	[p15l2029t916r2149b981],
21	three	CD	NUMBER	three	num	22	SENT_180	[p15l7t1027r206b1093],
22	loci	NNS	O	locus	prep_of	18	SENT_180	[p15l289t1027r426b1093],
23	examined	VBN	O	examine	partmod	22	SENT_180	[p15l509t1027r901b1093],
24	.	.	O	.	_	0	SENT_180	[p15l509t1027r901b1093],

1	As	IN	O	as	_	0	SENT_181	[p15l987t1028r1092b1093],
2	such	JJ	O	such	prep_such_as	6	SENT_181	[p15l1174t1027r1365b1106],
3	,	,	O	,	_	0	SENT_181	[p15l1174t1027r1365b1106],
4	these	DT	O	these	det	5	SENT_181	[p15l1448t1027r1647b1093],
5	individuals	NNS	O	individual	nsubj	6	SENT_181	[p15l1729t1027r2149b1093],
6	required	VBD	O	require	_	0	SENT_181	[p15l7t1139r338b1226],
7	a	DT	O	a	det	10	SENT_181	[p15l384t1161r424b1205],
8	reduced	VBN	O	reduce	amod	10	SENT_181	[p15l467t1140r777b1205],
9	warfarin	NN	O	warfarin	nn	10	SENT_181	[p15l820t1140r1147b1205],
10	dose	NN	O	dose	dobj	6	SENT_181	[p15l1192t1140r1364b1205],
11	compared	VBN	O	compare	_	0	SENT_181	[p15l1411t1140r1795b1226],
12	to	TO	O	to	prepc_compared_to	10	SENT_181	[p15l1839t1149r1914b1205],
13	wildtype	JJ	O	wildtype	amod	14	SENT_181	[p15l1958t1140r2148b1205, p15l8t1261r172b1338],
14	subjects	NNS	O	subject	pobj	10	SENT_181	[p15l252t1252r576b1338],
15	.	.	O	.	_	0	SENT_181	[p15l252t1252r576b1338],

1	Excluding	VBG	O	exclude	_	0	SENT_182	[p15l657t1252r1048b1338],
2	medication	NN	O	medication	nn	3	SENT_182	[p15l1125t1251r1557b1317],
3	errors	NNS	O	error	prep_excluding	7	SENT_182	[p15l1636t1273r1884b1332],
4	,	,	O	,	_	0	SENT_182	[p15l1636t1273r1884b1332],
5	it	PRP	O	it	nsubj	7	SENT_182	[p15l1964t1252r2016b1317],
6	is	VBZ	O	be	cop	7	SENT_182	[p15l2093t1252r2149b1317],
7	probable	JJ	O	probable	_	0	SENT_182	[p15l7t1364r373b1450],
8	,	,	O	,	_	0	SENT_182	[p15l7t1364r373b1450],
9	based	VBN	O	base	_	0	SENT_182	[p15l436t1364r656b1429],
10	on	IN	O	on	prepc_based_on	7	SENT_182	[p15l719t1385r814b1429],
11	prior	JJ	O	prior	amod	13	SENT_182	[p15l874t1364r1066b1450],
12	clinical	JJ	O	clinical	amod	13	SENT_182	[p15l1127t1363r1399b1429],
13	observation	NN	O	observation	pobj	7	SENT_182	[p15l1462t1364r1936b1443],
14	,	,	O	,	_	0	SENT_182	[p15l1462t1364r1936b1443],
15	that	IN	O	that	dep	21	SENT_182	[p15l1999t1364r2150b1429],
16	the	DT	O	the	det	17	SENT_182	[p15l8t1475r127b1540],
17	majority	NN	O	majority	nsubj	21	SENT_182	[p15l193t1475r520b1560],
18	of	IN	O	of	_	0	SENT_182	[p15l587t1476r665b1540],
19	bleeding	VBG	O	bleed	amod	20	SENT_182	[p15l725t1475r1057b1560],
20	events	NNS	O	event	prep_of	17	SENT_182	[p15l1123t1484r1366b1540],
21	occur	VBP	O	occur	dep	13	SENT_182	[p15l1434t1496r1644b1540],
22	within	IN	O	within	_	0	SENT_182	[p15l1707t1475r1950b1540],
23	this	DT	O	this	det	24	SENT_182	[p15l2015t1475r2149b1540],
24	group	NN	O	group	prep_within	21	SENT_182	[p15l8t1607r231b1671],
25	of	IN	O	of	_	0	SENT_182	[p15l269t1587r348b1651],
26	individuals	NNS	O	individual	prep_of	24	SENT_182	[p15l378t1586r818b1651],
27	.	.	O	.	_	0	SENT_182	[p15l378t1586r818b1651],

1	Because	IN	O	because	mark	10	SENT_183	[p15l857t1588r1176b1651],
2	these	DT	O	these	nsubjpass	10	SENT_183	[p15l1213t1586r1412b1651],
3	at	IN	O	at	_	0	SENT_183	[p15l1451t1586r1694b1651],
4	—	CD	NUMBER	—	num	6	SENT_183	[p15l1451t1586r1694b1651],
5	risk	NN	O	risk	nn	6	SENT_183	[p15l1451t1586r1694b1651],
6	individuals	NNS	O	individual	prep_at	2	SENT_183	[p15l1729t1586r2149b1651],
7	can	MD	O	can	aux	10	SENT_183	[p15l8t1707r269b1763],
8	not	RB	O	not	neg	10	SENT_183	[p15l8t1707r269b1763],
9	be	VB	O	be	auxpass	10	SENT_183	[p15l315t1698r405b1763],
10	identiﬁed	VBN	O	identiﬁed	advcl	28	SENT_183	[p15l453t1698r818b1763],
11	by	IN	O	by	_	0	SENT_183	[p15l865t1698r957b1783],
12	traditional	JJ	O	traditional	amod	14	SENT_183	[p15l1003t1698r1409b1763],
13	demographic	JJ	O	demographic	amod	14	SENT_183	[p15l1457t1698r1962b1783],
14	factors	NNS	O	factor	agent	10	SENT_183	[p15l2009t1698r2148b1763, p15l7t1818r152b1874],
15	(	VBP	O	(	rcmod	14	SENT_183	[p15l221t1806r404b1895],
16	age	NN	O	age	nn	21	SENT_183	[p15l221t1806r404b1895],
17	,	,	O	,	_	0	SENT_183	[p15l221t1806r404b1895],
18	weight	NN	O	weight	dep	21	SENT_183	[p15l469t1808r747b1894],
19	,	,	O	,	_	0	SENT_183	[p15l469t1808r747b1894],
20	gender	NN	O	gender	dep	21	SENT_183	[p15l814t1806r1109b1894],
21	)	NN	O	)	dobj	15	SENT_183	[p15l814t1806r1109b1894],
22	alone	RB	O	alone	advmod	15	SENT_183	[p15l1180t1809r1409b1888],
23	,	,	O	,	_	0	SENT_183	[p15l1180t1809r1409b1888],
24	dosing	NN	O	dosing	nn	25	SENT_183	[p15l1477t1808r1726b1894],
25	protocols	NNS	O	protocol	nsubj	28	SENT_183	[p15l1789t1809r2149b1894],
26	have	VBP	O	have	aux	28	SENT_183	[p15l7t1920r187b1985],
27	typically	RB	O	typically	advmod	28	SENT_183	[p15l241t1920r569b2005],
28	followed	VBN	O	follow	_	0	SENT_183	[p15l621t1920r957b1985],
29	an	DT	O	a	det	33	SENT_183	[p15l1012t1941r1101b1985],
30	empirical	JJ	O	empirical	amod	33	SENT_183	[p15l1155t1920r1536b2005],
31	,	,	O	,	_	0	SENT_183	[p15l1155t1920r1536b2005],
32	trial	NN	O	trial	dep	33	SENT_183	[p15l1591t1920r2151b1985],
33	—	NN	O	—	nsubj	38	SENT_183	[p15l1591t1920r2151b1985],
34	and	CC	O	and	_	0	SENT_183	[p15l1591t1920r2151b1985],
35	—	NN	O	—	nn	37	SENT_183	[p15l1591t1920r2151b1985],
36	error	NN	O	error	nn	37	SENT_183	[p15l1591t1920r2151b1985],
37	process	NN	O	process	nsubj	38	SENT_183	[p15l7t2052r291b2116],
38	relying	VBG	O	rely	dep	28	SENT_183	[p15l336t2031r602b2116],
39	on	IN	O	on	_	0	SENT_183	[p15l646t2052r742b2096],
40	multiple	JJ	O	multiple	amod	42	SENT_183	[p15l784t2031r1104b2116],
41	INR	NN	O	inr	nn	42	SENT_183	[p15l1150t2033r1321b2096],
42	measurements	NNS	O	measurement	prep_on	38	SENT_183	[p15l1364t2040r1942b2096],
43	.	.	O	.	_	0	SENT_183	[p15l1364t2040r1942b2096],

1	It	PRP	O	it	nsubjpass	4	SENT_184	[p15l1990t2033r2051b2096],
2	is	VBZ	O	be	auxpass	4	SENT_184	[p15l2094t2031r2150b2096],
3	not	RB	O	not	neg	4	SENT_184	[p15l7t2152r134b2208],
4	foreseen	VBN	O	foresee	_	0	SENT_184	[p15l179t2143r510b2208],
5	that	IN	O	that	complm	8	SENT_184	[p15l556t2143r707b2208],
6	genotyping	VBG	O	genotype	nsubj	8	SENT_184	[p15l754t2142r1184b2229],
7	will	MD	O	will	aux	8	SENT_184	[p15l1229t2143r1367b2208],
8	replace	VB	O	replace	ccomp	4	SENT_184	[p15l1413t2143r1693b2229],
9	INR	NNP	O	INR	nn	10	SENT_184	[p15l1742t2144r1913b2208],
10	measurement	NN	O	measurement	dobj	8	SENT_184	[p15l1959t2164r2148b2208, p15l8t2264r368b2320],
11	in	IN	O	in	_	0	SENT_184	[p15l433t2254r505b2319],
12	guiding	VBG	O	guide	amod	13	SENT_184	[p15l569t2254r855b2341],
13	therapy	NN	O	therapy	prep_in	8	SENT_184	[p15l920t2255r1236b2341],
14	;	:	O	;	_	0	SENT_184	[p15l920t2255r1236b2341],
15	however	RB	O	however	advmod	19	SENT_184	[p15l1302t2255r1653b2334],
16	,	,	O	,	_	0	SENT_184	[p15l1302t2255r1653b2334],
17	genotyping	VBG	O	genotype	nsubj	19	SENT_184	[p15l1720t2254r2150b2341],
18	may	MD	O	may	aux	19	SENT_184	[p15l7t2388r169b2453],
19	be	VB	O	be	parataxis	4	SENT_184	[p15l208t2367r298b2432],
20	of	IN	O	of	_	0	SENT_184	[p15l340t2367r419b2432],
21	value	NN	O	value	prep_of	19	SENT_184	[p15l453t2367r659b2432],
22	in	IN	O	in	_	0	SENT_184	[p15l699t2366r771b2431],
23	predicting	VBG	O	predict	prepc_in	19	SENT_184	[p15l809t2366r1201b2453],
24	initial	JJ	O	initial	amod	25	SENT_184	[p15l1240t2366r1463b2432],
25	dosing	NN	O	dosing	dobj	23	SENT_184	[p15l1504t2367r1773b2453],
26	,	,	O	,	_	0	SENT_184	[p15l1504t2367r1773b2453],
27	reducing	VBG	O	reduce	dep	23	SENT_184	[p15l1814t2366r2150b2453],
28	the	DT	O	the	det	29	SENT_184	[p15l8t2478r127b2543],
29	risk	NN	O	risk	dobj	27	SENT_184	[p15l186t2478r326b2543],
30	of	IN	O	of	_	0	SENT_184	[p15l387t2479r466b2543],
31	excessive	JJ	O	excessive	amod	32	SENT_184	[p15l521t2478r873b2543],
32	anticoagulation	NN	O	anticoagulation	prep_of	29	SENT_184	[p15l935t2478r1534b2563],
33	in	IN	O	in	_	0	SENT_184	[p15l1591t2478r1663b2542],
34	the	DT	O	the	det	35	SENT_184	[p15l1721t2478r1840b2543],
35	period	NN	O	period	prep_in	32	SENT_184	[p15l1899t2478r2150b2563],
36	before	IN	O	before	mark	40	SENT_184	[p15l7t2589r256b2654],
37	dose	NN	O	dose	nn	38	SENT_184	[p15l306t2589r479b2654],
38	stabilization	NN	O	stabilization	nsubjpass	40	SENT_184	[p15l528t2589r999b2654],
39	is	VBZ	O	be	auxpass	40	SENT_184	[p15l1045t2589r1100b2654],
40	achieved	VBN	O	achieve	advcl	27	SENT_184	[p15l1150t2589r1510b2668],
41	,	,	O	,	_	0	SENT_184	[p15l1150t2589r1510b2668],
42	the	DT	O	the	det	43	SENT_184	[p15l1559t2589r1678b2654],
43	time	NN	O	time	dobj	23	SENT_184	[p15l1727t2589r1897b2654],
44	when	WRB	O	when	advmod	48	SENT_184	[p15l1944t2589r2150b2654],
45	bleeding	VBG	O	bleed	amod	46	SENT_184	[p15l7t2702r339b2787],
46	risk	NN	O	risk	nsubj	48	SENT_184	[p15l375t2702r515b2767],
47	is	VBZ	O	be	cop	48	SENT_184	[p15l552t2702r608b2767],
48	greatest	JJS	O	greatest	dep	43	SENT_184	[p15l645t2710r971b2787],
49	,	,	O	,	_	0	SENT_184	[p15l645t2710r971b2787],
50	as	RB	O	as	_	0	SENT_184	[p15l1012t2722r1085b2767],
51	well	RB	O	well	_	0	SENT_184	[p15l1121t2702r1278b2767],
52	as	IN	O	as	_	0	SENT_184	[p15l1317t2722r1390b2767],
53	facilitating	VBG	O	facilitate	conj_and	23	SENT_184	[p15l1427t2702r1840b2787],
54	earlier	JJR	O	earlier	dobj	53	SENT_184	[p15l1878t2702r2148b2781],
55	,	,	O	,	_	0	SENT_184	[p15l1878t2702r2148b2781],
56	safe	JJ	O	safe	amod	57	SENT_184	[p15l8t2813r157b2878],
57	achievement	NN	O	achievement	conj_and	23	SENT_184	[p15l209t2812r698b2878],
58	of	IN	O	of	_	0	SENT_184	[p15l749t2813r828b2878],
59	therapeutic	JJ	O	therapeutic	amod	60	SENT_184	[p15l873t2812r1314b2897],
60	INR	NN	O	inr	prep_of	57	SENT_184	[p15l1364t2814r1535b2877],
61	in	IN	O	in	_	0	SENT_184	[p15l1583t2812r1655b2877],
62	the	DT	O	the	det	67	SENT_184	[p15l1704t2812r1823b2878],
63	genetic	JJ	O	genetic	amod	67	SENT_184	[p15l1874t2812r2150b2897],
64	wild	JJ	O	wild	amod	67	SENT_184	[p15l7t2923r366b3008],
65	—	NN	O	—	nn	67	SENT_184	[p15l7t2923r366b3008],
66	type	NN	O	type	nn	67	SENT_184	[p15l7t2923r366b3008],
67	majority	NN	O	majority	prep_in	60	SENT_184	[p15l408t2923r753b3008],
68	.	.	O	.	_	0	SENT_184	[p15l408t2923r753b3008],

1	In	IN	O	in	_	0	SENT_185	[p15l111t3036r191b3099],
2	the	DT	O	the	det	6	SENT_185	[p15l232t3034r351b3099],
3	multiple	JJ	O	multiple	amod	6	SENT_185	[p15l394t3034r715b3119],
4	linear	JJ	O	linear	amod	6	SENT_185	[p15l757t3034r979b3099],
5	regression	NN	O	regression	nn	6	SENT_185	[p15l1019t3034r1415b3119],
6	model	NN	O	model	prep_in	19	SENT_185	[p15l1455t3034r1718b3113],
7	,	,	O	,	_	0	SENT_185	[p15l1455t3034r1718b3113],
8	a	DT	O	a	det	10	SENT_185	[p15l1763t3055r1803b3099],
9	sizeable	JJ	O	sizeable	amod	10	SENT_185	[p15l1845t3034r2148b3099],
10	fraction	NN	O	fraction	nsubj	19	SENT_185	[p15l7t3146r309b3211],
11	of	IN	O	of	_	0	SENT_185	[p15l360t3146r439b3211],
12	the	DT	O	the	det	14	SENT_185	[p15l485t3146r604b3211],
13	intra-individual	JJ	O	intra-individual	amod	14	SENT_185	[p15l656t3145r1257b3211],
14	variation	NN	O	variation	prep_of	10	SENT_185	[p15l1306t3145r1654b3211],
15	in	IN	O	in	_	0	SENT_185	[p15l1703t3145r1775b3210],
16	warfarin	NN	O	warfarin	nn	17	SENT_185	[p15l1824t3146r2151b3211],
17	dose	NN	O	dose	prep_in	14	SENT_185	[p15l9t3258r181b3323],
18	remains	VBZ	O	remain	cop	19	SENT_185	[p15l218t3257r523b3323],
19	unattributed	JJ	O	unattributed	_	0	SENT_185	[p15l559t3258r1063b3323],
20	.	.	O	.	_	0	SENT_185	[p15l559t3258r1063b3323],

1	This	DT	O	this	nsubj	2	SENT_186	[p15l1101t3258r1266b3323],
2	suggests	VBZ	O	suggest	_	0	SENT_186	[p15l1304t3267r1617b3344],
3	the	DT	O	the	det	4	SENT_186	[p15l1653t3258r1773b3323],
4	presence	NN	O	presence	dobj	2	SENT_186	[p15l1809t3279r2149b3344],
5	of	IN	O	of	_	0	SENT_186	[p15l9t3370r88b3435],
6	additional	JJ	O	additional	prep_of	4	SENT_186	[p15l146t3369r535b3435],
7	modifying	VBG	O	modify	partmod	6	SENT_186	[p15l595t3369r986b3456],
8	genetic	JJ	O	genetic	amod	11	SENT_186	[p15l1047t3370r1324b3456],
9	and	CC	O	and	_	0	SENT_186	[p15l1386t3370r1525b3435],
10	environmental	JJ	O	environmental	amod	11	SENT_186	[p15l1586t3370r2150b3435],
11	factors	NNS	O	factor	dobj	7	SENT_186	[p15l7t3482r286b3546],
12	.	.	O	.	_	0	SENT_186	[p15l7t3482r286b3546],

1	One	CD	NUMBER	one	num	4	SENT_187	[p15l341t3482r503b3547],
2	additional	JJ	O	additional	amod	4	SENT_187	[p15l553t3481r942b3546],
3	environmental	JJ	O	environmental	amod	4	SENT_187	[p15l991t3481r1554b3546],
4	exposure	NN	O	exposure	nsubj	11	SENT_187	[p15l1603t3502r1950b3566],
5	that	WDT	O	that	nsubj	7	SENT_187	[p15l1999t3481r2150b3546],
6	can	MD	O	can	aux	7	SENT_187	[p15l8t3613r139b3657],
7	inﬂuence	VB	O	inﬂuence	rcmod	4	SENT_187	[p15l168t3592r517b3657],
8	anticoagulation	NN	O	anticoagulation	dobj	7	SENT_187	[p15l551t3592r1150b3677],
9	is	VBZ	O	be	cop	11	SENT_187	[p15l1179t3592r1235b3657],
10	coincident	JJ	O	coincident	amod	11	SENT_187	[p15l1266t3592r1667b3657],
11	medication	NN	O	medication	_	0	SENT_187	[p15l1696t3592r2146b3657],
12	.	.	O	.	_	0	SENT_187	[p15l1696t3592r2146b3657],

1	The	DT	O	the	det	2	SENT_188	[p15l7t3704r157b3769],
2	probability	NN	O	probability	nsubj	23	SENT_188	[p15l201t3704r628b3789],
3	of	IN	O	of	_	0	SENT_188	[p15l672t3704r751b3769],
4	additional	JJ	O	additional	amod	5	SENT_188	[p15l792t3704r1181b3769],
5	medications	NNS	O	medication	prep_of	2	SENT_188	[p15l1225t3704r1689b3769],
6	interacting	VBG	O	interact	partmod	5	SENT_188	[p15l1733t3704r2150b3789],
7	with	IN	O	with	mark	12	SENT_188	[p16l7t19r174b85],
8	oral	JJ	O	oral	amod	9	SENT_188	[p16l206t19r355b85],
9	anticoagulants	NNS	O	anticoagulant	nsubjpass	12	SENT_188	[p16l389t19r947b104],
10	has	VBZ	O	have	aux	12	SENT_188	[p16l979t19r1104b85],
11	been	VBN	O	be	auxpass	12	SENT_188	[p16l1135t20r1322b85],
12	shown	VBN	O	show	advcl	6	SENT_188	[p16l1354t19r1598b85],
13	to	TO	O	to	aux	16	SENT_188	[p16l1629t28r1704b85],
14	be	VB	O	be	cop	16	SENT_188	[p16l1736t20r1826b85],
15	directly	RB	O	directly	advmod	16	SENT_188	[p16l1860t19r2151b104],
16	proportional	JJ	O	proportional	xcomp	12	SENT_188	[p16l7t130r496b215],
17	to	TO	O	to	_	0	SENT_188	[p16l532t139r607b195],
18	the	DT	O	the	det	19	SENT_188	[p16l643t130r762b195],
19	number	NN	O	number	prep_to	16	SENT_188	[p16l799t130r1099b195],
20	of	IN	O	of	_	0	SENT_188	[p16l1135t131r1213b195],
21	prescribed	VBN	O	prescribe	amod	22	SENT_188	[p16l1243t130r1649b215],
22	medications	NNS	O	medication	prep_of	19	SENT_188	[p16l1684t130r2149b195],
23	[	VBP	O	[	_	0	SENT_188	[p16l13t239r173b327],
24	20	CD	NUMBER	20	number	25	SENT_188	[p16l13t239r173b327],
25	]	CD	NUMBER	]	dobj	23	SENT_188	[p16l13t239r173b327],
26	.	.	O	.	_	0	SENT_188	[p16l13t239r173b327],

1	Other	JJ	O	other	amod	2	SENT_189	[p16l204t241r432b308],
2	genes	NNS	O	gene	nsubjpass	6	SENT_189	[p16l457t262r671b327],
3	also	RB	O	also	advmod	6	SENT_189	[p16l699t241r847b307],
4	have	VBP	O	have	aux	6	SENT_189	[p16l872t241r1052b307],
5	been	VBN	O	be	auxpass	6	SENT_189	[p16l1078t241r1265b307],
6	studied	VBN	O	study	_	0	SENT_189	[p16l1290t241r1569b307],
7	in	IN	O	in	_	0	SENT_189	[p16l1594t241r1665b306],
8	relationship	NN	O	relationship	prep_in	6	SENT_189	[p16l1690t241r2149b327],
9	to	TO	O	to	_	0	SENT_189	[p16l8t363r83b419],
10	warfarin	NN	O	warfarin	nn	11	SENT_189	[p16l149t354r477b419],
11	dose	NN	O	dose	prep_to	6	SENT_189	[p16l543t354r736b419],
12	.	.	O	.	_	0	SENT_189	[p16l543t354r736b419],

1	These	DT	O	these	nsubj	2	SENT_190	[p16l805t354r1036b419],
2	include	VBP	O	include	_	0	SENT_190	[p16l1104t354r1384b419],
3	the	DT	O	the	det	8	SENT_190	[p16l1452t354r1571b419],
4	ATP-binding	JJ	O	atp-binding	amod	8	SENT_190	[p16l1639t353r2150b440],
5	cassette	NN	O	cassette	nn	8	SENT_190	[p16l8t475r307b531],
6	multidrug	JJ	O	multidrug	amod	8	SENT_190	[p16l360t465r741b552],
7	resistance	NN	O	resistance	nn	8	SENT_190	[p16l792t466r1172b531],
8	gene	NN	O	gene	dobj	2	SENT_190	[p16l1225t487r1426b552],
9	,	,	O	,	_	0	SENT_190	[p16l1225t487r1426b552],
10	ABCB1	NN	O	abcb1	dobj	2	SENT_190	[p16l1475t466r1778b532],
11	and	CC	O	and	_	0	SENT_190	[p16l1839t466r1978b531],
12	another	DT	O	another	det	15	SENT_190	[p16l2031t487r2148b531, p16l9t578r213b643],
13	cytochrome	NN	O	cytochrome	nn	15	SENT_190	[p16l251t578r705b664],
14	oxygenase	NN	O	oxygenase	nn	15	SENT_190	[p16l745t599r1143b664],
15	CYP3A5	NN	O	cyp3a5	dobj	2	SENT_190	[p16l1187t578r1528b644],
16	[	CD	NUMBER	[	number	17	SENT_190	[p16l1572t575r1731b664],
17	21	CD	NUMBER	21	num	18	SENT_190	[p16l1572t575r1731b664],
18	]	NN	O	]	dep	15	SENT_190	[p16l1572t575r1731b664],
19	.	.	O	.	_	0	SENT_190	[p16l1572t575r1731b664],

1	However	RB	O	however	advmod	9	SENT_191	[p16l1772t580r2148b657],
2	,	,	O	,	_	0	SENT_191	[p16l1772t580r2148b657],
3	when	WRB	O	when	advmod	4	SENT_191	[p16l7t689r213b754],
4	studied	VBN	O	study	advcl	9	SENT_191	[p16l253t689r552b768],
5	,	,	O	,	_	0	SENT_191	[p16l253t689r552b768],
6	no	DT	O	no	det	7	SENT_191	[p16l593t710r688b754],
7	effect	NN	O	effect	nsubjpass	9	SENT_191	[p16l729t690r944b754],
8	was	VBD	O	be	auxpass	9	SENT_191	[p16l982t710r1122b754],
9	attributed	VBN	O	attribute	_	0	SENT_191	[p16l1164t689r1548b754],
10	to	TO	O	to	_	0	SENT_191	[p16l1586t698r1662b754],
11	CYP3A5	NN	O	cyp3a5	prep_to	9	SENT_191	[p16l1706t690r2068b768],
12	;	:	O	;	_	0	SENT_191	[p16l1706t690r2068b768],
13	a	DT	O	a	det	14	SENT_191	[p16l2111t710r2151b755],
14	trend	NN	O	trend	nsubj	26	SENT_191	[p16l7t801r213b866],
15	toward	IN	O	toward	_	0	SENT_191	[p16l241t801r511b866],
16	reduce	VB	O	reduce	prepc_toward	14	SENT_191	[p16l538t801r797b866],
17	dose	NN	O	dose	dobj	16	SENT_191	[p16l828t801r1001b866],
18	for	IN	O	for	_	0	SENT_191	[p16l1030t802r1142b866],
19	subjects	NNS	O	subject	prep_for	16	SENT_191	[p16l1170t801r1473b886],
20	with	IN	O	with	_	0	SENT_191	[p16l1501t801r1668b866],
21	the	DT	O	the	det	24	SENT_191	[p16l1696t801r1815b866],
22	ABCB1	NN	O	abcb1	nn	24	SENT_191	[p16l1840t802r2146b867],
23	3435T	NN	O	3435t	nn	24	SENT_191	[p16l8t912r244b978],
24	variant	NN	O	variant	prep_with	19	SENT_191	[p16l277t912r549b978],
25	was	VBD	O	be	cop	26	SENT_191	[p16l581t933r722b978],
26	present	JJ	DATE	present	parataxis	9	SENT_191	[p16l756t921r1042b998],
27	[	CD	NUMBER	[	number	28	SENT_191	[p16l1082t909r1241b998],
28	21	CD	NUMBER	21	num	29	SENT_191	[p16l1082t909r1241b998],
29	]	NN	O	]	dep	26	SENT_191	[p16l1082t909r1241b998],
30	.	.	O	.	_	0	SENT_191	[p16l1082t909r1241b998],

1	Thus	RB	O	thus	advmod	16	SENT_192	[p16l1278t912r1489b992],
2	,	,	O	,	_	0	SENT_192	[p16l1278t912r1489b992],
3	other	JJ	O	other	amod	4	SENT_192	[p16l1527t912r1732b978],
4	inﬂuences	NNS	O	inﬂuences	nsubj	16	SENT_192	[p16l1765t912r2149b978],
5	that	WDT	O	that	nsubj	6	SENT_192	[p16l7t1025r159b1090],
6	impinge	VBP	O	impinge	rcmod	4	SENT_192	[p16l231t1024r540b1111],
7	upon	IN	O	upon	_	0	SENT_192	[p16l614t1046r810b1111],
8	warfarin	NN	O	warfarin	nn	9	SENT_192	[p16l881t1024r1208b1090],
9	anticoagulation	NN	O	anticoagulation	prep_upon	6	SENT_192	[p16l1281t1024r1900b1111],
10	,	,	O	,	_	0	SENT_192	[p16l1281t1024r1900b1111],
11	both	DT	O	both	det	12	SENT_192	[p16l1974t1025r2151b1090],
12	environmental	JJ	O	environmental	appos	4	SENT_192	[p16l9t1136r573b1202],
13	and	CC	O	and	_	0	SENT_192	[p16l608t1136r747b1202],
14	genetic	JJ	O	genetic	conj_and	12	SENT_192	[p16l781t1136r1077b1221],
15	,	,	O	,	_	0	SENT_192	[p16l781t1136r1077b1221],
16	remain	VBP	O	remain	_	0	SENT_192	[p16l1113t1136r1384b1202],
17	to	TO	O	to	aux	19	SENT_192	[p16l1418t1145r1493b1202],
18	be	VB	O	be	auxpass	19	SENT_192	[p16l1527t1136r1617b1202],
19	elucidated	VBN	O	elucidate	xcomp	16	SENT_192	[p16l1653t1136r2072b1202],
20	.	.	O	.	_	0	SENT_192	[p16l1653t1136r2072b1202],

1	@	IN	O	@	_	0	SENT_193	[p16l1805t1383r1877b1472],
2	Springer	NNP	PERSON	Springer	pobj	1	SENT_193	[p16l1905t1405r2150b1475],

1	196	CD	NUMBER	196	num	4	SENT_194	[p16l54t1551r104b1577],
2	J	NN	O	j	nn	4	SENT_194	[p16l1445t1552r1460b1577],
3	Thromb	NN	O	thromb	nn	4	SENT_194	[p16l1472t1551r1596b1577],
4	Thrombolysis	NN	O	thrombolysis	_	0	SENT_194	[p16l1609t1551r1817b1585],
5	(	CD	NUMBER	(	num	6	SENT_194	[p16l1832t1550r1926b1585],
6	2006	CD	DATE	2006	dep	4	SENT_194	[p16l1832t1550r1926b1585],
7	)	CD	NUMBER	)	number	8	SENT_194	[p16l1832t1550r1926b1585],
8	22:191	CD	NUMBER	22:191	num	9	SENT_194	[p16l1940t1551r2106b1577],
9	—	NN	O	—	dep	6	SENT_194	[p16l1940t1551r2106b1577],
10	197	CD	NUMBER	197	dep	4	SENT_194	[p16l1940t1551r2106b1577],

1	Comparisons	NNS	O	comparison	_	0	SENT_195	[p16l11t1715r516b1800],
2	with	IN	O	with	_	0	SENT_195	[p16l549t1715r717b1781],
3	previous	JJ	O	previous	amod	4	SENT_195	[p16l749t1715r1078b1800],
4	studies	NNS	O	study	prep_with	1	SENT_195	[p16l1114t1715r1377b1781],

1	The	DT	O	the	det	3	SENT_196	[p16l8t1939r158b2004],
2	present	JJ	DATE	present	amod	3	SENT_196	[p16l216t1948r501b2024],
3	study	NN	O	study	nsubj	4	SENT_196	[p16l560t1939r764b2024],
4	is	VBZ	O	be	_	0	SENT_196	[p16l821t1939r876b2004],
5	in	IN	O	in	_	0	SENT_196	[p16l934t1939r1006b2004],
6	good	JJ	O	good	amod	7	SENT_196	[p16l1063t1939r1253b2024],
7	agreement	NN	O	agreement	prep_in	4	SENT_196	[p16l1312t1948r1720b2024],
8	with	IN	O	with	_	0	SENT_196	[p16l1776t1939r1963b2018],
9	,	,	O	,	_	0	SENT_196	[p16l1776t1939r1963b2018],
10	but	CC	O	but	dep	11	SENT_196	[p16l2022t1939r2148b2004],
11	extends	VBZ	O	extend	dep	7	SENT_196	[p16l10t2050r324b2129],
12	,	,	O	,	_	0	SENT_196	[p16l10t2050r324b2129],
13	other	JJ	O	other	amod	14	SENT_196	[p16l373t2050r577b2116],
14	studies	NNS	O	study	prep_with	7	SENT_196	[p16l624t2050r887b2116],
15	of	IN	O	of	_	0	SENT_196	[p16l936t2051r1015b2116],
16	CYP2C9	NN	O	cyp2c9	prep_of	14	SENT_196	[p16l1061t2051r1397b2116],
17	and	CC	O	and	_	0	SENT_196	[p16l1444t2050r1583b2116],
18	VKORCI	NN	O	vkorcus	conj_and	16	SENT_196	[p16l1632t2051r2027b2116],
19	.	.	O	.	_	0	SENT_196	[p16l1632t2051r2027b2116],

1	A	DT	O	a	det	4	SENT_197	[p16l2076t2051r2149b2115],
2	recent	JJ	O	recent	amod	4	SENT_197	[p16l9t2172r249b2229],
3	meta	NN	O	meta	nn	4	SENT_197	[p16l319t2172r512b2228],
4	analysis	NN	O	analysis	nsubj	11	SENT_197	[p16l584t2163r881b2249],
5	including	VBG	O	include	_	0	SENT_197	[p16l953t2163r1308b2249],
6	2775	CD	NUMBER	2775	num	7	SENT_197	[p16l1379t2162r1552b2229],
7	subjects	NNS	O	subject	prep_including	4	SENT_197	[p16l1627t2163r1930b2249],
8	[	JJ	O	[	amod	7	SENT_197	[p16l2007t2160r2142b2249],
9	17	CD	NUMBER	17	num	10	SENT_197	[p16l2007t2160r2142b2249],
10	]	NN	O	]	dep	8	SENT_197	[p16l2007t2160r2142b2249],
11	reported	VBD	O	report	_	0	SENT_197	[p16l8t2275r343b2360],
12	almost	RB	O	almost	advmod	13	SENT_197	[p16l382t2275r636b2340],
13	identical	JJ	O	identical	amod	16	SENT_197	[p16l673t2274r1004b2340],
14	warfarin	NN	O	warfarin	nn	16	SENT_197	[p16l1040t2275r1366b2340],
15	dose	NN	O	dose	nn	16	SENT_197	[p16l1404t2275r1577b2340],
16	reductions	NNS	O	reduction	dobj	11	SENT_197	[p16l1615t2275r2019b2340],
17	by	IN	O	by	_	0	SENT_197	[p16l2057t2275r2149b2360],
18	CYPZC9	NN	O	cypzc9	nn	19	SENT_197	[p16l13t2386r350b2451],
19	genotype	NN	O	genotype	prep_by	11	SENT_197	[p16l382t2395r734b2471],
20	as	IN	O	as	mark	21	SENT_197	[p16l772t2406r844b2451],
21	found	VBN	O	find	advcl	11	SENT_197	[p16l878t2386r1103b2451],
22	in	IN	O	in	_	0	SENT_197	[p16l1136t2386r1208b2450],
23	the	DT	O	the	det	25	SENT_197	[p16l1241t2386r1360b2451],
24	present	JJ	DATE	present	amod	25	SENT_197	[p16l1394t2394r1679b2471],
25	study	NN	O	study	prep_in	21	SENT_197	[p16l1713t2386r1936b2471],
26	:	:	O	:	_	0	SENT_197	[p16l1713t2386r1936b2471],
27	both	CC	O	both	dep	11	SENT_197	[p16l1973t2386r2149b2451],
28	studies	NNS	O	study	nsubj	29	SENT_197	[p16l10t2496r273b2561],
29	report	VBP	O	report	conj	11	SENT_197	[p16l331t2505r571b2581],
30	a	DT	O	a	det	33	SENT_197	[p16l630t2517r669b2561],
31	6	CD	NUMBER	6	num	33	SENT_197	[p16l727t2496r766b2561],
32	mg/week	JJ	O	mg/week	amod	33	SENT_197	[p16l801t2496r1146b2581],
33	reduction	NN	O	reduction	dobj	29	SENT_197	[p16l1203t2496r1573b2561],
34	compared	VBN	O	compare	prep	33	SENT_197	[p16l1631t2496r2015b2581],
35	to	TO	O	to	pcomp	34	SENT_197	[p16l2072t2505r2147b2561],
36	wild	JJ	O	wild	amod	38	SENT_197	[p16l8t2607r367b2692],
37	—	NN	O	—	nn	38	SENT_197	[p16l8t2607r367b2692],
38	type	NN	O	type	pobj	35	SENT_197	[p16l8t2607r367b2692],
39	in	IN	O	in	_	0	SENT_197	[p16l401t2607r473b2671],
40	weekly	JJ	SET	weekly	amod	41	SENT_197	[p16l503t2607r775b2692],
41	dose	NN	O	dose	prep_in	38	SENT_197	[p16l807t2607r980b2672],
42	as	IN	O	as	amod	41	SENT_197	[p16l1016t2628r1088b2672],
43	compared	VBN	O	compare	_	0	SENT_197	[p16l1122t2607r1506b2692],
44	to	TO	O	to	prepc_compared_to	41	SENT_197	[p16l1537t2616r1612b2672],
45	wild	JJ	O	wild	amod	47	SENT_197	[p16l1644t2607r2004b2692],
46	—	NN	O	—	nn	47	SENT_197	[p16l1644t2607r2004b2692],
47	type	NN	O	type	pobj	41	SENT_197	[p16l1644t2607r2004b2692],
48	for	IN	O	for	_	0	SENT_197	[p16l2037t2608r2149b2672],
49	the	DT	O	the	det	52	SENT_197	[p16l9t2719r128b2784],
50	*	NN	O	*	nn	52	SENT_197	[p16l180t2720r255b2783],
51	2	CD	NUMBER	2	num	52	SENT_197	[p16l180t2720r255b2783],
52	allele	NN	O	allele	prep_for	47	SENT_197	[p16l303t2719r506b2784],
53	and	CC	O	and	_	0	SENT_197	[p16l554t2719r693b2784],
54	a	DT	O	a	det	57	SENT_197	[p16l739t2739r778b2784],
55	10	CD	NUMBER	10	num	57	SENT_197	[p16l825t2719r908b2784],
56	mg/week	JJ	O	mg/week	amod	57	SENT_197	[p16l941t2719r1287b2804],
57	reduction	NN	O	reduction	pobj	41	SENT_197	[p16l1331t2719r1702b2784],
58	for	IN	O	for	_	0	SENT_197	[p16l1745t2719r1856b2784],
59	the	DT	O	the	det	62	SENT_197	[p16l1900t2719r2019b2784],
60	*	NN	O	*	nn	62	SENT_197	[p16l2071t2720r2147b2784],
61	3	CD	NUMBER	3	num	62	SENT_197	[p16l2071t2720r2147b2784],
62	allele	NN	O	allele	prep_for	57	SENT_197	[p16l11t2829r234b2895],
63	.	.	O	.	_	0	SENT_197	[p16l11t2829r234b2895],

1	Similarly	RB	O	similarly	advmod	2	SENT_198	[p16l276t2829r622b2914],
2	for	IN	O	for	dep	6	SENT_198	[p16l656t2830r768b2895],
3	VKORCI	NNP	O	VKORCI	pobj	2	SENT_198	[p16l808t2830r1202b2895],
4	:	:	O	:	_	0	SENT_198	[p16l808t2830r1202b2895],
5	the	DT	O	the	det	6	SENT_198	[p16l1242t2829r1362b2895],
6	study	NN	O	study	_	0	SENT_198	[p16l1401t2829r1605b2914],
7	of	IN	O	of	_	0	SENT_198	[p16l1642t2830r1721b2895],
8	D’Andrea	NNP	O	D’Andrea	prep_of	6	SENT_198	[p16l1753t2829r2149b2895],
9	et	FW	O	et	dep	6	SENT_198	[p16l10t2948r80b3004],
10	al	FW	O	al	nn	13	SENT_198	[p16l115t2939r180b3004],
11	[	FW	O	[	dep	13	SENT_198	[p16l220t2937r354b3024],
12	15	CD	NUMBER	15	num	13	SENT_198	[p16l220t2937r354b3024],
13	]	CD	NUMBER	]	advmod	14	SENT_198	[p16l220t2937r354b3024],
14	found	VBN	O	find	partmod	6	SENT_198	[p16l393t2939r618b3004],
15	25.3	CD	PERCENT	25.3	number	19	SENT_198	[p16l651t2939r887b3004],
16	%	NN	PERCENT	%	dep	19	SENT_198	[p16l651t2939r887b3004],
17	and	CC	O	and	_	0	SENT_198	[p16l930t2939r1069b3004],
18	45.3	CD	PERCENT	45.3	num	20	SENT_198	[p16l1102t2939r1338b3004],
19	%	NN	PERCENT	%	num	20	SENT_198	[p16l1102t2939r1338b3004],
20	reductions	NNS	O	reduction	dobj	14	SENT_198	[p16l1380t2939r1783b3004],
21	in	IN	O	in	_	0	SENT_198	[p16l1817t2939r1889b3004],
22	stable	JJ	O	stable	amod	24	SENT_198	[p16l1924t2939r2147b3004],
23	warfarin	NN	O	warfarin	nn	24	SENT_198	[p16l8t3051r334b3116],
24	dose	NN	O	dose	prep_in	14	SENT_198	[p16l378t3051r550b3116],
25	for	IN	O	for	_	0	SENT_198	[p16l594t3052r706b3116],
26	the	DT	O	the	det	30	SENT_198	[p16l748t3051r867b3116],
27	CT	NN	O	ct	nn	30	SENT_198	[p16l914t3052r1033b3117],
28	and	CC	O	and	_	0	SENT_198	[p16l1078t3051r1216b3116],
29	TT	NN	O	tt	nn	30	SENT_198	[p16l1258t3053r1376b3116],
30	genotypes	NNS	O	genotype	prep_for	24	SENT_198	[p16l1419t3060r1828b3136],
31	,	,	O	,	_	0	SENT_198	[p16l1419t3060r1828b3136],
32	respectively	RB	O	respectively	advmod	14	SENT_198	[p16l1872t3072r2146b3136, p16l9t3163r238b3248],
33	.	.	O	.	_	0	SENT_198	[p16l1872t3072r2146b3136, p16l9t3163r238b3248],

1	These	DT	O	these	nsubj	2	SENT_199	[p16l269t3163r498b3228],
2	show	VBP	O	show	_	0	SENT_199	[p16l527t3163r722b3228],
3	striking	JJ	O	striking	amod	4	SENT_199	[p16l749t3163r1037b3248],
4	concurrence	NN	O	concurrence	dobj	2	SENT_199	[p16l1064t3183r1537b3228],
5	with	IN	O	with	_	0	SENT_199	[p16l1564t3162r1731b3228],
6	the	DT	O	the	det	12	SENT_199	[p16l1758t3163r1877b3228],
7	27.1	CD	PERCENT	27.1	number	11	SENT_199	[p16l1904t3163r2053b3228],
8	%	NN	PERCENT	%	dep	11	SENT_199	[p16l2070t3164r2140b3228],
9	and	CC	O	and	_	0	SENT_199	[p16l11t3274r149b3339],
10	47.1	CD	PERCENT	47.1	conj_and	11	SENT_199	[p16l204t3274r440b3339],
11	%	NN	PERCENT	%	num	12	SENT_199	[p16l204t3274r440b3339],
12	reductions	NNS	O	reduction	prep_with	2	SENT_199	[p16l504t3274r907b3339],
13	we	PRP	O	we	nsubj	14	SENT_199	[p16l963t3294r1068b3339],
14	observed	VBD	O	observe	rcmod	12	SENT_199	[p16l1127t3274r1474b3339],
15	for	IN	O	for	_	0	SENT_199	[p16l1530t3274r1641b3339],
16	these	DT	O	these	det	18	SENT_199	[p16l1697t3274r1895b3339],
17	same	JJ	O	same	amod	18	SENT_199	[p16l1953t3294r2146b3339],
18	genotypes	NNS	O	genotype	prep_for	14	SENT_199	[p16l9t3395r396b3471],
19	in	IN	O	in	_	0	SENT_199	[p16l452t3386r523b3450],
20	our	PRP$	O	we	poss	22	SENT_199	[p16l578t3406r707b3451],
21	population	NN	O	population	nn	22	SENT_199	[p16l760t3386r1180b3471],
22	sample	NN	O	sample	prep_in	14	SENT_199	[p16l1235t3386r1522b3471],
23	.	.	O	.	_	0	SENT_199	[p16l1235t3386r1522b3471],

1	Overall	RB	O	overall	advmod	7	SENT_200	[p16l1583t3386r1892b3464],
2	,	,	O	,	_	0	SENT_200	[p16l1583t3386r1892b3464],
3	these	DT	O	these	det	5	SENT_200	[p16l1948t3386r2146b3451],
4	various	JJ	O	various	amod	5	SENT_200	[p16l8t3496r288b3561],
5	studies	NNS	O	study	nsubj	7	SENT_200	[p16l329t3496r592b3561],
6	also	RB	O	also	advmod	7	SENT_200	[p16l634t3496r782b3561],
7	show	VBP	O	show	_	0	SENT_200	[p16l823t3496r1018b3561],
8	general	JJ	O	general	amod	9	SENT_200	[p16l1057t3496r1342b3581],
9	agreement	NN	O	agreement	dobj	7	SENT_200	[p16l1383t3505r1792b3581],
10	in	IN	O	in	_	0	SENT_200	[p16l1831t3496r1902b3560],
11	allele	NN	O	allele	nn	12	SENT_200	[p16l1943t3496r2146b3561],
12	frequencies	NNS	O	frequency	prep_in	9	SENT_200	[p16l8t3607r474b3692],
13	,	,	O	,	_	0	SENT_200	[p16l8t3607r474b3692],
14	with	IN	O	with	_	0	SENT_200	[p16l555t3607r722b3672],
15	minor	JJ	O	minor	amod	16	SENT_200	[p16l801t3607r1032b3672],
16	differences	NNS	O	difference	prep_with	7	SENT_200	[p16l1112t3607r1535b3672],
17	that	WDT	O	that	nsubjpass	20	SENT_200	[p16l1616t3607r1767b3672],
18	can	MD	O	can	aux	20	SENT_200	[p16l1847t3628r1977b3672],
19	be	VB	O	be	auxpass	20	SENT_200	[p16l2057t3607r2147b3672],
20	accounted	VBN	O	account	rcmod	16	SENT_200	[p16l11t3719r404b3784],
21	for	IN	O	for	dep	20	SENT_200	[p16l452t3719r563b3784],
22	by	IN	O	by	_	0	SENT_200	[p16l610t3719r702b3804],
23	sample	NN	O	sample	nn	25	SENT_200	[p16l750t3719r1018b3804],
24	population	NN	O	population	nn	25	SENT_200	[p16l1066t3719r1487b3804],
25	differences	NNS	O	difference	agent	20	SENT_200	[p16l1536t3719r1959b3784],
26	and	CC	O	and	_	0	SENT_200	[p16l2010t3719r2148b3784],
27	chance	NN	O	chance	nn	28	SENT_200	[p17l9t19r273b85],
28	variations	NNS	O	variation	agent	20	SENT_200	[p17l315t19r714b85],
29	.	.	O	.	_	0	SENT_200	[p17l315t19r714b85],

1	However	RB	O	however	advmod	14	SENT_201	[p17l760t21r1134b98],
2	,	,	O	,	_	0	SENT_201	[p17l760t21r1134b98],
3	within	IN	O	within	_	0	SENT_201	[p17l1177t19r1419b85],
4	the	DT	O	the	det	5	SENT_201	[p17l1460t19r1579b85],
5	groups	NNS	O	group	prep_within	14	SENT_201	[p17l1623t40r1880b104],
6	stratiﬁed	VBN	O	stratiﬁed	partmod	5	SENT_201	[p17l1924t19r2146b85, p17l8t130r149b195],
7	by	IN	O	by	_	0	SENT_201	[p17l214t130r306b215],
8	genotype	NN	O	genotype	agent	6	SENT_201	[p17l371t139r745b215],
9	,	,	O	,	_	0	SENT_201	[p17l371t139r745b215],
10	the	DT	O	the	det	13	SENT_201	[p17l812t130r932b195],
11	stable	JJ	O	stable	amod	13	SENT_201	[p17l999t130r1222b195],
12	warfarin	NN	O	warfarin	nn	13	SENT_201	[p17l1288t130r1613b195],
13	doses	NNS	O	dose	nsubj	14	SENT_201	[p17l1680t130r1887b195],
14	show	VBP	O	show	_	0	SENT_201	[p17l1954t130r2149b195],
15	exceptional	JJ	O	exceptional	amod	16	SENT_201	[p17l10t241r454b326],
16	reproducibility	NN	O	reproducibility	dobj	14	SENT_201	[p17l487t241r1062b326],
17	among	IN	O	among	_	0	SENT_201	[p17l1098t262r1355b326],
18	studies	NNS	O	study	prep_among	14	SENT_201	[p17l1390t241r1672b306],
19	.	.	O	.	_	0	SENT_201	[p17l1390t241r1672b306],

1	These	DT	O	these	det	2	SENT_202	[p17l1709t241r1938b306],
2	ﬁndings	NNS	O	ﬁndings	nsubj	3	SENT_202	[p17l1973t241r2146b306, p17l8t352r158b438],
3	provide	VBP	O	provide	_	0	SENT_202	[p17l205t353r499b438],
4	additional	JJ	O	additional	amod	5	SENT_202	[p17l549t353r938b418],
5	support	NN	O	support	dobj	3	SENT_202	[p17l985t362r1278b438],
6	for	IN	O	for	_	0	SENT_202	[p17l1324t353r1436b418],
7	the	DT	O	the	det	8	SENT_202	[p17l1482t353r1601b418],
8	feasibility	NN	O	feasibility	prep_for	3	SENT_202	[p17l1649t352r2026b438],
9	of	IN	O	of	_	0	SENT_202	[p17l2073t353r2152b418],
10	using	VBG	O	use	prepc_of	8	SENT_202	[p17l8t464r209b549],
11	genotype-based	JJ	O	genotype-based	amod	12	SENT_202	[p17l259t464r867b549],
12	algorithms	NNS	O	algorithm	dobj	10	SENT_202	[p17l919t463r1326b549],
13	to	TO	O	to	aux	14	SENT_202	[p17l1377t473r1452b529],
14	predict	VB	O	predict	xcomp	10	SENT_202	[p17l1502t463r1774b549],
15	warfarin	NN	O	warfarin	nn	16	SENT_202	[p17l1822t464r2149b529],
16	dose	NN	O	dose	dobj	14	SENT_202	[p17l10t575r182b640],
17	prior	RB	O	prior	_	0	SENT_202	[p17l247t575r438b660],
18	to	TO	O	to	_	0	SENT_202	[p17l501t584r576b640],
19	initiation	NN	O	initiation	prep_prior_to	14	SENT_202	[p17l641t574r992b640],
20	of	IN	O	of	_	0	SENT_202	[p17l1057t575r1136b640],
21	therapy	NN	O	therapy	prep_of	19	SENT_202	[p17l1196t575r1490b660],
22	broadly	RB	O	broadly	advmod	14	SENT_202	[p17l1554t575r1850b660],
23	across	IN	O	across	_	0	SENT_202	[p17l1915t595r2147b640],
24	populations	NNS	O	population	prep_across	14	SENT_202	[p17l8t685r481b770],
25	.	.	O	.	_	0	SENT_202	[p17l8t685r481b770],

1	Limitations	NNPS	O	Limitations	_	0	SENT_203	[p17l9t883r453b949],

1	The	DT	O	the	det	2	SENT_204	[p17l8t1107r158b1172],
2	study	NN	O	study	nsubj	3	SENT_204	[p17l187t1107r391b1192],
3	assessed	VBN	O	assess	_	0	SENT_204	[p17l419t1107r735b1172],
4	associations	NNS	O	association	dobj	3	SENT_204	[p17l764t1107r1242b1186],
5	,	,	O	,	_	0	SENT_204	[p17l764t1107r1242b1186],
6	but	CC	O	but	_	0	SENT_204	[p17l1270t1107r1396b1172],
7	prospective	JJ	O	prospective	amod	8	SENT_204	[p17l1421t1107r1865b1192],
8	testing	NN	O	testing	nsubjpass	14	SENT_204	[p17l1893t1107r2148b1192],
9	of	IN	O	of	_	0	SENT_204	[p17l10t1219r89b1284],
10	a	DT	O	a	det	12	SENT_204	[p17l115t1239r154b1284],
11	genotype-based	JJ	O	genotype-based	amod	12	SENT_204	[p17l182t1219r790b1304],
12	algorithm	NN	O	algorithm	prep_of	8	SENT_204	[p17l820t1219r1193b1304],
13	is	VBZ	O	be	auxpass	14	SENT_204	[p17l1221t1219r1277b1284],
14	needed	VBN	O	need	conj_but	3	SENT_204	[p17l1305t1219r1586b1284],
15	to	TO	O	to	aux	17	SENT_204	[p17l1613t1227r1688b1284],
16	deﬁnitively	RB	O	deﬁnitively	advmod	17	SENT_204	[p17l1719t1218r2149b1304],
17	establish	VB	O	establish	xcomp	14	SENT_204	[p17l10t1330r344b1395],
18	superiority	NN	O	superiority	dobj	17	SENT_204	[p17l403t1329r822b1415],
19	over	IN	O	over	_	0	SENT_204	[p17l881t1350r1051b1395],
20	empirical	JJ	O	empirical	amod	21	SENT_204	[p17l1109t1329r1469b1415],
21	dosing	NN	O	dosing	prep_over	18	SENT_204	[p17l1529t1330r1796b1415],
22	.	.	O	.	_	0	SENT_204	[p17l1529t1330r1796b1415],

1	Certain	JJ	O	certain	amod	2	SENT_205	[p17l1860t1330r2149b1395],
2	genotypes	NNS	O	genotype	nsubjpass	11	SENT_205	[p17l9t1449r396b1525],
3	and	CC	O	and	_	0	SENT_205	[p17l445t1440r583b1506],
4	double	JJ	O	double	amod	8	SENT_205	[p17l629t1440r891b1506],
5	or	CC	O	or	_	0	SENT_205	[p17l939t1461r1019b1506],
6	triple	JJ	O	triple	conj_or	4	SENT_205	[p17l1063t1440r1267b1525],
7	variant	JJ	O	variant	amod	8	SENT_205	[p17l1313t1440r1584b1506],
8	combinations	NNS	O	combination	conj_and	2	SENT_205	[p17l1629t1440r2147b1506],
9	were	VBD	O	be	auxpass	11	SENT_205	[p17l8t1572r192b1616],
10	infrequently	RB	O	infrequently	advmod	11	SENT_205	[p17l248t1551r723b1636],
11	represented	VBN	O	represent	_	0	SENT_205	[p17l776t1551r1254b1636],
12	.	.	O	.	_	0	SENT_205	[p17l776t1551r1254b1636],

1	Although	IN	O	although	mark	10	SENT_206	[p17l1312t1551r1681b1636],
2	rare	JJ	O	rare	amod	9	SENT_206	[p17l1735t1572r1911b1630],
3	,	,	O	,	_	0	SENT_206	[p17l1735t1572r1911b1630],
4	their	PRP$	O	they	poss	5	SENT_206	[p17l1967t1551r2149b1616],
5	impact	NN	O	impact	dep	2	SENT_206	[p17l8t1663r270b1749],
6	on	IN	O	on	_	0	SENT_206	[p17l319t1684r414b1729],
7	population	NN	O	population	prep_on	5	SENT_206	[p17l461t1663r882b1749],
8	adverse	JJ	O	adverse	amod	9	SENT_206	[p17l932t1663r1223b1729],
9	events	NNS	O	event	nsubj	10	SENT_206	[p17l1274t1672r1517b1729],
10	(	VBP	O	(	advcl	17	SENT_206	[p17l1570t1660r1733b1749],
11	i.e.	FW	O	i.e.	dobj	10	SENT_206	[p17l1570t1660r1733b1749],
12	,	,	O	,	_	0	SENT_206	[p17l1570t1660r1733b1749],
13	bleeding	VBG	O	bleed	amod	14	SENT_206	[p17l1782t1660r2145b1749],
14	)	NN	O	)	nsubj	17	SENT_206	[p17l1782t1660r2145b1749],
15	could	MD	O	could	aux	17	SENT_206	[p17l9t1775r219b1840],
16	be	VB	O	be	cop	17	SENT_206	[p17l278t1775r368b1840],
17	substantial	JJ	O	substantial	_	0	SENT_206	[p17l429t1775r863b1854],
18	,	,	O	,	_	0	SENT_206	[p17l429t1775r863b1854],
19	due	JJ	O	due	_	0	SENT_206	[p17l925t1775r1063b1840],
20	to	TO	O	to	_	0	SENT_206	[p17l1124t1784r1198b1840],
21	their	PRP$	O	they	poss	22	SENT_206	[p17l1259t1775r1440b1840],
22	association	NN	O	association	prep_due_to	17	SENT_206	[p17l1501t1775r1924b1840],
23	with	IN	O	with	_	0	SENT_206	[p17l1981t1775r2148b1840],
24	major	JJ	O	major	amod	25	SENT_206	[p17l8t1886r235b1971],
25	reductions	NNS	O	reduction	prep_with	17	SENT_206	[p17l264t1886r667b1951],
26	in	IN	O	in	_	0	SENT_206	[p17l698t1886r770b1951],
27	dosing	NN	O	dosing	nn	28	SENT_206	[p17l800t1886r1048b1971],
28	requirements	NNS	O	requirement	prep_in	25	SENT_206	[p17l1078t1886r1611b1971],
29	.	.	O	.	_	0	SENT_206	[p17l1078t1886r1611b1971],

1	In	IN	O	in	_	0	SENT_207	[p17l1645t1888r1725b1951],
2	this	DT	O	this	det	3	SENT_207	[p17l1755t1886r1890b1951],
3	study	NN	O	study	prep_in	12	SENT_207	[p17l1922t1886r2146b1971],
4	,	,	O	,	_	0	SENT_207	[p17l1922t1886r2146b1971],
5	their	PRP$	O	they	poss	6	SENT_207	[p17l9t1997r190b2062],
6	impact	NN	O	impact	nsubjpass	12	SENT_207	[p17l221t1997r482b2082],
7	on	IN	O	on	_	0	SENT_207	[p17l515t2018r609b2062],
8	dose	NN	O	dose	prep_on	6	SENT_207	[p17l642t1997r814b2062],
9	may	MD	O	may	aux	12	SENT_207	[p17l846t2018r1008b2082],
10	be	VB	O	be	auxpass	12	SENT_207	[p17l1039t1997r1129b2062],
11	imperfectly	RB	O	imperfectly	advmod	12	SENT_207	[p17l1161t1997r1604b2082],
12	assessed	VBN	O	assess	_	0	SENT_207	[p17l1636t1997r1974b2076],
13	,	,	O	,	_	0	SENT_207	[p17l1636t1997r1974b2076],
14	due	JJ	O	due	_	0	SENT_207	[p17l2009t1997r2147b2062],
15	to	TO	O	to	_	0	SENT_207	[p17l9t2117r84b2173],
16	small	JJ	O	small	amod	18	SENT_207	[p17l133t2108r334b2173],
17	sample	NN	O	sample	nn	18	SENT_207	[p17l384t2108r651b2193],
18	sizes	NNS	O	size	prep_due_to	12	SENT_207	[p17l702t2108r898b2187],
19	;	:	O	;	_	0	SENT_207	[p17l702t2108r898b2187],
20	however	RB	O	however	advmod	37	SENT_207	[p17l948t2108r1298b2187],
21	,	,	O	,	_	0	SENT_207	[p17l948t2108r1298b2187],
22	given	VBN	O	give	prep	37	SENT_207	[p17l1349t2108r1555b2193],
23	similarities	NNS	O	similarity	dep	22	SENT_207	[p17l1604t2108r2023b2173],
24	of	IN	O	of	_	0	SENT_207	[p17l2073t2109r2152b2173],
25	dose	NN	O	dose	nn	26	SENT_207	[p17l10t2220r182b2285],
26	requirements	NNS	O	requirement	prep_of	23	SENT_207	[p17l211t2219r724b2305],
27	across	IN	O	across	_	0	SENT_207	[p17l754t2240r985b2285],
28	studies	NNS	O	study	prep_across	26	SENT_207	[p17l1015t2220r1277b2285],
29	for	IN	O	for	_	0	SENT_207	[p17l1305t2220r1417b2285],
30	the	DT	O	the	det	34	SENT_207	[p17l1443t2220r1563b2285],
31	more	JJR	O	more	amod	34	SENT_207	[p17l1590t2240r1789b2285],
32	frequent	JJ	O	frequent	amod	34	SENT_207	[p17l1818t2220r2148b2305],
33	genotype	NN	O	genotype	nn	34	SENT_207	[p17l9t2339r361b2416],
34	variants	NNS	O	variant	prep_for	28	SENT_207	[p17l422t2330r749b2409],
35	,	,	O	,	_	0	SENT_207	[p17l422t2330r749b2409],
36	we	PRP	O	we	nsubj	37	SENT_207	[p17l809t2351r914b2396],
37	believe	VBP	O	believe	parataxis	12	SENT_207	[p17l975t2331r1250b2396],
38	that	IN	O	that	complm	48	SENT_207	[p17l1312t2331r1463b2396],
39	a	DT	O	a	det	40	SENT_207	[p17l1524t2351r1564b2396],
40	meta-analysis	NN	O	meta-analysis	nsubj	48	SENT_207	[p17l1623t2331r2147b2416],
41	across	IN	O	across	_	0	SENT_207	[p17l11t2462r242b2507],
42	studies	NNS	O	study	prep_across	40	SENT_207	[p17l300t2441r563b2507],
43	for	IN	O	for	_	0	SENT_207	[p17l618t2442r730b2507],
44	these	DT	O	these	det	46	SENT_207	[p17l784t2441r983b2507],
45	rare	JJ	O	rare	amod	46	SENT_207	[p17l1039t2462r1193b2507],
46	genotypes	NNS	O	genotype	prep_for	42	SENT_207	[p17l1251t2450r1638b2526],
47	is	VBZ	O	be	cop	48	SENT_207	[p17l1694t2441r1750b2507],
48	likely	JJ	O	likely	ccomp	37	SENT_207	[p17l1805t2441r2018b2526],
49	to	TO	O	to	aux	50	SENT_207	[p17l2072t2450r2147b2507],
50	provide	VB	O	provide	xcomp	48	SENT_207	[p17l8t2552r302b2637],
51	acceptably	RB	O	acceptably	advmod	52	SENT_207	[p17l397t2552r806b2637],
52	reliable	JJ	O	reliable	amod	53	SENT_207	[p17l897t2552r1187b2617],
53	estimates	NNS	O	estimate	dobj	50	SENT_207	[p17l1280t2552r1639b2617],
54	of	IN	O	of	_	0	SENT_207	[p17l1732t2553r1811b2617],
55	dosing	NN	O	dosing	nn	56	SENT_207	[p17l1899t2552r2148b2637],
56	requirements	NNS	O	requirement	prep_of	53	SENT_207	[p17l8t2664r541b2749],
57	.	.	O	.	_	0	SENT_207	[p17l8t2664r541b2749],

1	The	DT	O	the	det	3	SENT_208	[p17l611t2664r760b2729],
2	study	NN	O	study	nn	3	SENT_208	[p17l830t2664r1034b2749],
3	population	NN	O	population	nsubj	6	SENT_208	[p17l1100t2664r1520b2749],
4	was	VBD	O	be	cop	6	SENT_208	[p17l1585t2684r1726b2729],
5	predominantly	RB	O	predominantly	advmod	6	SENT_208	[p17l1792t2664r2146b2749, p17l8t2775r250b2860],
6	white	JJ	O	white	_	0	SENT_208	[p17l301t2775r532b2854],
7	,	,	O	,	_	0	SENT_208	[p17l301t2775r532b2854],
8	of	IN	O	of	_	0	SENT_208	[p17l588t2775r667b2840],
9	Northern	JJ	MISC	northern	amod	11	SENT_208	[p17l714t2775r1074b2840],
10	European	JJ	MISC	european	amod	11	SENT_208	[p17l1126t2777r1511b2860],
11	extraction	NN	O	extraction	prep_of	6	SENT_208	[p17l1564t2775r1973b2854],
12	;	:	O	;	_	0	SENT_208	[p17l1564t2775r1973b2854],
13	the	DT	O	the	det	14	SENT_208	[p17l2027t2775r2147b2840],
14	applicability	NN	O	applicability	nsubj	21	SENT_208	[p17l11t2885r486b2970],
15	of	IN	O	of	_	0	SENT_208	[p17l567t2886r645b2950],
16	ﬁndings	NNS	O	ﬁndings	prep_of	14	SENT_208	[p17l721t2885r1019b2970],
17	to	TO	O	to	_	0	SENT_208	[p17l1101t2894r1176b2950],
18	different	JJ	O	different	amod	20	SENT_208	[p17l1258t2885r1592b2950],
19	racial/ethnic	JJ	O	racial/ethnic	amod	20	SENT_208	[p17l1671t2885r2148b2951],
20	groups	NNS	O	group	prep_to	16	SENT_208	[p17l9t3017r267b3082],
21	(	VBP	O	(	parataxis	6	SENT_208	[p17l324t2993r486b3082],
22	i.e.	FW	O	i.e.	nsubj	30	SENT_208	[p17l324t2993r486b3082],
23	,	,	O	,	_	0	SENT_208	[p17l324t2993r486b3082],
24	African	JJ	MISC	african	amod	28	SENT_208	[p17l540t2996r837b3062],
25	or	CC	O	or	_	0	SENT_208	[p17l889t3018r969b3062],
26	Asian	JJ	MISC	asian	amod	28	SENT_208	[p17l1020t2996r1246b3062],
27	descent	NN	O	descent	nn	28	SENT_208	[p17l1300t2993r1619b3082],
28	)	NN	O	)	appos	22	SENT_208	[p17l1300t2993r1619b3082],
29	is	VBZ	O	be	cop	30	SENT_208	[p17l1674t2996r1730b3062],
30	uncertain	JJ	O	uncertain	ccomp	21	SENT_208	[p17l1782t2996r2149b3062],
31	and	CC	O	and	_	0	SENT_208	[p17l11t3108r149b3173],
32	requires	VBZ	O	require	ccomp	21	SENT_208	[p17l183t3108r497b3193],
33	further	JJ	O	further	amod	34	SENT_208	[p17l532t3108r803b3173],
34	study	NN	O	study	dobj	32	SENT_208	[p17l837t3108r1059b3193],
35	.	.	O	.	_	0	SENT_208	[p17l837t3108r1059b3193],

1	Finally	RB	O	finally	advmod	27	SENT_209	[p17l1097t3108r1385b3193],
2	,	,	O	,	_	0	SENT_209	[p17l1097t3108r1385b3193],
3	as	IN	O	as	mark	4	SENT_209	[p17l1424t3129r1497b3173],
4	noted	VBN	O	note	dep	27	SENT_209	[p17l1532t3108r1772b3187],
5	,	,	O	,	_	0	SENT_209	[p17l1532t3108r1772b3187],
6	although	IN	O	although	mark	14	SENT_209	[p17l1810t3108r2149b3193],
7	genotyping	VBG	O	genotype	csubj	14	SENT_209	[p17l9t3220r438b3305],
8	for	IN	O	for	_	0	SENT_209	[p17l490t3220r601b3285],
9	CYP2C9	NN	O	cyp2c9	prep_for	7	SENT_209	[p17l657t3220r993b3285],
10	and	CC	O	and	_	0	SENT_209	[p17l1046t3220r1184b3285],
11	VKORCI	NN	O	vkorcus	conj_and	9	SENT_209	[p17l1239t3220r1609b3285],
12	dramatically	RB	O	dramatically	advmod	14	SENT_209	[p17l1668t3220r2148b3305],
13	have	VBP	O	have	aux	14	SENT_209	[p17l8t3331r188b3396],
14	improved	VBN	O	improve	dep	27	SENT_209	[p17l226t3331r596b3416],
15	the	DT	O	the	det	16	SENT_209	[p17l633t3331r752b3396],
16	prediction	NN	O	prediction	dobj	14	SENT_209	[p17l790t3330r1186b3416],
17	of	IN	O	of	_	0	SENT_209	[p17l1224t3331r1303b3396],
18	interindividual	JJ	O	interindividual	amod	19	SENT_209	[p17l1335t3331r1906b3396],
19	dosevariation	NN	O	dosevariation	prep_of	16	SENT_209	[p17l1944t3331r2146b3396, p17l8t3441r374b3520],
20	,	,	O	,	_	0	SENT_209	[p17l1944t3331r2146b3396, p17l8t3441r374b3520],
21	one	CD	NUMBER	one	number	22	SENT_209	[p17l416t3441r739b3507],
22	—	CD	NUMBER	—	num	23	SENT_209	[p17l416t3441r739b3507],
23	half	NN	O	half	nsubj	27	SENT_209	[p17l416t3441r739b3507],
24	of	IN	O	of	_	0	SENT_209	[p17l775t3442r854b3507],
25	dosing	NN	O	dosing	nn	26	SENT_209	[p17l889t3441r1137b3526],
26	requirements	NNS	O	requirement	prep_of	23	SENT_209	[p17l1176t3441r1689b3526],
27	remains	VBZ	O	remain	_	0	SENT_209	[p17l1728t3441r2032b3507],
28	to	TO	O	to	aux	30	SENT_209	[p17l2072t3450r2147b3507],
29	be	VB	O	be	auxpass	30	SENT_209	[p17l8t3552r98b3617],
30	explained	VBN	O	explain	xcomp	27	SENT_209	[p17l131t3552r505b3637],
31	and	CC	O	and	_	0	SENT_209	[p17l537t3552r676b3617],
32	accounting	NN	O	accounting	nsubj	37	SENT_209	[p17l708t3552r1126b3637],
33	for	IN	O	for	_	0	SENT_209	[p17l1156t3553r1267b3617],
34	this	DT	O	this	prep_for	32	SENT_209	[p17l1297t3552r1431b3617],
35	currently	RB	DATE	currently	advmod	37	SENT_209	[p17l1464t3552r1813b3637],
36	remains	VBZ	O	remain	cop	37	SENT_209	[p17l1843t3552r2147b3617],
37	empirical	JJ	O	empirical	conj_and	27	SENT_209	[p17l10t3664r388b3749],
38	.	.	O	.	_	0	SENT_209	[p17l10t3664r388b3749],

1	@	IN	O	@	_	0	SENT_210	[p18l7t126r80b215],
2	Springer	NNP	O	Springer	pobj	1	SENT_210	[p18l107t148r352b218],
3	Concluding	VBG	O	conclude	partmod	2	SENT_210	[p18l9t247r452b332],
4	clinical	JJ	O	clinical	amod	5	SENT_210	[p18l486t247r758b313],
5	perspective	NN	O	perspective	dobj	3	SENT_210	[p18l791t247r1231b332],

1	The	DT	O	the	det	3	SENT_211	[p18l6t471r156b536],
2	pharmacogenetic	JJ	O	pharmacogenetic	amod	3	SENT_211	[p18l260t471r927b556],
3	effects	NNS	O	effect	nsubj	15	SENT_211	[p18l1031t472r1280b536],
4	of	IN	O	of	_	0	SENT_211	[p18l1386t472r1465b536],
5	CYP2C9	NN	O	cyp2c9	prep_of	3	SENT_211	[p18l1570t472r1906b537],
6	and	CC	O	and	_	0	SENT_211	[p18l2011t471r2149b536],
7	VKORCZ	NN	O	vkorcz	prep_of	3	SENT_211	[p18l11t583r380b648],
8	on	IN	O	on	_	0	SENT_211	[p18l437t603r532b647],
9	warfarin	NN	O	warfarin	nn	10	SENT_211	[p18l579t582r906b647],
10	metabolism	NN	O	metabolism	prep_on	5	SENT_211	[p18l954t582r1406b647],
11	are	VBP	O	be	cop	13	SENT_211	[p18l1456t603r1574b647],
12	highly	RB	O	highly	advmod	13	SENT_211	[p18l1624t582r1861b667],
13	reproducible	JJ	O	reproducible	_	0	SENT_211	[p18l1909t603r2147b667, p18l8t694r287b759],
14	and	CC	O	and	_	0	SENT_211	[p18l339t694r478b759],
15	show	VBP	O	show	conj_and	13	SENT_211	[p18l528t694r723b759],
16	excellent	JJ	O	excellent	amod	17	SENT_211	[p18l774t694r1118b759],
17	replication	NN	O	replication	dobj	15	SENT_211	[p18l1168t693r1585b780],
18	across	IN	O	across	_	0	SENT_211	[p18l1636t715r1867b759],
19	North	JJ	LOCATION	north	amod	23	SENT_211	[p18l1917t694r2150b759],
20	American	JJ	LOCATION	american	amod	23	SENT_211	[p18l6t806r393b872],
21	and	CC	O	and	_	0	SENT_211	[p18l453t807r592b872],
22	European	JJ	LOCATION	european	conj_and	20	SENT_211	[p18l650t809r1035b893],
23	populations	NNS	O	population	prep_across	15	SENT_211	[p18l1093t807r1569b893],
24	,	,	O	,	_	0	SENT_211	[p18l1093t807r1569b893],
25	warranting	VBG	O	warrant	partmod	15	SENT_211	[p18l1628t807r2049b893],
26	a	DT	O	a	det	28	SENT_211	[p18l2110t828r2150b872],
27	prospective	JJ	O	prospective	amod	28	SENT_211	[p18l6t918r450b1003],
28	evaluation	NN	O	evaluation	dobj	25	SENT_211	[p18l486t918r891b984],
29	to	TO	O	to	aux	30	SENT_211	[p18l923t927r998b984],
30	assess	VB	O	assess	xcomp	25	SENT_211	[p18l1034t939r1256b984],
31	the	DT	O	the	det	33	SENT_211	[p18l1290t918r1409b984],
32	clinical	JJ	O	clinical	amod	33	SENT_211	[p18l1444t918r1715b984],
33	efﬁcacy	NN	O	efﬁcacy	nsubj	37	SENT_211	[p18l1750t919r2041b1003],
34	of	IN	O	of	_	0	SENT_211	[p18l2074t919r2153b984],
35	genotype	NN	O	genotype	nn	36	SENT_211	[p18l7t1029r711b1114],
36	—	NN	O	—	prep_of	33	SENT_211	[p18l7t1029r711b1114],
37	directed	VBD	O	direct	ccomp	30	SENT_211	[p18l7t1029r711b1114],
38	dosing	NN	O	dosing	dobj	37	SENT_211	[p18l759t1029r1008b1114],
39	of	IN	O	of	_	0	SENT_211	[p18l1055t1030r1134b1094],
40	warfarin	NN	O	warfarin	nn	42	SENT_211	[p18l1176t1029r1502b1094],
41	anticoagulation	NN	O	anticoagulation	nn	42	SENT_211	[p18l1550t1029r2149b1114],
42	therapy	NN	O	therapy	prep_of	38	SENT_211	[p18l7t1141r302b1226],
43	compared	VBN	O	compare	_	0	SENT_211	[p18l338t1141r722b1226],
44	with	IN	O	with	prepc_compared_with	37	SENT_211	[p18l757t1141r924b1206],
45	current	JJ	DATE	current	amod	48	SENT_211	[p18l960t1149r1239b1206],
46	empirical	JJ	O	empirical	amod	48	SENT_211	[p18l1276t1141r1636b1226],
47	dosing	NN	O	dosing	nn	48	SENT_211	[p18l1673t1141r1923b1226],
48	algorithms	NNS	O	algorithm	pobj	37	SENT_211	[p18l1960t1141r2147b1226, p18l6t1252r271b1317],
49	.	.	O	.	_	0	SENT_211	[p18l1960t1141r2147b1226, p18l6t1252r271b1317],

1	With	IN	O	with	_	0	SENT_212	[p18l302t1252r494b1317],
2	advances	NNS	O	advance	prep_with	14	SENT_212	[p18l524t1252r871b1317],
3	in	IN	O	in	_	0	SENT_212	[p18l900t1252r973b1316],
4	technology	NN	O	technology	prep_in	2	SENT_212	[p18l1000t1252r1446b1337],
5	,	,	O	,	_	0	SENT_212	[p18l1000t1252r1446b1337],
6	rapid-turnaround	JJ	O	rapid-turnaround	amod	7	SENT_212	[p18l1476t1252r2149b1337],
7	genotyping	NN	O	genotyping	nsubj	14	SENT_212	[p18l7t1362r437b1447],
8	to	TO	O	to	aux	9	SENT_212	[p18l480t1371r555b1427],
9	allow	VB	O	allow	infmod	7	SENT_212	[p18l601t1362r806b1427],
10	such	PDT	O	such	predet	12	SENT_212	[p18l850t1362r1020b1427],
11	a	DT	O	a	det	12	SENT_212	[p18l1065t1383r1104b1427],
12	study	NN	O	study	dobj	9	SENT_212	[p18l1147t1362r1352b1447],
13	is	VBZ	O	be	cop	14	SENT_212	[p18l1395t1362r1451b1427],
14	feasible	JJ	O	feasible	_	0	SENT_212	[p18l1494t1362r1809b1427],
15	.	.	O	.	_	0	SENT_212	[p18l1494t1362r1809b1427],

1	Indeed	RB	O	indeed	advmod	6	SENT_213	[p18l1857t1362r2147b1441],
2	,	,	O	,	_	0	SENT_213	[p18l1857t1362r2147b1441],
3	instrumentation	NN	O	instrumentation	nsubjpass	6	SENT_213	[p18l6t1473r627b1538],
4	has	VBZ	O	have	aux	6	SENT_213	[p18l665t1473r790b1538],
5	been	VBN	O	be	auxpass	6	SENT_213	[p18l829t1473r1016b1538],
6	developed	VBN	O	develop	_	0	SENT_213	[p18l1055t1473r1454b1558],
7	that	WDT	O	that	nsubj	9	SENT_213	[p18l1493t1473r1645b1538],
8	can	MD	O	can	aux	9	SENT_213	[p18l1684t1494r1815b1538],
9	provide	VB	O	provide	ccomp	6	SENT_213	[p18l1853t1473r2147b1558],
10	genotype	NN	O	genotype	nn	11	SENT_213	[p18l7t1593r360b1669],
11	information	NN	O	information	dobj	9	SENT_213	[p18l399t1584r859b1649],
12	within	IN	O	within	_	0	SENT_213	[p18l896t1584r1138b1649],
13	1	CD	NUMBER	1	num	14	SENT_213	[p18l1178t1585r1211b1649],
14	h.	NN	O	h.	prep_within	9	SENT_213	[p18l1250t1584r1315b1649],
15	The	DT	O	the	det	16	SENT_213	[p18l1355t1584r1505b1649],
16	availability	NN	O	availability	nsubj	22	SENT_213	[p18l1546t1584r1972b1669],
17	and	CC	O	and	_	0	SENT_213	[p18l2010t1584r2149b1649],
18	use	NN	O	use	conj_and	16	SENT_213	[p18l6t1716r131b1761],
19	of	IN	O	of	_	0	SENT_213	[p18l160t1696r239b1761],
20	such	JJ	O	such	amod	21	SENT_213	[p18l263t1696r433b1761],
21	instrumentation	NN	O	instrumentation	prep_of	16	SENT_213	[p18l459t1695r1079b1761],
22	removes	VBZ	O	remove	rcmod	14	SENT_213	[p18l1106t1716r1430b1761],
23	the	DT	O	the	det	25	SENT_213	[p18l1458t1696r1577b1761],
24	ﬁnal	JJ	O	ﬁnal	amod	25	SENT_213	[p18l1605t1696r1772b1761],
25	obstacles	NNS	O	obstacle	dobj	22	SENT_213	[p18l1800t1696r2148b1761],
26	to	TO	O	to	_	0	SENT_213	[p18l7t1817r82b1873],
27	applying	VBG	O	apply	prepc_to	25	SENT_213	[p18l127t1808r455b1894],
28	this	DT	O	this	det	29	SENT_213	[p18l498t1807r632b1873],
29	approach	NN	O	approach	dobj	27	SENT_213	[p18l678t1808r1036b1894],
30	in	IN	O	in	_	0	SENT_213	[p18l1077t1808r1149b1872],
31	the	DT	O	the	det	33	SENT_213	[p18l1191t1808r1311b1873],
32	clinical	JJ	O	clinical	amod	33	SENT_213	[p18l1355t1807r1627b1873],
33	setting	NN	O	setting	prep_in	27	SENT_213	[p18l1670t1808r1943b1894],
34	.	.	O	.	_	0	SENT_213	[p18l1670t1808r1943b1894],

1	It	PRP	O	it	nsubjpass	3	SENT_214	[p18l1991t1810r2051b1873],
2	is	VBZ	O	be	auxpass	3	SENT_214	[p18l2092t1808r2148b1873],
3	predicted	VBN	O	predict	_	0	SENT_214	[p18l6t1919r393b2004],
4	,	,	O	,	_	0	SENT_214	[p18l6t1919r393b2004],
5	but	CC	O	but	dep	6	SENT_214	[p18l420t1919r546b1985],
6	remains	VBZ	O	remain	dep	3	SENT_214	[p18l571t1919r876b1985],
7	to	TO	O	to	aux	9	SENT_214	[p18l903t1928r978b1985],
8	be	VB	O	be	auxpass	9	SENT_214	[p18l1004t1919r1094b1985],
9	proven	VBN	O	prove	xcomp	6	SENT_214	[p18l1121t1940r1411b2004],
10	,	,	O	,	_	0	SENT_214	[p18l1121t1940r1411b2004],
11	that	IN	O	that	complm	17	SENT_214	[p18l1439t1920r1590b1985],
12	application	NN	O	application	nsubj	17	SENT_214	[p18l1618t1919r2048b2004],
13	of	IN	O	of	_	0	SENT_214	[p18l2074t1920r2153b1985],
14	this	DT	O	this	det	15	SENT_214	[p18l7t2030r141b2095],
15	method	NN	O	method	prep_of	12	SENT_214	[p18l172t2030r468b2095],
16	should	MD	O	should	aux	17	SENT_214	[p18l499t2030r753b2095],
17	reduce	VB	O	reduce	ccomp	3	SENT_214	[p18l783t2030r1042b2095],
18	the	DT	O	the	det	19	SENT_214	[p18l1074t2030r1193b2095],
19	time	NN	O	time	dobj	17	SENT_214	[p18l1225t2030r1395b2095],
20	to	TO	O	to	aux	21	SENT_214	[p18l1427t2039r1502b2095],
21	ﬁrst	VB	O	ﬁrst	infmod	19	SENT_214	[p18l1532t2031r1678b2095],
22	therapeutic	JJ	O	therapeutic	amod	23	SENT_214	[p18l1709t2030r2150b2115],
23	INR	NN	O	inr	dobj	21	SENT_214	[p18l7t2144r178b2206],
24	without	IN	O	without	_	0	SENT_214	[p18l221t2142r517b2207],
25	exceeding	VBG	O	exceed	prepc_without	21	SENT_214	[p18l562t2142r947b2227],
26	target	NN	O	target	dobj	25	SENT_214	[p18l991t2151r1237b2227],
27	,	,	O	,	_	0	SENT_214	[p18l991t2151r1237b2227],
28	will	MD	O	will	aux	29	SENT_214	[p18l1282t2142r1420b2207],
29	increase	VB	O	increase	dep	26	SENT_214	[p18l1464t2142r1779b2207],
30	the	DT	O	the	det	31	SENT_214	[p18l1824t2142r1943b2207],
31	proportion	NN	O	proportion	dobj	29	SENT_214	[p18l1988t2162r2147b2227, p18l6t2253r292b2338],
32	of	IN	O	of	_	0	SENT_214	[p18l334t2253r413b2318],
33	therapeutic	JJ	O	therapeutic	amod	35	SENT_214	[p18l449t2253r890b2338],
34	INR	NN	O	inr	nn	35	SENT_214	[p18l931t2255r1102b2317],
35	measurements	NNS	O	measurement	prep_of	31	SENT_214	[p18l1143t2262r1702b2318],
36	over	IN	O	over	_	0	SENT_214	[p18l1745t2273r1915b2318],
37	time	NN	O	time	prep_over	29	SENT_214	[p18l1955t2253r2147b2332],
38	,	,	O	,	_	0	SENT_214	[p18l1955t2253r2147b2332],
39	will	MD	O	will	aux	40	SENT_214	[p18l6t2363r143b2428],
40	reduce	VB	O	reduce	dep	26	SENT_214	[p18l183t2363r442b2428],
41	the	DT	O	the	det	42	SENT_214	[p18l483t2363r603b2428],
42	need	NN	O	need	dobj	40	SENT_214	[p18l644t2363r830b2428],
43	for	IN	O	for	_	0	SENT_214	[p18l869t2364r981b2428],
44	unplanned	JJ	O	unplanned	amod	46	SENT_214	[p18l1020t2363r1429b2448],
45	dose	NN	O	dose	nn	46	SENT_214	[p18l1470t2363r1643b2428],
46	adjustments	NNS	O	adjustment	prep_for	40	SENT_214	[p18l1686t2363r2148b2448],
47	and	CC	O	and	_	0	SENT_214	[p18l8t2474r147b2540],
48	additional	JJ	O	additional	amod	50	SENT_214	[p18l203t2474r591b2540],
49	INR	NN	O	inr	nn	50	SENT_214	[p18l645t2476r816b2539],
50	measurements	NNS	O	measurement	conj_and	46	SENT_214	[p18l869t2483r1449b2553],
51	,	,	O	,	_	0	SENT_214	[p18l869t2483r1449b2553],
52	and	CC	O	and	_	0	SENT_214	[p18l1506t2474r1646b2540],
53	will	MD	O	will	aux	54	SENT_214	[p18l1697t2474r1835b2539],
54	reduce	VB	O	reduce	dep	26	SENT_214	[p18l1888t2474r2147b2540],
55	clinical	JJ	O	clinical	amod	57	SENT_214	[p18l7t2586r280b2651],
56	adverse	JJ	O	adverse	amod	57	SENT_214	[p18l319t2586r610b2651],
57	events	NNS	O	event	dobj	54	SENT_214	[p18l651t2595r916b2665],
58	,	,	O	,	_	0	SENT_214	[p18l651t2595r916b2665],
59	i.e.	FW	O	i.e.	dep	29	SENT_214	[p18l955t2586r1087b2665],
60	,	,	O	,	_	0	SENT_214	[p18l955t2586r1087b2665],
61	bleeding	VBG	O	bleed	dep	29	SENT_214	[p18l1126t2586r1457b2671],
62	complications	NNS	O	complication	nsubj	66	SENT_214	[p18l1495t2586r2030b2671],
63	or	CC	O	or	_	0	SENT_214	[p18l2070t2607r2150b2651],
64	thromboembolic	JJ	O	thromboembolic	amod	65	SENT_214	[p18l7t2697r652b2763],
65	events	NNS	O	event	nsubj	66	SENT_214	[p18l714t2707r957b2763],
66	due	JJ	O	due	xcomp	61	SENT_214	[p18l1019t2698r1157b2763],
67	to	TO	O	to	_	0	SENT_214	[p18l1219t2707r1294b2763],
68	incorrect	JJ	O	incorrect	amod	70	SENT_214	[p18l1356t2698r1702b2763],
69	individual	JJ	O	individual	amod	70	SENT_214	[p18l1762t2697r2149b2763],
70	dosing	NN	O	dosing	prep_to	66	SENT_214	[p18l8t2809r275b2896],
71	.	.	O	.	_	0	SENT_214	[p18l8t2809r275b2896],

1	Based	VBN	O	base	_	0	SENT_215	[p18l318t2810r553b2875],
2	on	IN	O	on	prepc_based_on	8	SENT_215	[p18l594t2831r689b2875],
3	retrospective	JJ	O	retrospective	amod	4	SENT_215	[p18l727t2809r1230b2896],
4	studies	NNS	O	study	pobj	8	SENT_215	[p18l1272t2810r1556b2889],
5	,	,	O	,	_	0	SENT_215	[p18l1272t2810r1556b2889],
6	it	PRP	O	it	nsubjpass	8	SENT_215	[p18l1598t2809r1650b2875],
7	is	VBZ	O	be	auxpass	8	SENT_215	[p18l1688t2810r1743b2875],
8	predicted	VBN	O	predict	_	0	SENT_215	[p18l1783t2810r2149b2896],
9	that	IN	O	that	complm	20	SENT_215	[p18l6t2921r157b2987],
10	both	CC	O	both	preconj	14	SENT_215	[p18l186t2922r362b2987],
11	overall	JJ	O	overall	amod	14	SENT_215	[p18l392t2921r657b2987],
12	adverse	JJ	O	adverse	amod	14	SENT_215	[p18l687t2921r979b2987],
13	event	NN	O	event	nn	14	SENT_215	[p18l1011t2931r1221b2987],
14	rates	NNS	O	rate	nsubjpass	20	SENT_215	[p18l1249t2931r1434b2987],
15	and	CC	O	and	_	0	SENT_215	[p18l1465t2921r1604b2987],
16	medical	JJ	O	medical	amod	17	SENT_215	[p18l1633t2921r1934b2987],
17	costs	NNS	O	cost	nsubjpass	20	SENT_215	[p18l1964t2930r2148b2987],
18	will	MD	O	will	aux	20	SENT_215	[p18l6t3033r143b3098],
19	be	VB	O	be	auxpass	20	SENT_215	[p18l179t3033r269b3098],
20	reduced	VBN	O	reduce	ccomp	8	SENT_215	[p18l306t3033r616b3098],
21	by	IN	O	by	_	0	SENT_215	[p18l652t3033r744b3118],
22	genotype	NN	O	genotype	nn	23	SENT_215	[p18l780t3033r1388b3118],
23	—	NN	O	—	agent	20	SENT_215	[p18l780t3033r1388b3118],
24	based	VBN	O	base	partmod	23	SENT_215	[p18l780t3033r1388b3118],
25	dosing	NN	O	dosing	dobj	24	SENT_215	[p18l1425t3033r1695b3118],
26	,	,	O	,	_	0	SENT_215	[p18l1425t3033r1695b3118],
27	potentially	RB	O	potentially	advmod	28	SENT_215	[p18l1732t3033r2149b3118],
28	one	CD	NUMBER	one	rcmod	25	SENT_215	[p18l8t3165r146b3210],
29	of	IN	O	of	_	0	SENT_215	[p18l176t3145r255b3210],
30	the	DT	O	the	det	32	SENT_215	[p18l278t3145r398b3210],
31	ﬁrst	JJ	O	ﬁrst	amod	32	SENT_215	[p18l427t3145r573b3210],
32	legacies	NNS	O	legacy	prep_of	28	SENT_215	[p18l600t3145r901b3230],
33	of	IN	O	of	_	0	SENT_215	[p18l931t3145r1010b3210],
34	the	DT	O	the	det	36	SENT_215	[p18l1033t3145r1153b3210],
35	pharmacogenomic	JJ	O	pharmacogenomic	amod	36	SENT_215	[p18l1181t3145r1897b3230],
36	era	NN	O	era	prep_of	32	SENT_215	[p18l1926t3165r2045b3210],
37	of	IN	O	of	_	0	SENT_215	[p18l2074t3145r2153b3210],
38	clinical	JJ	O	clinical	amod	39	SENT_215	[p18l7t3256r280b3321],
39	science	NN	O	science	prep_of	36	SENT_215	[p18l314t3256r608b3321],
40	.	.	O	.	_	0	SENT_215	[p18l314t3256r608b3321],

1	References	NNS	O	reference	_	0	SENT_216	[p18l7t3483r442b3548],

1	.	.	O	.	_	0	SENT_217	[p19l86t124r96b133],

1	Weiss	NNP	PERSON	Weiss	nn	2	SENT_218	[p19l137t77r329b133],
2	P	NN	O	p	nsubj	9	SENT_218	[p19l358t79r420b145],
3	,	,	O	,	_	0	SENT_218	[p19l358t79r420b145],
4	Halkin	NNP	PERSON	Halkin	nn	5	SENT_218	[p19l450t77r676b133],
5	H	NNP	PERSON	H	appos	2	SENT_218	[p19l704t79r782b145],
6	,	,	O	,	_	0	SENT_218	[p19l704t79r782b145],
7	Almog	NNP	PERSON	Almog	nn	8	SENT_218	[p19l813t77r1039b150],
8	S	NNP	O	S	appos	5	SENT_218	[p19l1068t78r1104b134],
9	(	VBD	O	(	_	0	SENT_218	[p19l1138t75r1341b151],
10	1986	CD	DATE	1986	num	11	SENT_218	[p19l1138t75r1341b151],
11	)	CD	NUMBER	)	dobj	9	SENT_218	[p19l1138t75r1341b151],
12	The	DT	O	the	det	14	SENT_218	[p19l1372t77r1499b133],
13	negative	JJ	O	negative	amod	14	SENT_218	[p19l1528t77r1804b150],
14	impact	NN	O	impact	dep	9	SENT_218	[p19l1834t77r2056b150],
15	of	IN	O	of	_	0	SENT_218	[p19l2086t78r2153b133],
16	biological	JJ	O	biological	amod	17	SENT_218	[p19l137t166r457b240],
17	variation	NN	O	variation	prep_of	14	SENT_218	[p19l479t166r773b223],
18	in	IN	O	in	_	0	SENT_218	[p19l795t166r856b222],
19	the	DT	O	the	det	20	SENT_218	[p19l878t167r980b223],
20	effect	NN	O	effect	prep_in	14	SENT_218	[p19l1004t167r1186b223],
21	and	CC	O	and	_	0	SENT_218	[p19l1211t167r1328b223],
22	clearance	NN	O	clearance	prep_in	14	SENT_218	[p19l1351t166r1660b223],
23	of	IN	O	of	_	0	SENT_218	[p19l1684t167r1752b223],
24	warfarin	NN	O	warfarin	prep_of	20	SENT_218	[p19l1769t166r2047b223],
25	on	IN	O	on	_	0	SENT_218	[p19l2069t184r2150b223],
26	methods	NNS	O	method	prep_on	9	SENT_218	[p19l138t256r417b312],
27	for	IN	O	for	_	0	SENT_218	[p19l479t256r574b312],
28	prediction	NN	O	prediction	prep_for	26	SENT_218	[p19l633t255r970b329],
29	of	IN	O	of	_	0	SENT_218	[p19l1031t256r1099b312],
30	dose	NN	O	dose	nn	31	SENT_218	[p19l1157t256r1303b312],
31	requirements	NNS	O	requirement	prep_of	28	SENT_218	[p19l1365t255r1818b329],
32	.	.	O	.	_	0	SENT_218	[p19l1365t255r1818b329],

1	Thromb	NNP	O	Thromb	nn	2	SENT_219	[p19l1881t256r2149b312],
2	Haemost	NNP	O	Haemost	_	0	SENT_219	[p19l138t346r435b400],
3	56	CD	NUMBER	56	number	4	SENT_219	[p19l464t342r918b418],
4	(	CD	NUMBER	(	dep	2	SENT_219	[p19l464t342r918b418],
5	3	CD	NUMBER	3	num	6	SENT_219	[p19l464t342r918b418],
6	)	NN	O	)	dep	4	SENT_219	[p19l464t342r918b418],
7	:371	CD	NUMBER	:371	num	8	SENT_219	[p19l464t342r918b418],
8	—	NN	O	—	dep	4	SENT_219	[p19l464t342r918b418],
9	375	CD	NUMBER	375	dep	2	SENT_219	[p19l464t342r918b418],

1	.	.	O	.	_	0	SENT_220	[p19l86t480r96b489],

1	Carlquist	NNP	O	Carlquist	nn	2	SENT_221	[p19l140t433r439b507],
2	JF	NNP	O	JF	nsubj	6	SENT_221	[p19l487t435r584b501],
3	,	,	O	,	_	0	SENT_221	[p19l487t435r584b501],
4	Anderson	NNP	PERSON	Anderson	nn	5	SENT_221	[p19l635t433r961b490],
5	JL	NNP	O	JL	nsubj	6	SENT_221	[p19l1009t435r1093b490],
6	(	VBD	O	(	_	0	SENT_221	[p19l1145t431r1346b507],
7	2004	CD	DATE	2004	num	9	SENT_221	[p19l1145t431r1346b507],
8	)	CD	NUMBER	)	num	9	SENT_221	[p19l1145t431r1346b507],
9	Pharmacogenomics	NNS	O	pharmacogenomic	dobj	6	SENT_221	[p19l1399t433r2039b507],
10	in	IN	O	in	_	0	SENT_221	[p19l2089t433r2150b489],
11	cardiovascular	JJ	O	cardiovascular	amod	12	SENT_221	[p19l138t522r614b579],
12	medicine	NN	O	medicine	prep_in	6	SENT_221	[p19l642t522r956b579],
13	.	.	O	.	_	0	SENT_221	[p19l642t522r956b579],

1	Drug	NN	O	drug	_	0	SENT_222	[p19l988t524r1158b596],
2	Develop	VB	O	develop	dep	1	SENT_222	[p19l1187t523r1466b596],
3	Res	NNP	O	Res	nsubj	6	SENT_222	[p19l1496t524r1619b579],
4	62:180	CD	NUMBER	62:180	number	5	SENT_222	[p19l1649t523r2008b579],
5	—	CD	NUMBER	—	num	6	SENT_222	[p19l1649t523r2008b579],
6	19O	NN	O	19o	xcomp	2	SENT_222	[p19l1649t523r2008b579],

1	.	.	O	.	_	0	SENT_223	[p19l86t658r96b667],

1	Bachmann	NNP	PERSON	Bachmann	nn	2	SENT_224	[p19l138t611r490b667],
2	K	NNP	PERSON	K	nsubj	8	SENT_224	[p19l552t613r609b667],
3	(	VBD	O	(	_	0	SENT_224	[p19l673t609r876b685],
4	2002	CD	DATE	2002	num	6	SENT_224	[p19l673t609r876b685],
5	)	CD	NUMBER	)	num	6	SENT_224	[p19l673t609r876b685],
6	Genotyping	NN	O	genotyping	dobj	3	SENT_224	[p19l943t611r1331b684],
7	and	CC	O	and	_	0	SENT_224	[p19l1394t611r1512b667],
8	phenotyping	VBG	O	phenotype	conj_and	3	SENT_224	[p19l1573t611r1985b684],
9	the	DT	O	the	det	12	SENT_224	[p19l2047t611r2148b667],
10	cytochrome	NN	O	cytochrome	nn	12	SENT_224	[p19l138t700r523b773],
11	p-450	NN	O	p-450	nn	12	SENT_224	[p19l552t700r732b773],
12	enzymes	NNS	O	enzyme	dobj	8	SENT_224	[p19l762t718r1057b773],
13	.	.	O	.	_	0	SENT_224	[p19l762t718r1057b773],

1	Am	NNP	O	Am	nn	3	SENT_225	[p19l1089t701r1214b756],
2	J	NNP	O	J	nn	3	SENT_225	[p19l1240t702r1272b757],
3	Ther	NNP	O	Ther	_	0	SENT_225	[p19l1301t700r1459b756],
4	9	CD	NUMBER	9	num	5	SENT_225	[p19l1488t698r1905b774],
5	(	NN	O	(	dep	3	SENT_225	[p19l1488t698r1905b774],
6	4	CD	NUMBER	4	number	7	SENT_225	[p19l1488t698r1905b774],
7	)	CD	NUMBER	)	dep	5	SENT_225	[p19l1488t698r1905b774],
8	:309	CD	NUMBER	:309	num	9	SENT_225	[p19l1488t698r1905b774],
9	—	NN	O	—	dep	7	SENT_225	[p19l1488t698r1905b774],
10	316	CD	NUMBER	316	dep	3	SENT_225	[p19l1488t698r1905b774],

1	.	.	O	.	_	0	SENT_226	[p19l86t836r96b845],

1	Rettie	NNP	O	Rettie	nn	2	SENT_227	[p19l139t789r342b846],
2	AE	NNP	O	AE	dep	18	SENT_227	[p19l373t790r506b857],
3	,	,	O	,	_	0	SENT_227	[p19l373t790r506b857],
4	Wienkers	NNP	ORGANIZATION	Wienkers	nn	5	SENT_227	[p19l537t789r851b846],
5	LC	NNP	ORGANIZATION	LC	appos	2	SENT_227	[p19l882t790r1002b857],
6	,	,	O	,	_	0	SENT_227	[p19l882t790r1002b857],
7	Gonzalez	NNP	PERSON	Gonzalez	nn	8	SENT_227	[p19l1037t789r1345b846],
8	FJ	NNP	O	FJ	appos	2	SENT_227	[p19l1374t791r1471b857],
9	,	,	O	,	_	0	SENT_227	[p19l1374t791r1471b857],
10	Trager	NNP	PERSON	Trager	nn	11	SENT_227	[p19l1502t791r1724b863],
11	WF	NNP	PERSON	WF	appos	2	SENT_227	[p19l1753t791r1892b857],
12	,	,	O	,	_	0	SENT_227	[p19l1753t791r1892b857],
13	Korze	NNP	O	Korze	nn	15	SENT_227	[p19l1924t791r2148b846],
14	—	CD	NUMBER	—	num	15	SENT_227	[p19l1924t791r2148b846],
15	kwa	NN	O	kwa	appos	2	SENT_227	[p19l138t879r270b935],
16	KR	NN	O	kr	dep	18	SENT_227	[p19l298t880r414b934],
17	(	CD	NUMBER	(	num	16	SENT_227	[p19l445t876r647b952],
18	1994	CD	DATE	1994	dep	22	SENT_227	[p19l445t876r647b952],
19	)	NNP	O	)	dep	18	SENT_227	[p19l445t876r647b952],
20	Impaired	JJ	O	impaired	amod	22	SENT_227	[p19l679t879r980b952],
21	(	NN	O	(	nn	22	SENT_227	[p19l1010t876r1409b952],
22	S	NN	O	s	_	0	SENT_227	[p19l1010t876r1409b952],
23	)	SYM	O	)	dep	26	SENT_227	[p19l1010t876r1409b952],
24	-	:	O	-	_	0	SENT_227	[p19l1010t876r1409b952],
25	warfarin	NN	O	warfarin	nn	26	SENT_227	[p19l1010t876r1409b952],
26	metabolism	NN	O	metabolism	dep	22	SENT_227	[p19l1437t879r1820b935],
27	catalysed	VBN	O	catalyse	partmod	26	SENT_227	[p19l1848t879r2149b952],
28	by	IN	O	by	_	0	SENT_227	[p19l137t966r215b1038],
29	the	DT	O	the	det	32	SENT_227	[p19l245t966r347b1022],
30	R144C	NN	O	r144c	nn	32	SENT_227	[p19l379t967r605b1022],
31	allelic	JJ	O	allelic	amod	32	SENT_227	[p19l635t966r828b1022],
32	variant	NN	O	variant	agent	27	SENT_227	[p19l856t966r1087b1022],
33	of	IN	O	of	_	0	SENT_227	[p19l1119t967r1185b1022],
34	CYP2C9	NN	O	cyp2c9	prep_of	32	SENT_227	[p19l1214t967r1517b1022],
35	.	.	O	.	_	0	SENT_227	[p19l1214t967r1517b1022],

1	Pharmacogenetics	NNS	ORGANIZATION	pharmacogenetic	_	0	SENT_228	[p19l1550t966r2148b1038],
2	4	CD	NUMBER	4	num	3	SENT_228	[p19l137t1053r480b1129],
3	(	NN	O	(	dep	1	SENT_228	[p19l137t1053r480b1129],
4	1	CD	NUMBER	1	number	5	SENT_228	[p19l137t1053r480b1129],
5	)	CD	NUMBER	)	dep	3	SENT_228	[p19l137t1053r480b1129],
6	:39	CD	NUMBER	:39	num	7	SENT_228	[p19l137t1053r480b1129],
7	—	NN	O	—	dep	5	SENT_228	[p19l137t1053r480b1129],
8	42	CD	NUMBER	42	dep	1	SENT_228	[p19l137t1053r480b1129],

1	.	.	O	.	_	0	SENT_229	[p19l86t1191r96b1201],

1	Furuya	NN	PERSON	furuya	nn	2	SENT_230	[p19l137t1146r372b1218],
2	H	NN	O	h	_	0	SENT_230	[p19l418t1146r496b1213],
3	,	,	O	,	_	0	SENT_230	[p19l418t1146r496b1213],
4	Fernandez	NNP	PERSON	Fernandez	appos	2	SENT_230	[p19l543t1145r1209b1218],
5	.	.	O	.	_	0	SENT_230	[p19l543t1145r1209b1218],

1	—	NN	O	—	_	0	SENT_231	[p19l543t1145r1209b1218],
2	.	.	O	.	_	0	SENT_231	[p19l543t1145r1209b1218],

1	Salguero	FW	PERSON	salguero	_	0	SENT_232	[p19l543t1145r1209b1218],
2	P	NN	O	p	dep	22	SENT_232	[p19l1256t1146r1318b1213],
3	,	,	O	,	_	0	SENT_232	[p19l1256t1146r1318b1213],
4	Gregory	NNP	PERSON	Gregory	nn	5	SENT_232	[p19l1368t1145r1643b1218],
5	W	NNP	PERSON	W	appos	2	SENT_232	[p19l1688t1146r1779b1212],
6	,	,	O	,	_	0	SENT_232	[p19l1688t1146r1779b1212],
7	Taber	NNP	PERSON	Taber	nn	8	SENT_232	[p19l1827t1145r2024b1201],
8	H	NNP	PERSON	H	appos	2	SENT_232	[p19l2070t1146r2148b1213],
9	,	,	O	,	_	0	SENT_232	[p19l2070t1146r2148b1213],
10	Steward	NNP	PERSON	Steward	nn	11	SENT_232	[p19l139t1232r405b1289],
11	A	NNP	O	A	appos	2	SENT_232	[p19l439t1233r517b1300],
12	,	,	O	,	_	0	SENT_232	[p19l439t1233r517b1300],
13	Gonzalez	NNP	PERSON	Gonzalez	nn	14	SENT_232	[p19l554t1232r862b1289],
14	FJ	NNP	O	FJ	appos	2	SENT_232	[p19l895t1234r991b1300],
15	,	,	O	,	_	0	SENT_232	[p19l895t1234r991b1300],
16	Idle	NNP	O	Idle	nn	17	SENT_232	[p19l1028t1232r1154b1288],
17	JR	NNP	O	JR	appos	2	SENT_232	[p19l1187t1234r1279b1289],
18	(	CD	NUMBER	(	dep	22	SENT_232	[p19l1316t1230r1518b1305],
19	1995	CD	DATE	1995	num	22	SENT_232	[p19l1316t1230r1518b1305],
20	)	NNP	O	)	nn	22	SENT_232	[p19l1316t1230r1518b1305],
21	Genetic	NNP	O	Genetic	nn	22	SENT_232	[p19l1556t1232r1815b1289],
22	polymorphism	NN	O	polymorphism	dep	32	SENT_232	[p19l1847t1232r2148b1305, p19l137t1322r334b1396],
23	of	IN	O	of	_	0	SENT_232	[p19l373t1323r441b1379],
24	CYP2C9	NN	O	cyp2c9	prep_of	22	SENT_232	[p19l477t1323r763b1379],
25	and	CC	O	and	_	0	SENT_232	[p19l805t1322r922b1379],
26	its	PRP$	O	its	poss	27	SENT_232	[p19l961t1322r1034b1379],
27	effect	NN	O	effect	conj_and	22	SENT_232	[p19l1073t1323r1256b1379],
28	on	IN	O	on	_	0	SENT_232	[p19l1296t1340r1376b1379],
29	warfarin	NN	O	warfarin	nn	30	SENT_232	[p19l1413t1322r1690b1379],
30	maintenance	NN	O	maintenance	prep_on	27	SENT_232	[p19l1729t1322r2148b1379],
31	dose	NN	O	dose	nn	32	SENT_232	[p19l139t1411r285b1466],
32	requirement	NN	O	requirement	dep	1	SENT_232	[p19l337t1411r745b1483],
33	in	IN	O	in	dep	32	SENT_232	[p19l794t1411r856b1465],
34	patients	NNS	O	patient	nsubj	35	SENT_232	[p19l906t1411r1165b1483],
35	undergoing	VBG	O	undergo	pcomp	33	SENT_232	[p19l1216t1411r1589b1483],
36	anticoagulation	NN	O	anticoagulation	nn	37	SENT_232	[p19l1641t1411r2150b1483],
37	therapy	NN	O	therapy	dobj	35	SENT_232	[p19l138t1498r404b1571],
38	.	.	O	.	_	0	SENT_232	[p19l138t1498r404b1571],

1	Pharmacogenetics	NNS	O	pharmacogenetic	_	0	SENT_233	[p19l436t1498r1034b1571],
2	5	CD	NUMBER	5	number	3	SENT_233	[p19l1064t1496r1482b1571],
3	(	CD	NUMBER	(	dep	1	SENT_233	[p19l1064t1496r1482b1571],
4	6	CD	NUMBER	6	num	5	SENT_233	[p19l1064t1496r1482b1571],
5	)	NN	O	)	dep	3	SENT_233	[p19l1064t1496r1482b1571],
6	:389	CD	NUMBER	:389	num	7	SENT_233	[p19l1064t1496r1482b1571],
7	—	NN	O	—	dep	3	SENT_233	[p19l1064t1496r1482b1571],
8	392	CD	NUMBER	392	dep	1	SENT_233	[p19l1064t1496r1482b1571],

1	.	.	O	.	_	0	SENT_234	[p19l86t1634r96b1644],

1	Stubbins	NNP	ORGANIZATION	Stubbins	nn	2	SENT_235	[p19l139t1588r421b1644],
2	MJ	NNP	ORGANIZATION	MJ	_	0	SENT_235	[p19l457t1590r577b1656],
3	,	,	O	,	_	0	SENT_235	[p19l457t1590r577b1656],
4	Harries	NNP	PERSON	Harries	nn	5	SENT_235	[p19l614t1588r860b1644],
5	LW	NNP	O	LW	appos	2	SENT_235	[p19l896t1590r1037b1656],
6	,	,	O	,	_	0	SENT_235	[p19l896t1590r1037b1656],
7	Smith	NNP	PERSON	Smith	nn	8	SENT_235	[p19l1075t1588r1266b1644],
8	G	NNP	O	G	appos	2	SENT_235	[p19l1303t1589r1378b1655],
9	,	,	O	,	_	0	SENT_235	[p19l1303t1589r1378b1655],
10	Tarbit	NNP	O	Tarbit	nn	11	SENT_235	[p19l1414t1588r1619b1644],
11	MH	NNP	O	MH	appos	2	SENT_235	[p19l1653t1590r1804b1656],
12	,	,	O	,	_	0	SENT_235	[p19l1653t1590r1804b1656],
13	Wolf	NNP	PERSON	Wolf	nn	14	SENT_235	[p19l1840t1589r2007b1644],
14	CR	NN	O	cr	appos	2	SENT_235	[p19l2040t1589r2150b1644],
15	(	CD	NUMBER	(	num	16	SENT_235	[p19l141t1675r343b1751],
16	1996	CD	DATE	1996	dep	14	SENT_235	[p19l141t1675r343b1751],
17	)	NNP	O	)	nn	19	SENT_235	[p19l141t1675r343b1751],
18	Genetic	JJ	O	genetic	amod	19	SENT_235	[p19l398t1678r657b1734],
19	analysis	NN	O	analysis	dep	2	SENT_235	[p19l708t1678r961b1751],
20	of	IN	O	of	_	0	SENT_235	[p19l1013t1678r1080b1734],
21	the	DT	O	the	det	26	SENT_235	[p19l1126t1678r1228b1734],
22	human	JJ	O	human	amod	26	SENT_235	[p19l1279t1678r1505b1734],
23	cytochrome	NN	O	cytochrome	nn	26	SENT_235	[p19l1555t1678r1940b1751],
24	P450	NN	O	p450	nn	26	SENT_235	[p19l1991t1677r2149b1734],
25	CYPZC9	NN	O	cypzc9	nn	26	SENT_235	[p19l140t1767r426b1823],
26	locus	NN	O	locus	prep_of	19	SENT_235	[p19l456t1767r638b1823],
27	.	.	O	.	_	0	SENT_235	[p19l456t1767r638b1823],

1	Pharmacogenetics	NNS	O	pharmacogenetic	_	0	SENT_236	[p19l670t1767r1267b1840],
2	6	CD	NUMBER	6	num	3	SENT_236	[p19l1297t1764r1715b1840],
3	(	NN	O	(	dep	1	SENT_236	[p19l1297t1764r1715b1840],
4	5	CD	NUMBER	5	number	5	SENT_236	[p19l1297t1764r1715b1840],
5	)	CD	NUMBER	)	dep	3	SENT_236	[p19l1297t1764r1715b1840],
6	:429	CD	NUMBER	:429	num	7	SENT_236	[p19l1297t1764r1715b1840],
7	—	NN	O	—	dep	5	SENT_236	[p19l1297t1764r1715b1840],
8	439	CD	NUMBER	439	dep	1	SENT_236	[p19l1297t1764r1715b1840],

1	.	.	O	.	_	0	SENT_237	[p19l86t1900r96b1909],

1	Yasar	NNP	PERSON	Yasar	nn	2	SENT_238	[p19l137t1855r330b1909],
2	U	NNP	PERSON	U	_	0	SENT_238	[p19l376t1855r454b1921],
3	,	,	O	,	_	0	SENT_238	[p19l376t1855r454b1921],
4	Eliasson	NNP	PERSON	Eliasson	nn	5	SENT_238	[p19l502t1854r778b1909],
5	E	NNP	PERSON	E	appos	2	SENT_238	[p19l824t1855r894b1921],
6	,	,	O	,	_	0	SENT_238	[p19l824t1855r894b1921],
7	Dahl	NNP	PERSON	Dahl	nn	8	SENT_238	[p19l942t1854r1104b1909],
8	ML	NNP	O	ML	appos	2	SENT_238	[p19l1151t1855r1289b1921],
9	,	,	O	,	_	0	SENT_238	[p19l1151t1855r1289b1921],
10	Johansson	NNP	PERSON	Johansson	appos	2	SENT_238	[p19l1335t1854r1676b1910],
11	1	CD	NUMBER	1	num	10	SENT_238	[p19l1722t1855r1766b1921],
12	,	,	O	,	_	0	SENT_238	[p19l1722t1855r1766b1921],
13	Inge1manSundberg	NN	O	inge1mansundberg	nn	14	SENT_238	[p19l1814t1854r2148b1926, p19l139t1944r451b2017],
14	M	NN	O	m	appos	2	SENT_238	[p19l490t1945r577b2012],
15	,	,	O	,	_	0	SENT_238	[p19l490t1945r577b2012],
16	Sjoqvist	NNP	O	Sjoqvist	nn	17	SENT_238	[p19l619t1944r877b2017],
17	F	NN	O	f	appos	2	SENT_238	[p19l914t1945r960b1999],
18	(	CD	NUMBER	(	num	17	SENT_238	[p19l1001t1941r1204b2017],
19	1999	CD	DATE	1999	num	21	SENT_238	[p19l1001t1941r1204b2017],
20	)	CD	NUMBER	)	num	21	SENT_238	[p19l1001t1941r1204b2017],
21	Validation	NN	O	validation	dep	17	SENT_238	[p19l1245t1944r1595b2000],
22	of	IN	O	of	_	0	SENT_238	[p19l1635t1944r1702b2000],
23	methods	NNS	O	method	prep_of	2	SENT_238	[p19l1736t1944r2016b2000],
24	for	IN	O	for	_	0	SENT_238	[p19l2055t1944r2150b2000],
25	CYP2C9	NN	O	cyp2c9	nn	26	SENT_238	[p19l140t2032r426b2087],
26	genotyping	NN	O	genotyping	prep_for	23	SENT_238	[p19l479t2032r860b2104],
27	:	:	O	:	_	0	SENT_238	[p19l479t2032r860b2104],
28	frequencies	NNS	O	frequency	dep	2	SENT_238	[p19l914t2032r1292b2104],
29	of	IN	O	of	_	0	SENT_238	[p19l1345t2032r1412b2087],
30	mutant	JJ	O	mutant	amod	31	SENT_238	[p19l1460t2039r1694b2087],
31	alleles	NNS	O	allele	prep_of	28	SENT_238	[p19l1747t2032r1950b2087],
32	in	IN	O	in	_	0	SENT_238	[p19l2002t2032r2063b2086],
33	a	DT	O	a	det	35	SENT_238	[p19l2116t2049r2150b2087],
34	Swedish	JJ	MISC	swedish	amod	35	SENT_238	[p19l139t2119r405b2175],
35	population	NN	O	population	prep_in	31	SENT_238	[p19l480t2119r853b2191],
36	.	.	O	.	_	0	SENT_238	[p19l480t2119r853b2191],

1	Biochem	NNP	ORGANIZATION	Biochem	nn	4	SENT_239	[p19l932t2119r1226b2174],
2	Biophys	NNP	ORGANIZATION	Biophys	nn	4	SENT_239	[p19l1301t2119r1568b2191],
3	Res	NNP	ORGANIZATION	Res	nn	4	SENT_239	[p19l1645t2121r1767b2174],
4	Commun	NNP	ORGANIZATION	Commun	dep	10	SENT_239	[p19l1846t2119r2150b2175],
5	254	CD	NUMBER	254	num	6	SENT_239	[p19l138t2205r628b2280],
6	(	NN	O	(	dep	4	SENT_239	[p19l138t2205r628b2280],
7	3	CD	NUMBER	3	num	8	SENT_239	[p19l138t2205r628b2280],
8	)	NN	O	)	dep	10	SENT_239	[p19l138t2205r628b2280],
9	:628	CD	NUMBER	:628	num	10	SENT_239	[p19l138t2205r628b2280],
10	—	NN	O	—	_	0	SENT_239	[p19l138t2205r628b2280],
11	631	CD	NUMBER	631	dep	10	SENT_239	[p19l138t2205r628b2280],

1	J	NN	O	j	nn	3	SENT_240	[p19l52t2357r67b2382],
2	Thromb	NN	O	thromb	nn	3	SENT_240	[p19l80t2356r203b2382],
3	Thrombolysis	NN	O	thrombolysis	_	0	SENT_240	[p19l217t2356r424b2390],
4	(	CD	NUMBER	(	num	5	SENT_240	[p19l439t2355r533b2390],
5	2006	CD	DATE	2006	dep	3	SENT_240	[p19l439t2355r533b2390],
6	)	CD	NUMBER	)	number	7	SENT_240	[p19l439t2355r533b2390],
7	22:191	CD	NUMBER	22:191	num	8	SENT_240	[p19l547t2356r713b2382],
8	—	NN	O	—	dep	5	SENT_240	[p19l547t2356r713b2382],
9	197	CD	NUMBER	197	num	10	SENT_240	[p19l547t2356r713b2382],
10	197	CD	NUMBER	197	dep	3	SENT_240	[p19l2056t2357r2106b2382],

1	Crespi	NNP	ORGANIZATION	Crespi	nn	2	SENT_241	[p19l137t2521r348b2594],
2	CL	NN	ORGANIZATION	cl	nsubj	18	SENT_241	[p19l397t2522r515b2589],
3	,	,	O	,	_	0	SENT_241	[p19l397t2522r515b2589],
4	Miller	NNP	PERSON	Miller	nn	6	SENT_241	[p19l563t2521r766b2577],
5	VP	NNP	O	VP	nn	6	SENT_241	[p19l811t2523r915b2577],
6	(	NNP	O	(	dep	11	SENT_241	[p19l965t2519r1167b2595],
7	1997	CD	DATE	1997	dep	6	SENT_241	[p19l965t2519r1167b2595],
8	)	CD	NUMBER	)	dep	11	SENT_241	[p19l965t2519r1167b2595],
9	The	DT	O	the	det	11	SENT_241	[p19l1217t2521r1345b2577],
10	R144C	NN	O	r144c	nn	11	SENT_241	[p19l1393t2522r1620b2578],
11	change	NN	O	change	dep	18	SENT_241	[p19l1666t2521r1895b2594],
12	in	IN	O	in	_	0	SENT_241	[p19l1942t2521r2004b2577],
13	the	DT	O	the	det	15	SENT_241	[p19l2050t2521r2151b2577],
14	CYP2C9	NN	O	cyp2c9	nn	15	SENT_241	[p19l137t2610r502b2666],
15	*	NN	O	*	prep_in	11	SENT_241	[p19l137t2610r502b2666],
16	2	CD	NUMBER	2	num	17	SENT_241	[p19l137t2610r502b2666],
17	allele	NN	O	allele	nsubj	18	SENT_241	[p19l535t2610r709b2666],
18	alters	VBZ	O	alter	_	0	SENT_241	[p19l743t2610r921b2666],
19	interaction	NN	O	interaction	dobj	18	SENT_241	[p19l953t2610r1312b2666],
20	of	IN	O	of	_	0	SENT_241	[p19l1345t2610r1412b2666],
21	the	DT	O	the	det	23	SENT_241	[p19l1440t2610r1541b2666],
22	cytochrome	NN	O	cytochrome	nn	23	SENT_241	[p19l1575t2610r1961b2683],
23	P450	NN	O	p450	prep_of	19	SENT_241	[p19l1993t2610r2153b2666],
24	with	IN	O	with	_	0	SENT_241	[p19l134t2699r276b2755],
25	NADPH	NN	O	nadph	prep_with	23	SENT_241	[p19l303t2700r615b2755],
26	:	:	O	:	_	0	SENT_241	[p19l303t2700r615b2755],
27	cytochrome	NN	O	cytochrome	nn	29	SENT_241	[p19l646t2699r1032b2772],
28	P450	NN	O	p450	nn	29	SENT_241	[p19l1059t2699r1219b2755],
29	oxidoreductase	NN	O	oxidoreductase	dep	19	SENT_241	[p19l1247t2699r1764b2755],
30	.	.	O	.	_	0	SENT_241	[p19l1247t2699r1764b2755],

1	Pharmacogenetics	NNS	O	pharmacogenetic	_	0	SENT_242	[p19l1794t2699r2151b2755, p19l135t2788r415b2861],
2	.	.	O	.	_	0	SENT_242	[p19l1794t2699r2151b2755, p19l135t2788r415b2861],

1	7	CD	NUMBER	7	num	2	SENT_243	[p19l447t2786r867b2862],
2	(	CD	NUMBER	(	nsubj	25	SENT_243	[p19l447t2786r867b2862],
3	3	CD	NUMBER	3	num	4	SENT_243	[p19l447t2786r867b2862],
4	)	NN	O	)	dep	2	SENT_243	[p19l447t2786r867b2862],
5	:203	CD	NUMBER	:203	num	9	SENT_243	[p19l447t2786r867b2862],
6	—	CD	NUMBER	—	num	9	SENT_243	[p19l447t2786r867b2862],
7	21O	NNP	O	21O	nn	9	SENT_243	[p19l447t2786r867b2862],
8	Takanashi	NNP	PERSON	Takanashi	nn	9	SENT_243	[p19l134t2877r475b2933],
9	K	NNP	PERSON	K	dep	2	SENT_243	[p19l539t2878r613b2945],
10	,	,	O	,	_	0	SENT_243	[p19l539t2878r613b2945],
11	Tainaka	NNP	PERSON	Tainaka	nn	12	SENT_243	[p19l675t2877r945b2933],
12	H	NNP	PERSON	H	appos	9	SENT_243	[p19l1007t2879r1086b2945],
13	,	,	O	,	_	0	SENT_243	[p19l1007t2879r1086b2945],
14	Kobayashi	NNP	LOCATION	Kobayashi	nn	15	SENT_243	[p19l1149t2877r1499b2950],
15	K	NNP	LOCATION	K	appos	9	SENT_243	[p19l1562t2879r1636b2945],
16	,	,	O	,	_	0	SENT_243	[p19l1562t2879r1636b2945],
17	Yasumori	NNP	ORGANIZATION	Yasumori	nn	18	SENT_243	[p19l1698t2877r2023b2933],
18	T	NN	ORGANIZATION	t	appos	9	SENT_243	[p19l2085t2878r2151b2945],
19	,	,	O	,	_	0	SENT_243	[p19l2085t2878r2151b2945],
20	Hosakawa	NNP	ORGANIZATION	Hosakawa	nn	21	SENT_243	[p19l135t2965r479b3021],
21	M	NNP	ORGANIZATION	M	appos	9	SENT_243	[p19l513t2967r600b3033],
22	,	,	O	,	_	0	SENT_243	[p19l513t2967r600b3033],
23	Chiba	NNP	ORGANIZATION	Chiba	nn	24	SENT_243	[p19l637t2965r832b3022],
24	K	NNP	ORGANIZATION	K	appos	9	SENT_243	[p19l866t2967r922b3021],
25	(	VBD	O	(	_	0	SENT_243	[p19l958t2963r1161b3038],
26	2000	CD	DATE	2000	dobj	25	SENT_243	[p19l958t2963r1161b3038],
27	)	CD	NUMBER	)	num	29	SENT_243	[p19l958t2963r1161b3038],
28	CYPZC9	NN	O	cypzc9	nn	29	SENT_243	[p19l1200t2966r1487b3022],
29	Ile359	NN	O	ile359	dep	26	SENT_243	[p19l1523t2965r1722b3022],
30	and	CC	O	and	_	0	SENT_243	[p19l1758t2965r1876b3021],
31	Leu359	NN	O	leu359	nn	32	SENT_243	[p19l1910t2965r2152b3022],
32	variants	NNS	O	variant	dep	26	SENT_243	[p19l134t3055r411b3111],
33	:	:	O	:	_	0	SENT_243	[p19l134t3055r411b3111],
34	enzyme	NN	O	enzyme	nn	36	SENT_243	[p19l450t3073r699b3128],
35	kinetic	JJ	O	kinetic	amod	36	SENT_243	[p19l734t3055r958b3111],
36	study	NN	O	study	dep	26	SENT_243	[p19l992t3055r1167b3128],
37	with	IN	O	with	_	0	SENT_243	[p19l1199t3055r1342b3111],
38	seven	CD	NUMBER	seven	num	39	SENT_243	[p19l1376t3073r1559b3111],
39	substrates	NNS	O	substrate	prep_with	36	SENT_243	[p19l1594t3055r1936b3111],
40	.	.	O	.	_	0	SENT_243	[p19l1594t3055r1936b3111],

1	Pharmacogenetics	NNS	O	pharmacogenetic	_	0	SENT_244	[p19l1973t3055r2151b3111, p19l135t3144r594b3218],
2	.	.	O	.	_	0	SENT_244	[p19l1973t3055r2151b3111, p19l135t3144r594b3218],

1	10	CD	NUMBER	10	num	2	SENT_245	[p19l629t3142r1046b3218],
2	(	NN	O	(	dep	9	SENT_245	[p19l629t3142r1046b3218],
3	2	CD	NUMBER	2	number	4	SENT_245	[p19l629t3142r1046b3218],
4	)	CD	NUMBER	)	dep	2	SENT_245	[p19l629t3142r1046b3218],
5	:95	CD	NUMBER	:95	dep	4	SENT_245	[p19l629t3142r1046b3218],
6	—	NN	O	—	dep	9	SENT_245	[p19l629t3142r1046b3218],
7	104	CD	NUMBER	104	num	6	SENT_245	[p19l629t3142r1046b3218],
8	Aithal	NNP	O	Aithal	nn	9	SENT_245	[p19l135t3232r345b3288],
9	GP	NNP	O	GP	dep	33	SENT_245	[p19l379t3233r502b3300],
10	,	,	O	,	_	0	SENT_245	[p19l379t3233r502b3300],
11	Day	NNP	DURATION	Day	nn	12	SENT_245	[p19l536t3234r674b3305],
12	CP	NNP	O	CP	appos	9	SENT_245	[p19l708t3233r822b3300],
13	,	,	O	,	_	0	SENT_245	[p19l708t3233r822b3300],
14	Kesteven	NNP	O	Kesteven	nn	15	SENT_245	[p19l856t3234r1163b3288],
15	PJ	NNP	O	PJ	appos	9	SENT_245	[p19l1195t3234r1291b3300],
16	,	,	O	,	_	0	SENT_245	[p19l1195t3234r1291b3300],
17	Daly	NNP	ORGANIZATION	Daly	nn	18	SENT_245	[p19l1324t3232r1484b3305],
18	AK	NNP	ORGANIZATION	AK	dep	22	SENT_245	[p19l1515t3233r1636b3288],
19	(	CD	NUMBER	(	dep	18	SENT_245	[p19l1671t3230r1874b3305],
20	1999	CD	DATE	1999	dep	22	SENT_245	[p19l1671t3230r1874b3305],
21	)	NNP	O	)	nn	22	SENT_245	[p19l1671t3230r1874b3305],
22	Association	NNP	O	Association	dep	33	SENT_245	[p19l1909t3232r2151b3288, p19l137t3322r302b3379],
23	of	IN	O	of	_	0	SENT_245	[p19l342t3323r410b3378],
24	polymorphisms	NNS	O	polymorphism	prep_of	22	SENT_245	[p19l445t3322r951b3395],
25	in	IN	O	in	_	0	SENT_245	[p19l992t3322r1054b3378],
26	the	DT	O	the	det	29	SENT_245	[p19l1093t3322r1194b3378],
27	cytochrome	NN	O	cytochrome	nn	29	SENT_245	[p19l1236t3322r1622b3395],
28	P450	NN	O	p450	nn	29	SENT_245	[p19l1663t3322r1822b3379],
29	CYP2C9	NN	O	cyp2c9	prep_in	24	SENT_245	[p19l1864t3323r2152b3379],
30	with	IN	O	with	_	0	SENT_245	[p19l134t3411r276b3467],
31	warfarin	NN	O	warfarin	nn	32	SENT_245	[p19l340t3411r618b3467],
32	dose	NN	O	dose	prep_with	29	SENT_245	[p19l684t3411r832b3467],
33	requirement	NN	O	requirement	_	0	SENT_245	[p19l897t3411r1306b3484],
34	and	CC	O	and	_	0	SENT_245	[p19l1373t3411r1491b3467],
35	risk	NN	O	risk	conj_and	33	SENT_245	[p19l1556t3411r1676b3467],
36	of	IN	O	of	_	0	SENT_245	[p19l1742t3412r1809b3467],
37	bleeding	VBG	O	bleed	amod	38	SENT_245	[p19l1870t3411r2153b3484],
38	complications	NNS	O	complication	prep_of	33	SENT_245	[p19l135t3500r607b3574],
39	.	.	O	.	_	0	SENT_245	[p19l135t3500r607b3574],

1	Lancet	NNP	O	Lancet	nn	9	SENT_246	[p19l639t3502r866b3557],
2	353	CD	NUMBER	353	num	9	SENT_246	[p19l894t3498r1274b3574],
3	(	CD	NUMBER	(	num	9	SENT_246	[p19l894t3498r1274b3574],
4	9154	CD	NUMBER	9154	num	9	SENT_246	[p19l894t3498r1274b3574],
5	)	CD	NUMBER	)	num	9	SENT_246	[p19l894t3498r1274b3574],
6	:7	CD	NUMBER	:7	num	9	SENT_246	[p19l894t3498r1274b3574],
7	17-719	CD	NUMBER	17-719	num	9	SENT_246	[p19l1282t3501r1504b3557],
8	Higashi	NNP	PERSON	Higashi	nn	9	SENT_246	[p19l135t3589r387b3662],
9	MK	NNP	O	MK	dep	29	SENT_246	[p19l428t3591r575b3657],
10	,	,	O	,	_	0	SENT_246	[p19l428t3591r575b3657],
11	Veenstra	NNP	ORGANIZATION	Veenstra	nn	12	SENT_246	[p19l617t3591r916b3645],
12	DL	NNP	ORGANIZATION	DL	appos	9	SENT_246	[p19l957t3591r1086b3657],
13	,	,	O	,	_	0	SENT_246	[p19l957t3591r1086b3657],
14	Kondo	NNP	PERSON	Kondo	nn	15	SENT_246	[p19l1129t3589r1354b3645],
15	LM	NNP	O	LM	appos	9	SENT_246	[p19l1396t3591r1534b3657],
16	,	,	O	,	_	0	SENT_246	[p19l1396t3591r1534b3657],
17	Wittkowsky	NNP	ORGANIZATION	Wittkowsky	nn	18	SENT_246	[p19l1575t3589r1972b3662],
18	AK	NNP	ORGANIZATION	AK	appos	9	SENT_246	[p19l2013t3590r2151b3657],
19	,	,	O	,	_	0	SENT_246	[p19l2013t3590r2151b3657],
20	Srinouanprachanh	NNP	ORGANIZATION	Srinouanprachanh	nn	21	SENT_246	[p19l136t3678r742b3751],
21	SL	NNP	ORGANIZATION	SL	appos	9	SENT_246	[p19l774t3679r881b3746],
22	,	,	O	,	_	0	SENT_246	[p19l774t3679r881b3746],
23	Farin	NNP	PERSON	Farin	nn	24	SENT_246	[p19l912t3678r1089b3734],
24	FM	NNP	O	FM	appos	9	SENT_246	[p19l1118t3680r1254b3746],
25	,	,	O	,	_	0	SENT_246	[p19l1118t3680r1254b3746],
26	Rettie	NNP	ORGANIZATION	Rettie	nn	27	SENT_246	[p19l1287t3678r1490b3734],
27	AE	NNP	ORGANIZATION	AE	appos	9	SENT_246	[p19l1523t3679r1638b3734],
28	(	CD	NUMBER	(	dep	29	SENT_246	[p19l1673t3676r1875b3752],
29	2002	CD	DATE	2002	_	0	SENT_246	[p19l1673t3676r1875b3752],
30	)	NNP	O	)	nn	31	SENT_246	[p19l1673t3676r1875b3752],
31	Association	NNP	O	Association	dep	29	SENT_246	[p19l1909t3678r2151b3734, p20l137t14r302b71],

1	between	IN	O	between	quantmod	2	SENT_247	[p20l323t15r601b71],
2	CYPZC9	CD	NUMBER	cypzc9	num	4	SENT_247	[p20l624t15r912b71],
3	genetic	JJ	O	genetic	amod	4	SENT_247	[p20l935t14r1171b88],
4	variants	NNS	O	variant	_	0	SENT_247	[p20l1192t14r1451b71],
5	and	CC	O	and	_	0	SENT_247	[p20l1476t15r1594b71],
6	anticoagulationrelated	JJ	O	anticoagulationrelated	amod	7	SENT_247	[p20l1617t14r2151b88, p20l135t104r365b160],
7	outcomes	NNS	O	outcome	conj_and	4	SENT_247	[p20l462t111r775b160],
8	during	IN	O	during	_	0	SENT_247	[p20l874t104r1086b177],
9	warfarin	NN	O	warfarin	nn	10	SENT_247	[p20l1181t104r1459b160],
10	therapy	NN	O	therapy	prep_during	7	SENT_247	[p20l1555t104r1822b177],
11	.	.	O	.	_	0	SENT_247	[p20l1555t104r1822b177],

1	JAMA	NN	O	jama	_	0	SENT_248	[p20l1920t105r2153b160],
2	287	CD	NUMBER	287	number	3	SENT_248	[p20l135t190r745b266],
3	(	CD	NUMBER	(	dep	1	SENT_248	[p20l135t190r745b266],
4	13	CD	NUMBER	13	num	5	SENT_248	[p20l135t190r745b266],
5	)	NN	O	)	dep	3	SENT_248	[p20l135t190r745b266],
6	:1690	CD	NUMBER	:1690	num	10	SENT_248	[p20l135t190r745b266],
7	—	CD	NUMBER	—	num	10	SENT_248	[p20l135t190r745b266],
8	1698	CD	DATE	1698	num	10	SENT_248	[p20l135t190r745b266],
9	Taube	NNP	PERSON	Taube	nn	10	SENT_248	[p20l134t282r343b338],
10	J	NNP	PERSON	J	dep	1	SENT_248	[p20l367t283r399b338],
11	,	,	O	,	_	0	SENT_248	[p20l405t329r417b349],
12	Halsall	NNP	PERSON	Halsall	nn	13	SENT_248	[p20l442t282r673b338],
13	D	NNP	O	D	appos	10	SENT_248	[p20l698t283r776b349],
14	,	,	O	,	_	0	SENT_248	[p20l698t283r776b349],
15	Baglin	NNP	PERSON	Baglin	nn	16	SENT_248	[p20l802t281r1016b355],
16	T	NN	PERSON	t	appos	1	SENT_248	[p20l1039t283r1089b337],
17	(	CD	NUMBER	(	num	18	SENT_248	[p20l1116t279r1318b355],
18	2000	CD	DATE	2000	dep	16	SENT_248	[p20l1116t279r1318b355],
19	)	CD	NUMBER	)	num	20	SENT_248	[p20l1116t279r1318b355],
20	Inﬂuence	NN	O	inﬂuence	dep	1	SENT_248	[p20l1346t282r1651b338],
21	of	IN	O	of	_	0	SENT_248	[p20l1677t282r1744b338],
22	cytochrome	NN	O	cytochrome	nn	23	SENT_248	[p20l1765t282r2151b355],
23	P-450	NN	O	p-450	prep_of	20	SENT_248	[p20l135t370r319b427],
24	CYPZC9	NN	O	cypzc9	nn	25	SENT_248	[p20l360t371r647b427],
25	polymorphisms	NNS	O	polymorphism	dep	1	SENT_248	[p20l685t371r1191b444],
26	on	IN	O	on	_	0	SENT_248	[p20l1232t388r1312b427],
27	Warfarin	NNP	MISC	Warfarin	nn	28	SENT_248	[p20l1350t371r1628b427],
28	sensitivity	NN	O	sensitivity	prep_on	25	SENT_248	[p20l1667t371r1995b444],
29	and	CC	O	and	_	0	SENT_248	[p20l2035t371r2153b427],
30	risk	NN	O	risk	conj_and	28	SENT_248	[p20l135t459r254b515],
31	of	IN	O	of	_	0	SENT_248	[p20l290t460r358b515],
32	over	IN	O	over	quantmod	33	SENT_248	[p20l390t459r1074b532],
33	—	CD	NUMBER	—	num	34	SENT_248	[p20l390t459r1074b532],
34	anticoagulation	NN	O	anticoagulation	prep_of	28	SENT_248	[p20l390t459r1074b532],
35	in	IN	O	in	_	0	SENT_248	[p20l1108t459r1170b515],
36	patients	NNS	O	patient	prep_in	34	SENT_248	[p20l1203t459r1463b532],
37	on	IN	O	on	_	0	SENT_248	[p20l1500t477r1580b515],
38	long-term	JJ	O	long-term	amod	39	SENT_248	[p20l1614t459r1939b532],
39	treatment	NN	O	treatment	prep_on	36	SENT_248	[p20l1973t467r2151b515, p20l135t557r317b605],
40	.	.	O	.	_	0	SENT_248	[p20l1973t467r2151b515, p20l135t557r317b605],

1	Blood	NN	O	blood	_	0	SENT_249	[p20l349t549r550b605],
2	96	CD	NUMBER	96	number	3	SENT_249	[p20l579t546r1112b622],
3	(	CD	NUMBER	(	dep	1	SENT_249	[p20l579t546r1112b622],
4	5	CD	NUMBER	5	num	5	SENT_249	[p20l579t546r1112b622],
5	)	NN	O	)	dep	3	SENT_249	[p20l579t546r1112b622],
6	:1816	CD	NUMBER	:1816	num	10	SENT_249	[p20l579t546r1112b622],
7	—	CD	NUMBER	—	num	10	SENT_249	[p20l579t546r1112b622],
8	1819	CD	DATE	1819	num	10	SENT_249	[p20l579t546r1112b622],
9	Rieder	NNP	PERSON	Rieder	nn	10	SENT_249	[p20l136t638r362b694],
10	MJ	NNP	PERSON	MJ	dep	1	SENT_249	[p20l394t639r515b705],
11	,	,	O	,	_	0	SENT_249	[p20l394t639r515b705],
12	Reiner	NNP	ORGANIZATION	Reiner	nn	13	SENT_249	[p20l551t638r777b694],
13	AP	NNP	ORGANIZATION	AP	appos	10	SENT_249	[p20l809t639r935b706],
14	,	,	O	,	_	0	SENT_249	[p20l809t639r935b706],
15	Gage	NNP	PERSON	Gage	nn	16	SENT_249	[p20l971t638r1143b711],
16	BF	NNP	O	BF	appos	10	SENT_249	[p20l1177t639r1294b706],
17	,	,	O	,	_	0	SENT_249	[p20l1177t639r1294b706],
18	Nickerson	NNP	ORGANIZATION	Nickerson	nn	19	SENT_249	[p20l1327t638r1665b694],
19	DA	NNP	ORGANIZATION	DA	appos	10	SENT_249	[p20l1697t639r1840b706],
20	,	,	O	,	_	0	SENT_249	[p20l1697t639r1840b706],
21	Eby	NNP	PERSON	Eby	nn	22	SENT_249	[p20l1874t638r2007b711],
22	CS	NNP	O	CS	appos	10	SENT_249	[p20l2042t638r2151b706],
23	,	,	O	,	_	0	SENT_249	[p20l2042t638r2151b706],
24	McLeod	NNP	PERSON	McLeod	nn	25	SENT_249	[p20l135t727r413b783],
25	HL	NNS	O	hl	appos	10	SENT_249	[p20l463t728r592b795],
26	,	,	O	,	_	0	SENT_249	[p20l463t728r592b795],
27	Blough	NNP	ORGANIZATION	Blough	nn	28	SENT_249	[p20l644t727r883b800],
28	DK	NNP	ORGANIZATION	DK	appos	10	SENT_249	[p20l932t728r1070b794],
29	,	,	O	,	_	0	SENT_249	[p20l932t728r1070b794],
30	Thummel	NNP	PERSON	Thummel	nn	31	SENT_249	[p20l1121t727r1442b783],
31	KE	NNP	PERSON	KE	appos	10	SENT_249	[p20l1492t728r1621b795],
32	,	,	O	,	_	0	SENT_249	[p20l1492t728r1621b795],
33	Veenstra	NNP	ORGANIZATION	Veenstra	nn	34	SENT_249	[p20l1672t728r1972b783],
34	DL	NNP	ORGANIZATION	DL	appos	10	SENT_249	[p20l2022t728r2151b795],
35	,	,	O	,	_	0	SENT_249	[p20l2022t728r2151b795],
36	Rettie	NNP	ORGANIZATION	Rettie	nn	37	SENT_249	[p20l136t815r339b872],
37	AE	NNP	ORGANIZATION	AE	appos	10	SENT_249	[p20l405t816r520b871],
38	(	CD	NUMBER	(	dep	37	SENT_249	[p20l588t813r791b889],
39	2005	CD	DATE	2005	num	41	SENT_249	[p20l588t813r791b889],
40	)	NN	O	)	nn	41	SENT_249	[p20l588t813r791b889],
41	Effect	NN	O	effect	dep	1	SENT_249	[p20l858t816r1059b872],
42	of	IN	O	of	_	0	SENT_249	[p20l1124t816r1192b872],
43	VKORC1	NN	O	vkorc1	nn	44	SENT_249	[p20l1251t816r1581b872],
44	haplotypes	NNS	O	haplotype	prep_of	41	SENT_249	[p20l1650t816r2007b889],
45	on	IN	O	on	_	0	SENT_249	[p20l2072t833r2153b872],
46	transcriptional	JJ	O	transcriptional	amod	47	SENT_249	[p20l135t904r616b978],
47	regulation	NN	O	regulation	prep_on	44	SENT_249	[p20l646t904r984b978],
48	and	CC	O	and	_	0	SENT_249	[p20l1015t905r1133b961],
49	warfarin	NN	O	warfarin	nn	50	SENT_249	[p20l1163t904r1441b961],
50	dose	NN	O	dose	prep_on	44	SENT_249	[p20l1472t905r1636b961],
51	.	.	O	.	_	0	SENT_249	[p20l1472t905r1636b961],

1	N	NN	O	n	nn	3	SENT_250	[p20l1669t906r1726b960],
2	Engl	NNP	O	Engl	nn	3	SENT_250	[p20l1757t905r1910b978],
3	J	NNP	O	J	nsubj	4	SENT_250	[p20l1940t906r1972b961],
4	Med	VBD	O	med	ccomp	30	SENT_250	[p20l2002t905r2153b961],
5	352	CD	NUMBER	352	number	6	SENT_250	[p20l135t991r743b1067],
6	(	CD	NUMBER	(	dobj	4	SENT_250	[p20l135t991r743b1067],
7	22	CD	NUMBER	22	num	8	SENT_250	[p20l135t991r743b1067],
8	)	NN	O	)	dep	6	SENT_250	[p20l135t991r743b1067],
9	:2285	CD	NUMBER	:2285	number	10	SENT_250	[p20l135t991r743b1067],
10	—	CD	NUMBER	—	dep	6	SENT_250	[p20l135t991r743b1067],
11	2293	CD	DATE	2293	num	13	SENT_250	[p20l135t991r743b1067],
12	Li	NNP	PERSON	Li	nn	13	SENT_250	[p20l135t1082r204b1137],
13	T	NN	PERSON	t	dep	10	SENT_250	[p20l229t1083r295b1150],
14	,	,	O	,	_	0	SENT_250	[p20l229t1083r295b1150],
15	Chang	NNP	PERSON	Chang	nn	16	SENT_250	[p20l325t1082r536b1155],
16	CY	NNP	O	CY	appos	6	SENT_250	[p20l563t1082r690b1150],
17	,	,	O	,	_	0	SENT_250	[p20l563t1082r690b1150],
18	J	NNP	O	J	appos	16	SENT_250	[p20l716t1083r748b1138],
19	in	IN	O	in	_	0	SENT_250	[p20l751t1082r812b1137],
20	DY	NNP	O	DY	prep_in	18	SENT_250	[p20l838t1083r976b1150],
21	,	,	O	,	_	0	SENT_250	[p20l838t1083r976b1150],
22	Lin	NNP	PERSON	Lin	nn	23	SENT_250	[p20l1003t1082r1115b1137],
23	PJ	NNP	PERSON	PJ	appos	6	SENT_250	[p20l1140t1083r1236b1150],
24	,	,	O	,	_	0	SENT_250	[p20l1140t1083r1236b1150],
25	Khvorova	NNP	PERSON	Khvorova	nn	26	SENT_250	[p20l1263t1082r1591b1138],
26	A	NNP	O	A	appos	23	SENT_250	[p20l1617t1083r1695b1150],
27	,	,	O	,	_	0	SENT_250	[p20l1617t1083r1695b1150],
28	Stafford	NNP	PERSON	Stafford	nn	29	SENT_250	[p20l1723t1082r1990b1138],
29	DW	NNP	O	DW	nsubj	30	SENT_250	[p20l2015t1083r2153b1138],
30	(	VBD	O	(	_	0	SENT_250	[p20l138t1169r341b1245],
31	2004	CD	DATE	2004	num	33	SENT_250	[p20l138t1169r341b1245],
32	)	CD	NUMBER	)	num	33	SENT_250	[p20l138t1169r341b1245],
33	Identiﬁcation	NN	O	identiﬁcation	dobj	30	SENT_250	[p20l393t1171r835b1228],
34	of	IN	O	of	_	0	SENT_250	[p20l884t1172r951b1228],
35	the	DT	O	the	det	36	SENT_250	[p20l996t1172r1098b1228],
36	gene	NN	O	gene	prep_of	33	SENT_250	[p20l1147t1189r1300b1245],
37	for	IN	O	for	_	0	SENT_250	[p20l1349t1172r1444b1228],
38	vitamin	NN	O	vitamin	nn	41	SENT_250	[p20l1491t1171r1740b1228],
39	K	NN	O	k	nn	41	SENT_250	[p20l1788t1173r1845b1227],
40	epoxide	NN	O	epoxide	nn	41	SENT_250	[p20l1894t1171r2151b1245],
41	reductase	NN	O	reductase	prep_for	30	SENT_250	[p20l135t1261r466b1317],
42	.	.	O	.	_	0	SENT_250	[p20l135t1261r466b1317],

1	Nature	NNP	O	Nature	dep	10	SENT_251	[p20l497t1262r727b1317],
2	427	CD	NUMBER	427	num	1	SENT_251	[p20l757t1258r1368b1334],
3	(	CD	NUMBER	(	number	4	SENT_251	[p20l757t1258r1368b1334],
4	6974	CD	NUMBER	6974	dep	1	SENT_251	[p20l757t1258r1368b1334],
5	)	CD	NUMBER	)	num	6	SENT_251	[p20l757t1258r1368b1334],
6	:541	CD	NUMBER	:541	dep	4	SENT_251	[p20l757t1258r1368b1334],
7	—	NN	O	—	dep	10	SENT_251	[p20l757t1258r1368b1334],
8	544	CD	NUMBER	544	num	7	SENT_251	[p20l757t1258r1368b1334],
9	D’Andrea	NN	O	d’andrea	nn	10	SENT_251	[p20l138t1349r474b1405],
10	G	NN	O	g	dep	33	SENT_251	[p20l527t1350r603b1416],
11	,	,	O	,	_	0	SENT_251	[p20l527t1350r603b1416],
12	D’Ambrosio	NNP	O	D’Ambrosio	nn	13	SENT_251	[p20l656t1349r1071b1405],
13	RL	NNP	O	RL	appos	10	SENT_251	[p20l1124t1351r1249b1416],
14	,	,	O	,	_	0	SENT_251	[p20l1124t1351r1249b1416],
15	Di	NNP	PERSON	Di	nn	17	SENT_251	[p20l1301t1349r1383b1404],
16	Perna	NNP	PERSON	Perna	nn	17	SENT_251	[p20l1435t1351r1627b1405],
17	P	NN	O	p	appos	10	SENT_251	[p20l1677t1351r1739b1416],
18	,	,	O	,	_	0	SENT_251	[p20l1677t1351r1739b1416],
19	Chetta	NNP	PERSON	Chetta	nn	20	SENT_251	[p20l1793t1349r2013b1405],
20	M	NNP	PERSON	M	appos	10	SENT_251	[p20l2064t1351r2151b1416],
21	,	,	O	,	_	0	SENT_251	[p20l2064t1351r2151b1416],
22	Santacroce	NNP	PERSON	Santacroce	nn	23	SENT_251	[p20l139t1439r498b1495],
23	R	NNP	PERSON	R	appos	10	SENT_251	[p20l535t1440r608b1506],
24	,	,	O	,	_	0	SENT_251	[p20l535t1440r608b1506],
25	Brancaccio	NNP	PERSON	Brancaccio	nn	26	SENT_251	[p20l644t1438r1010b1494],
26	V	NNP	PERSON	V	appos	10	SENT_251	[p20l1044t1440r1120b1506],
27	,	,	O	,	_	0	SENT_251	[p20l1044t1440r1120b1506],
28	Grandone	NNP	O	Grandone	nn	29	SENT_251	[p20l1158t1438r1490b1495],
29	E	NNP	O	E	appos	10	SENT_251	[p20l1526t1440r1595b1506],
30	,	,	O	,	_	0	SENT_251	[p20l1526t1440r1595b1506],
31	Margaglione	NNP	O	Margaglione	nn	32	SENT_251	[p20l1631t1438r2047b1511],
32	M	NNP	O	M	appos	10	SENT_251	[p20l2083t1440r2152b1494],
33	(	VBD	O	(	_	0	SENT_251	[p20l141t1524r344b1599],
34	2005	CD	DATE	2005	num	35	SENT_251	[p20l141t1524r344b1599],
35	)	CD	NUMBER	)	dobj	33	SENT_251	[p20l141t1524r344b1599],
36	A	DT	O	a	det	37	SENT_251	[p20l377t1527r438b1582],
37	polymorphism	NN	O	polymorphism	nsubjpass	43	SENT_251	[p20l468t1526r944b1599],
38	in	IN	O	in	_	0	SENT_251	[p20l974t1526r1036b1582],
39	the	DT	O	the	det	41	SENT_251	[p20l1066t1526r1168b1582],
40	VKORC1	NN	O	vkorc1	nn	41	SENT_251	[p20l1203t1527r1517b1583],
41	gene	NN	O	gene	prep_in	37	SENT_251	[p20l1554t1544r1706b1599],
42	is	VBZ	O	be	auxpass	43	SENT_251	[p20l1738t1526r1785b1582],
43	associated	VBN	O	associate	dep	33	SENT_251	[p20l1818t1526r2153b1582],
44	with	IN	O	with	_	0	SENT_251	[p20l137t1616r279b1673],
45	an	DT	O	a	det	47	SENT_251	[p20l312t1634r389b1672],
46	interindividual	JJ	O	interindividual	amod	47	SENT_251	[p20l420t1616r904b1672],
47	variability	NN	O	variability	prep_with	43	SENT_251	[p20l936t1616r1270b1689],
48	in	IN	O	in	_	0	SENT_251	[p20l1301t1616r1362b1672],
49	the	DT	O	the	det	51	SENT_251	[p20l1394t1616r1496b1672],
50	dose-anticoagulant	JJ	O	dose-anticoagulant	amod	51	SENT_251	[p20l1529t1616r2153b1689],
51	effect	NN	O	effect	prep_in	47	SENT_251	[p20l139t1704r322b1760],
52	of	IN	O	of	_	0	SENT_251	[p20l352t1704r419b1760],
53	warfarin	NN	O	warfarin	prep_of	51	SENT_251	[p20l443t1704r736b1760],
54	.	.	O	.	_	0	SENT_251	[p20l443t1704r736b1760],

1	Blood	NN	O	blood	nn	3	SENT_252	[p20l767t1704r968b1760],
2	105	CD	NUMBER	105	num	3	SENT_252	[p20l999t1701r1491b1777],
3	(	NN	O	(	_	0	SENT_252	[p20l999t1701r1491b1777],
4	2	CD	NUMBER	2	number	5	SENT_252	[p20l999t1701r1491b1777],
5	)	CD	NUMBER	)	dep	3	SENT_252	[p20l999t1701r1491b1777],
6	:645	CD	NUMBER	:645	num	7	SENT_252	[p20l999t1701r1491b1777],
7	—	NN	O	—	dep	5	SENT_252	[p20l999t1701r1491b1777],
8	649	CD	NUMBER	649	num	13	SENT_252	[p20l999t1701r1491b1777],
9	Landefeld	NNP	ORGANIZATION	Landefeld	nn	13	SENT_252	[p20l138t1793r474b1849],
10	CS	NNP	ORGANIZATION	CS	nn	13	SENT_252	[p20l544t1794r653b1861],
11	,	,	O	,	_	0	SENT_252	[p20l544t1794r653b1861],
12	Beyth	NNP	PERSON	Beyth	appos	13	SENT_252	[p20l723t1793r919b1866],
13	RJ	NN	PERSON	rj	dep	3	SENT_252	[p20l987t1795r1077b1850],
14	(	CD	NUMBER	(	num	13	SENT_252	[p20l1148t1791r1351b1866],
15	1993	CD	DATE	1993	num	16	SENT_252	[p20l1148t1791r1351b1866],
16	)	CD	NUMBER	)	dep	13	SENT_252	[p20l1148t1791r1351b1866],
17	Anticoagulant-related	JJ	O	anticoagulant-related	amod	18	SENT_252	[p20l1421t1793r2152b1866],
18	bleeding	NN	O	bleeding	dep	3	SENT_252	[p20l138t1883r435b1956],
19	:	:	O	:	_	0	SENT_252	[p20l138t1883r435b1956],
20	clinical	JJ	O	clinical	amod	21	SENT_252	[p20l472t1883r703b1939],
21	epidemiology	NN	O	epidemiology	dep	18	SENT_252	[p20l737t1883r1200b1956],
22	,	,	O	,	_	0	SENT_252	[p20l737t1883r1200b1956],
23	prediction	NN	O	prediction	dep	18	SENT_252	[p20l1234t1883r1589b1956],
24	,	,	O	,	_	0	SENT_252	[p20l1234t1883r1589b1956],
25	and	CC	O	and	_	0	SENT_252	[p20l1625t1883r1744b1939],
26	prevention	NN	O	prevention	dep	18	SENT_252	[p20l1776t1883r2149b1956],
27	.	.	O	.	_	0	SENT_252	[p20l1776t1883r2149b1956],

1	Am	VBP	O	be	_	0	SENT_253	[p20l138t1973r263b2028],
2	J	NN	O	j	dep	3	SENT_253	[p20l290t1974r322b2029],
3	Med	VBD	O	med	dep	1	SENT_253	[p20l351t1973r501b2029],
4	95	CD	NUMBER	95	number	5	SENT_253	[p20l530t1970r985b2046],
5	(	CD	NUMBER	(	dobj	3	SENT_253	[p20l530t1970r985b2046],
6	3	CD	NUMBER	3	num	9	SENT_253	[p20l530t1970r985b2046],
7	)	NN	O	)	nn	9	SENT_253	[p20l530t1970r985b2046],
8	:315	CD	NUMBER	:315	num	9	SENT_253	[p20l530t1970r985b2046],
9	—	NN	O	—	nsubj	3	SENT_253	[p20l530t1970r985b2046],
10	328	CD	NUMBER	328	num	12	SENT_253	[p20l530t1970r985b2046],
11	Sanderson	NNP	PERSON	Sanderson	nn	12	SENT_253	[p20l139t2060r482b2117],
12	S	NN	O	s	nsubj	1	SENT_253	[p20l533t2061r589b2128],
13	,	,	O	,	_	0	SENT_253	[p20l533t2061r589b2128],
14	Emery	NNP	ORGANIZATION	Emery	nn	15	SENT_253	[p20l641t2062r863b2133],
15	J	NNP	ORGANIZATION	J	nsubj	19	SENT_253	[p20l912t2062r944b2117],
16	,	,	O	,	_	0	SENT_253	[p20l950t2107r962b2128],
17	Higgins	NNP	PERSON	Higgins	nn	18	SENT_253	[p20l1014t2060r1265b2133],
18	J	NNP	PERSON	J	appos	15	SENT_253	[p20l1316t2062r1348b2117],
19	(	VBD	O	(	ccomp	1	SENT_253	[p20l1402t2058r1605b2133],
20	2005	CD	DATE	2005	num	24	SENT_253	[p20l1402t2058r1605b2133],
21	)	CD	NUMBER	)	num	24	SENT_253	[p20l1402t2058r1605b2133],
22	CYP2C9	NN	O	cyp2c9	nn	24	SENT_253	[p20l1661t2061r1947b2117],
23	gene	NN	O	gene	nn	24	SENT_253	[p20l1999t2078r2151b2133],
24	variants	NNS	O	variant	dobj	19	SENT_253	[p20l137t2150r415b2218],
25	,	,	O	,	_	0	SENT_253	[p20l137t2150r415b2218],
26	drug	NN	O	drug	nn	27	SENT_253	[p20l460t2150r608b2223],
27	dose	NN	O	dose	dobj	19	SENT_253	[p20l652t2150r818b2218],
28	,	,	O	,	_	0	SENT_253	[p20l652t2150r818b2218],
29	and	CC	O	and	_	0	SENT_253	[p20l864t2150r982b2206],
30	bleeding	VBG	O	bleed	amod	31	SENT_253	[p20l1024t2150r1305b2223],
31	risk	NN	O	risk	dobj	19	SENT_253	[p20l1348t2150r1467b2206],
32	in	IN	O	in	_	0	SENT_253	[p20l1510t2150r1571b2206],
33	warfarin-treated	JJ	O	warfarin-treated	amod	34	SENT_253	[p20l1612t2150r2152b2207],
34	patients	NNS	O	patient	prep_in	31	SENT_253	[p20l137t2239r413b2313],
35	:	:	O	:	_	0	SENT_253	[p20l137t2239r413b2313],
36	a	DT	O	a	det	39	SENT_253	[p20l457t2257r490b2296],
37	HuGEnet	NNP	O	HuGEnet	nn	39	SENT_253	[p20l528t2240r856b2296],
38	systematic	JJ	O	systematic	amod	39	SENT_253	[p20l894t2239r1235b2313],
39	review	NN	O	review	dep	31	SENT_253	[p20l1273t2239r1491b2296],
40	and	CC	O	and	_	0	SENT_253	[p20l1531t2239r1648b2296],
41	meta	NN	O	meta	nn	43	SENT_253	[p20l1686t2239r2149b2313],
42	—	NN	O	—	nn	43	SENT_253	[p20l1686t2239r2149b2313],
43	analysis	NN	O	analysis	conj_and	39	SENT_253	[p20l1686t2239r2149b2313],
44	.	.	O	.	_	0	SENT_253	[p20l1686t2239r2149b2313],

1	Genet	NNP	O	Genet	nn	2	SENT_254	[p20l140t2329r343b2385],
2	Med	NNP	O	Med	_	0	SENT_254	[p20l371t2328r521b2385],
3	7	CD	NUMBER	7	num	4	SENT_254	[p20l549t2330r584b2385],
4	(	NN	O	(	dep	2	SENT_254	[p20l592t2326r930b2402],
5	2	CD	NUMBER	2	dep	4	SENT_254	[p20l592t2326r930b2402],
6	)	CD	NUMBER	)	number	7	SENT_254	[p20l592t2326r930b2402],
7	:97	CD	NUMBER	:97	dep	2	SENT_254	[p20l592t2326r930b2402],
8	—	NN	O	—	nn	11	SENT_254	[p20l592t2326r930b2402],
9	104	CD	NUMBER	104	num	11	SENT_254	[p20l592t2326r930b2402],
10	Hamby	NNP	ORGANIZATION	Hamby	nn	11	SENT_254	[p20l138t2417r382b2490],
11	L	NNP	ORGANIZATION	L	dep	7	SENT_254	[p20l412t2419r477b2485],
12	,	,	O	,	_	0	SENT_254	[p20l412t2419r477b2485],
13	Weeks	NNP	DURATION	Weeks	nn	14	SENT_254	[p20l509t2417r730b2473],
14	WB	NNP	O	WB	conj_and	2	SENT_254	[p20l761t2419r907b2485],
15	,	,	O	,	_	0	SENT_254	[p20l761t2419r907b2485],
16	Malikowski	NNP	PERSON	Malikowski	nn	17	SENT_254	[p20l940t2417r1323b2473],
17	C	NNP	PERSON	C	conj_and	2	SENT_254	[p20l1356t2418r1407b2474],
18	(	JJ	O	(	amod	17	SENT_254	[p20l1440t2415r1642b2491],
19	2000	CD	DATE	2000	tmod	18	SENT_254	[p20l1440t2415r1642b2491],
20	)	CD	NUMBER	)	num	21	SENT_254	[p20l1440t2415r1642b2491],
21	Complications	NNS	O	complication	dep	2	SENT_254	[p20l1678t2417r2152b2490],
22	of	IN	O	of	_	0	SENT_254	[p20l139t2507r206b2562],
23	warfarin	NN	O	warfarin	nn	24	SENT_254	[p20l255t2506r533b2562],
24	therapy	NN	O	therapy	prep_of	21	SENT_254	[p20l586t2506r852b2579],
25	:	:	O	:	_	0	SENT_254	[p20l586t2506r852b2579],
26	causes	NNS	O	cause	dep	21	SENT_254	[p20l909t2524r1135b2574],
27	,	,	O	,	_	0	SENT_254	[p20l909t2524r1135b2574],
28	costs	NNS	O	cost	conj_and	2	SENT_254	[p20l1191t2514r1366b2574],
29	,	,	O	,	_	0	SENT_254	[p20l1191t2514r1366b2574],
30	and	CC	O	and	_	0	SENT_254	[p20l1423t2506r1541b2562],
31	the	DT	O	the	det	32	SENT_254	[p20l1594t2506r1695b2562],
32	role	NN	O	role	conj_and	2	SENT_254	[p20l1750t2506r1877b2562],
33	of	IN	O	of	_	0	SENT_254	[p20l1933t2507r2000b2562],
34	the	DT	O	the	det	36	SENT_254	[p20l2050t2506r2151b2562],
35	anticoagulation	NN	O	anticoagulation	nn	36	SENT_254	[p20l140t2595r649b2669],
36	clinic	NN	O	clinic	prep_of	32	SENT_254	[p20l678t2595r865b2652],
37	.	.	O	.	_	0	SENT_254	[p20l678t2595r865b2652],

1	Eff	NN	O	eff	nn	3	SENT_255	[p20l897t2596r1003b2651],
2	Clin	NN	O	clin	nn	3	SENT_255	[p20l1031t2595r1166b2652],
3	Pract	NN	O	pract	_	0	SENT_255	[p20l1194t2597r1366b2652],
4	3	CD	NUMBER	3	num	5	SENT_255	[p20l1394t2593r1813b2669],
5	(	NN	O	(	dep	3	SENT_255	[p20l1394t2593r1813b2669],
6	4	CD	NUMBER	4	number	7	SENT_255	[p20l1394t2593r1813b2669],
7	)	CD	NUMBER	)	dep	5	SENT_255	[p20l1394t2593r1813b2669],
8	:179	CD	NUMBER	:179	num	9	SENT_255	[p20l1394t2593r1813b2669],
9	—	NN	O	—	dep	3	SENT_255	[p20l1394t2593r1813b2669],
10	184	CD	NUMBER	184	num	12	SENT_255	[p20l1394t2593r1813b2669],
11	Caro	NNP	PERSON	Caro	nn	12	SENT_255	[p20l140t2685r299b2741],
12	JJ	NN	PERSON	jj	dep	9	SENT_255	[p20l349t2686r416b2741],
13	(	CD	NUMBER	(	dep	3	SENT_255	[p20l470t2682r672b2758],
14	2004	CD	DATE	2004	num	15	SENT_255	[p20l470t2682r672b2758],
15	)	CD	NUMBER	)	dep	13	SENT_255	[p20l470t2682r672b2758],
16	An	DT	O	a	det	18	SENT_255	[p20l725t2686r828b2740],
17	economic	JJ	O	economic	amod	18	SENT_255	[p20l880t2685r1195b2741],
18	model	NN	O	model	dep	3	SENT_255	[p20l1244t2685r1449b2741],
19	of	IN	O	of	_	0	SENT_255	[p20l1502t2685r1568b2741],
20	stroke	NN	O	stroke	prep_of	18	SENT_255	[p20l1616t2685r1818b2741],
21	in	IN	O	in	_	0	SENT_255	[p20l1870t2685r1931b2740],
22	atrial	JJ	O	atrial	amod	23	SENT_255	[p20l1983t2685r2152b2741],
23	ﬁbrillation	NN	O	ﬁbrillation	prep_in	20	SENT_255	[p20l138t2773r498b2829],
24	:	:	O	:	_	0	SENT_255	[p20l138t2773r498b2829],
25	the	DT	O	the	det	26	SENT_255	[p20l524t2773r626b2829],
26	cost	NN	O	cost	dep	18	SENT_255	[p20l649t2781r777b2829],
27	of	IN	O	of	_	0	SENT_255	[p20l800t2774r867b2829],
28	suboptimal	JJ	O	suboptimal	amod	30	SENT_255	[p20l886t2773r1251b2846],
29	oral	JJ	O	oral	amod	30	SENT_255	[p20l1274t2773r1401b2829],
30	anticoagulation	NN	O	anticoagulation	prep_of	26	SENT_255	[p20l1425t2773r1950b2846],
31	.	.	O	.	_	0	SENT_255	[p20l1425t2773r1950b2846],

1	Am	VBP	O	be	dep	4	SENT_256	[p20l1975t2774r2100b2829],
2	J	NN	O	j	nn	4	SENT_256	[p20l2120t2775r2152b2830],
3	Manag	NNP	O	Manag	nn	4	SENT_256	[p20l138t2864r364b2936],
4	Care	NNP	O	Care	dep	32	SENT_256	[p20l395t2863r549b2919],
5	10	CD	NUMBER	10	number	6	SENT_256	[p20l582t2860r758b2936],
6	(	CD	NUMBER	(	dep	4	SENT_256	[p20l582t2860r758b2936],
7	14	CD	NUMBER	14	num	9	SENT_256	[p20l582t2860r758b2936],
8	Suppl	NN	O	suppl	nn	9	SENT_256	[p20l788t2860r1331b2936],
9	)	NN	O	)	dep	6	SENT_256	[p20l788t2860r1331b2936],
10	:	:	O	:	_	0	SENT_256	[p20l788t2860r1331b2936],
11	S451	NN	O	s451	dep	16	SENT_256	[p20l788t2860r1331b2936],
12	—	NN	O	—	dep	11	SENT_256	[p20l788t2860r1331b2936],
13	458	CD	NUMBER	458	dep	16	SENT_256	[p20l788t2860r1331b2936],
14	Hull	NNP	PERSON	Hull	nn	16	SENT_256	[p20l138t2952r283b3008],
15	J	NNP	PERSON	J	nn	16	SENT_256	[p20l304t2953r336b3008],
16	H	NNP	PERSON	H	dep	32	SENT_256	[p20l339t2953r418b3020],
17	,	,	O	,	_	0	SENT_256	[p20l339t2953r418b3020],
18	Murray	NNP	PERSON	Murray	nn	19	SENT_256	[p20l440t2953r688b3025],
19	WJ	NNP	O	WJ	appos	16	SENT_256	[p20l708t2953r834b3020],
20	,	,	O	,	_	0	SENT_256	[p20l708t2953r834b3020],
21	Brown	NNP	PERSON	Brown	nn	22	SENT_256	[p20l856t2953r1078b3008],
22	HS	NN	O	h	appos	16	SENT_256	[p20l1098t2952r1219b3019],
23	,	,	O	,	_	0	SENT_256	[p20l1098t2952r1219b3019],
24	Williams	NNP	ORGANIZATION	Williams	nn	25	SENT_256	[p20l1241t2952r1532b3008],
25	BO	NNP	ORGANIZATION	BO	appos	16	SENT_256	[p20l1554t2952r1687b3019],
26	,	,	O	,	_	0	SENT_256	[p20l1554t2952r1687b3019],
27	Chi	NNP	O	Chi	nn	28	SENT_256	[p20l1712t2952r1825b3008],
28	SL	NNP	O	SL	appos	16	SENT_256	[p20l1848t2952r1954b3019],
29	,	,	O	,	_	0	SENT_256	[p20l1848t2952r1954b3019],
30	Koch	NNP	PERSON	Koch	appos	16	SENT_256	[p20l1977t2952r2153b3008],
31	GG	NNS	PERSON	gg	nsubj	32	SENT_256	[p20l140t3041r262b3097],
32	(	VBP	O	(	_	0	SENT_256	[p20l322t3038r524b3114],
33	1978	CD	DATE	1978	number	34	SENT_256	[p20l322t3038r524b3114],
34	)	CD	NUMBER	)	num	38	SENT_256	[p20l322t3038r524b3114],
35	Potential	JJ	O	potential	amod	38	SENT_256	[p20l584t3040r883b3096],
36	anticoagulant	JJ	O	anticoagulant	amod	38	SENT_256	[p20l941t3040r1386b3113],
37	drug	NN	O	drug	nn	38	SENT_256	[p20l1444t3040r1592b3113],
38	interactions	NNS	O	interaction	dobj	32	SENT_256	[p20l1648t3040r2034b3096],
39	in	IN	O	in	_	0	SENT_256	[p20l2091t3040r2153b3096],
40	ambulatory	JJ	O	ambulatory	amod	41	SENT_256	[p20l140t3130r517b3203],
41	patients	NNS	O	patient	prep_in	38	SENT_256	[p20l544t3129r820b3203],
42	.	.	O	.	_	0	SENT_256	[p20l544t3129r820b3203],

1	Clin	NNP	O	Clin	nn	3	SENT_257	[p20l854t3129r990b3186],
2	Pharmacol	NNP	O	Pharmacol	nn	3	SENT_257	[p20l1018t3130r1371b3186],
3	Ther	NNP	O	Ther	_	0	SENT_257	[p20l1400t3130r1559b3186],
4	24	CD	NUMBER	24	number	5	SENT_257	[p20l1586t3127r2043b3203],
5	(	CD	NUMBER	(	dep	3	SENT_257	[p20l1586t3127r2043b3203],
6	6	CD	NUMBER	6	num	7	SENT_257	[p20l1586t3127r2043b3203],
7	)	NN	O	)	dep	5	SENT_257	[p20l1586t3127r2043b3203],
8	:644	CD	NUMBER	:644	num	9	SENT_257	[p20l1586t3127r2043b3203],
9	—	NN	O	—	dep	3	SENT_257	[p20l1586t3127r2043b3203],
10	649	CD	NUMBER	649	num	12	SENT_257	[p20l1586t3127r2043b3203],
11	Wadelius	NNP	O	Wadelius	nn	12	SENT_257	[p20l137t3219r444b3274],
12	M	NN	O	m	dep	9	SENT_257	[p20l476t3220r563b3286],
13	,	,	O	,	_	0	SENT_257	[p20l476t3220r563b3286],
14	Sorlin	NNP	LOCATION	Sorlin	nn	15	SENT_257	[p20l597t3219r793b3275],
15	K	NNP	LOCATION	K	appos	3	SENT_257	[p20l825t3220r899b3286],
16	,	,	O	,	_	0	SENT_257	[p20l825t3220r899b3286],
17	Wallerman	NNP	PERSON	Wallerman	nn	18	SENT_257	[p20l931t3219r1299b3274],
18	O	NNP	PERSON	O	appos	15	SENT_257	[p20l1332t3219r1408b3286],
19	,	,	O	,	_	0	SENT_257	[p20l1332t3219r1408b3286],
20	Karlsson	NNP	PERSON	Karlsson	nn	21	SENT_257	[p20l1441t3219r1731b3274],
21	J	NNP	PERSON	J	appos	15	SENT_257	[p20l1761t3220r1793b3275],
22	,	,	O	,	_	0	SENT_257	[p20l1800t3265r1811b3286],
23	Yue	NNP	O	Yue	nn	24	SENT_257	[p20l1844t3220r1981b3274],
24	QY	NNP	O	QY	appos	15	SENT_257	[p20l2015t3219r2151b3286],
25	,	,	O	,	_	0	SENT_257	[p20l2015t3219r2151b3286],
26	Magnusson	NNP	ORGANIZATION	Magnusson	nn	27	SENT_257	[p20l138t3308r512b3379],
27	PK	NNP	ORGANIZATION	PK	appos	15	SENT_257	[p20l558t3308r680b3374],
28	,	,	O	,	_	0	SENT_257	[p20l558t3308r680b3374],
29	Wadelius	NNP	O	Wadelius	nn	30	SENT_257	[p20l727t3306r1034b3362],
30	C	NNP	O	C	appos	15	SENT_257	[p20l1085t3306r1152b3374],
31	,	,	O	,	_	0	SENT_257	[p20l1085t3306r1152b3374],
32	Melhus	NNP	O	Melhus	nn	33	SENT_257	[p20l1201t3306r1443b3362],
33	H	NNP	O	H	appos	15	SENT_257	[p20l1491t3308r1552b3361],
34	(	CD	NUMBER	(	num	37	SENT_257	[p20l1602t3304r1804b3379],
35	2004	CD	DATE	2004	num	37	SENT_257	[p20l1602t3304r1804b3379],
36	)	NNP	O	)	nn	37	SENT_257	[p20l1602t3304r1804b3379],
37	Warfarin	NNP	O	Warfarin	dep	33	SENT_257	[p20l1854t3306r2153b3362],
38	sensitivity	NN	O	sensitivity	dep	3	SENT_257	[p20l139t3396r467b3470],
39	related	JJ	O	related	amod	38	SENT_257	[p20l510t3397r740b3453],
40	to	TO	O	to	_	0	SENT_257	[p20l784t3405r848b3453],
41	CYP2C9	NN	O	cyp2c9	prep_to	39	SENT_257	[p20l897t3397r1194b3464],
42	,	,	O	,	_	0	SENT_257	[p20l897t3397r1194b3464],
43	CYP3A5	NN	O	cyp3a5	prep_to	39	SENT_257	[p20l1249t3397r1551b3465],
44	,	,	O	,	_	0	SENT_257	[p20l1249t3397r1551b3465],
45	ABCB1	NN	O	abcb1	nn	48	SENT_257	[p20l1598t3397r1856b3453],
46	(	CD	NUMBER	(	num	48	SENT_257	[p20l1909t3394r2150b3470],
47	MDR	NN	ORGANIZATION	mdr	nn	48	SENT_257	[p20l1909t3394r2150b3470],
48	)	NN	O	)	prep_to	39	SENT_257	[p20l1909t3394r2150b3470],
49	and	CC	O	and	_	0	SENT_257	[p20l140t3486r258b3542],
50	other	JJ	O	other	amod	51	SENT_257	[p20l287t3486r461b3542],
51	factors	NNS	O	factor	prep_to	39	SENT_257	[p20l489t3486r726b3542],
52	.	.	O	.	_	0	SENT_257	[p20l489t3486r726b3542],

1	Pharmacogenomics	NNS	O	pharmacogenomic	nn	2	SENT_258	[p20l758t3486r1399b3559],
2	J	NN	O	j	_	0	SENT_258	[p20l1428t3487r1460b3542],
3	4	CD	NUMBER	4	num	4	SENT_258	[p20l1488t3483r1830b3559],
4	(	NN	O	(	dep	2	SENT_258	[p20l1488t3483r1830b3559],
5	1	CD	NUMBER	1	number	6	SENT_258	[p20l1488t3483r1830b3559],
6	)	CD	NUMBER	)	dep	4	SENT_258	[p20l1488t3483r1830b3559],
7	:40	CD	NUMBER	:40	num	8	SENT_258	[p20l1488t3483r1830b3559],
8	—	NN	O	—	dep	6	SENT_258	[p20l1488t3483r1830b3559],
9	48	CD	NUMBER	48	dep	2	SENT_258	[p20l1488t3483r1830b3559],

1	@	IN	O	@	_	0	SENT_259	[p20l1806t3722r1879b3811],
2	Springer	NNP	PERSON	Springer	pobj	1	SENT_259	[p20l1906t3744r2152b3814],

